salicylic acid has been researched along with Alopecia in 1660 studies
Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).
Alopecia: Absence of hair from areas where it is normally present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 20 min PICT is as effective as 45 and 90 min to prevent weekly paclitaxel-induced alopecia and should be the new standard of care." | 9.51 | Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial. ( Deursen, MAGDH; Gelderblom, H; Houtsma, D; Kaptein, AA; Kroep, JR; Lugtenberg, RT; Mosch, L; Smorenburg, CH; van den Hurk, CJG, 2022) |
| "Topical minoxidil 5% are effective in androgenetic alopecia (AGA)." | 9.41 | A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study. ( Abdel-Aziz, RTA; Abdel-Raouf, H; Ahmed, SS; Aly, UF; Medhat, W, 2021) |
| " Combining fractional Er:Glass laser therapy with topical minoxidil may yield therapeutic benefits for patients with androgenetic alopecia (AGA)." | 9.30 | A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. ( Khunkhet, S; Rojhirunsakool, S; Suchonwanit, P, 2019) |
| "25% finasteride (P-3074), a type 2 5α-reductase, were investigated in men with androgenetic alopecia." | 9.22 | Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. ( Caserini, M; Iorizzo, M; Leuratti, C; Palmieri, R; Radicioni, M; Terragni, E, 2016) |
| "Data suggest that androgenetic alopecia is a process dependent on dihydrotestosterone (DHT) and type 2 5alpha-reductase." | 9.09 | The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. ( Carrington, P; Cole, GW; Cotterill, PC; Dallob, A; Drake, L; Epstein, ES; Fiedler, V; Geissler, L; Gencheff, C; Griffin, EI; Hordinsky, M; Jacobson, C; Kraus, SJ; Lowe, N; Pariser, DM; Stieglitz, S; Swinehart, J; Tanaka, W; Thiboutot, DM; Unger, WP; Vandormael, K; Waldstreicher, J; Weiss, D; Whiting, D, 1999) |
| "Finasteride, an inhibitor of type 2 5alpha-reductase, decreases serum and scalp dihydrotestosterone (DHT) by inhibiting conversion of testosterone to DHT and has been shown to be effective in men with androgenetic alopecia (AGA)." | 9.09 | Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. ( Bergfeld, W; Culbertson, J; Fiedler, V; Hordinsky, M; Kotey, P; Lucky, A; Meehan, A; Olsen, EA; Pappas, F; Price, VH; Roberts, JL; Savin, R; Waldstreicher, J; Whiting, DA, 2000) |
| "The safety and efficacy of minoxidil 2% for the treatment of female androgenetic alopecia was assessed in a 32-week double-blind placebo-controlled trial." | 9.07 | Treatment of female androgenetic alopecia with minoxidil 2%. ( Jacobson, C; Whiting, DA, 1992) |
| "We report the case of a 70-year-old woman affected by breast cancer in treatment with Palbociclib, who developed alopecia." | 8.02 | A new treatment of alopecia induced by palbociclib: Topical cetirizine. ( Carlesimo, M; Caro, G; Federico, A; Fortuna, MC; Magri, F; Rossi, A, 2021) |
| "We analyzed 68 female Japanese patients with breast cancer (median age 53 years, range 29-76 years) who received perioperative adjuvant chemotherapy with fluorouracil/epirubicin/cyclophosphamide (FEC) and taxane." | 8.02 | Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients. ( Fujii, T; Honda, C; Ichiba, K; Kurozumi, S; Nakazawa, Y; Obayashi, S; Ogino, M; Shirabe, K; Tokuda, S; Yajima, R, 2021) |
| "Dutasteride has been proposed as an effective therapy for frontal fibrosing alopecia (FFA)." | 8.02 | Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice. ( Hermosa-Gelbard, Á; Jaén-Olasolo, P; Moreno-Arrones, ÓM; Pindado-Ortega, C; Rodrigues-Barata, AR; Saceda-Corralo, D; Vañó-Galván, S, 2021) |
| " Since scalp inflammation was recognized as a potential physiological obstacle to the efficacy of the reference hair regrowth drug Minoxidil in vivo and since perifollicular inflammation is the hallmark of about 50%-70% follicular units in androgenetic alopecia, we decided to investigate whether the anti-inflammatory activity of LLLT/GentleWaves® device were assigned to L'Oréal by Light BioScience L." | 8.02 | Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth Activity. ( Antonelli, R; Barbarat, P; Buffat, L; Cheniti, A; de Bernard, S; Kanoun-Copy, L; Mahe, YF; Planard-Luong, L; Tacheau, C, 2021) |
| "The combination of nonablative laser and topical minoxidil may be a good alternative therapy for AA patients, including alopecia totalis and alopecia universalis, without systemic and local side effects." | 7.91 | Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil. ( Li, Y; Wang, W, 2019) |
| " Based on these findings, a diagnosis of dissecting cellulitis of the scalp was made and the patient was successfully treated with oral isotretinoin therapy." | 7.85 | Dissecting Cellulitis of the Scalp with Excellent Response to Isotretinoin. ( Christensen, LC; Marquis, K; Rajpara, A, 2017) |
| "Patterns of fibrosis highlighted by elastin staining in primary cicatricial alopecia appear to be disease specific." | 7.79 | Elastin staining patterns in primary cicatricial alopecia. ( Barr, KL; Fung, MA; Konia, TH; Mirmirani, P; Ratnarathorn, M; Sharon, VR, 2013) |
| "We report the case of a 64-year-old man with androgenetic alopecia who was started on methotrexate therapy for treatment of psoriasis after traditional modalities failed." | 7.79 | Partial reversal of androgenetic alopecia with methotrexate therapy for psoriasis. ( Famenini, S; Wu, JJ, 2013) |
| "Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 7.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
| "The aim of the present study was to evaluate the efficacy and safety of topical treatment of androgenetic alopecia (AGA) with estradiolbenzoate, prednisolon and salicylic acid solution (EPS) in females." | 7.70 | Treatment of androgenetic alopecia in females in reproductive age with topical estradiolbenzoate, prednisolon and salicylic acid. ( Abadjieva, TI, 2000) |
| "We report the case of a 82-year-old man who, after multiple treatments with aminolevulinic acid photodynamic therapy for solar keratoses and superficial squamous cell carcinomas, developed malignant melanoma at the exposed site on the scalp." | 7.69 | Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. ( Fink-Puches, R; Kerl, H; Reimann-Weber, A; Wolf, P, 1997) |
| "Androgenetic alopecia (AGA) is a hair loss disorder that frequently affects the male population." | 7.01 | Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double-Blind Half-Head Controlled Trial. ( Contin, LA; de Brito, FF; Donati, A; Ferrara, F; Kakizaki, P; Machado, CJ, 2021) |
| "A 20 min PICT is as effective as 45 and 90 min to prevent weekly paclitaxel-induced alopecia and should be the new standard of care." | 5.51 | Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial. ( Deursen, MAGDH; Gelderblom, H; Houtsma, D; Kaptein, AA; Kroep, JR; Lugtenberg, RT; Mosch, L; Smorenburg, CH; van den Hurk, CJG, 2022) |
| "Lupus alopecia is usually difficult to treat." | 5.48 | Dramatic effect of hydroxychloroquine on lupus alopecia. ( Igari, S; Yamamoto, T, 2018) |
| "While consensus is that androgenic alopecia is genetic and androgen-mediated by dihydrotestosterone, questions remain regarding dihydrotestosterone's exact role in androgenic alopecia onset." | 5.48 | A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. ( English, RS, 2018) |
| "Chemotherapy for breast cancer induces alopecia, representing a major source of patient distress." | 5.48 | Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy. ( Schoenegg, W; Vasconcelos, I; Wiesske, A, 2018) |
| "Minoxidil has been approved for the treatment of hair loss, however its mechanism of action is still not fully clarified." | 5.46 | An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia. ( Aliper, A; Consolo, M; Cooper, KD; McCormick, TS; Mirmirani, P; Ozerov, IV; Pappas, A; Schastnaya, J; Stamatas, GN; Wu, J; Zhavoronkov, A, 2017) |
| "A total of 11 human studies were identified with evidence of melatonin use in subjects with diagnosed alopecia (2,267 patients; 1,140M)." | 5.41 | Melatonin and the Human Hair Follicle. ( Babadjouni, A; Mesinkovska, N; Phong, C; Raffi, J; Reddy, M; Zhang, R, 2023) |
| "Topical minoxidil 5% are effective in androgenetic alopecia (AGA)." | 5.41 | A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study. ( Abdel-Aziz, RTA; Abdel-Raouf, H; Ahmed, SS; Aly, UF; Medhat, W, 2021) |
| "Female-pattern androgenetic alopecia is a very common disorder that has been associated with extreme psychological morbidity." | 5.37 | Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution. ( Emer, JJ; Markowitz, O; Stevenson, ML, 2011) |
| "Randomized controlled trials (RCT) of scalp cooling (SC) to prevent chemotherapy induced alopecia (CIA) did not evaluate its effect on hair regrowth (HR) and was conducted in a predominantly taxane (T) treated population." | 5.34 | "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia". ( Bajpai, J; Banavali, SD; Chandrasekharan, A; Dandekar, S; Ghosh, J; Gupta, S; Kagwade, S; Kanan, S; Kembhavi, Y, 2020) |
| "preclinical stages of androgenetic alopecia (AGA) in androgen sensitive areas was documented." | 5.33 | Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride. ( Van Neste, D, 2006) |
| " Combining fractional Er:Glass laser therapy with topical minoxidil may yield therapeutic benefits for patients with androgenetic alopecia (AGA)." | 5.30 | A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. ( Khunkhet, S; Rojhirunsakool, S; Suchonwanit, P, 2019) |
| " Cyclosporine A did not produce any side effects because the administered dosage was relatively low." | 5.28 | Alopecia universalis treated with oral cyclosporine A and prednisolone: immunologic studies. ( Hori, Y; Irie, M; Nakagawa, T; Nakayama, J; Teshima, H; Urabe, A, 1992) |
| "Among women with stage I to II breast cancer receiving chemotherapy with a taxane, anthracycline, or both, those who underwent scalp cooling were significantly more likely to have less than 50% hair loss after the fourth chemotherapy cycle compared with those who received no scalp cooling." | 5.24 | Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. ( Abraham, J; Courtright, J; Hilsenbeck, S; Holmes, F; Lacouture, M; Nangia, J; Niravath, P; Osborne, C; Osborne, CK; Otte, K; Papish, S; Paxman, R; Rimawi, M; Rude, M; Wang, T, 2017) |
| "25% finasteride (P-3074), a type 2 5α-reductase, were investigated in men with androgenetic alopecia." | 5.22 | Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. ( Caserini, M; Iorizzo, M; Leuratti, C; Palmieri, R; Radicioni, M; Terragni, E, 2016) |
| "The applicability and efficacy of a scalp cooling system were studied in 105 breast cancer patients receiving four cycles of adjuvant chemotherapy with mitoxantrone + cyclophosphamide (NC chemotherapy)." | 5.10 | Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. ( Camerlo, J; d'Ingrado, MP; Evans, K; Genre, D; Macquart-Moulin, G; Maraninchi, D; Protière, C; Viens, P, 2002) |
| "The MSC cold cap system is effective in preventing alopecia from anthracycline, etoposide or taxane but not from anthracycline-taxane combinations or ifosfamide-containing regimens." | 5.10 | Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia. ( Christodoulou, C; Efstathiou, E; Klouvas, G; Papazachariou, E; Plyta, M; Skarlos, DV; Zervakis, D, 2002) |
| "Data suggest that androgenetic alopecia is a process dependent on dihydrotestosterone (DHT) and type 2 5alpha-reductase." | 5.09 | The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. ( Carrington, P; Cole, GW; Cotterill, PC; Dallob, A; Drake, L; Epstein, ES; Fiedler, V; Geissler, L; Gencheff, C; Griffin, EI; Hordinsky, M; Jacobson, C; Kraus, SJ; Lowe, N; Pariser, DM; Stieglitz, S; Swinehart, J; Tanaka, W; Thiboutot, DM; Unger, WP; Vandormael, K; Waldstreicher, J; Weiss, D; Whiting, D, 1999) |
| "Finasteride, an inhibitor of type 2 5alpha-reductase, decreases serum and scalp dihydrotestosterone (DHT) by inhibiting conversion of testosterone to DHT and has been shown to be effective in men with androgenetic alopecia (AGA)." | 5.09 | Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. ( Bergfeld, W; Culbertson, J; Fiedler, V; Hordinsky, M; Kotey, P; Lucky, A; Meehan, A; Olsen, EA; Pappas, F; Price, VH; Roberts, JL; Savin, R; Waldstreicher, J; Whiting, DA, 2000) |
| "The safety and efficacy of minoxidil 2% for the treatment of female androgenetic alopecia was assessed in a 32-week double-blind placebo-controlled trial." | 5.07 | Treatment of female androgenetic alopecia with minoxidil 2%. ( Jacobson, C; Whiting, DA, 1992) |
| "We report the case of a 70-year-old woman affected by breast cancer in treatment with Palbociclib, who developed alopecia." | 4.02 | A new treatment of alopecia induced by palbociclib: Topical cetirizine. ( Carlesimo, M; Caro, G; Federico, A; Fortuna, MC; Magri, F; Rossi, A, 2021) |
| "We analyzed 68 female Japanese patients with breast cancer (median age 53 years, range 29-76 years) who received perioperative adjuvant chemotherapy with fluorouracil/epirubicin/cyclophosphamide (FEC) and taxane." | 4.02 | Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients. ( Fujii, T; Honda, C; Ichiba, K; Kurozumi, S; Nakazawa, Y; Obayashi, S; Ogino, M; Shirabe, K; Tokuda, S; Yajima, R, 2021) |
| "Dutasteride has been proposed as an effective therapy for frontal fibrosing alopecia (FFA)." | 4.02 | Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice. ( Hermosa-Gelbard, Á; Jaén-Olasolo, P; Moreno-Arrones, ÓM; Pindado-Ortega, C; Rodrigues-Barata, AR; Saceda-Corralo, D; Vañó-Galván, S, 2021) |
| " Since scalp inflammation was recognized as a potential physiological obstacle to the efficacy of the reference hair regrowth drug Minoxidil in vivo and since perifollicular inflammation is the hallmark of about 50%-70% follicular units in androgenetic alopecia, we decided to investigate whether the anti-inflammatory activity of LLLT/GentleWaves® device were assigned to L'Oréal by Light BioScience L." | 4.02 | Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth Activity. ( Antonelli, R; Barbarat, P; Buffat, L; Cheniti, A; de Bernard, S; Kanoun-Copy, L; Mahe, YF; Planard-Luong, L; Tacheau, C, 2021) |
| "The combination of nonablative laser and topical minoxidil may be a good alternative therapy for AA patients, including alopecia totalis and alopecia universalis, without systemic and local side effects." | 3.91 | Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil. ( Li, Y; Wang, W, 2019) |
| " Based on these findings, a diagnosis of dissecting cellulitis of the scalp was made and the patient was successfully treated with oral isotretinoin therapy." | 3.85 | Dissecting Cellulitis of the Scalp with Excellent Response to Isotretinoin. ( Christensen, LC; Marquis, K; Rajpara, A, 2017) |
| "A prospective cohort study conducted at 5 US medical centers of women with stage I or II breast cancer receiving adjuvant or neoadjuvant chemotherapy regimens excluding sequential or combination anthracycline and taxane (106 patients in the scalp cooling group and 16 in the control group; 14 matched by both age and chemotherapy regimen)." | 3.85 | Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. ( Bågeman, E; Cigler, T; D'Agostino, RB; Esserman, L; Hurvitz, SA; Klein, P; Melin, SA; Melisko, ME; Mitchel, J; Moore, A; Park, G; Rugo, HS; Ver Hoeve, ES, 2017) |
| "Patterns of fibrosis highlighted by elastin staining in primary cicatricial alopecia appear to be disease specific." | 3.79 | Elastin staining patterns in primary cicatricial alopecia. ( Barr, KL; Fung, MA; Konia, TH; Mirmirani, P; Ratnarathorn, M; Sharon, VR, 2013) |
| "We report the case of a 64-year-old man with androgenetic alopecia who was started on methotrexate therapy for treatment of psoriasis after traditional modalities failed." | 3.79 | Partial reversal of androgenetic alopecia with methotrexate therapy for psoriasis. ( Famenini, S; Wu, JJ, 2013) |
| "With current adjuvant chemotherapy for breast cancer, in which a combination of cyclophosphamide and an anthracycline is often used, there is no place for scalp hypothermia." | 3.77 | Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer. ( Liefers, GJ; Repelaer van Driel, OJ; Tollenaar, RA; van de Velde, CJ, 1994) |
| "Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 3.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
| "The aim of the present study was to evaluate the efficacy and safety of topical treatment of androgenetic alopecia (AGA) with estradiolbenzoate, prednisolon and salicylic acid solution (EPS) in females." | 3.70 | Treatment of androgenetic alopecia in females in reproductive age with topical estradiolbenzoate, prednisolon and salicylic acid. ( Abadjieva, TI, 2000) |
| "We report the case of a 82-year-old man who, after multiple treatments with aminolevulinic acid photodynamic therapy for solar keratoses and superficial squamous cell carcinomas, developed malignant melanoma at the exposed site on the scalp." | 3.69 | Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. ( Fink-Puches, R; Kerl, H; Reimann-Weber, A; Wolf, P, 1997) |
| "Plant-derived secondary metabolites (polyphenols/terpenes/alkaloids) and microbial exometabolites/membrane components of fermented tropical fruits are known as highly bioavailable biomolecules causing skin and hair improvement effects (wound healing, anti-inflammatory, antioxidant, antidiabetic, antiacne, skin/hair microbiota balancing, hair growth-promoting, and hair loss-inhibiting)." | 3.30 | Biomolecules of Fermented Tropical Fruits and Fermenting Microbes as Regulators of Human Hair Loss, Hair Quality, and Scalp Microbiota. ( Chandler, DL; De Luca, C; Ibragimova, G; Kharaeva, Z; Korkina, L; Mayer, W; Trakhtman, I; Weibel, M, 2023) |
| "Forty women with early breast cancer were randomly assigned to EHW (n = 20) or observation (n = 20) during neo(adjuvant) chemotherapy." | 3.30 | Electric hand warmer versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia prevention: a randomized study. ( Almeida, P; Bomfim, VHV; Costa E Silva, M; da Silva, CF; de Castro, ALR; de Cerqueira Mathias, CM; de Oliveira Dantas Viana, P; Dienstmann, R; Dos Santos, APT; Freitas Muniz Teixeira, A; Jamile Santiago Costa, M; Landeiro, LCG; Lopes Paim Miranda, D; Mathias Machado, R; Teixeira Machado, B; Viviane Carvalho Rodrigues Gonçalves, M, 2023) |
| "Alopecia is one of the most common adverse effects of chemotherapy." | 3.30 | The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial. ( Chang, ZY; Cheng, HY; Lee, CH; Li, CH; Shiao, YH; Wu, CX; Wu, TH; Yeh, YC, 2023) |
| " No apparent adverse events were observed throughout treatment duration." | 3.11 | Safety and efficacy of Trimax-360 serum in healthy adult subjects with mild to moderate alopecia of scalp. ( Chew, SK; Gajjar, T; Sethi, S, 2022) |
| "Catiana Martinez Cánovas of the Spanish Breast Cancer Federation [FECMA]) participated in the review of the study protocol, as well as in the results, discussion and conclusions, making their contributions." | 3.01 | Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy-induced alopecia: A systematic review. ( Del Mar Trujillo-Martín, M; Delgado Rodríguez, J; Infante-Ventura, D; Ramos-García, V; Rueda-Domínguez, A; Serrano-Aguilar, P; Suarez-Herrera, JC, 2023) |
| "When untreated, scarring alopecia develops." | 3.01 | EROSIVE PUSTULAR DERMATOSIS OF THE SCALP (EPDS) - A CASE SERIES AND SHORT REVIEW. ( Wollina, U, 2023) |
| "The diagnosis of tinea capitis is usually made by clinical signs and direct microscopic examination." | 3.01 | Histopathology in the Diagnosis of Tinea Capitis: When to Do, How to Interpret? ( Durdu, M; Elmas, ÖF, 2023) |
| "Alopecia is one of the most common adverse effects of chemotherapy, having a significant impact on the quality of life of patients who suffer from it." | 3.01 | [Scalp cooling for the prevention of chemotherapy-induced alopecia: systematic review and meta-analysis.] ( Abt-Sack, A; de Armas-Castellano, A; Del Pino-Sedeño, T; González-Hernández, Y; González-Pacheco, H; Infante-Ventura, D; Ramallo-Fariña, Y; Rueda Domínguez, A; Serrano-Aguilar, P; Trujillo-Martín, MM, 2023) |
| "Specifically, androgenetic alopecia (AGA), commonly known as male or female pattern baldness, is the most common form of hair loss." | 3.01 | Commonly used hair oils in the Black community: a narrative review in their use to treat androgenetic alopecia. ( Adotama, P; Akintilo, L; Dinkins, J; Iwuala, C; Shapiro, J; Sicco, KL; Ugonabo, N, 2023) |
| "Alopecia areata is an autoimmune hair loss disease that is non-scarring and is characterized by chronic inflammation at the hair follicle level." | 3.01 | Alopecia Areata: Current Treatments and New Directions. ( Bar, J; Dahabreh, D; Del Duca, E; Guttman-Yassky, E; Jung, S; Renert-Yuval, Y, 2023) |
| "Androgenetic alopecia (AGA) is a hair loss disorder that frequently affects the male population." | 3.01 | Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double-Blind Half-Head Controlled Trial. ( Contin, LA; de Brito, FF; Donati, A; Ferrara, F; Kakizaki, P; Machado, CJ, 2021) |
| "Pattern hair loss is a very common skin disorder, but more therapeutic modalities for hair growth are still required." | 2.94 | Effect of a sphingolipid-mimetic compound on the promotion of hair growth: A randomized, double-blind, placebo-controlled clinical trial. ( Jang, YH; Kim, JY; Lee, SJ; Lee, WJ; Park, KD; Sohng, C, 2020) |
| "Drug trials for male-pattern hair loss (MPHL) did not investigate hair cycling." | 2.94 | Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol. ( Van Neste, D, 2020) |
| "Hair preservation was defined as hair loss ≤ grade 2 (≤ 50%)." | 2.90 | COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. ( Feißt, M; Hassel, JC; Heil, J; Hennigs, A; Jaeger, D; Junio, P; Marmé, F; Matthies, LM; Mayer, L; Schneeweiss, A; Schumann, A; Seitz, J; Smetanay, K; Sohn, C, 2019) |
| "Some studies reported a reduction of hair loss with the use of the scalp cooling device." | 2.90 | Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience. ( Andreis, F; Huscher, A; Mirandola, M; Mutti, S; Pedrali, C; Pomentale, B; Prochilo, T; Zaina, E; Zaniboni, A; Zanotti, L, 2019) |
| "Androgenetic alopecia is the most common type of hair loss in men, which is manifested by a progressive terminal hair loss in specific areas of scalp." | 2.90 | The effect of platelet-rich plasma injection in the treatment of androgenetic alopecia. ( Banihashemi, M; Bayat, M; Hamidi Alamdari, D; Salehi, M; Yazdanpanah, MJ, 2019) |
| "Hair loss was assessed by patients using a 100-point Visual Analog Scale (VAS) and by physicians using the 5-point Dean Scale at baseline, every 3-4 weeks during chemotherapy, and at least 1 month after completion of chemotherapy." | 2.87 | Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. ( DeLuca, AN; Esserman, LJ; Melisko, ME; Rice, BA; Rugo, HS; Ver Hoeve, ES, 2018) |
| "When a cicatricial alopecia is suspected, scalp biopsy is recommended." | 2.82 | Treatment of Alopecia in Children. ( Gold, M; Goldust, M; Grabbe, S; Mishra, P; Patil, A; Rudnicka, L; Sinclair, R, 2022) |
| "Alopecia is a common sequela in children undergoing chemotherapy, radiation, and hematopoietic stem cell transplantation." | 2.82 | Alopecia in children undergoing chemotherapy, radiation, and hematopoietic stem cell transplantation: Scoping review and approach to management. ( Beebe, K; Kessler, S; Marzooq, A; Montoya, L; Price, H; Sood, A; Walsh, A, 2022) |
| "Alopecia areata is a common condition that leads to nonscarring hair loss." | 2.82 | [Janus kinase inhibitors for the treatment of alopecia areata]. ( Kobal, I; Ramot, Y, 2022) |
| "Chemotherapy-induced hair loss in cancer is usually temporary but can take a significant emotional toll on patients and lead to treatment refusal in many cases." | 2.82 | Chemotherapy, Alopecia, and Scalp Cooling Systems. ( Amarillo, D; Cuello, M; de Boni, D, 2022) |
| "Female Pattern Hair Loss (FPHL) is one of the most common types of hair loss in women." | 2.82 | Minimally invasive procedures for the management of female pattern hair loss. ( Cortez de Almeida, RF; Frattini, SC; Melo, DF; Ramos, PM; Santos, LDN, 2022) |
| "Traction alopecia is hair loss that occurs after persistent pulling (e." | 2.82 | α1 -AR agonist induced piloerection protects against the development of traction alopecia. ( Goren, A; Kovacevic, M; McCoy, J; Shapiro, J; Sinclair, R, 2016) |
| "non-alopetic scalp of patients with androgenetic alopecia." | 2.79 | A prostaglandin D-synthase-positive mast cell gradient characterizes scalp patterning. ( Fragoso, AC; Johnson, E; Larson, AR; Murphy, GF; Wan, M; Zhan, Q, 2014) |
| "Imiquimod 3." | 2.75 | Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp. ( Adams, M; Fein, MC; Furst, J; Kulp, J; Levy, S; Meng, TC, 2010) |
| "Even though patients knew hair loss was temporary, it was a burden to 54% of them (n = 100)." | 2.74 | Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations. ( Breed, WP; Mols, F; van den Hurk, CJ; Vingerhoets, AJ, 2009) |
| "The most important hair diseases are divided in non- cicatricial and cicatricial ones." | 2.72 | Common causes of hair loss - clinical manifestations, trichoscopy and therapy. ( Alessandrini, A; Bruni, F; Piraccini, BM; Starace, M, 2021) |
| "Pattern hair loss is the most common type of hair loss in both men and women." | 2.72 | Male and female pattern hair loss: Treatable and worth treating. ( Bergfeld, WF; Tamashunas, NL, 2021) |
| "Tinea capitis is seen world-wide among children up to 12 years." | 2.72 | [Kerion Celsi due to Microsporum canis infection]. ( Birsan, C; Chiriac, A; Mares, M; Wollina, U, 2021) |
| "Male androgenetic alopecia and female pattern hair loss are the most common reasons for hair loss consultations with dermatologists and will be the primary focus of this review." | 2.72 | Hair transplantation: Basic overview. ( Alam, M; Avram, M; Jimenez, F; Vogel, JE, 2021) |
| "The precise and reliable diagnosis of hair loss disorders is essential for developing a successful management plan." | 2.72 | New Diagnostic Tools to Evaluate Hair Loss. ( Eisinger, A; Jagdeo, J; Kurtti, A; Sukhdeo, K, 2021) |
| "Male pattern hair loss (MPHL) is a potentially reversible condition in which dihydrotestosterone is an important etiologic factor." | 2.72 | The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. ( Ellis, ML; Hobbs, S; Hordinsky, M; Olsen, EA; Rittmaster, RS; Stough, D; Whiting, D; Wilson, T, 2006) |
| "The digitized, controlled, scalp-cooling system represents an effective and safe device that should be clinically evaluated in a randomized trial and in studies using other chemotherapy regimens to determine optimal temperatures and durations of cooling for maximal efficacy." | 2.71 | Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. ( Bjurberg, M; Gustavsson, A; Ridderheim, M, 2003) |
| "Procyanidin B-2 is a compound we have identified in apple which acts as a growth-promoting factor on murine hair epithelial cells." | 2.70 | The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent. ( Honda, S; Kamimura, A; Takahashi, T; Watanabe, Y; Yokoo, Y, 2001) |
| "In male androgenetic alopecia (AGA), global changes of scalp hair observed on many years are the cumulative result of discrete changes." | 2.70 | Contrast enhanced phototrichogram pinpoints scalp hair changes in androgen sensitive areas of male androgenetic alopecia. ( Leroy, T; Van Neste, D, 2002) |
| "Protection from hair loss was achieved by maintaining scalp temperatures below 15 degrees C before, during and after chemotherapy by frequent changing of the caps." | 2.69 | Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. ( Bamias, A; Katsimbri, P; Pavlidis, N, 2000) |
| "Procyanidin B-2 is a polyphenol compound we have identified in apple which acts as a hair-growing factor in the murine model both in vitro and in vivo." | 2.69 | Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent. ( Kamimura, A; Takahashi, T; Watanabe, Y, 2000) |
| "Androgenic baldness (androgenic alopecia) and circular/spot baldness (alopecia areata) are the most common forms of hair loss." | 2.66 | Herbal preparations for the treatment of hair loss. ( Kočevar Glavač, N; Kreft, S; Poljšak, N; Zgonc Škulj, A, 2020) |
| "In men, male pattern-balding (androgenetic alopecia) is driven by androgens and follows a specific pattern of frontotemporal and vertex regression." | 2.66 | Getting under the skin of hair aging: the impact of the hair follicle environment. ( Pawlus, AD; Thornton, MJ; Williams, R, 2020) |
| "Its use in alopecia has been much less studied in the literature." | 2.66 | Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: A systematic review of the literature. ( Carloni, R; Gandolfi, S; Pechevy, L; Postel, F; Zielinski, M, 2020) |
| "Cephalgia alopecia is a rare headache disorder described as recurrent burning, stabbing head, and neck pain that is followed by hair loss in the corresponding region of the scalp." | 2.66 | Cephalgia Alopecia. ( Bedrin, KO; Dougherty, C, 2020) |
| "Analyzing other scarring diseases (lichen planopilaris, fibrotic kidney disease and scleroderma) may help to clarify the mechanism of scarring in CCCA." | 2.66 | A proposed mechanism for central centrifugal cicatricial alopecia. ( Alexander, T; Beamer, V; McMichael, A; Subash, J, 2020) |
| "Androgenic alopecia is a common and unpleasant problem that directly influences the self-confidence and individual life quality." | 2.66 | Herbal Medicines For Treatment of Androgenic Alopecia. ( Asnaashari, S; Javadzadeh, Y, 2020) |
| "Nine healthy men with type IVa or Va male pattern baldness completed a 4-month single-blinded controlled pilot study designed to assess the effect of ultraviolet light (UVL) on topical minoxidil-induced hair growth." | 2.66 | Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness. ( Delong, ER; Murray, JC; Olsen, EA; Pestana, A, 1987) |
| "Alopecia areata is an autoimmune disease that results in non-scarring hair loss, and it is clinically characterised by small patches of baldness on the scalp and/or around the body." | 2.61 | Alopecia areata: A multifactorial autoimmune condition. ( Butcher, JP; Henriquez, FL; Reid, S; Simakou, T, 2019) |
| "(i) The term "female pattern hair loss" should be used, avoiding the previous terms of alopecia or androgenetic alopecia." | 2.61 | Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. ( Azziz, R; Bergfeld, W; Carmina, E; Escobar-Morreale, HF; Futterweit, W; Huddleston, H; Lobo, R; Olsen, E, 2019) |
| "Failure to prevent hair loss in patients undergoing an expensive and potentially uncomfortable treatment likely contributes to decreased well-being, impacting the overall distribution of QoL measures in scalp cooling patients compared to controls." | 2.61 | The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. ( Hagigeorges, D; Isakoff, SJ; Lacouture, ME; Manatis-Lornell, AJ; Marks, DH; Okhovat, JP; Senna, MM, 2019) |
| "Alopecia is a side effect of chemotherapy and affects a patient's quality of life." | 2.58 | Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Rugo, HS; Voigt, J, 2018) |
| "The result is a permanent scarring hair loss accentuated at the front hairline with backward movement towards the neck mostly accompanied by a typical loss of the eyebrows." | 2.58 | [Postmenopausal lichen planopilaris also known as fibrosing frontotemporal alopecia Kossard : An evidence-oriented practical guide to treatment from the University of the Saarland, Hair Research Center of the Dr. Rolf M. Schwiete Foundation]. ( Christmann, R; Lehr, CM; Loretz, B; Mawlood, D; Müller, C; Reichrath, J; Schäfer, U; Schilling, L; Thomas, C; Vogt, T, 2018) |
| "With regards to non-scarring alopecia, there were eight horizontal and eight vertical section studies." | 2.53 | Diagnostic value of horizontal versus vertical sections for scarring and non-scarring alopecia: a systematic review and meta-analysis. ( Du, X; Fan, W; Li, Z; Song, C; Tang, S; Xu, W; Zhou, X, 2016) |
| "The use of the medical term androgenetic alopecia reflects current knowledge about the important role of androgens and genetic factors in its etiology." | 2.53 | Multi-therapies in androgenetic alopecia: review and clinical experiences. ( Anzalone, A; Carlesimo, M; Caro, G; Fortuna, MC; Garelli, V; Pranteda, G; Rossi, A, 2016) |
| "Folliculitis keloidalis is a cicatricial alopecia with a mixed inflammatory infiltrate." | 2.52 | Primary scarring alopecias. ( Ioannides, D; Rigopoulos, D; Stamatios, G, 2015) |
| "Hair loss is commonly seen in autoimmune diseases." | 2.50 | Hair loss in autoimmune systemic diseases. ( Cozzani, E; Parodi, A, 2014) |
| "Keloid scarring is more prevalent in individuals of African, Asian, and Hispanic descent." | 2.50 | Follicular and scarring disorders in skin of color: presentation and management. ( Kundu, RV; Madu, P, 2014) |
| "We present a 65-year-old man with Darier disease with pityriasis amiantacea on the scalp, alopecia, and congenital facial nerve palsy." | 2.49 | Extensive Darier's disease with pityriasis amiantacea, alopecia and congenital facial nerve palsy. ( Anuradha, P; Nath, AK; Udayashankar, C, 2013) |
| "Female hair loss is a devastating issue for women that has only relatively recently been publicly acknowledged as a significant problem." | 2.49 | Female hair restoration. ( Unger, RH, 2013) |
| "Treatment with hydroxychloroquine and local steroid injection resulted in complete hair regrowth but recurrence was noted." | 2.48 | Linear lupus panniculitis of the scalp presenting as alopecia along Blaschko's lines: a distinct variant of lupus panniculitis in East Asians? ( Chen, YA; Hsu, CK; Lee, JY; Yang, CC, 2012) |
| "Hair loss is a common problem for both men and women and may impact negatively on self-esteem." | 2.48 | A review of scalp camouflaging agents and prostheses for individuals with hair loss. ( Donovan, JC; Hordinsky, MK; Pierre-Louis, M; Shapiro, P; Shapiro, RL; Zupan, M, 2012) |
| "The subjective assessment of hair loss is classically determined by hair density but it is apparent that other factors contribute to the clinical picture." | 2.47 | Hair through the female life cycle. ( Messenger, AG, 2011) |
| "Traumatic hair loss is a scalp injury that can cause secondary scarring alopecia." | 2.46 | Hairpin-induced alopecia: case reports and a review of the literature. ( Ntuen, E; Stein, SL, 2010) |
| "The relationship between nonscarring scalp alopecia in women and iron deficiency continues to be a subject of debate." | 2.46 | Iron deficiency and diffuse nonscarring scalp alopecia in women: more pieces to the puzzle. ( Donovan, JC; Hordinsky, MK; St Pierre, SA; Vercellotti, GM, 2010) |
| "Fortunately, chemotherapy-induced hair loss is mostly reversible, and appropriate hair and scalp care and temporarily wearing a wig may be the most effective coping strategy." | 2.46 | Chemotherapy-induced alopecia. ( Trüeb, RM, 2010) |
| "Cicatricial or scarring alopecia represents permanent destruction of the hair follicle, histopathologically showing a decreased number of follicular units leaving streamers of fibrosis or hyalinization of surrounding collagen." | 2.44 | Cicatricial alopecia secondary to radiation therapy: case report and review of the literature. ( Griffin, T; Severs, GA; Werner-Wasik, M, 2008) |
| "Frontal scalp DPCs from androgenetic alopecia (AGA) are the target cells of androgen action." | 2.44 | [Hair follicle regeneration]. ( Itami, S, 2008) |
| "Chemotherapy-induced temporary hair loss is one of the most common and distressing side-effects of cancer therapy." | 2.43 | Prevention of chemotherapy-induced hair loss by scalp cooling. ( Breed, WP; Grevelman, EG, 2005) |
| "However, when baldness has appeared, as the hair follicle's culture is not actually effective, the state of art is still to plan a surgical strategy using successive stages of this large panel of techniques to reach a natural effect with the best hair orientation and density." | 2.42 | [Baldness surgery]. ( Dardour, JC; Hennebert, H, 2003) |
| "Hair loss is complex and can be classified in many ways." | 2.42 | Natural hair patterns. ( Parsley, WM, 2004) |
| "Localized scalp hair loss is associated with many processes, including alopecia areata, trichotillomania, tinea capitis, and early lupus erythematosus." | 2.42 | Ant-induced alopecia: report of 2 cases and review of the literature. ( Mansouri, P; Mortazavi, M, 2004) |
| "scalp hair growth or hair loss in the hair clinic." | 2.41 | Assessment of hair loss: clinical relevance of hair growth evaluation methods. ( Van Neste, MD, 2002) |
| "To establish the cause of the hair loss, one requires a history to identify known triggers, biochemical investigations to exclude endocrine, nutritional or autoimmune aetiologies and in many cases histology to identify the earliest stages of androgenetic alopecia." | 2.41 | Telogen effluvium. ( Harrison, S; Sinclair, R, 2002) |
| "Histopathology of the traumatic arteriovenous fistula may appear similar to that of an arteriovenous malformation." | 2.40 | Arteriovenous fistula of the scalp secondary to punch autograft hair transplantation: angioarchitecture, histopathology, and endovascular and surgical therapy. ( Davis, AJ; Nelson, PK, 1997) |
| "Primary and secondary scarring alopecia are differentiated: While the former is due to preferential destruction of the follicle, the latter results from events outside the follicle, which eventually impinge upon and eradicate the follicle." | 2.40 | [Cicatricial alopecias: diagnosis and therapy]. ( Trüeb, RM, 1997) |
| "A woman with no previous history of breast carcinoma presented with focal hair loss, which was presumptively diagnosed as alopecia areata." | 2.39 | Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast carcinoma. ( Carson, HJ; Lack, E; Pellettiere, EV, 1994) |
| "We report herein two cases of keratosis follicularis spinulosa decalvans (KFSD) and review the literature on this condition." | 2.36 | Keratosis follicularis spinulosa decalvans. Report of two cases and literature review. ( Baden, HP; Rand, R, 1983) |
| "The most prevalent HSRDs included androgenetic alopecia (30." | 1.91 | Changing spectrum of hair and scalp disorders over the last decade in a tertiary medical centre. ( Barzilai, A; Baum, S; Galili, E; Gilboa, S; Lyakhovitsky, A; Segal, O; Tzanani, I, 2023) |
| "Minoxidil was radiolabeled with technetium (99mTc) with an efficiency of 99." | 1.91 | In Vitro and In Vivo Scalp Retention and Penetration of 99mTc-Minoxidil Solution. ( Arora, G; Chandra, N; Jain, GK; Kesharwani, P; Mishra, A, 2023) |
| "A generalizable automated assessment of hair loss would provide a way to standardize measurements of hair loss across a range of conditions." | 1.91 | Automating Hair Loss Labels for Universally Scoring Alopecia From Images: Rethinking Alopecia Scores. ( Bayramova, A; Bernardis, E; Castelo-Soccio, L; Cotsarelis, G; Gudobba, C; Mane, T; Ogunleye, TA; Rodriguez, N; Taylor, SC, 2023) |
| "We have found evidence of hair loss preferentially occurring in multi-hair follicular units, which was more pronounced in men." | 1.91 | Scalp hair loss is not random across follicular units: A new insight into human hair ageing. ( Bhogal, R; Fu, B; Gripkauskaite, I; Gu, X; Gunn, DA; Jin, L; Li, B; Li, J; Luo, J; Murray, P; Qian, Q; Rowson, M; Wang, S; Wu, S; Xue, X; Yang, Y; Zhang, M; Zheng, W, 2023) |
| " Regarding safety, all subjects in both the scalp cooling and hair loss observation groups experienced adverse events; only 1 subject in each group experienced a severe adverse event due to chemotherapy and majority of the subjects in both groups experienced minor adverse events." | 1.91 | [Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients]. ( Fukuma, E; Kato, M; Nomizu, T; Ueo, H, 2023) |
| "A 23-year-old man with frontal hair loss underwent follicular unit strip surgery." | 1.91 | A Scalp Scar-Reducing Procedure for the Hair Transplant Donor Area Using a Columnar Trichophytic Suture: A Case Report. ( Kim, J; Kim, T; Park, G; Park, J, 2023) |
| "Scalp expansion is an optimal treatment for alopecia resulting from burn injuries, especially in the pediatric population through providing highly vascularized adjacent local tissues with optimal hair density, color matching, texture, and hair-bearing characteristics." | 1.91 | The Efficacy of Anterior Capsulotomy and Basal Capsulectomy Adherent to Expanded Scalp Flap During Alopecia Reconstruction in Pediatric Burned Patients. ( AboShaban, MS; Alkashty, SM; Ghareeb, FM, 2023) |
| "Scalp involvement and hair loss have not been reported among cutaneous changes associated with collagen VI mutations." | 1.91 | Alopecia in Patients with Collagen VI-Related Myopathies: A Novel/Unrecognized Scalp Phenotype. ( Baraldi, C; Bruni, F; Cedirian, S; Di Martino, A; Merlini, L; Misciali, C; Pampaloni, F; Piraccini, BM; Quadrelli, F; Sabatelli, P; Starace, M, 2023) |
| "The SLE hair loss patients demonstrated mucin deposition (91." | 1.91 | Comparative histopathological analyses of non-scarring alopecia in systemic lupus erythematosus patients in Lagos Nigeria. ( Anaba, EL; Cole-Adeife, O; Dawodu, OO; Olaosebikan, H, 2023) |
| "Male pattern hair loss (MPHL), also referred to as male androgenetic alopecia (AGA) is the most common type of non-scarring progressive hair loss, with 80% of men suffering from this condition in their lifetime." | 1.91 | Male pattern hair loss: Can developmental origins explain the pattern? ( Farjo, B; Higgins, CA; Limbu, S; Messenger, AG; Redmond, LC, 2023) |
| "Sarcoidosis is an idiopathic multisystem inflammatory disease that can affect virtually any part of the body." | 1.91 | Sarcoidosis Coexisting With Distinct Forms of Alopecia on the Scalp: A Case Series. ( Hosler, GA; Khalid, I; Ogwumike, E; Sode, T, 2023) |
| "Recent studies have suggested that androgenetic alopecia (AGA) may be associated with other disorders, especially metabolic syndrome (MetS)." | 1.91 | Increase in subcutaneous adipose tissue in the frontal scalp may be associated with androgenetic alopecia and metabolic syndrome. ( Bilen, A; Bilen, H; Çapoğlu, I; Çiftel, E; Çiftel, S; Dayanan, R; Demirci, T; Mercantepe, F; Önalan, E; Tonkaz, G; Yakar, B, 2023) |
| "Alopecia is one of the most common dermatologic conditions affecting black patients, with a significantly negative impact on quality of life." | 1.91 | Minimizing Bias in Alopecia Diagnosis in Skin of Color Patients. ( Adotama, P; Axler, E; Balazic, E; Kim, R; Kobets, K; Lo Sicco, K; Nwankwo, C, 2023) |
| "None of the cases had diagnosis of type 2 diabetes mellitus, but 17." | 1.91 | Central centrifugal cicatricial alopecia in males. ( Ayoade, KO; Jackson, TK; Ogunleye, T; Seykora, JT; Sow, Y; Taylor, SC, 2023) |
| "Myxedema is a rare, cutaneous complication of autoimmune thyroid diseases that most often affects the anterior shins." | 1.91 | Localized alopecic myxedema of the scalp. ( Doost, MS; Fung, MA; Love, NR; Tartar, DM, 2023) |
| "Localized hypertrichosis has been extensively reported after bone fractures, burn injury, chronic venous ulcer, etc." | 1.91 | What Do We Know About Hair Growth Induced by Wounding and Its Therapeutic Applications? ( Jimenez, F; Vathananai, W, 2023) |
| "Institutions conducting research on treatment for alopecia areata can use the results of this study to better understand the needs of their target population." | 1.72 | Characterizing the willingness to undergo treatment in patients with alopecia areata. ( O'Connor, LF; Wells, KM, 2022) |
| "Telogen effluvium, androgenetic alopecia, and alopecia areata are the most common forms of nonscarring alopecias." | 1.72 | Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? ( Akdeniz, N; Öner, Ü, 2022) |
| "Treatment-induced alopecia is a common concern among women preparing for chemotherapy." | 1.72 | Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early-stage breast cancer-The COOL study. ( Jackson, K; Krishnasamy, M; Renehan, S; Tencic, M, 2022) |
| "Dickkopf-1 (DKK1), a major hair loss factor secreted from dermal papilla (DP) cells in response to the secretion of dihydrotestosterone (DHT), has been reported to induce and accelerate androgenetic alopecia (AGA)." | 1.72 | Effects of watercress extract fraction on R-spondin 1-mediated growth of human hair. ( Hashimoto, M; Iddamalgoda, A; Ito, K; Kawai, Y; Masutani, T; Tanaka, K, 2022) |
| "We prospectively monitored cancer patients from August 2017 to October 2019 receiving oncological treatments with SC, using the sensor-controlled system "DigniCap." | 1.72 | Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany. ( Ebner, F; Hempel, D; Hempel, L; Keim, S; Milani, V; Retzer-Lidl, M; Wohlmuth, K, 2022) |
| "However, it is the most common skin cancer in that patient population." | 1.72 | Giant cutaneous squamous cell carcinoma of the scalp arising in the setting of folliculitis decalvans. ( Bogner, P; DeGiovanni, JC; Ding, L; Soofi, Y, 2022) |
| "Female pattern hair loss (FPHL), the most common cause of alopecia in adult women, is classified into two subtypes: early onset and late onset (or postmenopausal)." | 1.72 | Early onset female pattern hair loss: A case-control study for analyzing clinical features and genetic variants. ( Kim, JI; Kim, MS; Kwon, O; Kwon, S; Ohn, J; Park, WS; Son, HY; Yu, DA, 2022) |
| "Long-term alopecia was defined as no signs of terminal hair regrowth for at least 2 years in this study." | 1.72 | Risk factors of long-term alopecia after pulsed-dye laser treatment for infantile scalp hemangiomas: A retrospective study. ( Alamgir, M; An, X; Dong, L; Gao, Y; Li, Y; Tao, J; Wang, Z; Yang, J; Yang, L; Zhang, Y; Zhou, N, 2022) |
| "She had a 10-year history of Crohn's disease associated with arthritis, for which she had been taking adalimumab." | 1.72 | Adalimumab-Induced Psoriasis with Severe Alopecia. ( El Sayed, F; Kabbani, M, 2022) |
| " Most adverse effects were mild and moderate, and scalp cooling did not increase the risk of scalp metastases." | 1.72 | Effectiveness, Safety, and Tolerance of Scalp Cooling for Chemotherapy-Induced Alopecia. ( Huang, J; Liu, WQ; Ning, N; Yang, KL; Zhang, XY, 2022) |
| "We diagnosed aplasia cutis congenita, a rare disorder with a wide variation in clinical symptoms." | 1.72 | [A child with a bald spot on her scalp]. ( de Jong, N; Janse, I, 2022) |
| "Extensive hair loss with clustered short vellus hairs was visible on the scalp." | 1.72 | Leucoderma secondary to wig wearing. ( Feng, Y; Lu, Y; Wang, H, 2022) |
| "Female pattern hair loss (FPHL) is a non-scarring alopecia resulting from the progressive conversion of the terminal (t) scalp hair follicles (HFs) into intermediate/miniaturized (i/m) HFs." | 1.72 | Intermediate Hair Follicles from Patients with Female Pattern Hair Loss Are Associated with Nutrient Insufficiency and a Quiescent Metabolic Phenotype. ( Altendorf, S; Bertolini, M; Bíró, T; Edelkamp, J; Funk, W; Jakobs, M; Jimenez, F; Paus, R; Piccini, I; Rossi, A; Seibel, J; Sousa, M; Yesilkaya, T, 2022) |
| "Hair loss, specifically androgenetic alopecia (AGA), is a common outpatient dermatology complaint." | 1.72 | A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss. ( Friedman, A; Gonzalez-Lopez, A; Murphy, E; Nelson, K; Nussbaum, D; Qureshi, A; Schwartz, J, 2022) |
| "SG atrophy is observed in seborrheic dermatitis and is not specific for psoriasis or psoriatic alopecia." | 1.72 | Sebaceous gland atrophy in seborrheic dermatitis of the scalp; a pilot study. ( Goldberg, LJ; Nagrani, NS, 2022) |
| "Pattern hair loss (PHL) is a chronic regressive condition of the scalp, where follicular miniaturisation and decreased scalp hair coverage occurs in affected areas." | 1.72 | Following historical "tracks" of hair follicle miniaturisation in patterned hair loss: Are elastin bodies the forgotten aetiology? ( Rushton, DH; Van Neste, DJ; Westgate, GE, 2022) |
| "Early diagnosis and treatment of hair loss disorders is vital in providing patients with improved psychological outcomes." | 1.62 | Optical Coherence Tomography in the Evaluation of the Scalp and Hair: Common Features and Clinical Utility. ( Asghari, A; Choi, F; Csuka, E; Ekelem, C; Feil, N; Heydarlou, D; Juhasz, M; Lin, J; Mesinkovska, NA, 2021) |
| "Although androgenetic alopecia (AGA) is a common cause of hair loss, little is known regarding the magnetic resonance imaging (MRI) of the AGA or scalp." | 1.62 | MR Imaging of Hair and Scalp for the Evaluation of Androgenetic Alopecia. ( Arafune, T; Kawashima, M; Kobayashi, K; Koyama, T; Mikoshi, A; Shinmoto, H; Soga, S, 2021) |
| "Female Japanese breast cancer patients who planned to receive (neo)adjuvant chemotherapy participated in this prospective study on the efficacy of scalp cooling using the Paxman Scalp Cooling System for alopecia prevention." | 1.62 | Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy. ( Aogi, K; Doi, M; Hara, F; Kiyoto, S; Matsuda, M; Ohsumi, S; Takahashi, M; Takashima, S; Yamamura, N, 2021) |
| "Chemotherapy-induced hair loss (alopecia) (CIA) remains a major unsolved problem in clinical oncology." | 1.62 | Inhibition of Shh Signaling through MAPK Activation Controls Chemotherapy-Induced Alopecia. ( Ao, X; Farjo, B; Farjo, N; Haslam, IS; Huang, Z; Paus, R; Rutkowski, D; Smart, E; Teng, X; Wierzbicka, J; Xie, G; Yan, Z; Yue, Z; Zhang, Y; Zhou, G; Zhou, Y, 2021) |
| "Recipient site necrosis is a rare but potentially devastating complication of hair restoration surgery." | 1.62 | Prevention of impending scalp necrosis by topical nitroglycerine in hair transplant surgery. ( Abbas, Z; Kufi, H, 2021) |
| "Hair loss was assessed using the Dean scale, where a score of 0-2 (hair loss ≤50%) was defined as successful." | 1.62 | Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device. ( Amoroso, V; Ardine, M; Berruti, A; Bianchi, S; Conti, E; Cosentini, D; Dalla Volta, A; di Mauro, P; Fornaro, C; Gelmi, M; Motta, P; Pedersini, R; Pierini, M; Rodella, F; Simoncini, EL; Turla, A; Vassalli, L, 2021) |
| "Mucosal lichen planus was found in four patients (21." | 1.62 | Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients. ( Cantwell, HM; Imhof, RL; Proffer, SL; Tolkachjov, SN; Torgerson, RR; Wieland, CN, 2021) |
| "Hair loss is a common problem in dermatological patients." | 1.62 | High-frequency ultrasonography of the scalp - Comparison of ultrasound and trichoscopic images in healthy individuals. ( Adamski, Z; Dańczak-Pazdrowska, A; Mikiel, D; Polańska, A; Żaba, R, 2021) |
| "Female pattern hair loss (FPHL) is a non-scarring hair disease characterized by progressive hair diminishment and decrease of its density." | 1.62 | Accuracy of clinical diagnosis and videodermoscopy in female pattern hair loss. ( Mancilla, GA; Restrepo, R; Sanclemente, G, 2021) |
| "04)The most common adverse events reported during the scalp cooling sessions were chills (7%), and chills with headaches (6%)." | 1.62 | Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study. ( Baby, V; Joseph, S; Kate, S; Nagarkar, R; Pathan, D; Patil, R; Ramesh, YV; Vyavhare, R, 2021) |
| "Nine patients with androgenetic alopecia (7 women and 2 men) were enrolled to our study." | 1.62 | Autologous whole fat injection stimulates hair growth in resistant Androgenetic Alopecia: Report of nine cases. ( Hanifnia, AR; Heidari-Kharaji, M; Lotfi, E; Nilforoushzadeh, MA; Torkamaniha, E, 2021) |
| "Alopecia was assessed by trained oncology providers using the modified Dean scale (MDS) prior to each chemotherapy session." | 1.62 | Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer? ( Adams-Campbell, L; Alintah, P; Chitalia, A; Dash, C; Dilawari, A; Gallagher, C; Paxman, R; Tiwari, S, 2021) |
| "Though androgenetic alopecia (AGA) is one of the most common diseases affecting both sexes and all races, its pathogenesis is not completely clarified." | 1.62 | The role of prostaglandins in androgenetic alopecia. ( Chovarda, E; Ioannides, D; Lazaridou, E; Sotiriou, E; Vakirlis, E, 2021) |
| "Androgenic alopecia is a genetically determined and leads to a progressive hair loss of the vertex, affecting both men and women." | 1.62 | [A new treatment for androgenetic alopecia : platelet-rich plasma injections]. ( Castronovo, C; Kaux, JF; Moreau, T; Nikkels, AF; Paquet, P, 2021) |
| "Burn scar and alopecia on hair-bearing areas can severely affect the social life of patients." | 1.62 | Hair Transplantation in Burn Scar Alopecia After Combined Non-Ablative Fractional Laser and Microfat Graft Treatment. ( Agaoglu, E; Agaoglu, G; Erol, O; Karademir, S; Özer, F, 2021) |
| "Characteristics of hair loss in male AGA reveal the possibility of different biophysical and physiological profiles between androgen-sensitive (vertex) and androgen-insensitive (occipital) scalps." | 1.62 | Scalp Biophysical Characteristics in Males with Androgenetic Alopecia: A Comparative Study with Healthy Controls. ( Chanprapaph, K; Suchonwanit, P; Sutharaphan, T, 2021) |
| "Patients who complain of hair loss without any supportive findings can be encountered in daily practice." | 1.62 | Clinicopathological insight into self-reported hair loss with no findings: How do we manage this enigmatic condition? ( Fukuyama, M; Kinoshita-Ise, M; Ohyama, M, 2021) |
| "The current medical treatments of androgenetic alopecia (AGA) have hardly achieved a satisfying clinical improvement." | 1.62 | Autologous Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: Results of a 54-Patient Prospective Study. ( Bongiorno, MR; Mazzola, G; Patti, I; Pistone, G; Sorce, M, 2021) |
| "Traction alopecia is a protracted form of hair loss resulting from persistent tension on the hair follicle ." | 1.62 | Acute onset traction-associated ulceration and alopecia. ( Johns, HR; Pourciau, CY; Wright, TS, 2021) |
| "Six patients had progression of their hair loss in spite of treatment." | 1.62 | Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study. ( Bhoyrul, B; Jerjen, R; Pinczewski, J; Sinclair, R, 2021) |
| "Initial hair loss showed specific dots not previously described, named CIA dots." | 1.56 | Dermoscopy and confocal microscopy for different chemotherapy-induced alopecia (CIA) phases characterization: Preliminary study. ( Ardigò, M; Caro, G; Franceschini, C; Garelli, V; Persechino, F; Rossi, A; Sperduti, I, 2020) |
| "Consecutive early breast cancer patients admitted to Istituto Oncologico Veneto who were recommended to receive neoadjuvant or adjuvant CT, were eligible to undergo scalp cooling during the CT administration within this study." | 1.56 | Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study. ( Di Liso, E; Dieci, MV; Faggioni, G; Falci, C; Frezzini, S; Giarratano, T; Giorgi, CA; Griguolo, G; Grosso, D; Guarneri, V; Mantiero, M; Menichetti, A; Miglietta, F; Mioranza, E; Tasca, G; Vernaci, G; Zanocco, M, 2020) |
| "Female pattern hair loss affects the central scalp, sparing the frontal hairline." | 1.56 | Significant relationship between temporal hair loss and other scalp areas in female pattern hair loss. ( Byun, JW; Choi, GS; Heo, JH; Shin, J; Yeom, SD, 2020) |
| "Scalp-hair loss was the most bothersome AA sign/symptom for most patients." | 1.56 | The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials. ( Aldhouse, NVJ; Dutronc, Y; King, BA; Kitchen, H; Knight, S; Ko, JM; Macey, J; Mesinkovska, N; Nunes, FP; Wyrwich, KW, 2020) |
| "In early male hair loss, this therapy demonstrated a statistically significant increase in terminal hair counts relative to the control population at 24 weeks and represents a promising approach for early androgenetic alopecia." | 1.56 | Cell Enriched Autologous Fat Grafts to Follicular Niche Improves Hair Regrowth in Early Androgenetic Alopecia. ( Aronowitz, J; Brown, W; Daniels, EJ; Epstein, J; Geronemus, RG; Glasgold, MJ; Kuka, G; Rogal, JG; Washenik, K, 2020) |
| "All patients named scalp hair loss as a key AA sign or symptom." | 1.56 | Development of the Scalp Hair Assessment PRO™ measure for alopecia areata. ( Aldhouse, NVJ; Dutronc, Y; King, BA; Kitchen, H; Knight, S; Ko, JM; Macey, J; Mesinkovska, N; Nunes, FP; Wyrwich, KW, 2020) |
| "Alopecia is one of these." | 1.56 | Eosinophilic folliculitis of the scalp associated with PD-1/PDL1 inhibitors. ( Carlesimo, M; Caro, G; De Vincentiis, L; Federico, A; Fortuna, MC; Magri, F; Rossi, A; Soda, G, 2020) |
| "The clinical and trichoscopic features, scalp radiation dose-response relationship, and response to topical minoxidil were assessed using standardized clinical photographs of the scalp, trichoscopic images, and radiotherapy treatment plans." | 1.56 | Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer. ( Beal, K; Disa, JJ; Dusza, SW; Freites-Martinez, A; Freret, ME; Friedman, DN; Kukoyi, O; Lacouture, ME; Mechalakos, JG; Phillips, GS; Tinkle, CL; Trelles, S; Unger, RH; Wexler, LH; Wolden, SL, 2020) |
| "The role of microflora during hair loss remains to be understood." | 1.56 | Characteristics of healthy and androgenetic alopecia scalp microbiome: Effect of Lindera strychnifolia roots extract as a natural solution for its modulation. ( Berthon, JY; Boutot, C; Dreux, A; Filaire, E; Ranouille, E, 2020) |
| "Alopecia areata (AA) is an autoimmune hair loss condition that is difficult to treat and frequently disruptive to the psychosocial well-being of patients." | 1.56 | Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A Case Series. ( Chen, Z; Choi, F; Csuka, E; Ekelem, C; Heidari, AE; Hosking, AM; Juhasz, M; Mesinkovska, NA; Pham, CT; Rapaport, JA; Valdebran, M; Yu, J, 2020) |
| "A circular zone of hair loss was noted in a two-weeks old male baby, born prematurely." | 1.56 | [A premature baby with hair loss]. ( Korver, CRW; Schoenmaker, MHA; Thorsen, P, 2020) |
| "Lipedematous alopecia is a rare, non-androgenic form of alopecia that is challenging to diagnose, often requiring clinical-pathological correlation." | 1.56 | Occipital alopecia in a young man. ( Bennett, D; Keenan, T; Rolnick, K; Shields, BE; Weinhammer, A, 2020) |
| "Although this type of hair loss is being seen with increased frequency worldwide, the etiology of the condition is unknown." | 1.56 | Frontal fibrosing alopecia with involvement of the central hair part: distribution of hair loss corresponding to areas of sunscreen application. ( Mirmirani, P; Vanderweil, SG, 2020) |
| "Clinically, 4 patterns of hair loss were described-patchy nonscarring (41." | 1.51 | Histologic and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease. ( Chapman, CM; Manatis-Lornell, A; Marks, DH; Naftulin, JS; Penzi, LR; Rao, SR; Saavedra, A; Senna, MM; Yasuda, MR, 2019) |
| "Frontal fibrosing alopecia is a condition of unknown origin, histologically similar to classic lichen planopilaris and generally observed in postmenopausal women with alopecia of the frontal-temporal hairline." | 1.51 | Clinical-histopathological profile of the frontal fibrosing alopecia: a retrospective study of 16 cases of a university hospital. ( Andrade, LCDS; Paula, NÁO; Quintella, DC; Secchin, P; Sodré, CT, 2019) |
| "Patients with androgenetic alopecia (AGA) and alopecia areata (AA), and scarring alopecia, in particular frontal fibrosing alopecia (FFA) were recruited and imaged from July 2016 to July 2017." | 1.51 | Feature characterization of scarring and non-scarring types of alopecia by multiphoton microscopy. ( Atanaskova Mesinkovska, N; Balu, M; Koenig, K; Lentsch, G; Lin, J; Saknite, I; Tromberg, BJ; Valdebran, M; Williams, JN, 2019) |
| "There are several types of hair loss that differ in causes, symptoms, and spatial and temporal progression." | 1.51 | A liposome-based formulation containing equol, dihomo-γ-linolenic acid and propionyl-l-carnitine to prevent and treat hair loss: A prospective investigation. ( Brotzu, G; Campisi, M; Consolaro, F; Fadda, AM; Manca, ML; Manca, T; Marongiu, F, 2019) |
| "The most infallible approach to male pattern baldness (MPB) is hair transplantation in the thinning area in parallel to medical treatment to prevent further alopecia progression." | 1.51 | Shaved hair style scalp medical tattooing technique for treatment of advanced male pattern baldness patients. ( Kim, N; Park, JH; You, SH, 2019) |
| "Depending on the severity and region of baldness, numerous researchers proposed different classifications of alopecia." | 1.51 | A semiquantitative grading scale for frontal and vertex of androgenetic alopecia. ( Hou, W; Nie, J, 2019) |
| "Thirty-five patients with hair loss who have been using hair straightening devices and 25 patients with telogen effluvium were enrolled in this prospective study." | 1.51 | New pattern hair loss in young Turkish women; What's wrong in their daily life? ( Kalkan, G; Pancar, GS; Sahin, G, 2019) |
| "Female pattern hair loss patients showed reduced hair density, hair diameter, and terminal/vellus hair ratio." | 1.51 | Characteristic findings by phototrichogram in southern Chinese women with Female pattern hair loss. ( Lin, D; Liu, X; Lu, D; Mai, W; Sun, Y, 2019) |
| "Sixty biopsies from androgenetic alopecia served as controls." | 1.51 | Adipose Infiltration of the Dermis, Involving the Arrector Pili Muscle, and Dermal Displacement of Eccrine Sweat Coils: New Histologic Observations in Frontal Fibrosing Alopecia. ( Castillo, D; Miteva, M; Sabiq, S, 2019) |
| "The mean time from chemotherapy until hair loss was 18." | 1.51 | A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients. ( Hasegawa, Y; Imai, H; Nozawa, K; Ohashi, Y; Okada, H; Saito, M; Sangai, T; Shimozuma, K; Takayama, T; Tamai, N; Watanabe, T; Yagata, H; Yajima, T; Yamaguchi, T; Yoshida, Y; Yoshimura, A, 2019) |
| "When hair loss is diffuse and severe, there were associations with haematologic (P = 0." | 1.51 | Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls. ( Chanprapaph, K; Suchonwanit, P; Thadanipon, K; Udompanich, S, 2019) |
| "Cranial hair loss is one of the characteristics of age." | 1.51 | Types of hairline recession in androgenetic alopecia and perceptions of aging in Asian males. ( Cao, DX; Chen, Q; Feng, CB; Guo, ZH; Hu, ZQ; Liu, F; Liu, Y; Miao, Y; Qu, Q; Shi, PL, 2019) |
| "Chemotherapy-induced alopecia (CIA) is a distressing side effect of cancer therapy." | 1.51 | Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines. ( Bagnardi, V; Bianco, N; Campennì, G; Cancello, G; Cardillo, A; Colleoni, M; Dellapasqua, S; Iorfida, M; Masiero, M; Mazza, M; Mazzocco, K; Montagna, E; Munzone, E; Pagan, E; Palazzo, A; Pettini, G; Pravettoni, G; Sangalli, C; Tramacere, A; Veronesi, P, 2019) |
| "In follicular scars, EVG demonstrated central attenuation and loss of the elastic network with peripheral clumping and recoil of elastic fibers." | 1.48 | Elastic Staining in Differentiating Between Follicular Streamers and Follicular Scars in Horizontal Scalp Biopsy Sections. ( Gerami, P; Guitart, J; Tan, T; Yazdan, P, 2018) |
| "Lupus alopecia is usually difficult to treat." | 1.48 | Dramatic effect of hydroxychloroquine on lupus alopecia. ( Igari, S; Yamamoto, T, 2018) |
| "Curiously, the area of hair loss gradually expanded outwards while the central region showed normal hair regrowth." | 1.48 | Centrifugal lipodystrophy of the scalp manifesting as centrifugal lipodystrophic alopecia. ( Go, K; Harada, K; Irisawa, R; Maeda, T; Matsubayashi, J; Tsuboi, R; Uchiyama, M, 2018) |
| "The pattern of hair loss was more likely to be unifocal-ragged border in CCCA and DLE, multifocal-interconnected in LPP and FD, and multifocal-separated in DC." | 1.48 | Primary scarring alopecia: A retrospective study of 89 patients in Taiwan. ( Cheng, AY; Chu, CB; Hsu, CK; Lee, CN; Lee, JY; Liu, CH; Su, HJ; Yang, CC, 2018) |
| "While consensus is that androgenic alopecia is genetic and androgen-mediated by dihydrotestosterone, questions remain regarding dihydrotestosterone's exact role in androgenic alopecia onset." | 1.48 | A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. ( English, RS, 2018) |
| "One patient had a hypertrophic scar and no hair transfers to the recipient areas were observed." | 1.48 | Scalp as a donor site in children: Is it really the best option? ( Adams, S; Rode, H; van Niekerk, G, 2018) |
| "Chemotherapy for breast cancer induces alopecia, representing a major source of patient distress." | 1.48 | Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy. ( Schoenegg, W; Vasconcelos, I; Wiesske, A, 2018) |
| "Frontal fibrosing alopecia is characterized by frontotemporal hairline recession and eybrow loss." | 1.48 | Coexistence of chronic cutaneous lupus erythematosus and frontal fibrosing alopecia. ( Enokihara, MMSES; Nascimento, LLD; Vasconcellos, MRA, 2018) |
| "Androgenetic alopecia or female pattern hair loss is the condition that most commonly leads to hair loss in adult females." | 1.48 | White and yellow dots as new trichoscopic signs of severe female androgenetic alopecia in dark skin phototypes. ( Alariny, AF; Elmorsy, EH; Moneib, H; Sorour, OA; Tawfik, SS, 2018) |
| "Minimising hair loss may improve mood and body image." | 1.48 | Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens. ( Bauwens, A; Chan, A; Chih, J; Ernenwein, T; Jackson, S; McGlone, F; Pontre, S; Reid, C, 2018) |
| "The incidence of hair loss among Chinese male has increased to 21." | 1.48 | Study on Hair Distribution in Healthy Males for Hair Restoration Design. ( Bao, Y; Chen, Y; Lin, J; Wu, K; Wu, W, 2018) |
| "Sarcoidosis is a granulomatous condition that has a highly variable presentation." | 1.48 | Scalp Sarcoidosis Presenting as Cicatricial Alopecia. ( Cook, C; Demaree, E; Powers, J; Prohaska, J, 2018) |
| "In stage 2, scarring tissues were excised and the expanded hair-bearing flaps were advanced to the defect." | 1.48 | Staged reconstructive treatment for extensive irregular cicatricial alopecia after burn. ( Cheng, H; Jia, M; Li, J; Shen, H; Sun, Z; Tang, L; Tang, S; Wu, X; Zhang, J; Zhou, J, 2018) |
| "More than 75% of patients with cancer cite alopecia as the most feared side effect of treatment, with as many as 10% considering treatment refusal." | 1.46 | Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia . ( Fischer-Cartlidge, E; Ross, M, 2017) |
| "We concluded on the diagnosis of scalp dermatofibrosarcoma protuberans with breast metastasis and probable pleuropulmonary metastasis." | 1.46 | Breast and pleuropulmonary metastasis of multirecurrent scalp dermatofibrosarcoma protuberans: a case report. ( Bambara, HA; Lamien/Sanou, A; Ouédraogo Nde, NA; Ouédraogo, MS; Ouédraogo, NA; Tapsoba, GP; Thouraya Chtioui, A; Tiemtoré-Kambou, BM; Traoré, F; Zongo, N, 2017) |
| "Minoxidil has been approved for the treatment of hair loss, however its mechanism of action is still not fully clarified." | 1.46 | An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia. ( Aliper, A; Consolo, M; Cooper, KD; McCormick, TS; Mirmirani, P; Ozerov, IV; Pappas, A; Schastnaya, J; Stamatas, GN; Wu, J; Zhavoronkov, A, 2017) |
| "Kerion celsi is a deep inflammatory fungal infection on the scalp." | 1.46 | [A baby with progressive skin lesions on the scalp]. ( Hoekzema, R; Middelkamp-Hup, MA; van der Rhee, EA, 2017) |
| "One patient had hair loss of the upper cutaneous lip." | 1.46 | Frontal fibrosing alopecia among men: A clinicopathologic study of 7 cases. ( Camilleri, MJ; Chaudhry, HM; Tolkachjov, SN; Torgerson, RR, 2017) |
| "DPCs derived from the androgenetic alopecia (AGA) area undergo premature senescence in vitro, associated with p16INK4a expression." | 1.46 | Knockout of p16INK4a promotes aggregative growth of dermal papilla cells. ( Cheng, Y; Gao, S; Gao, Y; Zhang, G; Zhang, Y; Zhao, L, 2017) |
| "Cutaneous sarcoidosis is not an uncommon disorder, and the skin can be the sole manifestation in about 10% of patients." | 1.46 | Atrophic and Annular Scarring Alopecia of the Scalp as a Finding in Underlying Systemic Sarcoidosis. ( Didona, D; Donati, M; Donati, P; Panetta, C; Paolino, G, 2017) |
| "Hair loss is one of the most noticeable esthetic problems of the mankind." | 1.46 | Study of frontal hairline patterns for natural design and restoration. ( Bagheri, H; Govsa, F; Ozer, MA; Pinar, Y; Sirinturk, S, 2017) |
| "Patients with preexisting baldness as well as patients not following up for the minimum period were excluded." | 1.46 | Alopecia Following Bicoronal Incisions. ( Ashai, S; Badhey, A; Ducic, Y; Kadakia, S; Lee, TS, 2017) |
| "Frontal fibrosing alopecia is a scarring alopecia thatis characterized by recession of the frontotemporalhairline with the frequent loss of eyebrows." | 1.43 | Frontal fibrosing alopecia in a 46-year-old man. ( Callahan, S; Kim, RH; Meehan, SA; Stein, J; White, F, 2016) |
| "Several reported cases have described scarring alopecia of the scalp, which is the area of skin most commonly affected by sarcoidosis." | 1.43 | Sarcoidosis presenting as non-scarring non-scalp alopecia. ( Dan, L; Relic, J, 2016) |
| "Males with pattern hair loss showed further reduction in growth rates as clinical severity worsened." | 1.43 | Gender differences in scalp hair growth rates are maintained but reduced in pattern hair loss compared to controls. ( Rushton, DH; Van Neste, DJ, 2016) |
| "Pressure-induced hair loss after general anaesthesia is uncommon and typically temporary, but may be disconcerting to the patient." | 1.43 | Postoperative permanent pressure alopecia. ( Chang, ZY; Chong, C; Chong, CT; Liew, QY; Ngian, J, 2016) |
| "The average duration of hair loss was 5." | 1.43 | Factors affecting the severity of central centrifugal cicatricial alopecia. ( Bin Saif, GA; Hector, CE; McMichael, AJ; Suchonwanit, P, 2016) |
| "Appreciation of different types of hair loss (alopecia) that may be encountered in hospital medicine is important to ensure accurate diagnosis and management, identify underlying medical conditions or treatments that may present with increased hair loss, recognise autoimmune alopecias and their associations, and understand the significant psychological impact of hair loss on an individual." | 1.43 | Alopecia in general medicine. ( Harries, M; Nalluri, R, 2016) |
| "Chemotherapy-induced hair loss is a common and distressing side effect." | 1.43 | Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. ( Andrews, K; Baylock, B; Boyle, F; O'Reilly, A; Pugliano, L; Shaw, J; Winstanley, J, 2016) |
| "A new subtype of LPP mimicking androgenetic alopecia (AGA) may be misdiagnosed." | 1.43 | A New Subtype of Lichen Planopilaris Affecting Vellus Hairs and Clinically Mimicking Androgenetic Alopecia. ( Abbasi, A; Abbasi, S; Kamyab-Hesari, K; Mollaee, F; Rabbani, R, 2016) |
| "Imiquimod 5% cream is an immune-response-modifying drug with antiviral and anti-tumour activity." | 1.42 | Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome. ( Argenziano, G; Drummond, A; Lallas, A; Longo, C; Moscarella, E; Piana, S; Pichler, J; Zalaudek, I, 2015) |
| "Cicatricial alopecia is a form of hair loss that causes both cosmetic and psychological concerns." | 1.42 | Our experiences on the reconstruction of lateral scalp burn alopecia with tissue expanders. ( Alhan, D; Aykan, A; Eski, M; Guzey, S; Nişancı, M; Şahin, I, 2015) |
| "Therefore, scar widening and hair loss after craniotomy, which sometimes occurs in this disease, are serious problems for patients." | 1.42 | Zigzag skin incision effectively camouflages the scar and alopecia for moyamoya disease: technical note. ( Kato, A; Kubota, H; Sanada, Y; Yabuuchi, T; Yoshioka, H, 2015) |
| "Degree of hair loss was assessed by a single practitioner using Dean's alopecia scale (grade 1/excellent [< 25% hair loss], grade 2/good [25%-50% hair loss], grade 3/moderate [50%-75% hair loss], grade 4/poor [> 75% hair loss]), by digital photographs, and by patient self-report of hair thinning or the need to wear a wig/head covering, or both." | 1.42 | Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy. ( Chuang, E; Cigler, T; Fiederlein, B; Isseroff, D; Moore, A; Schneider, S; Vahdat, L, 2015) |
| "She was diagnosed as follicular mucinosis co-existed with alopecia universalis." | 1.42 | Childhood follicular mucinosis co-existed with alopecia universalis. ( Jirasuthat, S; Tangjaturonrusamee, C; Wipavakul, S, 2015) |
| "The degree of androgenetic alopecia was classified according to the Hamilton-Norwood and Ludwig classifications." | 1.42 | Prevalence and types of androgenetic alopecia in north Anatolian population: A community-based study. ( Bas, Y; Citil, R; Demir, AK; Kalkan, G; Önder, Y; Sahin, S; Seckin, HY; Takci, Z, 2015) |
| "Alopecia is a frequently occurring side effect of chemotherapy that often can be prevented by cooling the scalp during the infusion." | 1.40 | Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia. ( Breed, WP; Coebergh, JW; Nortier, JW; van de Poll-Franse, LV; van den Akker-van Marle, ME; van den Hurk, CJ, 2014) |
| "The progression of baldness results in smaller hair papillae, thinner hair and a shortened hair cycle." | 1.40 | Morphological and morphometric study of the androgenetic alopecic scalp using two- and three-dimensional analysis comparing regional differences. ( Gil, YC; Kim, JN; Koh, KS; Lee, JY; Shin, KJ; Song, WC, 2014) |
| "Androgenetic alopecia is a common condition, with severe attendant psychosocial implications, and for which it is difficult to obtain a satisfactory degree of clinical improvement." | 1.40 | Platelet-rich plasma for androgenetic alopecia: a pilot study. ( Abeni, D; Greco, J; Raskovic, D; Schiavone, G, 2014) |
| "Alopecia is the fifth most common dermatologic diagnosis in African-American patients." | 1.39 | Prospective histologic examinations in patients who practice traumatic hairstyling. ( Mehregan, DM; Uhlenhake, EE, 2013) |
| "Cytotoxic therapy for patients with cancer frequently induces reversible, but long-lasting alopecia which might be prevented by scalp cooling." | 1.39 | Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. ( Breed, WP; Coebergh, JW; Nortier, JW; van de Poll-Franse, LV; van den Akker-van Marle, ME; van den Hurk, CJ, 2013) |
| "The pathogenesis of scarring alopecia in African American women remains poorly understood." | 1.39 | Transversely sectioned biopsies in the diagnosis of end-stage traction alopecia. ( Donovan, JC; Mirmirani, P, 2013) |
| "Scalp hair loss is often encountered in clinical practice in Japan after successful surgery for acromegaly." | 1.39 | Scalp hair loss after transsphenoidal adenomectomy in patients with acromegaly. ( Fukuhara, N; Nishioka, H; Takeshita, A; Takeuchi, Y; Yamada, S; Yamaguchi-Okada, M, 2013) |
| "Using CTS, hair loss due to CIA was quite measurable and ranged from 13 to 82 %." | 1.39 | Hair mass index obtained by cross-section trichometry: an objective and clinically useful parameter to quantify hair in chemotherapy-induced alopecia. ( Breed, WP; Dercksen, MW; Houterman, S; Peerbooms, M; van Poppel, JE; Vleut, RE, 2013) |
| "FFA is an increasingly common form of scarring hair loss, but the origin remains unknown." | 1.39 | Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University. ( Bazakas, A; Ladizinski, B; Olsen, EA; Selim, MA, 2013) |
| "The scalp was examined in 43 men with androgenic alopecia." | 1.38 | Field melanin mapping of the hairless scalp. ( Piérard, GE; Piérard-Franchimont, C; Quatresooz, P, 2012) |
| "Whether hair loss associated with androgenetic alopecia (AGA) involves caspase-1 activation is not known." | 1.38 | Caspase-1 level is higher in the scalp in androgenetic alopecia. ( Bauman, AJ; Bramlett, HM; Brand, F; de Rivero Vaccari, JP; Dietrich, WD; Keane, RW; Nusbaum, BP; Sawaya, ME, 2012) |
| "Dermatophyte infection is almost exclusively a superficial cutaneous mycosis usually confined to the stratum corneum of nails and hairs of normal hosts." | 1.38 | Disseminated dermatophytic pseudomycetoma caused by Microsporum species. ( Ball, E; de Morentin, HM; Finkel, O; Gat, A; Golan, H; Goudet, CE; Rodriguez, Y; Ruiz, A; Sprecher, E; Sprecher, H; Tirado-González, M, 2012) |
| "Diffuse generalized hair loss was the most common form of scalp hair loss, reported by 26% of women." | 1.37 | Physiological changes in scalp, facial and body hair after the menopause: a cross-sectional population-based study of subjective changes. ( Ali, I; Wojnarowska, F, 2011) |
| "Sarcoidosis is an idiopathic systemic granulomatous disease, in which non-caseating granulomas formations can occur in any organ." | 1.37 | Trichoscopy as a clue to the diagnosis of scalp sarcoidosis. ( Lorenzi, S; Misciali, C; Torres, F; Tosti, A, 2011) |
| "Tinea capitis is a common skin infection that should be considered in any type of scalp lesion." | 1.37 | Severe kerion celsi due to Trichophyton mentagrophytes: a case report. ( Jagtman, BA; Jaspers, GJ; Loza, B; Werrij, BG, 2011) |
| "A dutasteride treatment resulted in decreases in the DHT and 5α-androstanedione concentrations and DHT/T ratio in the hair samples." | 1.37 | Gas chromatography/mass spectrometry based hair steroid profiling may reveal pathogenesis in hair follicles of the scalp. ( Choi, MH; Chung, BC; Jung, HJ; Kim, SJ; Lee, WY, 2011) |
| "On day 12, we evaluated hair loss and histologic changes to scalp tissue for each group (n = 10)." | 1.37 | The α-lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: a pilot study. ( Hagiwara, S; Inomata, M; Kitano, S; Koga, H; Moriyama, M; Noguchi, T; Uchida, T; Yoshizumi, F, 2011) |
| "Female-pattern androgenetic alopecia is a very common disorder that has been associated with extreme psychological morbidity." | 1.37 | Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution. ( Emer, JJ; Markowitz, O; Stevenson, ML, 2011) |
| "The menopause is a period in which significant changes in oestrogen levels are recorded, and this review discusses studies that help to clarify the link between menopause and the perception of thinning hair." | 1.37 | Hormonal changes in menopause: do they contribute to a 'midlife hair crisis' in women? ( Mirmirani, P, 2011) |
| "Female pattern hair loss (FPHL) is characterized by diffuse thinning of hair in the frontal and parietal areas of the scalp, and preservation of the frontal hairline is the norm." | 1.36 | Occipital involvement in female pattern hair loss: histopathological evidences. ( Ekmekci, TR; Koslu, A; Sakiz, D, 2010) |
| "Lichen planopilaris (LPP) and pseudopelade of Brocq (PPB) are two scarring alopecia diagnoses that exhibit similar clinical features." | 1.36 | Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray. ( Bell, RH; Haegert, A; Isaac-Renton, M; Lo, BK; Martinka, M; McElwee, KJ; Ross, EK; Shapiro, J; Yu, M, 2010) |
| "While androgenetic alopecia (AGA) is the most common form of hair loss in adults, little is known about its prevalence, clinical features and response to treatments in the paediatric population." | 1.36 | Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients. ( Cantatore-Francis, J; Gonzalez, ME; Orlow, SJ, 2010) |
| "To investigate the incidence of scalp metastases in high-risk breast cancer patients in order to assess whether caution is warranted with scalp cooling during adjuvant therapy." | 1.36 | [Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur]. ( Breed, WP; Nortier, JW; van de Sande, MA; van den Hurk, CJ, 2010) |
| "However, eyebrow loss and hair loss in other body sites may also occur; this has been documented clinically, but rarely histopathologically." | 1.36 | Expanding the spectrum of frontal fibrosing alopecia: a unifying concept. ( Bashir, SJ; Chew, AL; Fenton, DA; Stefanato, CM; Wain, EM, 2010) |
| "In female pattern hair loss, investigations to rule out any underlying cause for hair loss such as anemia and thyroid deficiency should be carried out." | 1.35 | Hair transplantation: standard guidelines of care. ( Mysore, V; Patwardhan, N, 2008) |
| "Diffuse hair loss in women with AA is due to a reduction in the number of terminal hairs per FU and an increase in the number of vellus hairs." | 1.35 | The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unit. ( Harrison, S; Magee, J; Sinclair, R; Yazdabadi, A, 2008) |
| "All had frontotemporal recession with scarring." | 1.35 | Frontal fibrosing alopecia: clinical presentations and prognosis. ( Messenger, AG; Tan, KT, 2009) |
| "In a specialized hair loss clinic, a group of patients was identified with focal or complete hair loss at the scalp periphery, with a normal scalp surface." | 1.35 | Cicatricial marginal alopecia: is it all traction? ( Goldberg, LJ, 2009) |
| "Female pattern hair loss is devastating to many of the 21 million U." | 1.35 | Understanding and management of female pattern alopecia. ( Leavitt, M, 2008) |
| "We must anticipate future hair loss, communicate that to the patient, and consider it in surgical planning." | 1.35 | Scalp reconstruction and repair. ( Mangubat, EA, 2008) |
| "Tinea capitis is the most common dermatophyte infection in children." | 1.35 | Tinea capitis mimicking cicatricial alopecia: what host and dermatophyte factors lead to this unusual clinical presentation? ( Chamlin, S; Frieden, IJ; Mirmirani, P; Price, VH; Willey, A, 2009) |
| "Alopecia neoplastica is defined as hair loss secondary to a visceral malignancy that has metastasized to the scalp." | 1.35 | Cutaneous metastasis of breast carcinoma presenting as alopecia neoplastica. ( Cohen, PR; Conner, KB, 2009) |
| "The "Headspin Hole" is a common overuse syndrome of the scalp specific to headspins causing hair loss, inflammation and lumps on the skull." | 1.35 | [Breakdancer's "Headspin Hole" - first description of a common overuse syndrome]. ( Kauther, KM; Kauther, MD; von Knoch, M; Wedemeyer, C; Wegner, A; Weidle, PA, 2009) |
| "It also explains other aspects of androgenic alopecia." | 1.35 | Androgenic alopecia: a counterproductive outcome of the anabolic effect of androgens. ( Soni, VK, 2009) |
| "The rates of androgenetic alopecia and telogen effluvium were 26." | 1.35 | The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control study. ( Adiguzel, A; Arikan, S; Budakoglu, IY; Durusoy, C; Gulec, AT; Ozenli, Y; Tugal, O; Uslu, A, 2009) |
| "Androgenetic alopecia is a common cosmetic hair disorder, resulting from interplay of genetic, endocrine, and aging factors leading to a patterned follicular miniaturization." | 1.35 | Androgenetic alopecia in males: a histopathological and ultrastructural study. ( Abdel-Wahab, H; Attia, S; El-Domyati, M; Saleh, F, 2009) |
| "Cicatricial or scarring alopecia results in the destruction of hair follicles and is a significant cosmetic concern in African-American women." | 1.35 | Scarring alopecia: clinical and pathologic study of 54 African-American women. ( Borovicka, JH; Mehregan, DR; Prince, C; Thomas, L, 2009) |
| "Caffeine was identified as a stimulator of human hair growth in vitro; a fact which may have important clinical impact in the management of AGA." | 1.34 | Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro. ( Elsner, P; Fischer, TW; Hipler, UC, 2007) |
| "CT of the abdomen identified widespread metastases in the liver, pancreatic head, and lumbar spine." | 1.34 | Cervical cancer metastasis to the scalp presenting as alopecia neoplastica. ( Chung, JJ; Johnson, DW; Namiki, T, 2007) |
| "Although non-scarring diffuse hair loss has been frequently observed in systemic lupus erythematosus (SLE) patients, the pattern of hair loss with regard to its frequency in SLE has been rarely studied." | 1.34 | Cross-sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopecia. ( Kim, SJ; Kim, SY; Lee, JB; Lee, JW; Lee, SC; Lee, SS; Won, YH; Yoon, HJ; Yun, SJ, 2007) |
| "The clinical presentation of hair loss and scalp disorders in children varies widely, often ranging from subtle to disfiguring forms, and may be acquired or congenital." | 1.34 | Hair loss in children in South-East Nigeria: common and uncommon cases. ( Maduechesi, C; Nnoruka, EN; Obiagboso, I, 2007) |
| "Clinical examination showed hair loss with thinning and widening of the central parting of the scalp, both in boys and girls." | 1.33 | Androgenetic alopecia in children: report of 20 cases. ( Iorizzo, M; Piraccini, BM; Tosti, A, 2005) |
| "Specialist hair loss referral clinic in a teaching hospital." | 1.33 | The lack of significant changes in scalp hair follicle density with advancing age. ( Chapman, A; Magee, J; Sinclair, R, 2005) |
| "This method of reducing hair loss has been available since the 1970s." | 1.33 | Hair loss with chemotherapy: at a loss over its management? ( Randall, J; Ream, E, 2005) |
| "Aplasia cutis congenita is a special condition, with local vascular abnormalities: local flaps are prohibited." | 1.33 | [Scalp surgery in children: principles and therapeutic aspects]. ( Buis, J; Delbecque, M; Franchi, G; Picard, A; Sergent, B; Vazquez, MP, 2005) |
| "Female pattern hair loss (FPHL) is a common hair disorder of the central scalp." | 1.33 | Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective. ( Olsen, EA, 2005) |
| "Although female pattern hair loss can be a feature of hyperandrogenism, many women with hair loss show no clinical or biochemical features of androgen excess." | 1.33 | Female pattern hair loss, sebum excretion and the end-organ response to androgens. ( Agarwal, S; Birch, MP; Lashen, H; Messenger, AG, 2006) |
| "Sclerodermatous skin changes and scarring alopecia are described in up to 20% of patients." | 1.33 | Large, nonhealing scalp ulcer associated with scarring alopecia and sclerodermatous change in a patient with porphyria cutanea tarda. ( Bergamo, BM; Inglese, MJ, 2005) |
| "Androgenetic alopecia, or male pattern baldness, is a common, progressive disorder where large, terminal scalp hairs are gradually replaced by smaller hairs in precise patterns until only tiny vellus hairs remain." | 1.33 | Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness. ( Hamada, K; Randall, VA, 2006) |
| "preclinical stages of androgenetic alopecia (AGA) in androgen sensitive areas was documented." | 1.33 | Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride. ( Van Neste, D, 2006) |
| "Atretic cephalocele is a clinicopathological entity, which is different from the common form of cephalocele." | 1.33 | Autosomal dominant atretic cephalocele with phenotype variability: report of a Brazilian family with six affected in four generations. ( Carvalho, DR; Giuliani, LR; Pina-Neto, JM; Santos, AC; Simão, GN, 2006) |
| "The pathology of female pattern hair loss (FPHL) is characterized by an increase in the proportion of vellus follicles, manifest as a low terminal/vellus ratio." | 1.33 | Follicular miniaturization in female pattern hair loss: clinicopathological correlations. ( Messenger, AG; Sinclair, R, 2006) |
| "Patterned hair loss, follicular miniaturization, and increased telogen hair counts characterize androgenic alopecia (AGA)." | 1.33 | Female-patterned alopecia in teenage brothers with unusual histologic features. ( Carlson, JA; Malysz, J; Schwartz, J, 2006) |
| "To summarize the prevention and treatment of postoperative complications after the skin soft tissue expansion for scar alopecia." | 1.33 | [Prevention and treatment of postoperative complications after skin soft tissue expansion for scar alopecia]. ( Cen, Y; Liu, Y; Qing, Y, 2006) |
| "Most patients were men treated for androgenic alopecia." | 1.32 | Algorithm of hair restoration surgery in children. ( Kolasiñski, J; Kolenda, M, 2003) |
| "Actinic keratosis is an exceedingly common premalignant lesion that can develop into squamous cell carcinoma." | 1.32 | Delayed wound healing after three different treatments for widespread actinic keratosis on the atrophic bald scalp. ( Krekels, GA; Neumann, HA; Ostertag, JU; Quaedvlieg, PJ, 2003) |
| "Connective tissue nevi are benign hamartomas that usually appear as widespread, multiple, papular, skin lesions." | 1.32 | Familial localized connective tissue nevus of the scalp with alopecia (report of a very unusual case). ( Aivaliotis, M; Aroni, K; Davaris, P; Kyriazi, E, 2004) |
| "Chronic diffuse telogen hair loss is common in women." | 1.32 | The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. ( Jolley, D; Magee, J; Mallari, R; Sinclair, R, 2004) |
| "Cutis aplasia (or aplasia cutis congenita) is a congenital absence of all skin layers, often extending through bone." | 1.31 | Complete osseous regeneration of a large skull defect in a patient with cutis aplasia: a conservative approach. ( Buchman, SR; Colville, C; Muraszko, K; Rhee, ST, 2002) |
| "The authors report a case of aplasia cutis congenita of the scalp associated with bilateral coronal synostosis." | 1.31 | Surgical treatment of aplasia cutis congenita of the scalp associated with bilateral coronal synostosis. ( Arai, H; Ichida, M; Inoue, M; Komuro, Y; Miyajima, M; Sato, K; Seno, H; Yanai, A, 2002) |
| "Hair loss from the flap was rare." | 1.31 | New treatment of a visible linear scar in the scalp: multiple hair-bearing flap technique. ( Sawada, Y; Urushidate, S; Watanabe, Y; Yamashita, K; Yokoi, K; Yotsuyanagi, T, 2002) |
| "This is a case report of a patient with pseudopelade that involves both his scalp and beard area." | 1.31 | Pseudopelade of Brocq in beard area. ( Madani, S; Shapiro, J; Trotter, MJ, 2000) |
| "To better define the pathogenesis of acne keloidalis (AK)." | 1.31 | Acne keloidalis is a form of primary scarring alopecia. ( Homoky, C; Pratt, L; Sau, P; Sperling, LC, 2000) |
| "Various classifications of male androgenetic alopecia have been described." | 1.31 | Multifactorial classification of male and female androgenetic alopecia. ( Bouhanna, P, 2000) |
| "The GAPO syndrome is a rare but distinct genetic disorder." | 1.31 | [GAPO syndrome]. ( Abid, R; Elandaloussi, H; Ezzine, N; Fazaa, B; Goucha, S; Jaber, K; Kamoun, MR, 2000) |
| "All patients experienced hair loss." | 1.31 | A pilot study to assess the feasibility of prior scalp cooling with palliative whole brain radiotherapy. ( Groom, N; Hoskin, P; Jackson, S; Shah, N; Sibtain, A, 2000) |
| "Increased hair loss was detected in 4 of the 7 patients who completed the study." | 1.31 | Telogen effluvium after allergic contact dermatitis of the scalp. ( Piraccini, BM; Tosti, A; van Neste, DJ, 2001) |
| "Female pattern hair loss is common but estimates of its prevalence have varied widely." | 1.31 | Hair density, hair diameter and the prevalence of female pattern hair loss. ( Birch, MP; Messenger, AG; Messenger, JF, 2001) |
| "She also had typical androgenetic alopecia seen in this disorder." | 1.31 | [Multiple pigmented basalioma of the scalp in a patient with Curschmann-Steinert myotonia dystrophica. Confirmation of a rare symptom constellation]. ( Itin, PH; Laeng, RH, 2001) |
| "The biggest dimension of repaired baldness was 340 cm2, one expander exposed and one failed in expanding after operation and be corrected immediately." | 1.31 | [Treating cicatricial baldness with scalp expanding and hair autografting]. ( Li, AL; Yan, YZ; Yu, MS, 2001) |
| " We describe the effectiveness of cyclosporin A in a case of GLPLS at the dosage of 4 mg/kg/day." | 1.31 | Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A. ( Bianchi, L; Carboni, I; Chimenti, S; Paro Vidolin, A; Piemonte, P, 2001) |
| "A series of 35 breast cancer patients receiving adjuvant chemotherapy were consecutively assigned either to a scalp cooling regimen (19 patients) or to an ambient temperature regimen (16 patients)." | 1.30 | Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. ( Chaitchik, S; Inbar, M; Kalmus, Y; Kalmus, Z; Ron, IG, 1997) |
| "Tufted hair folliculitis is a characteristic localized scarring bacterial folliculitis of the scalp due to Staphylococcus aureus." | 1.30 | [Tufted hair folliculitis]. ( Burg, G; Hafner, J; Pericin, M; Trüeb, RM, 1997) |
| "Acquired ichthyosis is an important clinical finding; internal malignancy, systemic disease and medication are recognised associations." | 1.30 | Acquired ichthyosis, alopecia and loss of hair pigment associated with leiomyosarcoma. ( Bunker, CB; Farrell, AM; Fisher, C; Ross, JS; Thomas, JM, 1998) |
| "The visible linear scar of the scalp is a cosmetically serious complication of a scalp incision in scalp surgery, forehead lift, and craniofacial surgery, especially on the temporal scalp." | 1.30 | Prevention and treatment of wide scar and alopecia in the scalp: wedge excision and double relaxation suture. ( Burm, JS; Oh, SJ, 1999) |
| "POEMS syndrome is a rare condition with cutaneous manifestations commonly including angiomas, hypertrichosis, hyperpigmentation, and thickening of the skin." | 1.30 | POEMS syndrome: cicatricial alopecia as an unusual cutaneous manifestation associated with an underlying plasmacytoma. ( Feller, AC; Meigel, W; Mensing, H; Ramsauer, J; Stemm, AV; Weichenthal, M, 1999) |
| "When cryosections of scalp from men with androgenetic alopecia were stained with antibody against 5aR2, using immunoperoxidase avidin-biotin complex methodology, immunostaining was observed in the inner layer of the outer root sheath and, in more proximal regions of the follicle, in the inner root sheath." | 1.30 | Immunohistochemical localization of types 1 and 2 5alpha-reductase in human scalp. ( Ayala, J; Azzolina, B; Bayne, EK; Chang, B; Einstein, M; Flanagan, J; Harris, G; Mumford, RA; Singer, II; Thiboutot, D; Whiting, DA, 1999) |
| "45 cases with baldness following burn from 1988 to 1998 were reported." | 1.30 | [The clinical application of scalp expansion in the repair of cicatricial baldness in children]. ( Gao, Z; Liu, Y; Yang, J, 1999) |
| "In 20 patients with male pattern alopecia, an anterior and posterior paramedian incision was performed along contralateral borders of the bald scalp." | 1.29 | The Burow's triangle scalp reduction. A new and improved technique for paramedian scalp reduction. ( Cohen, BH, 1995) |
| "Temporary hair loss is well accepted as a possible result of psoriatic plaques." | 1.29 | [Scarring psoriatic alopecia]. ( Bonsmann, G; Kretzschmar, L; Luger, TA; Metze, D; Schwarz, T, 1995) |
| "Tissue expansion for correction of male pattern baldness has not gained wide acceptance by patients or surgeons because of the substantial albeit temporary deformity of the expansion." | 1.29 | Minimal expansion for correction of male pattern baldness. ( Howard, PS; McCafferty, LR, 1995) |
| "Male pattern baldness is a common affliction affecting up to half the adult male population." | 1.29 | Male pattern baldness. ( Duplechain, G; White, JA, 1994) |
| "The extensive horizontal scalp reduction technique with its difficulties and known limitations in relocation of flap and horizontal reduction was performed twice in combination with a Juri flap technique as treatment of wide scar alopecia resulting from a thermal burn." | 1.29 | Post-thermal burn alopecia and its treatment using extensive horizontal scalp reduction in combination with a Juri flap. ( Felman, G, 1994) |
| "The diagnosis of Goltz syndrome was made by histological findings such as upward extension of the subcutaneous tissue to the papillary dermis and marked diminution in the thickness of the dermis, although typical linear atrophy-like eruptions and other mesoectodermal dysplasia were absent." | 1.29 | A case of Goltz syndrome presenting as congenital incomplete alopecia. ( Hashimoto, H; Honda, T; Ishii, Y; Kurata, S; Sonoda, T; Takasaki, S; Takayasu, S; Terashi, H, 1994) |
| "A strategy of surgical treatment for male pattern baldness has been conceived using a combination of flaps and tissue expansion." | 1.29 | A preliminary report on a strategy for treatment of male pattern baldness: bilateral vertical flaps plus tissue expansion. ( Trott, JA, 1993) |
| "This type of hair loss and current hair replacement surgical techniques are discussed." | 1.29 | Hair replacement surgery for male pattern alopecia. ( Farrior, EH; Green, D; Josephson, JS, 1993) |
| "Both minoxidil-SEPA treatments produced significantly greater cumulative hair weight over the entire 16-week study compared to either of the Rogaine TS treatments." | 1.29 | The penetration enhancer SEPA augments stimulation of scalp hair growth by topical minoxidil in the balding stumptail macaque. ( Brunden, MN; Diani, AR; Shull, KL; Zaya, MJ, 1995) |
| "Hair loss is common in patients with HIV-1 infection, and in black patients this loss may be associated with straightening." | 1.29 | Clinical and histopathologic features of hair loss in patients with HIV-1 infection. ( Angritt, P; DeRusso, D; Skelton, HG; Smith, KJ; Sperling, L; Wagner, KF; Yeager, J, 1996) |
| "Basaloid follicular hyperplasia has been previously described as a component of follicular mucinosis but may apparently develop in the absence of overt mucinosis." | 1.29 | Basaloid folliculolymphoid hyperplasia with alopecia as an expression of mycosis fungoides (CTCL). ( Killingsworth, M; Kossard, S; White, A, 1995) |
| "Nine men had male pattern baldness (Juri degree II or III), and nine were controls (no male pattern baldness)." | 1.29 | Transcutaneous PO2 of the scalp in male pattern baldness: a new piece to the puzzle. ( Fisher, DM; Goldman, BE; Ringler, SL, 1996) |
| "Scalp cooling can help prevent hair loss, but is time-consuming and uncomfortable." | 1.29 | Scalp cooling to prevent hair loss in chemotherapy. ( Dougherty, L, 1996) |
| "Male pattern baldness is a common, androgen-dependent skin problem in adult men which is not well understood, although androgens are believed to act on the hair follicle via the mesenchyme-derived dermal papilla situated in the middle of the hair follicle bulb." | 1.29 | A comparison of the culture and growth of dermal papilla cells from hair follicles from non-balding and balding (androgenetic alopecia) scalp. ( Hamada, K; Hibberts, NA; Randall, VA, 1996) |
| "Even so, pseudopelade has been classified as scarring alopecia with postinflammatory alopecias." | 1.29 | Pseudopelade: an inherited alopecia. ( Sahl, WJ, 1996) |
| "Dermoids are congenital subcutaneous cysts, which gradually flatten and scar over a number of years." | 1.28 | Congenital inclusion dermoid cysts of the scalp. ( Darley, C; Dawber, RP; Sinclair, RD, 1992) |
| "Radiation-induced meningiomas have a characteristic biological behaviour, so that their recognition is important as regards follow-up." | 1.28 | A scalp lesion over an extracerebral mass: a sign of a radiation-induced meningioma. ( Climent, V; García Santos, JM, 1992) |
| " Cyclosporine A did not produce any side effects because the administered dosage was relatively low." | 1.28 | Alopecia universalis treated with oral cyclosporine A and prednisolone: immunologic studies. ( Hori, Y; Irie, M; Nakagawa, T; Nakayama, J; Teshima, H; Urabe, A, 1992) |
| "Male pattern baldness is assumed to result from a combination of normal serum concentrations of androgen and an appropriate genetic background." | 1.28 | Cutaneous immunopathology of androgenetic alopecia. ( Conte, ET; Leavitt, ML; Nafz, MA; Schroeter, AL; Young, JW, 1991) |
| "In six patients with isolated occipital baldness, specially designed flaps were used." | 1.28 | [Surgical treatment of male baldness using Juri's crescent flap]. ( Exner, K; Kostka, KH; Lemperle, G, 1991) |
| "Twenty-six men who presented with male pattern baldness (androgen-dependent alopecia), were quantitatively evaluated for scalp hair variables and compared with 13 age-matched controls." | 1.28 | Natural progression of male pattern baldness in young men. ( Gilkes, JJ; Norris, MJ; Ramsay, ID; Rushton, DH, 1991) |
| "In 1885 Brocq described a type of scarring alopecia he called pseudopelade (PPB), whose character as a separate disease entity has been denied in recent decades." | 1.28 | [The Brocq pseudopelade--a disease picture or disease entity]. ( Bergner, T; Braun-Falco, O; Heilgemeir, GP, 1989) |
| "A case of squamous cell carcinoma is presented that developed within a tense, fibrotic scar caused by chronic discoid lupus erythematosus." | 1.27 | [Spinocellular cancer at the site of chronic discoid lupus erythematosus]. ( Heider, L; Schmoeckel, C; Steger, O, 1984) |
| "The hair loss is obviously a consequence of the ichthyosiform erythroderma, and therefore we propose for this type of pseudopelade the term alopecia ichthyotica." | 1.27 | Alopecia ichthyotica. A characteristic feature of congenital ichthyosis. ( Happle, R; Traupe, H, 1983) |
| "The percent of hair loss was rated at each visit and photographs were used to further quantitate any hair loss." | 1.27 | Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopecia. ( Cetas, TC; Dean, JC; Griffith, KS; Jones, SE; Mackel, CL; Salmon, SE, 1983) |
| "A case of naevoid hypotrichosis affecting two symmetrical areas in the parietal regions is described." | 1.27 | Focal naevoid hypotrichosis. ( Barth, JH; Dawber, RP, 1987) |
| "The mechanisms which induce androgenetic alopecia in females are only poorly understood at the molecular biological level." | 1.27 | [Endocrine constellation in androgenetic alopecia in the female]. ( Schmidt, JB, 1987) |
| "In this study of atretic cephaloceles, the authors have considered the pedunculated or sessile type of cephalocele and also small nonpedunculated scalp defects developing in the vertex midline." | 1.27 | Parietal cephalocele: clinical importance of its atretic form and associated malformations. ( Fuwa, I; Kajiwara, H; Kohchi, M; Wada, H; Yokota, A, 1988) |
| "Male pattern baldness may be effectively eliminated in most patients through the use of soft-tissue expansion." | 1.27 | Scalp expansion for male pattern baldness. ( Au, VK; Manders, EK; Wong, RK, 1987) |
| "Both procedures leave areas of baldness in patients with more extensive losses (Juri classes II and II)." | 1.27 | Expansion-assisted treatment of male pattern baldness. ( Anderson, RD, 1987) |
| "Alopecia (hair loss) is often singled out as the most distressing side-effect of cancer chemotherapy treatment." | 1.27 | Preventing chemotherapy-induced alopecia in cancer patients: is scalp cooling worthwhile? ( Tierney, AJ, 1987) |
| "Male pattern hair loss in blacks appears to occur later, less frequently, and with less severity, than in whites." | 1.27 | Hair transplantation, scalp reduction, and flap rotation in black men. ( Earles, RM, 1986) |
| "41 cases with scarring alopecia seen from 1979 to 1983 were analyzed and differentiated." | 1.27 | Pseudopelade of Brocq. ( Bergner, T; Braun-Falco, O; Imai, S; Schmoeckel, C; Steger, O, 1986) |
| "The most frequent causes of hair loss in pediatric patients include tinea capitis, alopecia areata, traction alopecia, and trichotillomania." | 1.27 | Hair loss. Common congenital and acquired causes. ( Phillips, JH; Smith, SL; Storer, JS, 1986) |
| "The cause of male pattern baldness remains unknown." | 1.27 | Unravelling the pathophysiology of male pattern baldness. ( Herring, BD, 1985) |
| "Corrective surgery for baldness now includes scalp reduction, hair-bearing flaps, and punch autografts." | 1.26 | Updating reduction and flap procedures for baldness. ( Cates, JA; Dean, AJ; Stough, DB, 1982) |
| "Hair transplantation for male pattern baldness has been done on many patients by dermatologists and plastic surgeons during the past 20 years." | 1.26 | The strip scalp graft. ( Vallis, CP, 1982) |
| "In general, follicular mucinosis may be regarded as a peculiar, nonspecific histological reaction pattern in follicular epithelium that may occur on its own or in association with other pathological processes, particularly lymphomas." | 1.26 | Angiolymphoid hyperplasia with follicular mucinosis. ( Ackerman, AB; Kinney, J; Wolff, HH, 1978) |
| "5 cases of dysgenetic hydrocephaly associated with scalp anomalies are described." | 1.26 | Congenital midline porencephaly: a new brain malformation associated with scalp anomaly. ( Matsukado, Y; Yokota, A, 1979) |
| "Whatever remains of baldness after as much hair-lifting as feasible has been performed, is filled with "punch" grafts or free or pedicled strips." | 1.26 | Obliteration of alopecia by hair-lifting: a new concept and technique. ( Blanchard, B; Blanchard, G, 1977) |
| "A technique is described to correct male pattern baldness by transferring a large, single, temporo-occipital flap after one delay." | 1.26 | Transfer of a large, single temporo-occipital flap for treatment of baldness. ( Lauzon, G, 1979) |
| "A 17-year-old boy had a large, scarred area of alopecia from a thermal burn." | 1.26 | Scalp reduction for alopecia. ( Roenigk, HH; Schultz, BC, 1979) |
| "While hair loss is usually of more psychologic than physiologic significance, accurate diagnosis can be of great importance." | 1.26 | Diagnosing the common alopecias. ( Ackerman, AB; Stengel, F, 1978) |
| "Of 223 patients we operated on for male pattern baldness, 43 were done with square grafts." | 1.26 | Use of square scalp grafts for male pattern baldness. ( Coiffman, F, 1977) |
| "Treatment for alopecia areata is of little avail." | 1.24 | Noncicatrizing alopecias; with special reference to alopecia areata. ( NEW, WN; NICKEL, WR, 1958) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 421 (25.36) | 18.7374 |
| 1990's | 241 (14.52) | 18.2507 |
| 2000's | 245 (14.76) | 29.6817 |
| 2010's | 432 (26.02) | 24.3611 |
| 2020's | 321 (19.34) | 2.80 |
| Authors | Studies |
|---|---|
| Hardcastle, NJ | 1 |
| Tunbridge, AJ | 1 |
| Shum, KW | 1 |
| Dockrell, DH | 1 |
| Green, ST | 1 |
| Emons, G | 1 |
| Diedrich, K | 1 |
| Krebs, D | 1 |
| Knuppen, R | 1 |
| Bettencourt, MS | 1 |
| Olsen, EA | 8 |
| Abadjieva, TI | 1 |
| Shen, XF | 1 |
| Ru, LX | 1 |
| Yao, XB | 1 |
| Dhurat, R | 4 |
| Shukla, D | 1 |
| Daruwalla, S | 1 |
| Doche, I | 4 |
| Hordinsky, MK | 16 |
| Valente, NS | 3 |
| Sotto, MN | 2 |
| Miotto, I | 1 |
| Rebeis, M | 1 |
| Rivitti-Machado, MC | 1 |
| Novice, M | 3 |
| Novice, T | 4 |
| Henry, NL | 2 |
| Johnson, K | 1 |
| Jeruss, JS | 2 |
| Kidwell, KM | 1 |
| Burness, ML | 2 |
| Suzuki, T | 1 |
| Ito, T | 2 |
| Gilhar, A | 5 |
| Tokura, Y | 1 |
| Reich, K | 1 |
| Paus, R | 11 |
| Pérez Cavazos, S | 1 |
| De la Cruz Cruz, RA | 1 |
| Castillo Bejarano, JI | 1 |
| Vaquera Aparicio, DN | 1 |
| Mascareñas de Los Santos, AH | 1 |
| Zárate Hernández, MDC | 1 |
| O'Connor, LF | 1 |
| Wells, KM | 1 |
| Öner, Ü | 1 |
| Akdeniz, N | 2 |
| Samrao, A | 2 |
| Lyon, L | 1 |
| Mirmirani, P | 15 |
| Macey, J | 3 |
| Kitchen, H | 3 |
| Aldhouse, NVJ | 3 |
| Edson-Heredia, E | 1 |
| Burge, R | 1 |
| Prakash, A | 1 |
| King, BA | 3 |
| Mesinkovska, N | 7 |
| Guttman-Yassky, E | 4 |
| Pavel, AB | 3 |
| Diaz, A | 1 |
| Zhang, N | 3 |
| Del Duca, E | 4 |
| Estrada, Y | 1 |
| King, B | 1 |
| Banerjee, A | 1 |
| Banfield, C | 1 |
| Cox, LA | 1 |
| Dowty, ME | 1 |
| Page, K | 1 |
| Vincent, MS | 1 |
| Zhang, W | 1 |
| Zhu, L | 1 |
| Peeva, E | 1 |
| Renehan, S | 1 |
| Tencic, M | 1 |
| Jackson, K | 1 |
| Krishnasamy, M | 1 |
| Fozia, F | 1 |
| Shah, K | 1 |
| Nazli, R | 1 |
| Khan, SA | 1 |
| Ahmad, I | 1 |
| Mohammad, N | 1 |
| Khan, S | 2 |
| Alotaibi, A | 1 |
| Keren, A | 1 |
| Ullmann, Y | 2 |
| Wu, J | 3 |
| Mishra, P | 1 |
| Patil, A | 1 |
| Sinclair, R | 21 |
| Gold, M | 1 |
| Rudnicka, L | 8 |
| Grabbe, S | 1 |
| Goldust, M | 3 |
| Jamerson, TA | 1 |
| Conover Talbot, C | 1 |
| Dina, Y | 3 |
| Kwatra, SG | 1 |
| Garza, LA | 3 |
| Aguh, C | 5 |
| Yam, PK | 1 |
| Lintzeri, DA | 1 |
| Constantinou, A | 2 |
| Hillmann, K | 2 |
| Ghoreschi, K | 1 |
| Vogt, A | 6 |
| Blume-Peytavi, U | 6 |
| Linkov, G | 1 |
| Sukhdeo, K | 2 |
| Grand, E | 1 |
| Frew, D | 1 |
| Oaxaca, G | 1 |
| Habermehl, G | 1 |
| Unwala, R | 1 |
| Bergfeld, W | 9 |
| Nassar, A | 1 |
| Abdel-Aleem, H | 1 |
| Samir, M | 1 |
| Khattab, FM | 2 |
| Shahidi-Dadras, M | 1 |
| Asadi Kani, Z | 1 |
| Dadkhahfar, S | 1 |
| Zartab, H | 1 |
| Rakhshan, A | 1 |
| Qiu, J | 1 |
| Yi, Y | 1 |
| Jiang, L | 1 |
| Miao, Y | 3 |
| Jia, J | 1 |
| Zou, J | 1 |
| Hu, Z | 2 |
| Hashimoto, M | 1 |
| Kawai, Y | 1 |
| Masutani, T | 1 |
| Tanaka, K | 1 |
| Ito, K | 1 |
| Iddamalgoda, A | 1 |
| Keim, S | 1 |
| Hempel, L | 1 |
| Ebner, F | 1 |
| Retzer-Lidl, M | 1 |
| Wohlmuth, K | 1 |
| Hempel, D | 1 |
| Milani, V | 1 |
| Andjelkov, K | 1 |
| Eremin, II | 1 |
| Korac, A | 1 |
| Ding, L | 1 |
| DeGiovanni, JC | 1 |
| Bogner, P | 1 |
| Soofi, Y | 1 |
| Yin, L | 1 |
| Klein, EJ | 1 |
| Svigos, K | 1 |
| Gutierrez, D | 4 |
| Oratz, R | 1 |
| Lacouture, ME | 4 |
| Powers, M | 1 |
| Senna, M | 2 |
| Shapiro, J | 20 |
| Lo Sicco, K | 6 |
| Ohn, J | 1 |
| Son, HY | 1 |
| Yu, DA | 1 |
| Kim, MS | 1 |
| Kwon, S | 1 |
| Park, WS | 1 |
| Kim, JI | 1 |
| Kwon, O | 1 |
| Chen, L | 3 |
| Xu, Y | 2 |
| Ye, X | 1 |
| Rafati, M | 1 |
| Mahmoudian, R | 1 |
| Golpour, M | 1 |
| Kazeminejad, A | 1 |
| Saeedi, M | 1 |
| Nekoukar, Z | 1 |
| Arasu, A | 1 |
| Meah, N | 2 |
| Marzola, M | 1 |
| Sitarz, J | 1 |
| Spencer, C | 1 |
| Yang, L | 1 |
| Zhou, N | 2 |
| Alamgir, M | 1 |
| Wang, Z | 1 |
| Gao, Y | 2 |
| Li, Y | 3 |
| An, X | 1 |
| Dong, L | 1 |
| Zhang, Y | 3 |
| Yang, J | 2 |
| Tao, J | 1 |
| Suzuki, K | 1 |
| Cho, O | 1 |
| Nagahama, T | 1 |
| Sugita, T | 1 |
| Kessler, S | 1 |
| Marzooq, A | 1 |
| Sood, A | 1 |
| Beebe, K | 1 |
| Walsh, A | 1 |
| Montoya, L | 1 |
| Price, H | 1 |
| Chew, SK | 1 |
| Gajjar, T | 1 |
| Sethi, S | 1 |
| Trüeb, RM | 13 |
| Luu, NC | 1 |
| Kobal, I | 1 |
| Ramot, Y | 2 |
| Lugtenberg, RT | 1 |
| van den Hurk, CJG | 4 |
| Smorenburg, CH | 6 |
| Mosch, L | 1 |
| Houtsma, D | 1 |
| Deursen, MAGDH | 1 |
| Kaptein, AA | 1 |
| Gelderblom, H | 1 |
| Kroep, JR | 1 |
| Pathoulas, JT | 6 |
| Flanagan, KE | 6 |
| Su, MY | 1 |
| Elmariah, SB | 1 |
| Zhan, Y | 1 |
| Walker, CJ | 6 |
| Burns, LJ | 2 |
| Manatis-Lornell, A | 2 |
| Penzi, L | 1 |
| Miller, DD | 1 |
| Senna, MM | 9 |
| Amarillo, D | 1 |
| de Boni, D | 1 |
| Cuello, M | 1 |
| Kabbani, M | 1 |
| El Sayed, F | 1 |
| Sasaki, R | 1 |
| Asano, Y | 1 |
| Fujimura, T | 1 |
| Negbenebor, NA | 1 |
| Shayegan, LH | 1 |
| Cohen, LM | 1 |
| Kroumpouzos, G | 1 |
| Brunner, C | 1 |
| Emmelheinz, M | 1 |
| Kofler, R | 1 |
| Abdel Azim, S | 1 |
| Lehmann, M | 1 |
| Wieser, V | 1 |
| Ritter, M | 1 |
| Oberguggenberger, A | 1 |
| Marth, C | 1 |
| Egle, D | 1 |
| Kaliyadan, F | 1 |
| Jayasree, P | 1 |
| Ashique, KT | 1 |
| de Andrade Lima, MMD | 1 |
| Benez, M | 1 |
| Gamonal, SBL | 1 |
| Melo, DF | 3 |
| Tortelly, VD | 1 |
| Frattini, S | 1 |
| de Andrade Lima, EV | 1 |
| Cortez de Almeida, RF | 1 |
| Frattini, SC | 1 |
| Santos, LDN | 2 |
| Ramos, PM | 1 |
| Sosh, D | 1 |
| Chung, C | 1 |
| Kaffenberger, J | 1 |
| Karim, M | 1 |
| Klein, E | 1 |
| Oh, C | 1 |
| Vastarella, M | 1 |
| Martora, F | 1 |
| Ocampo-Garza, S | 1 |
| Patri, A | 1 |
| Battista, T | 1 |
| Nappa, P | 1 |
| Fabbrocini, G | 1 |
| Cantelli, M | 1 |
| Kępińska, K | 1 |
| Jałowska, M | 1 |
| Bowszyc-Dmochowska, M | 1 |
| Charakida, A | 1 |
| Teixeira, F | 1 |
| Kubba, F | 1 |
| Anton, A | 1 |
| Schulman, D | 1 |
| Cintra, ML | 2 |
| Wiss, IP | 1 |
| Azimi, E | 2 |
| Zhang, XY | 1 |
| Yang, KL | 1 |
| Liu, WQ | 1 |
| Huang, J | 1 |
| Ning, N | 1 |
| Saad, S | 1 |
| Cavelier-Balloy, B | 2 |
| Smadja, J | 1 |
| Assouly, P | 3 |
| Reygagne, P | 6 |
| Portney, D | 1 |
| Goyert, J | 1 |
| de Jong, N | 1 |
| Janse, I | 1 |
| Feng, Y | 1 |
| Lu, Y | 1 |
| Wang, H | 1 |
| Clements, ML | 1 |
| Wimbish, PW | 1 |
| Wall, RE | 1 |
| Saxton, AS | 1 |
| Tung, P | 1 |
| Sasaki, GH | 2 |
| Park, JH | 5 |
| Ho, YH | 1 |
| Manonukul, K | 1 |
| Boaventura, O | 1 |
| Stuque, C | 1 |
| Ali, S | 4 |
| Collins, M | 1 |
| Taylor, SC | 4 |
| Kelley, K | 1 |
| Stratton, E | 1 |
| Piccini, I | 1 |
| Sousa, M | 1 |
| Altendorf, S | 1 |
| Jimenez, F | 9 |
| Rossi, A | 8 |
| Funk, W | 1 |
| Bíró, T | 3 |
| Seibel, J | 1 |
| Jakobs, M | 1 |
| Yesilkaya, T | 1 |
| Edelkamp, J | 1 |
| Bertolini, M | 2 |
| Porto, AC | 1 |
| Pinto Blumetti, T | 1 |
| Calsavara, VF | 1 |
| Tardin Torrezan, G | 1 |
| Andrade de Paula, CA | 1 |
| Lellis, R | 1 |
| Pedreira Duprat Neto, J | 1 |
| Carraro, DM | 1 |
| Casagrande Tavoloni Braga, J | 1 |
| Hu, D | 1 |
| Yang, S | 3 |
| Lyakhovitsky, A | 2 |
| Tzanani, I | 1 |
| Gilboa, S | 1 |
| Segal, O | 1 |
| Galili, E | 1 |
| Baum, S | 1 |
| Barzilai, A | 1 |
| Gupta, AK | 2 |
| Bamimore, M | 1 |
| Kukowski, M | 1 |
| Beatty, CJ | 1 |
| Cai, E | 1 |
| English, JC | 2 |
| Kazlouskaya, V | 1 |
| Arora, G | 1 |
| Mishra, A | 2 |
| Chandra, N | 1 |
| Kesharwani, P | 1 |
| Jain, GK | 1 |
| Sharma, A | 4 |
| Vinay, K | 2 |
| Chatterjee, D | 1 |
| Narang, T | 1 |
| Dogra, S | 1 |
| Miteva, M | 12 |
| Nadji, M | 1 |
| Billero, V | 1 |
| LaSenna, C | 2 |
| Nattkemper, L | 1 |
| Romanelli, P | 3 |
| Nussbaum, D | 1 |
| Murphy, E | 1 |
| Nelson, K | 1 |
| Gonzalez-Lopez, A | 1 |
| Qureshi, A | 1 |
| Schwartz, J | 2 |
| Friedman, A | 1 |
| Nagrani, NS | 1 |
| Goldberg, LJ | 5 |
| Zheng, C | 1 |
| Fu, Q | 1 |
| Zhou, GW | 1 |
| Xu, X | 2 |
| Tian, XM | 1 |
| Lai, LY | 1 |
| Wu, Q | 1 |
| Ding, HF | 1 |
| Yu, BY | 1 |
| Chen, ML | 1 |
| Carbognin, L | 1 |
| Accetta, C | 1 |
| Di Giorgio, D | 1 |
| Fuso, P | 1 |
| Muratore, M | 1 |
| Tiberi, G | 1 |
| Pavese, F | 1 |
| D'Angelo, T | 1 |
| Fabi, A | 1 |
| Giannarelli, D | 1 |
| Di Leone, A | 1 |
| Magno, S | 1 |
| Garganese, G | 1 |
| Sanchez, AM | 1 |
| Terribile, DA | 1 |
| Franceschini, G | 1 |
| Masetti, R | 1 |
| Scambia, G | 1 |
| Paris, I | 1 |
| Collins, MS | 3 |
| Pupo Wiss, IM | 3 |
| Cotsarelis, G | 11 |
| Milbar, H | 3 |
| Huang, K | 4 |
| Mostaghimi, A | 5 |
| Scott, D | 3 |
| Han, JJ | 3 |
| Lee, KJ | 3 |
| Farah, RS | 7 |
| Bellefeuille, G | 3 |
| Raymond, O | 3 |
| Ranasinghe, G | 3 |
| Lo Sicco, KI | 3 |
| Ko, J | 3 |
| Yale, KL | 3 |
| Tosti, A | 29 |
| Gwillim, EC | 3 |
| Goh, C | 3 |
| Kittigul, L | 3 |
| Meephansan, J | 4 |
| Sirithanabadeekul, P | 3 |
| Hanvivattanakul, S | 3 |
| Deenonpoe, R | 3 |
| Yingmema, W | 3 |
| Tantisantisom, K | 3 |
| Thongma, S | 3 |
| Rayanasukha, Y | 3 |
| Boonkoom, T | 3 |
| Adulyaritthikul, P | 3 |
| Khanchaitit, P | 3 |
| Heath, CR | 2 |
| Usatine, RP | 2 |
| Gudobba, C | 2 |
| Mane, T | 2 |
| Bayramova, A | 2 |
| Rodriguez, N | 2 |
| Castelo-Soccio, L | 3 |
| Ogunleye, TA | 2 |
| Bernardis, E | 2 |
| Delgado Rodríguez, J | 1 |
| Ramos-García, V | 1 |
| Infante-Ventura, D | 2 |
| Suarez-Herrera, JC | 1 |
| Rueda-Domínguez, A | 1 |
| Serrano-Aguilar, P | 2 |
| Del Mar Trujillo-Martín, M | 1 |
| Rose, L | 1 |
| Schnell, PM | 1 |
| Radcliff, L | 1 |
| Lustberg, M | 1 |
| Dulmage, B | 1 |
| Torizuka, D | 1 |
| Uto, M | 1 |
| Umeda, K | 1 |
| Kamitori, T | 1 |
| Iwai, A | 1 |
| Saida, S | 1 |
| Kato, I | 1 |
| Mineharu, Y | 1 |
| Arakawa, Y | 1 |
| Takita, J | 1 |
| Mizowaki, T | 1 |
| Douglas, A | 1 |
| Romisher, A | 1 |
| Cohen, A | 1 |
| Zaya, R | 1 |
| Wang, J | 5 |
| Suriano, J | 1 |
| Zachian, R | 1 |
| Nikbakht, N | 1 |
| Govender, K | 1 |
| Sibanda, W | 1 |
| Lenzy, Y | 1 |
| Dlova, NC | 2 |
| Di Bartolomeo, L | 1 |
| Ceravolo, I | 1 |
| Borgia, F | 1 |
| Vaccaro, F | 1 |
| Guarneri, C | 2 |
| Vaccaro, M | 2 |
| Luo, J | 1 |
| Qian, Q | 1 |
| Zheng, W | 1 |
| Gripkauskaite, I | 1 |
| Wu, S | 2 |
| Zhang, M | 1 |
| Li, J | 2 |
| Fu, B | 1 |
| Bhogal, R | 1 |
| Murray, P | 1 |
| Rowson, M | 1 |
| Li, B | 2 |
| Xue, X | 1 |
| Gu, X | 1 |
| Yang, Y | 2 |
| Jin, L | 1 |
| Gunn, DA | 1 |
| Wang, S | 4 |
| Wollina, U | 2 |
| Babadjouni, A | 1 |
| Reddy, M | 1 |
| Zhang, R | 1 |
| Raffi, J | 1 |
| Phong, C | 1 |
| Clarke, E | 1 |
| Roche, H | 1 |
| El-Heis, S | 1 |
| Murray, C | 1 |
| Nomizu, T | 1 |
| Ueo, H | 1 |
| Kato, M | 1 |
| Fukuma, E | 1 |
| Park, G | 2 |
| Kim, J | 3 |
| Kim, T | 1 |
| Park, J | 3 |
| AboShaban, MS | 1 |
| Ghareeb, FM | 1 |
| Alkashty, SM | 1 |
| Elmas, ÖF | 1 |
| Durdu, M | 1 |
| Trujillo-Martín, MM | 1 |
| de Armas-Castellano, A | 1 |
| González-Hernández, Y | 1 |
| González-Pacheco, H | 1 |
| Del Pino-Sedeño, T | 1 |
| Ramallo-Fariña, Y | 1 |
| Abt-Sack, A | 1 |
| Rueda Domínguez, A | 1 |
| Karim, N | 1 |
| Durbin-Johnson, BP | 1 |
| Rocke, DM | 1 |
| Salemi, M | 1 |
| Phinney, BS | 1 |
| Rice, RH | 1 |
| Dinkins, J | 1 |
| Iwuala, C | 1 |
| Akintilo, L | 1 |
| Ugonabo, N | 1 |
| Sicco, KL | 1 |
| Adotama, P | 2 |
| Budania, A | 1 |
| Mandal, S | 1 |
| Agrawal, A | 1 |
| Lahoria, U | 1 |
| Pathania, YS | 1 |
| Starace, M | 7 |
| Pampaloni, F | 1 |
| Bruni, F | 4 |
| Quadrelli, F | 1 |
| Cedirian, S | 1 |
| Baraldi, C | 2 |
| Misciali, C | 5 |
| Di Martino, A | 1 |
| Sabatelli, P | 1 |
| Merlini, L | 1 |
| Piraccini, BM | 14 |
| Anaba, EL | 1 |
| Dawodu, OO | 1 |
| Cole-Adeife, O | 1 |
| Olaosebikan, H | 1 |
| Heibloem, RE | 1 |
| Komen, MMC | 3 |
| Ilozumba, OUC | 1 |
| Mokthar, G | 1 |
| Chaker, C | 1 |
| Vadalà, M | 1 |
| Giacomello, M | 1 |
| Greco Lucchina, A | 1 |
| Scarano, A | 1 |
| Pleasant, VA | 1 |
| Purkiss, AS | 1 |
| Merjaver, SD | 1 |
| Pearce, J | 1 |
| Al-Wahab, Y | 1 |
| Brent, G | 1 |
| Natkunarajah, J | 1 |
| Mayer, W | 1 |
| Weibel, M | 1 |
| De Luca, C | 1 |
| Ibragimova, G | 1 |
| Trakhtman, I | 1 |
| Kharaeva, Z | 1 |
| Chandler, DL | 1 |
| Korkina, L | 1 |
| Larrondo, J | 2 |
| McMichael, AJ | 6 |
| Redmond, LC | 1 |
| Limbu, S | 1 |
| Farjo, B | 5 |
| Messenger, AG | 6 |
| Higgins, CA | 1 |
| Sode, T | 1 |
| Ogwumike, E | 1 |
| Hosler, GA | 1 |
| Khalid, I | 1 |
| Michel, A | 1 |
| Lee, RT | 1 |
| Salehi, E | 1 |
| Accordino, MK | 1 |
| Pitch, MA | 1 |
| Sperling, LC | 11 |
| Dayanan, R | 1 |
| Bilen, A | 1 |
| Çiftel, S | 1 |
| Çiftel, E | 1 |
| Mercantepe, F | 1 |
| Demirci, T | 1 |
| Tonkaz, G | 1 |
| Yakar, B | 1 |
| Önalan, E | 1 |
| Çapoğlu, I | 1 |
| Bilen, H | 1 |
| Chandler, BM | 1 |
| Drolshagen, H | 1 |
| Zoumberos, N | 1 |
| Evans, MS | 1 |
| Balazic, E | 1 |
| Axler, E | 1 |
| Nwankwo, C | 1 |
| Kim, R | 1 |
| Kobets, K | 1 |
| Liu, J | 2 |
| Chen, J | 1 |
| Wang, Y | 3 |
| Jackson, TK | 1 |
| Sow, Y | 1 |
| Ayoade, KO | 1 |
| Seykora, JT | 2 |
| Ogunleye, T | 1 |
| Ye, Y | 2 |
| Zhu, J | 2 |
| Huang, R | 1 |
| Yu, Q | 1 |
| Zhang, J | 2 |
| Chen, X | 2 |
| Wei, Z | 1 |
| Han, Y | 1 |
| Li, P | 1 |
| Umar, S | 4 |
| Khanna, R | 1 |
| Lohlun, B | 1 |
| Maldonado, JC | 1 |
| Zollinger, M | 1 |
| Osei-Tutu, A | 1 |
| Gonzales, A | 1 |
| Chouhan, K | 1 |
| Nusbaum, A | 1 |
| Doost, MS | 1 |
| Love, NR | 1 |
| Fung, MA | 2 |
| Tartar, DM | 1 |
| Buontempo, MG | 1 |
| Alhanshali, L | 1 |
| Vathananai, W | 1 |
| Dahabreh, D | 2 |
| Jung, S | 1 |
| Renert-Yuval, Y | 2 |
| Bar, J | 1 |
| Rubin, A | 1 |
| Shah, RR | 1 |
| Haroon, A | 1 |
| Rao, B | 1 |
| Leung, BW | 1 |
| Glass, DA | 1 |
| Ayoade, K | 1 |
| Heymann, WR | 2 |
| Villavisanis, DF | 1 |
| Chatterjee, A | 1 |
| Taylor, JA | 1 |
| de Abreu, EP | 1 |
| Rocha, VB | 1 |
| Queiroz de Melo, RF | 1 |
| Pereira, LB | 1 |
| Landeiro, LCG | 1 |
| Lopes Paim Miranda, D | 1 |
| Mathias Machado, R | 1 |
| Dienstmann, R | 1 |
| Costa E Silva, M | 1 |
| da Silva, CF | 1 |
| de Castro, ALR | 1 |
| Dos Santos, APT | 1 |
| Bomfim, VHV | 1 |
| Teixeira Machado, B | 1 |
| Viviane Carvalho Rodrigues Gonçalves, M | 1 |
| Freitas Muniz Teixeira, A | 1 |
| Jamile Santiago Costa, M | 1 |
| de Oliveira Dantas Viana, P | 1 |
| Almeida, P | 1 |
| de Cerqueira Mathias, CM | 1 |
| Kwack, MH | 3 |
| Hamida, OB | 1 |
| Kim, MK | 6 |
| Sung, YK | 4 |
| Wu, CX | 1 |
| Li, CH | 1 |
| Shiao, YH | 1 |
| Cheng, HY | 1 |
| Wu, TH | 1 |
| Lee, CH | 1 |
| Chang, ZY | 2 |
| Yeh, YC | 1 |
| Pathania, V | 1 |
| Bhatt, S | 1 |
| Ravaioli, GM | 1 |
| Alessandrini, AM | 1 |
| Guicciardi, F | 1 |
| Orlando, G | 1 |
| Salmaso, R | 1 |
| Piaserico, S | 1 |
| Marks, DH | 2 |
| Naftulin, JS | 1 |
| Penzi, LR | 1 |
| Yasuda, MR | 1 |
| Chapman, CM | 1 |
| Rao, SR | 1 |
| Saavedra, A | 1 |
| Narita, K | 1 |
| Fukuoka, H | 1 |
| Sekiyama, T | 1 |
| Suga, H | 1 |
| Harii, K | 2 |
| Dadaci, M | 1 |
| Yildirim, MEC | 1 |
| Ince, B | 1 |
| Premanand, A | 1 |
| Rajkumari, BR | 1 |
| Kako, J | 1 |
| Kajiwara, K | 1 |
| Kobayashi, M | 1 |
| Oosono, Y | 1 |
| Munzone, E | 2 |
| Pagan, E | 2 |
| Bagnardi, V | 2 |
| Mazzocco, K | 2 |
| Valdebran, M | 3 |
| Mo, J | 1 |
| Elston, DM | 4 |
| Doan, L | 1 |
| Franceschini, C | 1 |
| Garelli, V | 2 |
| Persechino, F | 1 |
| Sperduti, I | 1 |
| Caro, G | 5 |
| Ardigò, M | 1 |
| Pindado-Ortega, C | 2 |
| Perna, C | 1 |
| Saceda-Corralo, D | 5 |
| Fernández-Nieto, D | 1 |
| Jaén-Olasolo, P | 2 |
| Vañó-Galván, S | 6 |
| Suchonwanit, P | 9 |
| Pakornphadungsit, K | 2 |
| Leerunyakul, K | 3 |
| Khunkhet, S | 2 |
| Sriphojanart, T | 1 |
| Rojhirunsakool, S | 2 |
| Metwalli, M | 1 |
| Mandour, S | 1 |
| Ruiz, RG | 1 |
| Rosell, JMC | 1 |
| Ceccarelli, G | 1 |
| De Sio, C | 1 |
| De Angelis, GC | 1 |
| Pinto, H | 1 |
| Astarita, C | 1 |
| Graziano, A | 1 |
| Secchin, P | 1 |
| Quintella, DC | 1 |
| Paula, NÁO | 1 |
| Andrade, LCDS | 1 |
| Sodré, CT | 1 |
| Agrawal, S | 4 |
| Daruwalla, SB | 1 |
| Dhurat, RS | 1 |
| Zgonc Škulj, A | 1 |
| Poljšak, N | 1 |
| Kočevar Glavač, N | 1 |
| Kreft, S | 1 |
| Miyakawa, M | 1 |
| Yamaguchi, Y | 1 |
| Hirokado, M | 1 |
| Aihara, M | 1 |
| Nam, GH | 1 |
| Jo, KJ | 1 |
| Park, YS | 1 |
| Kawk, HW | 1 |
| Yoo, JG | 1 |
| Jang, JD | 1 |
| Kang, SM | 1 |
| Kim, SY | 3 |
| Kim, YM | 1 |
| Lee, WJ | 1 |
| Sohng, C | 1 |
| Kim, JY | 2 |
| Park, KD | 1 |
| Jang, YH | 1 |
| Lee, SJ | 1 |
| Tan, TL | 2 |
| Doytcheva, K | 1 |
| Guitart, J | 3 |
| Gerami, P | 2 |
| Yazdan, P | 3 |
| Boboljova, M | 1 |
| Uchida, Y | 1 |
| Corrigall, RS | 1 |
| Martin, CJ | 1 |
| Scott, I | 1 |
| Giarratano, T | 1 |
| Frezzini, S | 1 |
| Zanocco, M | 1 |
| Giorgi, CA | 1 |
| Mioranza, E | 1 |
| Miglietta, F | 1 |
| Griguolo, G | 1 |
| Falci, C | 1 |
| Faggioni, G | 1 |
| Tasca, G | 1 |
| Di Liso, E | 1 |
| Vernaci, G | 1 |
| Menichetti, A | 1 |
| Mantiero, M | 1 |
| Grosso, D | 1 |
| Guarneri, V | 1 |
| Dieci, MV | 1 |
| Bajpai, J | 2 |
| Kagwade, S | 1 |
| Chandrasekharan, A | 1 |
| Dandekar, S | 1 |
| Kanan, S | 1 |
| Kembhavi, Y | 1 |
| Ghosh, J | 1 |
| Banavali, SD | 1 |
| Gupta, S | 2 |
| Martinez-Jacobo, LA | 1 |
| Ancer-Arellano, CI | 1 |
| Villarreal-Villarreal, CD | 1 |
| Ortiz-Lopez, R | 1 |
| Montufar-Martinez, M | 1 |
| Trevino, V | 1 |
| Santuario-Facio, SK | 1 |
| Sanchez-Cornejo, R | 1 |
| Sanchez-Garcia, A | 1 |
| Medina-De la Garza, CE | 1 |
| Ancer-Rodriguez, J | 1 |
| Sinclair, RD | 2 |
| Ocampo-Candiani, J | 2 |
| Rojas-Martinez, A | 1 |
| Harries, M | 5 |
| Hardman, J | 1 |
| Chaudhry, I | 1 |
| Poblet, E | 4 |
| Heo, JH | 1 |
| Yeom, SD | 1 |
| Byun, JW | 1 |
| Shin, J | 1 |
| Choi, GS | 1 |
| Griggs, J | 1 |
| Gavazzoni Dias, MFR | 2 |
| Hordinsky, M | 7 |
| Chen, KY | 1 |
| Lin, SH | 1 |
| Cheng, SY | 1 |
| Lo, TK | 1 |
| Huang, HY | 1 |
| Tang, MJ | 1 |
| Yang, CC | 7 |
| Iorizzo, M | 5 |
| Piccolo, V | 1 |
| Argenziano, G | 3 |
| Camacho, FM | 1 |
| Gallyamova, Y | 1 |
| Umbert, I | 1 |
| Goren, A | 4 |
| Alessandrini, A | 5 |
| Van Neste, D | 10 |
| Wyrwich, KW | 2 |
| Knight, S | 2 |
| Nunes, FP | 2 |
| Dutronc, Y | 2 |
| Ko, JM | 2 |
| Siah, TW | 1 |
| Guo, H | 3 |
| Chu, T | 2 |
| Santos, L | 1 |
| Nakamura, H | 1 |
| Leung, G | 1 |
| McElwee, KJ | 3 |
| Kuka, G | 1 |
| Epstein, J | 2 |
| Aronowitz, J | 1 |
| Glasgold, MJ | 1 |
| Rogal, JG | 1 |
| Brown, W | 1 |
| Geronemus, RG | 1 |
| Daniels, EJ | 1 |
| Washenik, K | 2 |
| Patel, A | 1 |
| Lee, JA | 1 |
| Levy, DA | 1 |
| Patel, KG | 1 |
| Brennan, E | 1 |
| Oyer, SL | 1 |
| Triwongwaranat, D | 2 |
| Boonchai, W | 1 |
| Subchookul, C | 2 |
| Sitthinamsuwan, P | 1 |
| Thuangtong, R | 2 |
| Fernandez-Flores, A | 1 |
| Gentile, P | 2 |
| Scioli, MG | 2 |
| Cervelli, V | 2 |
| Orlandi, A | 2 |
| Garcovich, S | 2 |
| Kannan, S | 1 |
| Junejo, MH | 1 |
| Kentley, J | 1 |
| Rajpopat, M | 1 |
| Tan, XL | 1 |
| Mohd Mustapa, MF | 1 |
| Harwood, CA | 1 |
| Thakur, V | 1 |
| Bishnoi, A | 1 |
| Kumar, S | 1 |
| Aggarwal, D | 1 |
| Dass Radotra, B | 1 |
| Ruano Ruiz, J | 2 |
| Sanyal, RD | 1 |
| Song, T | 1 |
| Gay-Mimbrera, J | 2 |
| Estrada, YD | 2 |
| Peng, X | 1 |
| Phelps, RG | 2 |
| Krueger, JG | 2 |
| Ekelem, C | 3 |
| Feil, N | 2 |
| Csuka, E | 3 |
| Juhasz, M | 3 |
| Lin, J | 3 |
| Choi, F | 3 |
| Asghari, A | 1 |
| Heydarlou, D | 1 |
| Mesinkovska, NA | 4 |
| Kutlu, Ö | 1 |
| Magri, F | 3 |
| Federico, A | 2 |
| Fortuna, MC | 5 |
| Soda, G | 1 |
| De Vincentiis, L | 1 |
| Carlesimo, M | 4 |
| Andersen, PL | 1 |
| Jemec, GB | 1 |
| Arendrup, MC | 1 |
| Saunte, DM | 1 |
| Hou, SW | 1 |
| He, SY | 1 |
| Xie, J | 1 |
| Li, MY | 1 |
| Hong, MS | 1 |
| Guan, FL | 1 |
| Hu, YL | 1 |
| Huang, YL | 2 |
| Xu, CH | 1 |
| Bosch-Amate, X | 1 |
| Riquelme-McLoughlin, C | 1 |
| Morgado-Carrasco, D | 2 |
| Rojano-Fritz, L | 1 |
| Iranzo-Fernández, P | 1 |
| Epstein, GK | 1 |
| Abdelmaksoud, A | 1 |
| Williams, R | 1 |
| Pawlus, AD | 1 |
| Thornton, MJ | 1 |
| Maguire, M | 1 |
| Drumm, C | 1 |
| Woods, G | 1 |
| Mullally, W | 1 |
| Redmond, M | 1 |
| Grogan, L | 1 |
| O'Kane, M | 1 |
| Bhoyrul, B | 3 |
| Soga, S | 2 |
| Koyama, T | 2 |
| Mikoshi, A | 2 |
| Arafune, T | 2 |
| Kawashima, M | 2 |
| Kobayashi, K | 2 |
| Shinmoto, H | 2 |
| Ohsumi, S | 2 |
| Kiyoto, S | 2 |
| Takahashi, M | 2 |
| Hara, F | 1 |
| Takashima, S | 2 |
| Aogi, K | 2 |
| Matsuda, M | 1 |
| Yamamura, N | 1 |
| Doi, M | 2 |
| Al-Busani, H | 1 |
| Namiki, T | 2 |
| Miura, K | 1 |
| Yokozeki, H | 1 |
| Hagigeorges, D | 2 |
| Isakoff, SJ | 2 |
| Spring, L | 1 |
| Nazarian, R | 1 |
| Trindade de Carvalho, L | 1 |
| Wall, D | 1 |
| Farah, HA | 1 |
| Brown, MB | 1 |
| McAuley, WJ | 1 |
| El Shabrawi-Caelen, L | 1 |
| Fujita, J | 1 |
| Visessiri, Y | 1 |
| Rutnin, S | 1 |
| Srisont, S | 1 |
| Koumaki, D | 1 |
| Koumaki, V | 1 |
| Katoulis, A | 1 |
| Lagoudaki, E | 1 |
| Boumpoucheropoulos, S | 1 |
| Stefanidou, M | 1 |
| Miaris, O | 1 |
| Baltaga, L | 1 |
| Evangelou, G | 1 |
| Zografaki, K | 1 |
| Krueger-Krasagakis, SE | 1 |
| Krasagakis, K | 1 |
| Carloni, R | 2 |
| Pechevy, L | 1 |
| Postel, F | 1 |
| Zielinski, M | 1 |
| Gandolfi, S | 1 |
| Rencz, F | 1 |
| Gosch, M | 1 |
| Peña, C | 1 |
| Cabrera, R | 1 |
| Jeraldo, C | 1 |
| Castro, A | 1 |
| Jinzaki, M | 1 |
| Felix, K | 1 |
| De Souza, B | 1 |
| Portilla, N | 1 |
| Hogue, L | 1 |
| Ahn, CS | 1 |
| Sangueza, O | 1 |
| Singer, S | 1 |
| Tkachenko, E | 1 |
| Sharma, P | 1 |
| Nelson, C | 1 |
| LeBoeuf, NR | 1 |
| Carvalho, RM | 1 |
| Barreto, TM | 1 |
| Weffort, F | 1 |
| Machado, CJ | 2 |
| Sawada, M | 1 |
| Kunieda, E | 1 |
| Akiba, T | 1 |
| Kabuki, S | 1 |
| Nagao, R | 1 |
| Fukuzawa, T | 1 |
| Matsumoto, Y | 1 |
| Shigematsu, N | 1 |
| Altundag, K | 1 |
| Bedrin, KO | 1 |
| Dougherty, C | 1 |
| Haslam, IS | 2 |
| Zhou, G | 1 |
| Xie, G | 1 |
| Teng, X | 1 |
| Ao, X | 1 |
| Yan, Z | 1 |
| Smart, E | 2 |
| Rutkowski, D | 1 |
| Wierzbicka, J | 1 |
| Zhou, Y | 2 |
| Huang, Z | 1 |
| Farjo, N | 4 |
| Yue, Z | 1 |
| Platzer, KD | 1 |
| Steimle-Grauer, SA | 1 |
| Biedermann, T | 1 |
| Posch, C | 1 |
| Ohyama, M | 3 |
| Kurzeja, M | 1 |
| Czuwara, J | 1 |
| Walecka, I | 1 |
| Olszewska, M | 4 |
| McMichael, A | 6 |
| Phillips, GS | 1 |
| Freret, ME | 1 |
| Friedman, DN | 1 |
| Trelles, S | 1 |
| Kukoyi, O | 1 |
| Freites-Martinez, A | 1 |
| Unger, RH | 3 |
| Disa, JJ | 1 |
| Wexler, LH | 1 |
| Tinkle, CL | 1 |
| Mechalakos, JG | 1 |
| Dusza, SW | 1 |
| Beal, K | 1 |
| Wolden, SL | 1 |
| Abbas, Z | 1 |
| Kufi, H | 1 |
| Xiao, L | 1 |
| Zhang, X | 3 |
| Chen, Z | 2 |
| Li, L | 1 |
| Natpracha, W | 1 |
| Sukanjanapong, S | 1 |
| Chanprapaph, K | 3 |
| Filaire, E | 1 |
| Dreux, A | 1 |
| Boutot, C | 1 |
| Ranouille, E | 1 |
| Berthon, JY | 1 |
| Norrenberg, S | 1 |
| Monod, M | 1 |
| Christen-Zaech, S | 1 |
| Shin, JM | 1 |
| Kim, KH | 2 |
| Kim, SM | 1 |
| Hong, D | 1 |
| Lee, HY | 1 |
| Lim, WJ | 1 |
| Shin, YA | 1 |
| Kim, CD | 1 |
| Seo, YJ | 1 |
| Lee, JH | 4 |
| Kim, N | 2 |
| Lee, Y | 1 |
| El-Husseiny, RM | 1 |
| Saleh, HM | 1 |
| Moustafa, AA | 1 |
| Salem, SA | 1 |
| Araoye, EF | 1 |
| Stearns, V | 1 |
| Pakhomova, EE | 1 |
| Smirnova, IO | 1 |
| Creadore, A | 1 |
| Manjaly, P | 1 |
| Li, SJ | 1 |
| Joyce, C | 1 |
| Huang, KP | 1 |
| Marsh, RL | 1 |
| Spohn, GP | 1 |
| Kaffenberger, JA | 1 |
| Fujii, T | 1 |
| Ichiba, K | 1 |
| Honda, C | 1 |
| Tokuda, S | 1 |
| Nakazawa, Y | 1 |
| Ogino, M | 2 |
| Kurozumi, S | 1 |
| Obayashi, S | 1 |
| Yajima, R | 1 |
| Shirabe, K | 1 |
| Tisack, A | 1 |
| Jiang, A | 1 |
| Veenstra, J | 1 |
| Pedersini, R | 1 |
| Fornaro, C | 1 |
| di Mauro, P | 1 |
| Bianchi, S | 1 |
| Vassalli, L | 1 |
| Amoroso, V | 1 |
| Gelmi, M | 1 |
| Ardine, M | 1 |
| Rodella, F | 1 |
| Cosentini, D | 1 |
| Dalla Volta, A | 1 |
| Turla, A | 1 |
| Pierini, M | 1 |
| Motta, P | 1 |
| Conti, E | 1 |
| Simoncini, EL | 1 |
| Berruti, A | 1 |
| Urban, G | 1 |
| Hashemi, K | 1 |
| Baldi, P | 1 |
| Li, MF | 1 |
| Gu, L | 1 |
| Wang, L | 1 |
| Dai, JJ | 1 |
| Yang, XK | 1 |
| Guan, H | 1 |
| Han, JT | 1 |
| Hu, DH | 1 |
| Yamamoto, T | 2 |
| Moreno-Arrones, ÓM | 3 |
| Rodrigues-Barata, AR | 1 |
| Hermosa-Gelbard, Á | 1 |
| Haque, E | 1 |
| Alabdaljabar, MS | 1 |
| Ruddy, KJ | 1 |
| Haddad, TC | 1 |
| Thompson, CA | 1 |
| Lehman, JS | 1 |
| Hashmi, SK | 1 |
| Yu, J | 1 |
| Hosking, AM | 1 |
| Pham, CT | 1 |
| Heidari, AE | 1 |
| Rapaport, JA | 1 |
| Villarreal-Garza, C | 1 |
| Mesa-Chavez, F | 1 |
| Garza-Ledezma, MRA | 1 |
| Peña-Curiel, O | 1 |
| Martinez-Cannon, BA | 1 |
| Canavati-Marcos, M | 1 |
| Cardona-Huerta, S | 1 |
| Henning, A | 1 |
| Aldrich, N | 1 |
| Weaver, J | 1 |
| Cantwell, HM | 1 |
| Wieland, CN | 1 |
| Proffer, SL | 1 |
| Imhof, RL | 1 |
| Torgerson, RR | 2 |
| Tolkachjov, SN | 2 |
| Mikiel, D | 1 |
| Polańska, A | 1 |
| Żaba, R | 1 |
| Adamski, Z | 1 |
| Dańczak-Pazdrowska, A | 1 |
| Mancilla, GA | 1 |
| Restrepo, R | 1 |
| Sanclemente, G | 1 |
| Nemazee, L | 1 |
| Eginli, A | 2 |
| Cooley, J | 1 |
| Mofarrah, R | 2 |
| Jahani Amiri, K | 1 |
| Ghasemi, M | 1 |
| Wen, Y | 1 |
| Żychowska, M | 2 |
| Abdel-Raouf, H | 1 |
| Aly, UF | 1 |
| Medhat, W | 1 |
| Ahmed, SS | 1 |
| Abdel-Aziz, RTA | 1 |
| Schoenmaker, MHA | 1 |
| Thorsen, P | 1 |
| Korver, CRW | 1 |
| Kate, S | 1 |
| Patil, R | 1 |
| Pathan, D | 1 |
| Vyavhare, R | 1 |
| Joseph, S | 1 |
| Baby, V | 1 |
| Ramesh, YV | 1 |
| Nagarkar, R | 1 |
| Weinhammer, A | 1 |
| Rolnick, K | 1 |
| Shields, BE | 1 |
| Keenan, T | 1 |
| Bennett, D | 1 |
| Vanderweil, SG | 1 |
| Thatiparthi, A | 1 |
| Martin, A | 1 |
| Wu, JJ | 2 |
| Khan, A | 1 |
| Malik, S | 1 |
| Walia, J | 1 |
| Fridman, G | 1 |
| Fridman, A | 1 |
| Friedman, PC | 1 |
| Nilforoushzadeh, MA | 1 |
| Lotfi, E | 1 |
| Heidari-Kharaji, M | 1 |
| Torkamaniha, E | 1 |
| Hanifnia, AR | 1 |
| Taglia, L | 1 |
| Wiss, IMP | 1 |
| Morandi Stumpf, MA | 1 |
| do Rocio Valenga Baroni, E | 1 |
| Schafranski, MD | 1 |
| Porriño-Bustamante, ML | 1 |
| Fernández-Pugnaire, MA | 2 |
| Castellote-Caballero, L | 1 |
| Arias-Santiago, S | 3 |
| Cavanagh, G | 1 |
| Wambier, CG | 1 |
| Piccolo, D | 1 |
| Crisman, G | 1 |
| Conforti, C | 1 |
| Buzzi, M | 1 |
| Genovesi, C | 1 |
| Marchi, D | 1 |
| Mazzaracchio, D | 1 |
| Dilawari, A | 1 |
| Gallagher, C | 1 |
| Alintah, P | 1 |
| Chitalia, A | 1 |
| Tiwari, S | 1 |
| Paxman, R | 2 |
| Adams-Campbell, L | 1 |
| Dash, C | 1 |
| Sajid, MI | 1 |
| Najaf, DE | 1 |
| Niaz, A | 1 |
| Shabbir Balouch, S | 1 |
| Abaidullah, S | 1 |
| Chovarda, E | 1 |
| Sotiriou, E | 1 |
| Lazaridou, E | 1 |
| Vakirlis, E | 1 |
| Ioannides, D | 2 |
| Souissi, A | 3 |
| Ben Lagha, I | 1 |
| Mama, M | 1 |
| Chelly, I | 1 |
| Haouet, S | 2 |
| Mokni, M | 2 |
| Moreau, T | 1 |
| Castronovo, C | 1 |
| Kaux, JF | 1 |
| Nikkels, AF | 1 |
| Paquet, P | 1 |
| Tahara, J | 1 |
| Dainichi, T | 1 |
| Kaku, Y | 1 |
| Kataoka, T | 1 |
| Kishimoto, H | 1 |
| Kogame, T | 1 |
| Kabashima, K | 1 |
| Suh, S | 1 |
| Casale, FS | 1 |
| Atanaskova Mesinkovska, N | 2 |
| Samra, EB | 1 |
| Mahé, YF | 2 |
| Le Balch, M | 1 |
| Cavusoglu, N | 1 |
| Bouhanna, P | 4 |
| Bakkar, K | 1 |
| Tamashunas, NL | 1 |
| Bergfeld, WF | 7 |
| Jiang, W | 1 |
| Jia, L | 1 |
| Wang, M | 1 |
| Wang, B | 1 |
| Shimizu, S | 1 |
| Shome, D | 1 |
| Kapoor, R | 1 |
| Vadera, S | 1 |
| Doshi, K | 1 |
| Patel, G | 1 |
| Mohammad Khan, T | 1 |
| Yang, T | 1 |
| Shen, A | 1 |
| Qiang, W | 1 |
| Zhao, Z | 1 |
| Zhang, F | 1 |
| Reschke, R | 1 |
| Grunewald, S | 1 |
| Paasch, U | 1 |
| Averbeck, M | 1 |
| Simon, JC | 1 |
| Wetzig, T | 1 |
| Chiriac, A | 1 |
| Birsan, C | 1 |
| Mares, M | 1 |
| Keller, A | 1 |
| Pixberg, C | 1 |
| Hassel, J | 1 |
| Alam, M | 3 |
| Vogel, JE | 2 |
| Avram, M | 2 |
| Lorei, NC | 1 |
| Sullivan, JF | 1 |
| Lennon, RP | 1 |
| Milder, EA | 1 |
| Roman, JW | 1 |
| Cheniti, A | 1 |
| Tacheau, C | 1 |
| Antonelli, R | 1 |
| Planard-Luong, L | 1 |
| de Bernard, S | 1 |
| Buffat, L | 1 |
| Barbarat, P | 1 |
| Kanoun-Copy, L | 1 |
| Ferrara, F | 1 |
| Kakizaki, P | 1 |
| de Brito, FF | 1 |
| Contin, LA | 1 |
| Donati, A | 1 |
| Agaoglu, G | 1 |
| Özer, F | 1 |
| Karademir, S | 1 |
| Agaoglu, E | 1 |
| Erol, O | 1 |
| Nozawa, Y | 1 |
| Nakamura, Y | 2 |
| Ono, N | 1 |
| Hirai, I | 1 |
| Yashiro, K | 1 |
| Kameyama, K | 1 |
| Tanese, K | 1 |
| Sutharaphan, T | 1 |
| Rushton, DH | 5 |
| Westgate, GE | 1 |
| Van Neste, DJ | 5 |
| Dubin, C | 1 |
| Glickman, JW | 1 |
| Chennareddy, S | 1 |
| Han, J | 1 |
| Kimmel, GW | 1 |
| Singer, G | 1 |
| Chowdhury, M | 1 |
| Zheng, AY | 1 |
| Angelov, M | 1 |
| Kurtti, A | 1 |
| Jagdeo, J | 1 |
| Eisinger, A | 1 |
| Callender, V | 1 |
| Chasapi, V | 1 |
| Correia, O | 1 |
| Dlova, N | 1 |
| Enechukwu, N | 1 |
| Grimalt, R | 2 |
| Itami, S | 5 |
| Khobzei, K | 1 |
| Lee, WS | 4 |
| Malakar, S | 1 |
| Messenger, A | 1 |
| Ovcharenko, Y | 1 |
| Papanikou, S | 1 |
| Pinto, GM | 1 |
| Pirmez, R | 1 |
| Roberts, J | 1 |
| Silyuk, T | 1 |
| Soares, RO | 1 |
| Zlotogorski, A | 4 |
| Canfield, D | 1 |
| Yousaf, A | 1 |
| Tallman, R | 1 |
| Katzman, S | 1 |
| Brady, C | 1 |
| Fang, W | 1 |
| Kolodney, MS | 1 |
| Kinoshita-Ise, M | 1 |
| Fukuyama, M | 1 |
| Heng, K | 1 |
| Krichevsky, B | 1 |
| Groh, A | 1 |
| Heck, J | 1 |
| Fisher, J | 1 |
| Altemir, A | 1 |
| Lobato-Berezo, A | 2 |
| Pujol, RM | 2 |
| Majd, A | 1 |
| AlJasser, M | 1 |
| Mirzaalian, H | 1 |
| Hamarneh, G | 1 |
| Lui, H | 2 |
| Lee, TK | 1 |
| Di Giacomo, D | 1 |
| Guerra, F | 1 |
| Cannita, K | 1 |
| Di Profio, A | 1 |
| Ranieri, J | 1 |
| Sorce, M | 1 |
| Pistone, G | 1 |
| Mazzola, G | 1 |
| Patti, I | 1 |
| Bongiorno, MR | 1 |
| Michelini, S | 1 |
| Di Fraia, M | 1 |
| Pellacani, G | 1 |
| Johns, HR | 1 |
| Wright, TS | 1 |
| Pourciau, CY | 1 |
| Bretas, TLB | 1 |
| Issa, MC | 1 |
| Vargas, TJ | 1 |
| Sousa, MAJ | 1 |
| Jerjen, R | 1 |
| Pinczewski, J | 1 |
| Davis, MG | 2 |
| Piliang, MP | 2 |
| Caterino, TL | 2 |
| Fisher, BK | 2 |
| Sacha, JP | 2 |
| Carr, GJ | 2 |
| Moulton, LT | 2 |
| Whittenbarger, DJ | 2 |
| Punyani, S | 1 |
| Schwartz, JR | 2 |
| Satcher, KG | 1 |
| Schoch, JJ | 1 |
| Walker, A | 1 |
| Ross, M | 2 |
| Fischer-Cartlidge, E | 2 |
| White, F | 1 |
| Callahan, S | 1 |
| Kim, RH | 1 |
| Meehan, SA | 1 |
| Stein, J | 2 |
| Afanasiev, OK | 1 |
| Zhang, CZ | 1 |
| Ruhoy, SM | 1 |
| Yang, Q | 1 |
| Qiu, L | 1 |
| Yi, C | 1 |
| Xue, P | 1 |
| Yu, Z | 1 |
| Ma, X | 1 |
| Su, Y | 1 |
| Guo, S | 1 |
| Ouédraogo Nde, NA | 1 |
| Ouédraogo, NA | 1 |
| Bambara, HA | 1 |
| Tiemtoré-Kambou, BM | 1 |
| Traoré, F | 1 |
| Zongo, N | 1 |
| Ouédraogo, MS | 1 |
| Tapsoba, GP | 1 |
| Thouraya Chtioui, A | 1 |
| Lamien/Sanou, A | 1 |
| Chansky, P | 1 |
| Micheletti, RG | 1 |
| Dothard, E | 1 |
| Bagayoko, CW | 1 |
| Daniel, A | 1 |
| Marquis, K | 1 |
| Christensen, LC | 1 |
| Rajpara, A | 1 |
| Kruglikov, IL | 1 |
| Scherer, PE | 1 |
| Lim, JH | 1 |
| Siow, WS | 1 |
| Tan, LS | 1 |
| Stamatas, GN | 1 |
| Pappas, A | 1 |
| McCormick, TS | 1 |
| Cooper, KD | 1 |
| Consolo, M | 2 |
| Schastnaya, J | 1 |
| Ozerov, IV | 1 |
| Aliper, A | 1 |
| Zhavoronkov, A | 1 |
| Benati, E | 1 |
| Longo, C | 2 |
| Bombonato, C | 1 |
| Moscarella, E | 2 |
| Alfano, R | 1 |
| Udkoff, J | 1 |
| Cohen, PR | 4 |
| van der Rhee, EA | 1 |
| Middelkamp-Hup, MA | 1 |
| Hoekzema, R | 1 |
| Dressler, C | 1 |
| Blumeyer, A | 1 |
| Rosumeck, S | 1 |
| Arayesh, A | 1 |
| Nast, A | 1 |
| Yoshida, K | 1 |
| Ishii, K | 1 |
| Ishiko, A | 1 |
| Chaudhry, HM | 1 |
| Camilleri, MJ | 1 |
| Lis-Święty, A | 1 |
| Miziołek, B | 1 |
| Ranosz-Janicka, I | 1 |
| Bierzyńska-Macyszyn, G | 1 |
| Brzezińska-Wcisło, L | 1 |
| Liu, YS | 1 |
| Jee, SH | 1 |
| Chan, JL | 1 |
| Chen, SY | 1 |
| Yang, SY | 1 |
| Cheng, ST | 1 |
| Katz, A | 1 |
| Yesudian, PD | 1 |
| Power, DV | 1 |
| Disse, M | 1 |
| Tan, T | 1 |
| Bidier, M | 1 |
| Pushkarevskaya, A | 1 |
| Enk, A | 1 |
| Hartmann, M | 1 |
| Toberer, F | 1 |
| Shaw, JM | 1 |
| O'Brien, J | 1 |
| Chua, S | 1 |
| De Boer, R | 1 |
| Dear, R | 1 |
| Murray, N | 1 |
| Boyle, F | 2 |
| Vazquez-Herrera, NE | 1 |
| Eber, AE | 1 |
| Martinez-Velasco, MA | 1 |
| Perper, M | 1 |
| Cervantes, J | 1 |
| Verne, SH | 1 |
| Magno, RJ | 1 |
| Nouri, K | 1 |
| Holahan, HM | 1 |
| Moye, MS | 1 |
| Stone, MS | 1 |
| Swick, BL | 1 |
| Rice, BA | 1 |
| Ver Hoeve, ES | 2 |
| DeLuca, AN | 1 |
| Esserman, LJ | 2 |
| Rugo, HS | 6 |
| Melisko, ME | 3 |
| Voigt, J | 2 |
| Collier, NJ | 1 |
| Allan, D | 1 |
| Diaz Pesantes, F | 1 |
| Sheridan, L | 1 |
| Allan, E | 1 |
| Shah, VV | 1 |
| Wikramanayake, TC | 1 |
| DelCanto, GM | 1 |
| van den Hurk, C | 2 |
| Jimenez, JJ | 1 |
| Abo-Zeid, MA | 1 |
| Elmaddawy, AEA | 1 |
| El-Fahar, MH | 1 |
| El-Sabbagh, AH | 1 |
| Brandi, N | 2 |
| Zamperetti, M | 1 |
| Zelger, B | 2 |
| Höpfl, R | 1 |
| Rodríguez-Lobato, E | 1 |
| Giavedoni, P | 1 |
| Ferrando, J | 3 |
| Igari, S | 1 |
| Arenbergerova, M | 1 |
| Arenberger, P | 1 |
| Gkalpakiotis, S | 1 |
| Dahmen, RA | 1 |
| Sticova, E | 1 |
| Fialova, A | 1 |
| McCoy, J | 2 |
| Kovacevic, M | 2 |
| Situm, M | 1 |
| Stanimirovic, A | 1 |
| Katoulis, AC | 2 |
| Diamanti, K | 2 |
| Sgouros, D | 2 |
| Liakou, AI | 2 |
| Bozi, E | 2 |
| Avgerinou, G | 1 |
| Panayiotides, I | 2 |
| Rigopoulos, D | 3 |
| Harada, K | 2 |
| Maeda, T | 1 |
| Matsubayashi, J | 1 |
| Uchiyama, M | 1 |
| Irisawa, R | 1 |
| Go, K | 1 |
| Tsuboi, R | 1 |
| Cheng, Y | 1 |
| Zhao, L | 1 |
| Gao, S | 1 |
| Zhang, G | 1 |
| Yang, JM | 2 |
| Won, GH | 1 |
| Kim, JC | 3 |
| Cho, SB | 2 |
| Goo, BL | 1 |
| Zheng, Z | 1 |
| Yoo, KH | 1 |
| Kang, JS | 2 |
| Kim, H | 1 |
| Su, HJ | 1 |
| Cheng, AY | 1 |
| Liu, CH | 1 |
| Chu, CB | 1 |
| Lee, CN | 2 |
| Hsu, CK | 3 |
| Lee, JY | 5 |
| Sundberg, JP | 1 |
| Lenzy, YM | 1 |
| Christiano, AM | 5 |
| McGregor, T | 1 |
| Stenn, KS | 1 |
| Sivamani, RK | 1 |
| Pratt, CH | 1 |
| King, LE | 1 |
| Vogt, T | 1 |
| Thomas, C | 1 |
| Reichrath, J | 1 |
| Schilling, L | 1 |
| Mawlood, D | 1 |
| Christmann, R | 1 |
| Loretz, B | 1 |
| Schäfer, U | 1 |
| Lehr, CM | 1 |
| Müller, C | 1 |
| Rubio-Gonzalez, B | 1 |
| Fortman, J | 1 |
| March-Rodríguez, A | 1 |
| Deza, G | 1 |
| Bertolín-Colilla, M | 1 |
| Florez-Pollack, S | 1 |
| Chong, BF | 1 |
| Flores-Terry, MÁ | 1 |
| García-Arpa, M | 1 |
| Franco-Muñóz, M | 1 |
| González-Ruiz, L | 1 |
| English, RS | 1 |
| Liszewski, W | 1 |
| Stoff, BK | 1 |
| Darr-Foit, S | 1 |
| Schliemann, S | 1 |
| Schulz, S | 1 |
| Elsner, P | 2 |
| Melé-Ninot, G | 1 |
| Expósito-Serrano, V | 1 |
| Quintana Codina, M | 1 |
| Iglesias Sancho, M | 1 |
| Sánchez-Regaña, M | 1 |
| Umbert Millet, P | 1 |
| Salleras Redonnet, M | 1 |
| Murad, A | 1 |
| Ingprasert, S | 1 |
| Pathomvanich, D | 1 |
| Pinyopawasutthi, P | 1 |
| van Niekerk, G | 1 |
| Adams, S | 1 |
| Rode, H | 1 |
| Stevens, HP | 1 |
| Donners, S | 1 |
| de Bruijn, J | 1 |
| Okoye, GA | 1 |
| Brunet-Possenti, F | 1 |
| Deschamps, L | 1 |
| Colboc, H | 1 |
| Somogyi, A | 1 |
| Medjoubi, K | 1 |
| Bazin, D | 1 |
| Descamps, V | 1 |
| Rodman, R | 1 |
| Sturm, AK | 1 |
| Kanti, V | 1 |
| Röwert-Huber, J | 1 |
| Zimmerman, B | 2 |
| Ivars, M | 1 |
| Cordoro, KM | 1 |
| Subash, J | 1 |
| Alexander, T | 1 |
| Beamer, V | 1 |
| Vasconcelos, I | 1 |
| Wiesske, A | 1 |
| Schoenegg, W | 1 |
| Nascimento, LLD | 1 |
| Enokihara, MMSES | 1 |
| Vasconcellos, MRA | 1 |
| Maglie, R | 1 |
| Vannucchi, M | 1 |
| Quintarelli, L | 1 |
| Caproni, M | 1 |
| Massi, D | 3 |
| Antiga, E | 1 |
| Tzima, K | 1 |
| Sar-Pomian, M | 1 |
| Huang, H | 1 |
| Sun, J | 1 |
| Fu, L | 1 |
| Yang, C | 1 |
| Zheng, X | 1 |
| Tang, H | 1 |
| Sun, L | 1 |
| Yu, AJ | 1 |
| Luo, YJ | 1 |
| Xu, XG | 1 |
| Bao, LL | 1 |
| Tian, T | 1 |
| Li, ZX | 1 |
| Dong, YX | 1 |
| Li, YH | 1 |
| Leung, AKC | 1 |
| Barankin, B | 1 |
| Saito, A | 1 |
| Takamuki, R | 1 |
| Inoue, S | 1 |
| Fujisawa, Y | 1 |
| Okiyama, N | 1 |
| Watanabe, R | 1 |
| Ishitsuka, Y | 1 |
| Maruyama, H | 1 |
| Ishii, Y | 2 |
| Fujimoto, M | 1 |
| Mustoe, MM | 1 |
| Lee, CM | 1 |
| Tawfik, SS | 1 |
| Sorour, OA | 1 |
| Alariny, AF | 1 |
| Elmorsy, EH | 1 |
| Moneib, H | 1 |
| Chan, A | 1 |
| Bauwens, A | 1 |
| Pontre, S | 1 |
| Jackson, S | 2 |
| McGlone, F | 2 |
| Ernenwein, T | 1 |
| Chih, J | 1 |
| Reid, C | 2 |
| Paolino, G | 1 |
| Panetta, C | 1 |
| Didona, D | 1 |
| Donati, M | 1 |
| Donati, P | 1 |
| Lee, MC | 1 |
| Chang, SL | 1 |
| Hu, S | 1 |
| Chang, CS | 1 |
| Lin, YF | 1 |
| Cheng, CY | 1 |
| Ahmad, M | 1 |
| Yadav, D | 1 |
| Khandpur, S | 1 |
| Ramam, M | 1 |
| Singh, MK | 1 |
| Sharma, VK | 1 |
| Baldry, M | 1 |
| Timchenko, V | 1 |
| Menictas, C | 1 |
| Chen, W | 3 |
| Weng, TT | 1 |
| Kunapareddy, J | 1 |
| White, C | 1 |
| Davis, C | 1 |
| Nousari, C | 1 |
| Arif, T | 1 |
| Adil, M | 1 |
| Suhail Amin, S | 1 |
| Nortier, JWR | 2 |
| van der Ploeg, T | 3 |
| Nieboer, P | 1 |
| van der Hoeven, JJM | 2 |
| Veasey, JV | 1 |
| Meneses, OMS | 1 |
| da Silva, FO | 1 |
| Ambooken, B | 1 |
| Kesavan, A | 1 |
| Neelakandan, A | 1 |
| Mathew, A | 1 |
| Hernández, K | 1 |
| Featherstone, A | 1 |
| Haase, C | 1 |
| Saknite, I | 1 |
| Balu, M | 1 |
| Lentsch, G | 1 |
| Williams, JN | 1 |
| Koenig, K | 1 |
| Tromberg, BJ | 1 |
| Smetanay, K | 1 |
| Junio, P | 1 |
| Feißt, M | 1 |
| Seitz, J | 1 |
| Hassel, JC | 1 |
| Mayer, L | 1 |
| Matthies, LM | 1 |
| Schumann, A | 1 |
| Hennigs, A | 1 |
| Heil, J | 1 |
| Sohn, C | 1 |
| Jaeger, D | 1 |
| Schneeweiss, A | 1 |
| Marmé, F | 1 |
| Khanna, T | 1 |
| Sallee, B | 1 |
| Bordone, LA | 1 |
| Bao, Y | 1 |
| Wu, K | 1 |
| Chen, Y | 1 |
| Wu, W | 1 |
| Zhu, Z | 1 |
| Cao, H | 1 |
| Ling, Y | 1 |
| Bienenfeld, A | 1 |
| Azarchi, S | 1 |
| Marchbein, S | 1 |
| Nagler, AR | 1 |
| Miyachi, K | 1 |
| Yamada, T | 1 |
| Kawagishi-Hotta, M | 1 |
| Hasebe, Y | 1 |
| Date, Y | 1 |
| Hasegawa, S | 1 |
| Arima, M | 1 |
| Iwata, Y | 1 |
| Kobayashi, T | 2 |
| Numata, S | 1 |
| Yamamoto, N | 1 |
| Nakata, S | 1 |
| Sugiura, K | 1 |
| Akamatsu, H | 1 |
| Neuhaus, K | 1 |
| Schiestl, C | 1 |
| Adelsberger, R | 1 |
| Weibel, L | 1 |
| Meuli, M | 2 |
| Böttcher-Haberzeth, S | 1 |
| Neri, I | 1 |
| Barisani, A | 1 |
| Fanti, PA | 1 |
| Patrizi, A | 1 |
| Brotzu, G | 1 |
| Fadda, AM | 1 |
| Manca, ML | 1 |
| Manca, T | 1 |
| Marongiu, F | 1 |
| Campisi, M | 1 |
| Consolaro, F | 1 |
| Moritz, RKC | 1 |
| Romiti, R | 2 |
| Wilcox, GL | 1 |
| Ericson, M | 3 |
| McAdams, BD | 1 |
| You, SH | 3 |
| Kim, NR | 1 |
| Kushner, CJ | 1 |
| Concha, JSS | 1 |
| Pearson, DR | 1 |
| Werth, VP | 1 |
| Prochilo, T | 1 |
| Huscher, A | 1 |
| Andreis, F | 1 |
| Mirandola, M | 1 |
| Zaina, E | 1 |
| Pomentale, B | 1 |
| Pedrali, C | 1 |
| Zanotti, L | 1 |
| Mutti, S | 1 |
| Zaniboni, A | 1 |
| Prohaska, J | 1 |
| Demaree, E | 1 |
| Powers, J | 1 |
| Cook, C | 1 |
| Daly, T | 1 |
| Daly, K | 1 |
| Simakou, T | 1 |
| Butcher, JP | 1 |
| Reid, S | 1 |
| Henriquez, FL | 1 |
| Thompson, CT | 1 |
| Nie, J | 1 |
| Hou, W | 1 |
| Tang, S | 2 |
| Wu, X | 1 |
| Sun, Z | 1 |
| Cheng, H | 1 |
| Shen, H | 1 |
| Tang, L | 1 |
| Zhou, J | 1 |
| Jia, M | 1 |
| Wada, N | 1 |
| Uchi, H | 1 |
| Furue, M | 1 |
| Sahin, G | 1 |
| Pancar, GS | 1 |
| Kalkan, G | 2 |
| Mai, W | 1 |
| Sun, Y | 1 |
| Liu, X | 2 |
| Lin, D | 1 |
| Lu, D | 1 |
| Castillo, D | 1 |
| Sabiq, S | 1 |
| Watanabe, T | 1 |
| Yagata, H | 1 |
| Saito, M | 1 |
| Okada, H | 1 |
| Yajima, T | 1 |
| Tamai, N | 1 |
| Yoshida, Y | 1 |
| Takayama, T | 1 |
| Imai, H | 1 |
| Nozawa, K | 1 |
| Sangai, T | 1 |
| Yoshimura, A | 1 |
| Hasegawa, Y | 1 |
| Yamaguchi, T | 1 |
| Shimozuma, K | 1 |
| Ohashi, Y | 1 |
| Udompanich, S | 1 |
| Thadanipon, K | 1 |
| de Masson, A | 1 |
| Bouaziz, JD | 1 |
| Ram-Wolff, C | 1 |
| Brice, P | 1 |
| Moulonguet, I | 1 |
| Vignon-Pennamen, MD | 1 |
| Herms, F | 1 |
| Verneuil, L | 1 |
| Rivet, J | 1 |
| Bagot, M | 1 |
| Battistella, M | 1 |
| Dutra, H | 1 |
| Trüeb, R | 1 |
| Vilar, E | 1 |
| Rochael, M | 1 |
| Quattrino, A | 1 |
| Cury, A | 1 |
| Graham, PM | 1 |
| Gupta, N | 1 |
| Altman, DA | 1 |
| Teramura, K | 1 |
| Kato, T | 2 |
| Nishikawa, J | 1 |
| Nakanishi, T | 1 |
| Tanaka, T | 1 |
| Fujimoto, N | 1 |
| Malki, L | 1 |
| Sarig, O | 1 |
| Romano, MT | 1 |
| Méchin, MC | 1 |
| Peled, A | 1 |
| Pavlovsky, M | 1 |
| Warshauer, E | 1 |
| Samuelov, L | 1 |
| Uwakwe, L | 1 |
| Briskin, V | 1 |
| Mohamad, J | 1 |
| Gat, A | 2 |
| Isakov, O | 1 |
| Rabinowitz, T | 1 |
| Shomron, N | 1 |
| Adir, N | 1 |
| Simon, M | 1 |
| Betz, RC | 2 |
| Sprecher, E | 2 |
| Carmina, E | 1 |
| Azziz, R | 1 |
| Escobar-Morreale, HF | 1 |
| Futterweit, W | 1 |
| Huddleston, H | 1 |
| Lobo, R | 1 |
| Olsen, E | 1 |
| Garcia-Robledo, JE | 1 |
| Aragón, CC | 1 |
| Nieto-Aristizábal, I | 1 |
| Vásquez, S | 1 |
| Montoya, C | 1 |
| Tobón, GJ | 1 |
| Jiang, Y | 1 |
| Zhan, P | 1 |
| Al-Hatmi, AMS | 1 |
| Shi, G | 1 |
| Wei, Y | 1 |
| van den Ende, AHGG | 1 |
| Meis, JF | 1 |
| Lu, H | 1 |
| de Hoog, GS | 1 |
| Okhovat, JP | 1 |
| Manatis-Lornell, AJ | 1 |
| Kang, YR | 1 |
| Bak, SS | 1 |
| Joo, HW | 1 |
| Mali, NM | 1 |
| Shin, MJ | 1 |
| Oh, JW | 1 |
| Hosokawa, Y | 1 |
| Hamada, T | 1 |
| Ashida, H | 1 |
| Ikeda, M | 1 |
| Xiao, S | 1 |
| Chen, Q | 2 |
| Qu, Q | 1 |
| Guo, ZH | 1 |
| Feng, CB | 1 |
| Liu, Y | 4 |
| Liu, F | 2 |
| Shi, PL | 1 |
| Cao, DX | 1 |
| Hu, ZQ | 1 |
| Bayat, M | 1 |
| Yazdanpanah, MJ | 1 |
| Hamidi Alamdari, D | 1 |
| Banihashemi, M | 1 |
| Salehi, M | 1 |
| Ho, A | 1 |
| Polak-Witka, K | 1 |
| Sharma, R | 1 |
| Heery, M | 1 |
| Cohen, S | 2 |
| Mena, Z | 1 |
| Keophiphath, M | 1 |
| Courbière, C | 1 |
| Manzato, L | 1 |
| Lamour, I | 1 |
| Gaillard, E | 1 |
| Kaya İslamoğlu, ZG | 1 |
| Uysal, E | 1 |
| Ginzburg, A | 1 |
| Chahal, K | 1 |
| Ghate, S | 1 |
| Jage, M | 1 |
| Park, GH | 1 |
| Kim, WI | 1 |
| Yang, MY | 1 |
| Lee, WK | 1 |
| Kim, GW | 1 |
| Kim, HS | 1 |
| Ko, HC | 1 |
| Kim, BS | 1 |
| Kim, MB | 1 |
| Hou, Z | 1 |
| Lee, PK | 1 |
| Yoo, H | 1 |
| Moh, J | 1 |
| Park, JU | 1 |
| Asnaashari, S | 1 |
| Javadzadeh, Y | 1 |
| Tantarungsee, N | 1 |
| Bostan Ali, Z | 1 |
| Soi-Ampornkul, R | 1 |
| Rujitharanawong, C | 1 |
| Ritthaphai, A | 1 |
| Boonkaew, B | 1 |
| Wattanapanitch, M | 1 |
| Thanomkitti, K | 1 |
| Vatanashevanopakorn, C | 1 |
| Divine, J | 1 |
| Rudnick, EW | 1 |
| Lien, M | 1 |
| Wang, W | 1 |
| Lee, YR | 1 |
| Lee, J | 1 |
| Lew, BL | 1 |
| Sim, WY | 2 |
| Hong, J | 1 |
| Chung, BC | 3 |
| Lopez, AS | 1 |
| Lam, JM | 1 |
| Campennì, G | 1 |
| Tramacere, A | 1 |
| Masiero, M | 1 |
| Iorfida, M | 1 |
| Mazza, M | 1 |
| Montagna, E | 1 |
| Cancello, G | 1 |
| Bianco, N | 1 |
| Palazzo, A | 1 |
| Cardillo, A | 1 |
| Dellapasqua, S | 1 |
| Sangalli, C | 1 |
| Pettini, G | 1 |
| Pravettoni, G | 1 |
| Colleoni, M | 1 |
| Veronesi, P | 1 |
| Hawkshaw, NJ | 1 |
| Hardman, JA | 1 |
| Nirmal, B | 1 |
| George, R | 1 |
| Özkur, E | 1 |
| Altunay, İK | 1 |
| Leblebici, C | 1 |
| Topkarcı, Z | 1 |
| Erdem, Y | 1 |
| Park, MJ | 1 |
| Hong, SP | 2 |
| Kim, MH | 3 |
| Park, BC | 2 |
| Hong, JS | 1 |
| Lee, SH | 2 |
| Lee, AY | 1 |
| Eftekhari, H | 1 |
| Azimi, SZ | 1 |
| Rafiei, R | 1 |
| Darjani, A | 1 |
| Alizadeh, N | 1 |
| Rafiei, E | 1 |
| Ghadarjani, R | 1 |
| Gharaei Nejad, K | 1 |
| Avram, MR | 4 |
| Horenstein, MG | 1 |
| Bacheler, CJ | 1 |
| Uhlenhake, EE | 1 |
| Mehregan, DM | 1 |
| László, FG | 1 |
| Wiznia, LE | 1 |
| Choi, JN | 1 |
| Ibrahimi, OA | 1 |
| Jalian, HR | 1 |
| Shofner, JD | 1 |
| Anderson, RR | 1 |
| Kluger, N | 1 |
| van den Hurk, CJ | 10 |
| van den Akker-van Marle, ME | 2 |
| Breed, WP | 13 |
| van de Poll-Franse, LV | 4 |
| Nortier, JW | 8 |
| Coebergh, JW | 4 |
| Betticher, DC | 1 |
| Delmore, G | 1 |
| Breitenstein, U | 1 |
| Anchisi, S | 1 |
| Zimmerli-Schwab, B | 1 |
| Müller, A | 1 |
| von Moos, R | 1 |
| Hügli-Dayer, AM | 1 |
| Schefer, H | 1 |
| Bodenmann, S | 1 |
| Bühler, V | 1 |
| Trueb, RR | 1 |
| Komen, MM | 3 |
| Filbrandt, R | 1 |
| Rufaut, N | 2 |
| Jones, L | 2 |
| Cascio, A | 1 |
| Torina, A | 1 |
| Valenzise, M | 1 |
| Blanda, V | 1 |
| Camarda, N | 1 |
| Bombaci, S | 1 |
| Iaria, C | 1 |
| De Luca, F | 1 |
| Wasniewska, M | 1 |
| Fernandez-Crehuet, P | 1 |
| Cabeza-Calleja, P | 1 |
| Fernandez-Crehuet Serrano, JL | 1 |
| Martinez-Prieto, V | 1 |
| Lencastre, A | 1 |
| Karnik, P | 2 |
| Shah, S | 2 |
| Dvorkin-Wininger, Y | 1 |
| Oshtory, S | 1 |
| Udayashankar, C | 1 |
| Nath, AK | 1 |
| Anuradha, P | 1 |
| Rassman, WR | 6 |
| Pak, JP | 2 |
| Shapiro, R | 1 |
| Shapiro, P | 2 |
| Buchwach, KA | 1 |
| Beehner, ML | 2 |
| Harris, JA | 2 |
| Devroye, J | 1 |
| Gabel, S | 1 |
| Cooley, JE | 1 |
| Kabaker, SS | 4 |
| Champagne, JP | 1 |
| Mangubat, EA | 3 |
| Konior, RJ | 2 |
| Donovan, JC | 3 |
| Sharon, VR | 1 |
| Ratnarathorn, M | 1 |
| Konia, TH | 1 |
| Barr, KL | 1 |
| Lanzafame, RJ | 2 |
| Blanche, RR | 2 |
| Bodian, AB | 1 |
| Chiacchierini, RP | 2 |
| Fernandez-Obregon, A | 1 |
| Kazmirek, ER | 2 |
| Gan, SD | 1 |
| Itkin, A | 1 |
| Wolpowitz, D | 1 |
| Famenini, S | 1 |
| Leschka, SC | 1 |
| Maruschke, L | 1 |
| Liu, LH | 1 |
| Wang, JW | 2 |
| Chen, G | 1 |
| Chang, RX | 1 |
| Tang, HY | 1 |
| Wang, PG | 1 |
| Zhang, XJ | 1 |
| Moh, JS | 1 |
| Lee, SY | 1 |
| Lacarrubba, F | 5 |
| Micali, G | 5 |
| Lampeter, W | 1 |
| Larson, AR | 1 |
| Zhan, Q | 1 |
| Johnson, E | 1 |
| Fragoso, AC | 1 |
| Wan, M | 1 |
| Murphy, GF | 2 |
| Kim, JN | 1 |
| Shin, KJ | 1 |
| Gil, YC | 1 |
| Koh, KS | 1 |
| Song, WC | 1 |
| Pramono, LA | 1 |
| Anggoro, S | 1 |
| Langow, S | 1 |
| Hidayat, R | 1 |
| Setyohadi, B | 1 |
| Isbagio, H | 1 |
| Piérard-Franchimont, C | 7 |
| Loussouarn, G | 4 |
| Panhard, S | 1 |
| Saint Léger, D | 1 |
| Mellul, M | 1 |
| Piérard, GE | 8 |
| Panchaprateep, R | 1 |
| Asawanonda, P | 1 |
| BOWERS, RE | 1 |
| Parodi, A | 1 |
| Cozzani, E | 1 |
| Torres, F | 5 |
| Guarrera, M | 3 |
| Drummond, A | 1 |
| Pichler, J | 1 |
| Zalaudek, I | 1 |
| Lallas, A | 1 |
| Piana, S | 1 |
| Lim, YY | 1 |
| Kim, HM | 1 |
| Li, KS | 1 |
| Kim, MN | 1 |
| Park, KC | 1 |
| Kim, BJ | 1 |
| Kolb-Mäurer, A | 1 |
| Hamm, H | 1 |
| Sahin, B | 1 |
| Jouanique, C | 1 |
| Rashid, RM | 1 |
| Madu, P | 1 |
| Kundu, RV | 1 |
| Bielli, A | 1 |
| Cervelli, G | 1 |
| Curcio, BC | 1 |
| Lemieux, J | 3 |
| Provencher, L | 2 |
| Laflamme, C | 1 |
| Unlü, C | 1 |
| de Vries, JP | 1 |
| Jamwal, A | 1 |
| Sharma, SD | 1 |
| Schiavone, G | 1 |
| Raskovic, D | 1 |
| Greco, J | 1 |
| Abeni, D | 1 |
| Sklar, JA | 1 |
| Mubki, T | 1 |
| Watanabe-Okada, E | 1 |
| Amagai, M | 1 |
| Bittencourt, C | 1 |
| Ferraro, DA | 1 |
| Soares, TC | 1 |
| Moraes, AM | 1 |
| Oyetakin-White, P | 1 |
| Baron, E | 1 |
| Leahy, P | 1 |
| Zontos, G | 1 |
| Rose, PT | 2 |
| Nikiforidis, G | 1 |
| Kim, SR | 1 |
| Han, KD | 1 |
| Kim, CY | 1 |
| Abada, H | 1 |
| Aktouf, A | 1 |
| Delaunay, F | 1 |
| Lievain, L | 1 |
| Auquit-Auckbur, I | 1 |
| Chan, DV | 1 |
| Kartono, F | 1 |
| Ziegler, R | 1 |
| Abdulwahab, N | 1 |
| DiPaola, N | 1 |
| Flynn, J | 1 |
| Wong, HK | 1 |
| Guzey, S | 1 |
| Alhan, D | 2 |
| Şahin, I | 1 |
| Aykan, A | 1 |
| Eski, M | 1 |
| Nişancı, M | 1 |
| Verzì, AE | 1 |
| Garrido-Colmenero, C | 1 |
| Aneiros Fernández, J | 1 |
| García-Lora, E | 1 |
| Wang, HH | 1 |
| Lin, YT | 1 |
| Uce Özkol, H | 1 |
| Çalka, Ö | 1 |
| Wilk, M | 1 |
| Zelger, BG | 1 |
| Upton, JH | 1 |
| Hannen, RF | 1 |
| Bahta, AW | 2 |
| Philpott, MP | 2 |
| Sanada, Y | 1 |
| Yabuuchi, T | 1 |
| Yoshioka, H | 1 |
| Kubota, H | 1 |
| Kato, A | 1 |
| Feldstein, S | 1 |
| Totri, CR | 1 |
| Friedlander, SF | 1 |
| Cigler, T | 2 |
| Isseroff, D | 1 |
| Fiederlein, B | 1 |
| Schneider, S | 1 |
| Chuang, E | 1 |
| Vahdat, L | 1 |
| Moore, A | 2 |
| Pietrzak, A | 1 |
| Bartosinska, J | 1 |
| Filip, AA | 1 |
| Rakowska, A | 2 |
| Adamczyk, M | 1 |
| Szumilo, J | 1 |
| Kanitakis, J | 1 |
| Dan, L | 1 |
| Relic, J | 1 |
| Wipavakul, S | 1 |
| Jirasuthat, S | 1 |
| Tangjaturonrusamee, C | 1 |
| Holzapfel, C | 1 |
| Kronborg, C | 1 |
| Mahar, P | 1 |
| Howard, A | 1 |
| Yorulmaz, A | 1 |
| Artuz, F | 1 |
| Er, O | 1 |
| Guresci, S | 1 |
| Knopp, E | 1 |
| Fawzi, MM | 1 |
| Mahmoud, SB | 1 |
| Shaker, OG | 1 |
| Saleh, MA | 1 |
| Bas, Y | 1 |
| Seckin, HY | 1 |
| Takci, Z | 1 |
| Citil, R | 1 |
| Önder, Y | 1 |
| Sahin, S | 1 |
| Demir, AK | 1 |
| Moulton-Barrett, R | 1 |
| Vanderschelden, B | 1 |
| Goodier, M | 1 |
| Stamatios, G | 1 |
| de Beer, F | 1 |
| Dries, W | 1 |
| van de Sande, I | 1 |
| Hermsen, N | 1 |
| Breed, W | 2 |
| van der Sangen, M | 1 |
| Schaffrin-Nabe, D | 1 |
| Schmitz, I | 1 |
| Josten-Nabe, A | 1 |
| von Hehn, U | 1 |
| Voigtmann, R | 1 |
| Rebora, A | 6 |
| Drago, F | 1 |
| D'Ovidio, R | 1 |
| Chieco, P | 1 |
| McCrary, WJ | 1 |
| Hurst, MD | 1 |
| Hiatt, KM | 1 |
| Singh, ZN | 1 |
| Wirges, ML | 1 |
| Yildiz, H | 1 |
| Ercan, E | 1 |
| Sezgin, M | 1 |
| Ngian, J | 1 |
| Chong, C | 1 |
| Chong, CT | 1 |
| Liew, QY | 1 |
| Mahadevan, A | 1 |
| Sampson, C | 1 |
| LaRosa, S | 1 |
| Floyd, SR | 1 |
| Wong, ET | 1 |
| Uhlmann, EJ | 1 |
| Sengupta, S | 1 |
| Kasper, EM | 1 |
| Caserini, M | 1 |
| Radicioni, M | 1 |
| Leuratti, C | 1 |
| Terragni, E | 1 |
| Palmieri, R | 1 |
| Feily, A | 3 |
| Lal, K | 1 |
| Hector, CE | 1 |
| Bin Saif, GA | 1 |
| Goey, SH | 1 |
| van der Hoeven, JJ | 1 |
| Nalluri, R | 1 |
| Azar, RP | 2 |
| Thomas, AH | 2 |
| Maurer, M | 2 |
| Lindner, G | 2 |
| Pliskow, B | 1 |
| Mitra, K | 1 |
| Kaya, M | 1 |
| Lanoue, J | 1 |
| Yanofsky, VR | 1 |
| Mercer, SE | 1 |
| Wohltmann, WE | 1 |
| Sperling, L | 2 |
| Helou, W | 1 |
| Avitan-Hersh, E | 1 |
| Bergman, R | 3 |
| Campbell, C | 1 |
| Bahrami, S | 1 |
| Owen, C | 1 |
| Sahadevan, SW | 1 |
| Ding, SR | 1 |
| Del Priore, G | 1 |
| Chew, EGY | 1 |
| Tan, JHJ | 1 |
| Ho, BS | 1 |
| Lim, TC | 1 |
| Sia, YY | 1 |
| Bigliardi, PL | 1 |
| Heilmann, S | 1 |
| Wan, ACA | 1 |
| Nöthen, MM | 1 |
| Hillmer, AM | 1 |
| Shaw, J | 1 |
| Baylock, B | 1 |
| O'Reilly, A | 1 |
| Winstanley, J | 1 |
| Pugliano, L | 1 |
| Andrews, K | 1 |
| Yeung, H | 1 |
| Luk, KM | 1 |
| Chen, SC | 1 |
| Lynch, MC | 1 |
| Milchak, MA | 1 |
| Parnes, H | 1 |
| Ioffreda, MD | 2 |
| Amadu, V | 1 |
| Vidili, G | 1 |
| Muzzu, ML | 1 |
| Delitala, G | 1 |
| Biondi, G | 1 |
| Satta, R | 1 |
| Bernstein, RM | 7 |
| Wolfeld, MB | 1 |
| Tziotzios, C | 1 |
| Stefanato, CM | 2 |
| Fenton, DA | 2 |
| Simpson, MA | 1 |
| McGrath, JA | 1 |
| Du, X | 1 |
| Li, Z | 1 |
| Xu, W | 1 |
| Zhou, X | 1 |
| Song, C | 1 |
| Fan, W | 2 |
| Ben Tanfous, A | 1 |
| Azzouz, H | 1 |
| Karray, M | 1 |
| Zghal, M | 1 |
| El Euch, D | 1 |
| Zaraa, I | 1 |
| Anzalone, A | 1 |
| Pranteda, G | 1 |
| Torkamani, N | 1 |
| Yang, JS | 1 |
| Herlin, C | 1 |
| Chaput, B | 1 |
| De Runz, A | 1 |
| Watier, E | 1 |
| Bertheuil, N | 1 |
| Abbasi, A | 1 |
| Kamyab-Hesari, K | 1 |
| Rabbani, R | 1 |
| Mollaee, F | 1 |
| Abbasi, S | 1 |
| Kolivras, A | 1 |
| Thompson, C | 1 |
| Alegre-Sanchez, A | 1 |
| Park, SK | 1 |
| Kwak, HB | 1 |
| Yun, SK | 1 |
| Kim, HU | 1 |
| Zhang, Q | 1 |
| Song, L | 1 |
| Sirinturk, S | 1 |
| Bagheri, H | 1 |
| Govsa, F | 1 |
| Pinar, Y | 1 |
| Ozer, MA | 1 |
| Junqueira Bertin, AC | 1 |
| Ericson, ME | 2 |
| Ferneini, EM | 1 |
| Beauvais, D | 1 |
| Castiglione, C | 1 |
| Ferneini, MV | 1 |
| McDonald, KA | 1 |
| Shelley, AJ | 1 |
| Colantonio, S | 1 |
| Beecker, J | 1 |
| Bomar, L | 1 |
| Kadakia, S | 1 |
| Badhey, A | 1 |
| Ashai, S | 1 |
| Lee, TS | 1 |
| Ducic, Y | 1 |
| West, HJ | 1 |
| Hershman, DL | 1 |
| Nangia, J | 1 |
| Wang, T | 1 |
| Osborne, C | 1 |
| Niravath, P | 1 |
| Otte, K | 1 |
| Papish, S | 1 |
| Holmes, F | 1 |
| Abraham, J | 1 |
| Lacouture, M | 1 |
| Courtright, J | 1 |
| Rude, M | 1 |
| Hilsenbeck, S | 1 |
| Osborne, CK | 1 |
| Rimawi, M | 1 |
| Klein, P | 1 |
| Melin, SA | 2 |
| Hurvitz, SA | 1 |
| Mitchel, J | 1 |
| Bågeman, E | 1 |
| D'Agostino, RB | 1 |
| Esserman, L | 1 |
| Muth, CC | 1 |
| Brower, V | 1 |
| Barrón-Hernández, YL | 1 |
| Pfannes, EKB | 1 |
| Fimmel, S | 1 |
| Hadam, S | 1 |
| Andruck, A | 1 |
| Kottner, J | 1 |
| Rukwied, R | 1 |
| Yip, L | 2 |
| Ryan, A | 1 |
| Wasko, CA | 1 |
| Mackley, CL | 1 |
| Mauger, D | 1 |
| Miller, JJ | 2 |
| Mols, F | 2 |
| Vingerhoets, AJ | 2 |
| Tandon, YK | 1 |
| Somani, N | 1 |
| Cevasco, NC | 1 |
| Rogers, NE | 1 |
| Yano, H | 1 |
| Sakihama, N | 1 |
| Matsuo, T | 1 |
| Nakano, M | 1 |
| Hirano, A | 1 |
| Emsen, IM | 1 |
| Ustuner, ET | 1 |
| Patwardhan, N | 1 |
| Mysore, V | 1 |
| Khumalo, NP | 2 |
| Jessop, S | 1 |
| Gumedze, F | 2 |
| Ehrlich, R | 1 |
| Kowalska-Oledzka, E | 1 |
| Slowinska, M | 1 |
| Lypka, MA | 1 |
| Yamashita, DD | 1 |
| Urata, MM | 1 |
| Nagasao, T | 1 |
| Taylor, PJ | 1 |
| Yazdabadi, A | 1 |
| Magee, J | 4 |
| Harrison, S | 2 |
| Tan, KT | 1 |
| Abdennader, S | 1 |
| Yang, A | 1 |
| Vincenzi, C | 5 |
| White, N | 1 |
| Srivastava, S | 1 |
| Rousso, DE | 2 |
| Presti, PM | 1 |
| Beehner, M | 1 |
| Leavitt, M | 1 |
| Seyhan, T | 1 |
| Borman, H | 1 |
| Bal, N | 1 |
| Sato, M | 1 |
| Saga, K | 1 |
| Takahashi, H | 1 |
| Willey, A | 1 |
| Chamlin, S | 1 |
| Frieden, IJ | 1 |
| Price, VH | 3 |
| Amireault, C | 1 |
| Maunsell, E | 1 |
| Chan, WY | 1 |
| Laitung, JK | 2 |
| Conner, KB | 1 |
| Braverman, AS | 1 |
| Inui, S | 3 |
| Nakajima, T | 2 |
| Kauther, MD | 1 |
| Wedemeyer, C | 1 |
| Kauther, KM | 1 |
| Weidle, PA | 1 |
| Wegner, A | 1 |
| von Knoch, M | 1 |
| Fan, J | 3 |
| Liu, L | 1 |
| Tian, J | 1 |
| Gan, C | 1 |
| Lei, M | 1 |
| Quatresooz, P | 3 |
| Xhauflaire-Uhoda, E | 2 |
| Duque-Estrada, B | 2 |
| Soni, VK | 1 |
| Durusoy, C | 1 |
| Ozenli, Y | 1 |
| Adiguzel, A | 1 |
| Budakoglu, IY | 1 |
| Tugal, O | 1 |
| Arikan, S | 1 |
| Uslu, A | 1 |
| Gulec, AT | 2 |
| Aslani, FS | 1 |
| Dastgheib, L | 1 |
| Banihashemi, BM | 1 |
| Arun, B | 1 |
| Coupland, S | 1 |
| Parslew, R | 1 |
| El-Domyati, M | 2 |
| Attia, S | 2 |
| Saleh, F | 2 |
| Abdel-Wahab, H | 2 |
| Regula, CG | 1 |
| Clarke, JT | 1 |
| Hussey, S | 1 |
| Sorrells, T | 1 |
| Wang, JA | 1 |
| Darling, T | 1 |
| Borovicka, JH | 1 |
| Thomas, L | 1 |
| Prince, C | 1 |
| Mehregan, DR | 1 |
| Ekmekci, TR | 1 |
| Sakiz, D | 1 |
| Koslu, A | 1 |
| Cutrer, FM | 1 |
| Sandroni, P | 1 |
| Wendelschafer-Crabb, G | 1 |
| Santiago, F | 1 |
| Vieira, R | 1 |
| Figueiredo, A | 1 |
| Yu, M | 1 |
| Bell, RH | 1 |
| Ross, EK | 1 |
| Lo, BK | 1 |
| Isaac-Renton, M | 1 |
| Martinka, M | 2 |
| Haegert, A | 1 |
| Bathish, N | 1 |
| Ben Izhak, O | 1 |
| Shemer, A | 1 |
| Murrell, DF | 1 |
| Heugel, J | 1 |
| Spiro, D | 1 |
| Meckler, GD | 1 |
| Driscoll, DN | 1 |
| Tehrani, H | 1 |
| Hancock, K | 1 |
| Duncan, C | 1 |
| Farina, JA | 1 |
| Freitas, FA | 1 |
| Ungarelli, LF | 1 |
| Rodrigues, JM | 1 |
| Rossi, LA | 1 |
| Kulp, J | 1 |
| Levy, S | 1 |
| Fein, MC | 1 |
| Adams, M | 1 |
| Furst, J | 1 |
| Meng, TC | 1 |
| Stollery, N | 1 |
| Dorafshar, AH | 1 |
| Gitman, M | 1 |
| Roughton, M | 1 |
| Gottlieb, LJ | 1 |
| FOX, H | 1 |
| Gonzalez, ME | 1 |
| Cantatore-Francis, J | 1 |
| Orlow, SJ | 1 |
| Camacho, I | 1 |
| Tlemcani, K | 1 |
| Levine, D | 1 |
| Smith, RV | 1 |
| Brandwein-Gensler, M | 1 |
| Staffenberg, DA | 1 |
| Garg, MK | 1 |
| Shifteh, K | 1 |
| Haigentz, M | 1 |
| Ntuen, E | 1 |
| Stein, SL | 1 |
| Anshelevich, A | 1 |
| Osterhoudt, KC | 1 |
| Introcaso, CE | 1 |
| Treat, JR | 1 |
| Meier, MJ | 1 |
| Mutasim, DF | 1 |
| Möhrenschlager, M | 1 |
| Weichenmeier, I | 1 |
| Lauener, R | 1 |
| Worret, WI | 1 |
| Ring, J | 1 |
| Behrendt, H | 1 |
| Gilmore, S | 1 |
| Armenores, P | 1 |
| Shirato, K | 1 |
| Sidhu, S | 1 |
| Chew, AL | 2 |
| Price, V | 1 |
| Yéo, S | 1 |
| Perrot, P | 1 |
| Bellier-Waast, F | 1 |
| David, A | 1 |
| Duteille, F | 1 |
| Jeong, SH | 1 |
| Koo, SH | 1 |
| Han, SK | 1 |
| Kim, WK | 1 |
| van de Sande, MA | 1 |
| Jandali, S | 1 |
| Low, DW | 1 |
| Bashir, SJ | 1 |
| Wain, EM | 1 |
| St Pierre, SA | 1 |
| Vercellotti, GM | 1 |
| Letada, PR | 1 |
| Uebelhoer, NS | 1 |
| Masters, R | 1 |
| Satter, EK | 1 |
| Shumaker, PR | 1 |
| Zegarska, B | 1 |
| Kallas, D | 1 |
| Schwartz, RA | 2 |
| Czajkowski, R | 1 |
| Uchanska, G | 1 |
| Placek, W | 1 |
| Freund, BJ | 1 |
| Schwartz, M | 1 |
| Izeta, A | 1 |
| Oh, SJ | 2 |
| Koh, SH | 1 |
| Lee, JW | 2 |
| Jang, YC | 1 |
| Bassyouni, M | 1 |
| Barakat, M | 1 |
| Ali, I | 1 |
| Wojnarowska, F | 1 |
| Gho, CG | 1 |
| Neumann, HA | 2 |
| Zhao, T | 2 |
| Blatt, HB | 2 |
| Lee, M | 1 |
| He, H | 1 |
| Stanton, DC | 2 |
| Carrasco, L | 2 |
| Spiegel, JH | 1 |
| Tobias, JW | 1 |
| Lorenzi, S | 1 |
| Jaspers, GJ | 1 |
| Werrij, BG | 1 |
| Jagtman, BA | 1 |
| Loza, B | 1 |
| Jung, JH | 1 |
| Rah, DK | 1 |
| Yun, IS | 1 |
| Kluk, J | 1 |
| Charles-Holmes, R | 1 |
| Carr, RA | 1 |
| Wallis, KL | 1 |
| Gurusinghe, AD | 1 |
| Anwar, MU | 1 |
| Spyrou, G | 1 |
| Jung, HJ | 1 |
| Kim, SJ | 2 |
| Lee, WY | 1 |
| Choi, MH | 1 |
| Dall'oglio, F | 2 |
| Aber, C | 1 |
| Hagiwara, S | 1 |
| Uchida, T | 1 |
| Koga, H | 1 |
| Inomata, M | 1 |
| Yoshizumi, F | 1 |
| Moriyama, M | 1 |
| Kitano, S | 1 |
| Noguchi, T | 1 |
| Lee, EH | 1 |
| Kang, DS | 1 |
| Han, CS | 1 |
| Oh, SH | 1 |
| Borbíró, I | 1 |
| Lisztes, E | 1 |
| Tóth, BI | 1 |
| Czifra, G | 1 |
| Oláh, A | 1 |
| Szöllosi, AG | 1 |
| Szentandrássy, N | 1 |
| Nánási, PP | 1 |
| Péter, Z | 1 |
| Kovács, L | 1 |
| Klein, MB | 1 |
| Kargar, M | 1 |
| Sarvestani, RS | 1 |
| Khojasteh, HN | 1 |
| Heidari, MT | 1 |
| Emer, JJ | 1 |
| Stevenson, ML | 1 |
| Markowitz, O | 1 |
| Karaçal, N | 1 |
| Uraloğlu, M | 1 |
| Dindar, T | 1 |
| Livaoğlu, M | 1 |
| Mehrabyan, A | 1 |
| Guest, S | 1 |
| Essick, G | 1 |
| Ahn, JS | 1 |
| Poder, TG | 1 |
| He, J | 1 |
| Lemieux, R | 1 |
| Özcan, D | 1 |
| Özen, Ö | 1 |
| Seçkin, D | 1 |
| Cappel, JA | 1 |
| Kirby, JS | 1 |
| Karadağ Köse, Ö | 1 |
| Cannavò, SP | 1 |
| Wesley, CK | 1 |
| Rosenberg, M | 1 |
| Unger, MA | 1 |
| Unger, WP | 10 |
| Brafa, A | 1 |
| Campana, M | 1 |
| Nisi, G | 1 |
| Mourmouras, V | 1 |
| Miracco, C | 1 |
| D'Aniello, C | 1 |
| Chen, YA | 1 |
| Leirós, GJ | 1 |
| Attorresi, AI | 1 |
| Balañá, ME | 1 |
| Peerbooms, M | 2 |
| Kim, CR | 1 |
| Kim, HJ | 2 |
| Jung, MY | 1 |
| Lee, DY | 1 |
| Beach, RA | 1 |
| Wilkinson, KA | 1 |
| de Rivero Vaccari, JP | 1 |
| Sawaya, ME | 5 |
| Brand, F | 1 |
| Nusbaum, BP | 1 |
| Bauman, AJ | 1 |
| Bramlett, HM | 1 |
| Dietrich, WD | 1 |
| Keane, RW | 1 |
| Yang, Z | 1 |
| Alagesan, B | 1 |
| Lawson, JA | 1 |
| Norberg, SM | 1 |
| Loy, DE | 1 |
| Ahluwalia, G | 1 |
| Fischer, SM | 1 |
| FitzGerald, GA | 1 |
| Berton, M | 1 |
| Nojavan, H | 1 |
| Bens, G | 1 |
| Estève, E | 2 |
| Qiao, J | 1 |
| Fang, H | 1 |
| Huang, XS | 1 |
| Jiang, HO | 1 |
| Quan, QL | 1 |
| Shapiro, RL | 1 |
| Zupan, M | 1 |
| Pierre-Louis, M | 1 |
| House, NS | 1 |
| Welsh, JP | 1 |
| Yamada, S | 1 |
| Fukuhara, N | 1 |
| Nishioka, H | 1 |
| Yamaguchi-Okada, M | 1 |
| Takeshita, A | 1 |
| Takeuchi, Y | 1 |
| López, V | 1 |
| López, I | 1 |
| Ricart, JM | 1 |
| Osório, F | 1 |
| Magro, F | 1 |
| Lisboa, C | 1 |
| Lopes, S | 1 |
| Macedo, G | 1 |
| Bettencourt, H | 1 |
| Azevedo, F | 1 |
| Magina, S | 1 |
| Khidhir, KG | 1 |
| Woodward, DF | 1 |
| Farjo, NP | 1 |
| Farjo, BK | 1 |
| Tang, ES | 1 |
| Picksley, SM | 1 |
| Randall, VA | 4 |
| Childs, JM | 1 |
| Bunagan, MJ | 1 |
| Banka, N | 1 |
| Draelos, ZD | 1 |
| Tirado-González, M | 1 |
| Ball, E | 1 |
| Ruiz, A | 1 |
| Rodriguez, Y | 1 |
| Goudet, CE | 1 |
| Finkel, O | 1 |
| Golan, H | 1 |
| de Morentin, HM | 1 |
| Sprecher, H | 1 |
| Vleut, RE | 1 |
| van Poppel, JE | 1 |
| Dercksen, MW | 1 |
| Houterman, S | 1 |
| Orgaz-Molina, J | 1 |
| Girón-Prieto, MS | 1 |
| Binesh, F | 1 |
| Parichehr, K | 1 |
| Ladizinski, B | 1 |
| Bazakas, A | 1 |
| Selim, MA | 1 |
| Stockmeier, M | 1 |
| Kunte, C | 1 |
| Sander, CA | 1 |
| Wolff, H | 1 |
| Rhee, ST | 1 |
| Colville, C | 1 |
| Buchman, SR | 1 |
| Muraszko, K | 1 |
| Komuro, Y | 1 |
| Yanai, A | 1 |
| Seno, H | 1 |
| Ichida, M | 1 |
| Inoue, M | 1 |
| Miyajima, M | 1 |
| Arai, H | 1 |
| Sato, K | 1 |
| Yotsuyanagi, T | 1 |
| Watanabe, Y | 4 |
| Yamashita, K | 1 |
| Urushidate, S | 1 |
| Yokoi, K | 1 |
| Sawada, Y | 1 |
| McClellan, R | 1 |
| Jones, R | 1 |
| Worton, E | 1 |
| Uyttendaele, H | 1 |
| Van Neste, MD | 1 |
| Rashid, N | 2 |
| Shiell, RC | 4 |
| Brandy, DA | 17 |
| Protière, C | 1 |
| Evans, K | 1 |
| Camerlo, J | 1 |
| d'Ingrado, MP | 1 |
| Macquart-Moulin, G | 1 |
| Viens, P | 1 |
| Maraninchi, D | 1 |
| Genre, D | 1 |
| Chartier, MB | 1 |
| Hoss, DM | 1 |
| Grant-Kels, JM | 1 |
| Lam, SM | 1 |
| Hempstead, BR | 1 |
| Williams, EF | 1 |
| Leroy, T | 3 |
| Sandraps, E | 1 |
| Naz, E | 1 |
| Vidaurrázaga, C | 1 |
| Hernández-Cano, N | 1 |
| Herranz, P | 1 |
| Mayor, M | 1 |
| Hervella, M | 1 |
| Casado, M | 1 |
| Dawn, G | 1 |
| Holmes, SC | 1 |
| Moffat, D | 1 |
| Munro, CS | 1 |
| Kaufman, KD | 2 |
| Chamberlain, AJ | 1 |
| Dawber, RP | 8 |
| Shum, DT | 1 |
| Bernardo, O | 1 |
| Morgan, MB | 1 |
| Rose, P | 1 |
| Ridderheim, M | 1 |
| Bjurberg, M | 1 |
| Gustavsson, A | 1 |
| Jolley, D | 2 |
| Mallari, R | 2 |
| Piracinni, BM | 1 |
| Happle, R | 4 |
| Thérèse, L | 1 |
| Whiting, D | 3 |
| Kolasiñski, J | 1 |
| Kolenda, M | 1 |
| Quaedvlieg, PJ | 1 |
| Ostertag, JU | 1 |
| Krekels, GA | 1 |
| GARN, SM | 1 |
| SELBY, S | 1 |
| YOUNG, R | 1 |
| RINALDI, VG | 1 |
| FRANK, L | 2 |
| RUBY, A | 2 |
| MITCHELL, JH | 1 |
| CORREA-ITURRASPE, M | 1 |
| ARUFE, HN | 3 |
| MARINO, H | 1 |
| CORREA ITURRASPE, M | 1 |
| FOLDES, E | 2 |
| DEGOS, R | 1 |
| RABUT, R | 1 |
| LEFORT, P | 1 |
| GOLDBERG, HC | 1 |
| HANFLING, SL | 1 |
| REISS, F | 1 |
| REISCH, M | 1 |
| BUNCKE, CM | 1 |
| NEW, WN | 1 |
| NICKEL, WR | 1 |
| ZACKHEIM, HS | 1 |
| VAN SCOTT, EJ | 2 |
| EKEL, TM | 1 |
| KUTINCHEV, M | 1 |
| LORTAT-JACOB, E | 1 |
| TAABOR, HT | 1 |
| VAMOS, L | 1 |
| WINKELMANN, RK | 2 |
| JAFFE, MO | 1 |
| BRAUN-FALCO, O | 4 |
| HASSENPFLUG, K | 1 |
| CANELLIS, P | 1 |
| BORDA, JM | 1 |
| ABULAFIA, J | 1 |
| CORMIA, FE | 1 |
| ERNYEY, A | 1 |
| COSKEY, RJ | 1 |
| FOSNAUGH, RP | 1 |
| FINE, G | 1 |
| DANBOLT, N | 1 |
| LEIDER, M | 1 |
| BEGER, RA | 1 |
| ALTERAS, I | 1 |
| FALK, MS | 1 |
| PONTEN, B | 1 |
| CONLEY, JJ | 1 |
| VALLIS, CP | 5 |
| AMORETTI, AR | 1 |
| PANCONESI, E | 1 |
| SERTOLI, A | 1 |
| ONO, M | 1 |
| ERDELYI, R | 2 |
| MICHEL, PJ | 1 |
| ONIZUKA, T | 1 |
| OHMORI, S | 1 |
| RUSSELL, B | 1 |
| PRINGUET, R | 1 |
| ENGLISH, MP | 1 |
| WARIN, RP | 1 |
| HENRIQUEZ INCLAN, E | 1 |
| RONCHESE, F | 1 |
| SANNICANDRO, F | 1 |
| Solky, B | 1 |
| Elenitsas, R | 1 |
| Imai, Y | 1 |
| Isoda, K | 1 |
| Ito, E | 1 |
| Hakamada, A | 1 |
| Yamanishi, K | 1 |
| Mizutani, H | 1 |
| Dardour, JC | 6 |
| Hennebert, H | 1 |
| Vecchio, F | 1 |
| Seery, GE | 4 |
| Deloche, C | 1 |
| de Lacharrière, O | 1 |
| Bastien, P | 1 |
| Tardy, I | 1 |
| Bernard, BA | 3 |
| Tomioka, T | 1 |
| Hayashida, M | 1 |
| Hanaoka, K | 1 |
| NICHOLAS, L | 1 |
| LE MARQUAND, HS | 1 |
| BOHN, GL | 1 |
| PIGNOT, M | 1 |
| Ramsdell, WM | 1 |
| Hill, CJ | 1 |
| Lane, CM | 1 |
| Long, C | 1 |
| Clarke, A | 1 |
| Pilz, DT | 1 |
| Federici, S | 1 |
| Griffiths, D | 1 |
| Siberchicot, F | 1 |
| Chateil, JF | 1 |
| Gilbert, B | 1 |
| Lacombe, D | 1 |
| Aroni, K | 2 |
| Kyriazi, E | 1 |
| Aivaliotis, M | 1 |
| Davaris, P | 1 |
| Parsley, WM | 1 |
| Massey, CS | 1 |
| Rita Nasca, M | 1 |
| Zitelli, JA | 1 |
| Banky, JP | 1 |
| Sheridan, AT | 1 |
| Moretti, S | 2 |
| Amato, L | 2 |
| Bianchi, B | 1 |
| Gallerani, I | 1 |
| Fabbri, P | 2 |
| Chiarini, C | 1 |
| Lehmann, S | 1 |
| Ott, H | 1 |
| Barker, M | 1 |
| Heimann, G | 1 |
| Poblete-Gutiérrez, P | 1 |
| Frank, J | 1 |
| Bilkay, U | 1 |
| Kerem, H | 1 |
| Ozek, C | 1 |
| Erdem, O | 1 |
| Songur, E | 1 |
| Mortazavi, M | 1 |
| Mansouri, P | 1 |
| BERGER, W | 1 |
| KNIERER, W | 1 |
| Haas, N | 1 |
| Hauptmann, S | 1 |
| Aghaei, S | 1 |
| Sodaifi, M | 1 |
| Woods, R | 1 |
| Campbell, AW | 1 |
| Taylor, R | 1 |
| Matassa, J | 1 |
| Leavy, JE | 1 |
| Fritschi, L | 1 |
| Martín, JM | 1 |
| Monteagudo, C | 1 |
| Montesinos, E | 1 |
| Guijarro, J | 2 |
| Llombart, B | 1 |
| Jordá, E | 1 |
| Grevelman, EG | 1 |
| Ovesen, L | 1 |
| Kossard, S | 7 |
| Chapman, A | 1 |
| Tsolia, M | 1 |
| Konstantopoulou, I | 1 |
| Karpathios, T | 1 |
| Tsoukatou, T | 1 |
| Paraskevakou, H | 1 |
| Stavrinadis, C | 1 |
| Fretzayas, A | 1 |
| Motamed, S | 1 |
| Davami, B | 1 |
| Goon, P | 1 |
| Misra, A | 1 |
| Jumez, N | 1 |
| Bessis, D | 1 |
| Guillot, B | 1 |
| Tsuruta, D | 1 |
| Hayashi, A | 1 |
| Kobayashi, H | 1 |
| Nakagawa, K | 1 |
| Furukawa, M | 1 |
| Ishii, M | 1 |
| Randall, J | 1 |
| Ream, E | 1 |
| Hagemann, T | 1 |
| Schlütter-Böhmer, B | 1 |
| Allam, JP | 1 |
| Bieber, T | 2 |
| Novak, N | 1 |
| Müller, FB | 1 |
| High, WA | 1 |
| Hoang, MP | 1 |
| Böer, A | 1 |
| Hoene, K | 1 |
| He, Z | 1 |
| Yu, L | 1 |
| Luo, S | 1 |
| Gonzalez Guemes, M | 1 |
| Gonzalez Hermosa, R | 1 |
| Calderon Gutierrez, MJ | 1 |
| Gonzalez-Perez, R | 1 |
| Saracibar Oyon, N | 1 |
| Soloeta Arechavala, R | 1 |
| Christodoulou, C | 2 |
| Tsakalos, G | 1 |
| Galani, E | 1 |
| Skarlos, DV | 2 |
| Herrmann, A | 1 |
| Bormann, G | 1 |
| Marsch, WC | 1 |
| Wohlrab, J | 1 |
| Picard, A | 1 |
| Franchi, G | 1 |
| Delbecque, M | 1 |
| Sergent, B | 1 |
| Buis, J | 1 |
| Vazquez, MP | 1 |
| Nakai, N | 1 |
| Takenaka, H | 1 |
| Kishimoto, S | 1 |
| Conrad, F | 1 |
| Ohnemus, U | 1 |
| Bodo, E | 1 |
| Tychsen, B | 1 |
| Gerstmayer, B | 1 |
| Bosio, A | 1 |
| Schmidt-Rose, T | 1 |
| Altgilbers, S | 1 |
| Bettermann, A | 1 |
| Saathoff, M | 1 |
| Meyer, W | 1 |
| Whiting, DA | 8 |
| Hoffmann, R | 3 |
| Birch, MP | 2 |
| Lashen, H | 1 |
| Agarwal, S | 1 |
| Inglese, MJ | 1 |
| Bergamo, BM | 1 |
| Gammons, M | 1 |
| Wolter, B | 1 |
| Hamada, K | 2 |
| Ryu, HK | 1 |
| Kim, KM | 1 |
| Yoo, EA | 1 |
| Pascual, A | 1 |
| Piqué, E | 1 |
| Regev, E | 1 |
| Goldan, O | 1 |
| Orenstein, A | 1 |
| Winkler, E | 1 |
| Haik, J | 1 |
| Elston, GE | 1 |
| Harman, KE | 1 |
| Carvalho, DR | 1 |
| Giuliani, LR | 1 |
| Simão, GN | 1 |
| Santos, AC | 1 |
| Pina-Neto, JM | 1 |
| Tsai, SJ | 2 |
| Liao, CY | 2 |
| Tsai, RY | 2 |
| Chen, YJ | 1 |
| Pan, BJ | 1 |
| Hung, CL | 2 |
| Zouboulis, CC | 2 |
| Lahiri, A | 1 |
| Nishikawa, H | 1 |
| Michaelidis, IG | 1 |
| Stefanopoulos, PK | 1 |
| Papadimitriou, GA | 1 |
| Scheinfeld, N | 1 |
| Prakash, V | 1 |
| Tandon, R | 1 |
| Mantri, R | 1 |
| Barcaui, CB | 1 |
| Gonçalves da Silva, AM | 1 |
| Genser, B | 1 |
| Tan Baser, N | 1 |
| Cigsar, B | 1 |
| Balci Akbuga, U | 1 |
| Terzioglu, A | 1 |
| Aslan, G | 1 |
| Katz, KA | 1 |
| Gupta, R | 1 |
| Defo, D | 1 |
| Naouri, M | 1 |
| Martin, L | 2 |
| Carlson, JA | 1 |
| Malysz, J | 1 |
| Kwon, OS | 2 |
| Han, JH | 1 |
| Yoo, HG | 1 |
| Chung, JH | 2 |
| Cho, KH | 1 |
| Eun, HC | 2 |
| Nannapaneni, R | 1 |
| Behari, S | 1 |
| Mendelow, D | 1 |
| Gholkar, A | 1 |
| Stough, D | 2 |
| Hobbs, S | 1 |
| Ellis, ML | 1 |
| Wilson, T | 1 |
| Rittmaster, RS | 1 |
| Avninder, S | 1 |
| Ramesh, V | 1 |
| Fischer, TW | 1 |
| Hipler, UC | 1 |
| Gül, U | 1 |
| Kiliç, A | 1 |
| Akbaş, A | 1 |
| Aslan, E | 1 |
| Demiriz, M | 1 |
| Qing, Y | 1 |
| Cen, Y | 1 |
| Yaşar, S | 1 |
| Mansur, AT | 1 |
| Göktay, F | 1 |
| Sungurlu, F | 1 |
| Vardar Aker, F | 1 |
| Ozkara, S | 1 |
| Chung, JJ | 1 |
| Johnson, DW | 1 |
| Garcia, C | 1 |
| Poletti, E | 1 |
| Epstein, JS | 2 |
| Sehgal, VN | 1 |
| Kak, R | 1 |
| Aggarwal, A | 1 |
| Srivastava, G | 1 |
| Rajput, P | 1 |
| Yen, YT | 1 |
| Chen, KF | 1 |
| Voulliaume, D | 1 |
| Chichery, A | 1 |
| Chekaroua, K | 1 |
| Comparin, JP | 2 |
| Foyatier, JL | 2 |
| Wang, JP | 1 |
| Fan, JC | 1 |
| Park, SH | 1 |
| Oh, JK | 1 |
| Srivastava, M | 1 |
| Mikkilineni, R | 1 |
| Konstadt, J | 1 |
| Drissi Qeytoni, H | 1 |
| Nassih, M | 1 |
| Rzin, A | 1 |
| Jidal, B | 1 |
| Yun, SJ | 1 |
| Yoon, HJ | 1 |
| Lee, SS | 1 |
| Lee, JB | 1 |
| Lee, SC | 1 |
| Won, YH | 1 |
| Lykoudis, EG | 1 |
| Spyropoulou, GA | 1 |
| Lavasidis, LG | 1 |
| Paschopoulos, ME | 1 |
| Paraskevaidis, EA | 1 |
| Moravvej-Farshi, H | 1 |
| Mohtasham, N | 1 |
| Nnoruka, EN | 1 |
| Obiagboso, I | 1 |
| Maduechesi, C | 1 |
| Dogan, S | 1 |
| Cinar, C | 1 |
| Demirpolat, G | 1 |
| Memis, A | 1 |
| Dinh, HV | 1 |
| Martinick, J | 1 |
| Flotte, TJ | 1 |
| LIGHT, AE | 1 |
| Mason, G | 1 |
| Pohl, M | 1 |
| Blackwell, KE | 1 |
| Rawnsley, JD | 1 |
| Bregy, A | 1 |
| Severs, GA | 1 |
| Griffin, T | 1 |
| Werner-Wasik, M | 1 |
| González-Guerra, E | 1 |
| Haro, R | 1 |
| Angulo, J | 1 |
| Del Carmen Fariña, M | 1 |
| Requena, L | 1 |
| Lipsker, D | 1 |
| Boeckler, P | 1 |
| Cribier, B | 1 |
| Timothy, AR | 1 |
| Bates, TD | 1 |
| Hoy, AM | 1 |
| Guy, R | 1 |
| Parker, H | 1 |
| Geddes, D | 1 |
| Blanchard, G | 3 |
| Blanchard, B | 3 |
| Nordstrom, RE | 14 |
| Tamm, J | 1 |
| Seckelmann, M | 1 |
| Volkwein, U | 1 |
| Ludwig, E | 1 |
| Tonkin, N | 1 |
| Chavrakov, G | 1 |
| Popkhistova, E | 1 |
| Wester, RC | 2 |
| Maibach, HI | 1 |
| Guy, RH | 1 |
| Novak, E | 2 |
| Kiser, J | 1 |
| Jungi, E | 1 |
| Winkler, L | 1 |
| Dubach, C | 1 |
| Lampietti, R | 1 |
| Salchli, S | 1 |
| Heckendorn, V | 1 |
| Rand, R | 1 |
| Baden, HP | 2 |
| Fernandes Rodrigues, JC | 1 |
| Pinto Soares, A | 1 |
| Garcia E Silva, L | 1 |
| Norwood, OT | 5 |
| Morrison, ID | 1 |
| Roberts, AH | 2 |
| Satterwhite, B | 1 |
| Zimm, S | 1 |
| Cline, BW | 1 |
| Ranki, A | 1 |
| Kianto, U | 1 |
| Kanerva, L | 1 |
| Tolvanen, E | 1 |
| Johansson, E | 1 |
| Heider, L | 1 |
| Steger, O | 2 |
| Schmoeckel, C | 2 |
| Tigges, FJ | 2 |
| Fuhrmann-Rieger, A | 1 |
| Fuhrmann, W | 1 |
| Fodor, PB | 1 |
| Liverett, DM | 1 |
| Nataf, J | 4 |
| Stegman, SJ | 1 |
| Manders, EK | 2 |
| Graham, WP | 1 |
| Ohmori, K | 5 |
| Unger, MG | 5 |
| Neal, PR | 1 |
| Merk, PF | 1 |
| Norins, AL | 1 |
| Samonigg, H | 1 |
| Fereberger, W | 1 |
| Biffl, E | 1 |
| Akaike, F | 1 |
| Naito, K | 1 |
| Ise, T | 1 |
| McCray, MK | 1 |
| Roenigk, HH | 4 |
| Martin, J | 1 |
| Ross, JB | 2 |
| Traupe, H | 1 |
| Uebel, CO | 1 |
| Dean, JC | 2 |
| Griffith, KS | 2 |
| Cetas, TC | 1 |
| Mackel, CL | 1 |
| Jones, SE | 1 |
| Salmon, SE | 2 |
| Abramov, SN | 1 |
| Zen'kevich, AP | 1 |
| Shinaev, NN | 1 |
| Headington, JT | 5 |
| Dixon-Hughes, J | 1 |
| Jones, PB | 1 |
| Mitz, V | 1 |
| Dabos, N | 1 |
| Vilain, R | 1 |
| Jarczewska, M | 1 |
| Sibiga, W | 1 |
| Paletta, FX | 2 |
| Anderson, JE | 2 |
| Hunt, JM | 2 |
| Smith, IE | 2 |
| Cooke, T | 2 |
| Gregory, RP | 2 |
| Middleton, J | 3 |
| Williams, C | 1 |
| Buchanan, RB | 2 |
| Williams, CJ | 2 |
| Dutta, AK | 1 |
| Mandal, SB | 1 |
| Jopling, WH | 1 |
| Guaricci, N | 1 |
| Gasperoni, C | 1 |
| De Stefano, C | 1 |
| Proia, G | 1 |
| Standoli, L | 1 |
| Smith, FP | 1 |
| McCabe, MS | 1 |
| Fosså, SD | 1 |
| Nordbø, O | 1 |
| Gundersen, S | 1 |
| Skilshagen, SJ | 1 |
| Otto, F | 1 |
| Cates, JA | 3 |
| Maxwell, MB | 1 |
| Welch, D | 1 |
| Lewis, K | 1 |
| Igarashi, R | 1 |
| Sudo, S | 1 |
| Morohashi, M | 1 |
| Takeuchi, S | 1 |
| Sato, Y | 1 |
| Hanke, CW | 2 |
| Jordon, RE | 1 |
| Ceilley, RI | 2 |
| Belpomme, D | 1 |
| Mignot, L | 1 |
| Grandjean, M | 1 |
| Pujade-Lauraine, E | 1 |
| Le Rol, A | 1 |
| Gisselbrecht, C | 1 |
| Marty, M | 1 |
| Boiron, M | 1 |
| Bell, ML | 2 |
| Mayer, TG | 4 |
| Fleming, RW | 4 |
| Stough, DB | 16 |
| Dean, AJ | 1 |
| Wexler, MR | 1 |
| Faller, RG | 1 |
| Cherry, GW | 1 |
| Chajchir, A | 3 |
| Benzaquen, I | 3 |
| Walker, WD | 1 |
| Farber, GA | 1 |
| Coiffman, F | 3 |
| Elliott, RA | 2 |
| Juri, J | 8 |
| Juri, C | 8 |
| Fukamizu, H | 1 |
| Matsumoto, K | 1 |
| Inoue, K | 1 |
| Moriguchi, T | 1 |
| Knight, TE | 1 |
| Robinson, HM | 1 |
| Sina, B | 1 |
| Alt, TH | 3 |
| Pouteaux, P | 3 |
| Resnik, HL | 1 |
| Colnago, A | 3 |
| Baum, EM | 1 |
| Omura, EF | 1 |
| Payne, RR | 1 |
| Little, WP | 1 |
| Nielsen, T | 1 |
| Schmidt, H | 1 |
| Søgaard, H | 1 |
| Gandelman, IM | 1 |
| Curi, M | 1 |
| Bogdanowski, T | 1 |
| Rubisz-Brzezinska, J | 1 |
| Bonnefon, A | 1 |
| Barzó, P | 1 |
| Molnár, L | 1 |
| Tóth, E | 1 |
| Neild, VS | 1 |
| Cantú, JM | 1 |
| Sánchez-Corona, J | 1 |
| González-Mendoza, A | 1 |
| Martínez y Martínez, R | 1 |
| García-Cruz, D | 1 |
| Hill, TG | 1 |
| Bosley, LL | 1 |
| Hope, CR | 1 |
| Montroy, RE | 1 |
| Straub, PM | 1 |
| Shelley, WB | 1 |
| Wood, MG | 1 |
| Bader, C | 1 |
| Laugier, P | 1 |
| Auerback, R | 1 |
| Das, S | 1 |
| Lee, MS | 2 |
| Wilkinson, B | 2 |
| Doyle, JA | 1 |
| Fitzpatrick, RE | 1 |
| Ho, C | 1 |
| Nguyen, Q | 1 |
| Lask, G | 1 |
| Lowe, N | 2 |
| Anegawa, S | 1 |
| Hayashi, T | 1 |
| Torigoe, R | 1 |
| Araki, T | 1 |
| Yoshikawa, A | 1 |
| Fernandez-Gutierrez, L | 1 |
| Gomez-Flores, M | 1 |
| de Viragh, PA | 1 |
| Griffin, EI | 3 |
| Halsner, UE | 1 |
| Lucas, MW | 1 |
| Zapata, HH | 1 |
| Sletten, LJ | 1 |
| Pierpont, ME | 1 |
| Dzubow, LM | 3 |
| Cohen, BH | 2 |
| Rosati, P | 1 |
| Cohen, M | 1 |
| Shafir, R | 2 |
| Spencer, DM | 1 |
| Schauder, CS | 1 |
| Thigpen, AE | 1 |
| Silver, RI | 1 |
| Guileyardo, JM | 1 |
| Casey, ML | 1 |
| McConnell, JD | 1 |
| Russell, DW | 1 |
| Szafer, F | 1 |
| Oksenberg, JR | 1 |
| Steinman, L | 1 |
| Yoon, KH | 1 |
| Ahn, SK | 2 |
| Kretzschmar, L | 1 |
| Bonsmann, G | 1 |
| Metze, D | 1 |
| Luger, TA | 1 |
| Schwarz, T | 1 |
| McCafferty, LR | 1 |
| Howard, PS | 1 |
| Bernard, SL | 1 |
| Smith, JK | 1 |
| Fullana, F | 1 |
| González, M | 1 |
| Nó, M | 1 |
| Huc, O | 1 |
| González-Mestre, V | 1 |
| Tollenaar, RA | 1 |
| Liefers, GJ | 1 |
| Repelaer van Driel, OJ | 1 |
| van de Velde, CJ | 1 |
| Mathonnet, D | 1 |
| Aziza, R | 3 |
| Lange-Ionescu, S | 1 |
| Frosch, PJ | 1 |
| Marritt, E | 1 |
| Dzubow, L | 1 |
| Guinard, D | 1 |
| Lebeau, J | 1 |
| Moutet, F | 1 |
| Raphael, B | 1 |
| Huda, W | 1 |
| Peters, KR | 1 |
| Hofer, PA | 1 |
| Egelrud, T | 1 |
| Caballero, MJ | 1 |
| Kiesewetter, F | 1 |
| Schell, H | 1 |
| de Brouwer, B | 4 |
| De Coster, W | 2 |
| Courtois, M | 1 |
| Hourseau, C | 1 |
| Grollier, JF | 1 |
| Mallon, E | 1 |
| Trakimas, C | 1 |
| Skelton, HG | 2 |
| Smith, KJ | 3 |
| Buker, JL | 1 |
| Templeton, SF | 2 |
| Solomon, AR | 3 |
| Dallob, AL | 1 |
| Sadick, NS | 4 |
| Unger, W | 1 |
| Lipert, S | 1 |
| Geissler, LA | 1 |
| Gregoire, SL | 1 |
| Nguyen, HH | 1 |
| Moore, EC | 1 |
| Tanaka, WK | 1 |
| Long, J | 1 |
| Ma, E | 1 |
| Swinehart, JM | 2 |
| Puerto, AM | 3 |
| Mallol, J | 4 |
| Peterson, JL | 1 |
| Diani, AR | 2 |
| Mills, CJ | 1 |
| Duplechain, G | 1 |
| White, JA | 1 |
| Felman, G | 1 |
| Terashi, H | 1 |
| Kurata, S | 2 |
| Hashimoto, H | 1 |
| Takasaki, S | 1 |
| Sonoda, T | 3 |
| Takayasu, S | 3 |
| Honda, T | 1 |
| Carson, HJ | 1 |
| Pellettiere, EV | 1 |
| Lack, E | 1 |
| Alcaraz, MV | 1 |
| Villena, A | 1 |
| Pérez de Vargas, I | 1 |
| Alessi, E | 1 |
| Caputo, R | 1 |
| Trott, JA | 1 |
| Runne, U | 3 |
| Divaris, M | 1 |
| Mandy, SH | 2 |
| Anderson, RD | 3 |
| Delay, E | 1 |
| Latarjet, J | 1 |
| Masson, CL | 1 |
| Ozun, G | 1 |
| Vilmer, C | 1 |
| Trassard, M | 1 |
| Zagarella, S | 1 |
| Gershan, LA | 1 |
| Esterly, NB | 3 |
| Modan, B | 1 |
| Alfandary, E | 1 |
| Shapiro, D | 1 |
| Lusky, A | 1 |
| Chetrit, A | 1 |
| Shewach-Millet, M | 1 |
| Movshovitz, M | 1 |
| Schauer, DA | 1 |
| Coursey, BM | 1 |
| Dick, CE | 1 |
| McLaughlin, WL | 1 |
| Puhl, JM | 1 |
| Desrosiers, MF | 1 |
| Jacobson, AD | 1 |
| Frechet, P | 3 |
| Elliott, RM | 1 |
| Thomas, RA | 1 |
| True, RH | 1 |
| Krasovec, M | 1 |
| Widmer, M | 1 |
| Gilliet, F | 1 |
| Burg, G | 3 |
| Richard, G | 1 |
| Harth, W | 1 |
| Kurland, P | 1 |
| Green, D | 1 |
| Farrior, EH | 1 |
| Josephson, JS | 1 |
| Luelmo-Aguilar, J | 1 |
| Gonzalez-Castro, U | 1 |
| Castells-Rodellas, A | 1 |
| Nayar, M | 1 |
| Schomberg, K | 1 |
| Millard, PR | 1 |
| Nicholson, AG | 1 |
| Harland, CC | 1 |
| Bull, RH | 1 |
| Mortimer, PS | 1 |
| Cook, MG | 1 |
| Shull, KL | 1 |
| Zaya, MJ | 1 |
| Brunden, MN | 1 |
| DeRusso, D | 1 |
| Yeager, J | 1 |
| Wagner, KF | 1 |
| Angritt, P | 1 |
| White, A | 1 |
| Killingsworth, M | 1 |
| Goldman, BE | 1 |
| Fisher, DM | 1 |
| Ringler, SL | 1 |
| Har-Shai, Y | 1 |
| Hirshowitz, B | 1 |
| Frishberg, DP | 1 |
| Guthrie, VM | 1 |
| Dougherty, L | 1 |
| Chow, IJ | 1 |
| Balakrishnan, C | 1 |
| Meininger, MS | 1 |
| Spicer, MS | 1 |
| Leevy, CB | 1 |
| Ticker, JB | 1 |
| Lambert, WC | 1 |
| Hibberts, NA | 2 |
| Hu, H | 2 |
| Sun, G | 2 |
| He, W | 1 |
| Giralt, M | 1 |
| Cervello, I | 1 |
| Nogues, MR | 1 |
| Ortin, F | 1 |
| Argany, N | 1 |
| Santa Cruz, DJ | 1 |
| Sahl, WJ | 1 |
| Spinucci, G | 1 |
| Pasquali, R | 1 |
| Feldmann, R | 1 |
| Harms, M | 1 |
| Saurat, JH | 1 |
| Ramirez, RD | 1 |
| Wright, WE | 1 |
| Shay, JW | 1 |
| Taylor, RS | 1 |
| Kakibuchi, M | 1 |
| Asada, Y | 3 |
| Kobayashi, S | 1 |
| Cremer, G | 1 |
| Bournerias, I | 1 |
| Vandemeleubroucke, E | 1 |
| Houin, R | 1 |
| Revuz, J | 1 |
| Wolf, P | 1 |
| Fink-Puches, R | 1 |
| Reimann-Weber, A | 1 |
| Kerl, H | 1 |
| Ron, IG | 1 |
| Kalmus, Y | 1 |
| Kalmus, Z | 1 |
| Inbar, M | 1 |
| Chaitchik, S | 1 |
| Pericin, M | 1 |
| Hafner, J | 1 |
| Davis, AJ | 1 |
| Nelson, PK | 1 |
| Giraldo, F | 1 |
| González, C | 1 |
| Garnica, I | 1 |
| Ferrón, M | 1 |
| Rus, JA | 1 |
| Bridenstine, JB | 1 |
| Raposio, E | 6 |
| TerKonda, RP | 1 |
| Sykes, JM | 1 |
| Boudou, P | 1 |
| Jackow, CM | 1 |
| Papadopoulos, E | 1 |
| Nelson, B | 2 |
| Tschen, JA | 1 |
| Heatherington, G | 1 |
| Duvic, M | 1 |
| Barrera, A | 1 |
| Tételin, C | 1 |
| Bonfils, A | 1 |
| Hwang, SM | 1 |
| Howell, AE | 1 |
| Abraham, S | 1 |
| Ebenezer, GJ | 1 |
| Jesudasan, K | 1 |
| Mastruserio, DN | 1 |
| Cobb, MA | 1 |
| Ross, VE | 1 |
| Santi, PL | 2 |
| Farrell, AM | 1 |
| Ross, JS | 1 |
| Thomas, JM | 1 |
| Fisher, C | 1 |
| Bunker, CB | 2 |
| Kane, KS | 1 |
| Kwan, T | 1 |
| Bigby, M | 1 |
| Allbritton, J | 1 |
| Simmons-O'Brien, E | 1 |
| Hutcheons, D | 1 |
| Whitmore, SE | 1 |
| Spraggs, PD | 1 |
| Torricelli, R | 1 |
| Zhang, Z | 1 |
| Santi, P | 1 |
| De Dieuleveult, T | 1 |
| Sellam, P | 1 |
| Slama, M | 1 |
| Papay, FA | 1 |
| Luciano, M | 1 |
| Zins, JE | 1 |
| Hogan, P | 1 |
| Sullivan, JR | 1 |
| Schwarzenbach, R | 1 |
| Djawari, D | 1 |
| Signorello, LB | 1 |
| Wuu, J | 1 |
| Hsieh, Cc | 1 |
| Tzonou, A | 1 |
| Trichopoulos, D | 1 |
| Mantzoros, CS | 1 |
| Barret, JP | 1 |
| Dziewulski, P | 1 |
| Wolf, SE | 1 |
| Desai, MH | 2 |
| Herndon, DN | 2 |
| Burm, JS | 1 |
| Sato, T | 2 |
| Tadokoro, T | 1 |
| Moon, CM | 1 |
| Schissel, DJ | 1 |
| Weichenthal, M | 1 |
| Stemm, AV | 1 |
| Ramsauer, J | 1 |
| Mensing, H | 1 |
| Feller, AC | 1 |
| Meigel, W | 1 |
| Trakimas, CA | 1 |
| Suetake, K | 1 |
| Uede, T | 1 |
| Momota, H | 1 |
| Oka, S | 1 |
| Piao, H | 1 |
| Minamida, Y | 1 |
| Hashi, K | 1 |
| Shan, S | 2 |
| Gao, G | 1 |
| Zhang, D | 1 |
| Long, D | 2 |
| Shiell, R | 1 |
| Gabrielson, A | 1 |
| Worel, S | 1 |
| Noble-Adams, R | 1 |
| Drake, L | 1 |
| Fiedler, V | 2 |
| Swinehart, J | 1 |
| Cotterill, PC | 2 |
| Thiboutot, DM | 1 |
| Jacobson, C | 2 |
| Stieglitz, S | 1 |
| Kraus, SJ | 1 |
| Weiss, D | 1 |
| Carrington, P | 1 |
| Gencheff, C | 1 |
| Cole, GW | 1 |
| Pariser, DM | 1 |
| Epstein, ES | 1 |
| Tanaka, W | 1 |
| Dallob, A | 1 |
| Vandormael, K | 1 |
| Geissler, L | 1 |
| Waldstreicher, J | 3 |
| Bayne, EK | 1 |
| Flanagan, J | 1 |
| Einstein, M | 1 |
| Ayala, J | 1 |
| Chang, B | 1 |
| Azzolina, B | 1 |
| Mumford, RA | 1 |
| Thiboutot, D | 1 |
| Singer, II | 1 |
| Harris, G | 1 |
| Yoho, R | 1 |
| Tanaka, A | 1 |
| Hatoko, M | 1 |
| Shiba, A | 1 |
| Kuwahara, M | 1 |
| Tada, H | 1 |
| Okazaki, T | 1 |
| Muramatsu, T | 1 |
| Sintov, A | 1 |
| Serafimovich, S | 1 |
| Min, HG | 1 |
| Lee, ES | 1 |
| Fair, KP | 1 |
| Knoell, KA | 1 |
| Patterson, JW | 1 |
| Rudd, RJ | 1 |
| Greer, KE | 1 |
| Köstler, E | 1 |
| Hubl, W | 1 |
| Seebacher, C | 1 |
| Sanchez, M | 1 |
| Crittenden, J | 1 |
| Skelton, H | 1 |
| Katta, R | 1 |
| Chen, D | 1 |
| Roenigk, H | 1 |
| Silfen, R | 1 |
| Hudson, DA | 1 |
| Soldin, MG | 1 |
| Skoll, PJ | 1 |
| Katsimbri, P | 1 |
| Bamias, A | 1 |
| Pavlidis, N | 1 |
| Madani, S | 1 |
| Trotter, MJ | 1 |
| Homoky, C | 1 |
| Pratt, L | 1 |
| Sau, P | 1 |
| Pan, HJ | 1 |
| Uno, H | 4 |
| Fulmer, NO | 1 |
| Chang, C | 1 |
| Bridges, AG | 1 |
| von Kuster, LC | 1 |
| Estes, SA | 1 |
| Platz, EA | 1 |
| Pollak, MN | 1 |
| Willett, WC | 1 |
| Giovannucci, E | 1 |
| Goucha, S | 1 |
| Fazaa, B | 1 |
| Ezzine, N | 1 |
| Jaber, K | 1 |
| Elandaloussi, H | 1 |
| Abid, R | 1 |
| Kamoun, MR | 1 |
| Shah, N | 1 |
| Groom, N | 1 |
| Sibtain, A | 1 |
| Hoskin, P | 1 |
| Halloy, J | 2 |
| Goldbeter, A | 2 |
| Vabres, P | 1 |
| Moloney, JB | 1 |
| Blake, J | 1 |
| Denham, B | 1 |
| Mooney, D | 1 |
| Roberts, JL | 1 |
| Savin, R | 1 |
| Lucky, A | 1 |
| Pappas, F | 1 |
| Culbertson, J | 1 |
| Kotey, P | 1 |
| Meehan, A | 1 |
| Ikejima, A | 1 |
| Yamashita, M | 2 |
| Ikeda, S | 1 |
| Ogawa, H | 1 |
| Podda, M | 1 |
| Spieth, K | 1 |
| Kaufmann, R | 1 |
| Davis, ST | 1 |
| Benson, BG | 1 |
| Bramson, HN | 1 |
| Chapman, DE | 1 |
| Dickerson, SH | 1 |
| Dold, KM | 1 |
| Eberwein, DJ | 1 |
| Edelstein, M | 1 |
| Frye, SV | 1 |
| Gampe, RT | 1 |
| Griffin, RJ | 1 |
| Harris, PA | 1 |
| Hassell, AM | 1 |
| Holmes, WD | 1 |
| Hunter, RN | 1 |
| Knick, VB | 1 |
| Lackey, K | 1 |
| Lovejoy, B | 1 |
| Luzzio, MJ | 1 |
| Murray, D | 1 |
| Parker, P | 1 |
| Rocque, WJ | 1 |
| Shewchuk, L | 1 |
| Veal, JM | 1 |
| Walker, DH | 1 |
| Kuyper, LF | 1 |
| Schön, MP | 1 |
| Reifenberger, J | 1 |
| Gantke, B | 1 |
| Megahed, M | 1 |
| Lehmann, P | 1 |
| Kamimura, A | 2 |
| Takahashi, T | 2 |
| Greco, M | 1 |
| O'goshi, K | 1 |
| Iguchi, M | 1 |
| Tagami, H | 1 |
| Messenger, JF | 1 |
| Silvestre, JF | 1 |
| Ramón, RL | 1 |
| Betlloch, MI | 1 |
| Botella, R | 1 |
| Powell, J | 1 |
| Niiyama, S | 1 |
| Itin, PH | 1 |
| Laeng, RH | 1 |
| Li, AL | 1 |
| Yu, MS | 1 |
| Yan, YZ | 1 |
| Forsberg, SA | 2 |
| Cilotti, A | 1 |
| Danza, G | 1 |
| Serio, M | 1 |
| Strober, BE | 1 |
| Neidel, FG | 1 |
| Fuchs, M | 1 |
| Krahl, D | 1 |
| Ojiro, M | 1 |
| Ezaki, T | 1 |
| Yokoo, Y | 1 |
| Honda, S | 1 |
| Unay, B | 1 |
| Sarici, SU | 1 |
| Gül, D | 1 |
| Akin, R | 1 |
| Gökçay, E | 1 |
| Shea, CR | 2 |
| Nicholson, J | 1 |
| Gat, M | 1 |
| Lunievski, S | 1 |
| Prieto, VG | 1 |
| Bianchi, L | 1 |
| Paro Vidolin, A | 1 |
| Piemonte, P | 1 |
| Carboni, I | 1 |
| Chimenti, S | 1 |
| Batchelor, D | 1 |
| Turner, CD | 1 |
| Rosoff, PM | 1 |
| Panteleyev, AA | 2 |
| Aita, VM | 2 |
| Klouvas, G | 1 |
| Efstathiou, E | 1 |
| Zervakis, D | 1 |
| Papazachariou, E | 1 |
| Plyta, M | 1 |
| Gao, Z | 1 |
| Elmer, KB | 1 |
| George, RM | 1 |
| Edelstyn, GA | 1 |
| MacDonald, M | 1 |
| MacRae, KD | 1 |
| Forastero, MA | 1 |
| Bartolomé, M | 1 |
| Weigand, DA | 1 |
| Salamon, T | 3 |
| Lazović, O | 1 |
| Nikulin, A | 1 |
| Marković, Z | 1 |
| Brodiagin, VN | 1 |
| Markov, RM | 1 |
| Wolff, HH | 1 |
| Kinney, J | 1 |
| Ackerman, AB | 2 |
| Bovet, R | 1 |
| Delacrétaz, J | 1 |
| Marechal, RE | 1 |
| Strong, AM | 1 |
| Yokota, A | 2 |
| Matsukado, Y | 1 |
| Lauzon, G | 1 |
| Gonzalez, ER | 1 |
| McBride, G | 1 |
| Sebben, JE | 1 |
| Lewis, LA | 1 |
| Resnik, SS | 1 |
| Schultz, BC | 1 |
| Spiegl, B | 1 |
| Hundeiker, M | 1 |
| Auerbach, R | 1 |
| Pearlstein, HH | 1 |
| Slutzki, S | 1 |
| Bornstein, LA | 1 |
| Tsur, H | 1 |
| Kabaker, S | 1 |
| Barros d'Sa, AA | 1 |
| Heard, CE | 1 |
| Soukop, M | 1 |
| Campbell, A | 1 |
| Gray, MM | 1 |
| Calman, KC | 1 |
| Pesce, A | 2 |
| Cassuto, JP | 2 |
| Joyner, MV | 2 |
| DuJardin, P | 2 |
| Audoly, P | 2 |
| Lazović-Tepavac, O | 1 |
| Gaćinović-Kostanjsek, Z | 1 |
| Korić-Gackić, A | 1 |
| Stengel, F | 1 |
| Gabrilove, JL | 1 |
| Luria, M | 1 |
| Elbaz, JS | 2 |
| Zumer, L | 1 |
| Marchac, D | 1 |
| Toussaint, D | 1 |
| Ledoux, M | 1 |
| Bruneau, N | 1 |
| Lattanand, A | 1 |
| Johnson, WC | 1 |
| Bendl, BJ | 1 |
| Sasai, Y | 1 |
| Nakano, S | 1 |
| Ando, K | 1 |
| Pierce, HE | 1 |
| Knight, AG | 1 |
| Lachapelle, JM | 1 |
| Huang, TT | 2 |
| Larson, DL | 1 |
| Lewis, SR | 1 |
| Heimburger, RA | 1 |
| Pollet, J | 1 |
| Solomon, LM | 2 |
| Dyggve, H | 1 |
| Pedersen, KE | 1 |
| Normand, P | 1 |
| Boche, R | 1 |
| Salaun, R | 1 |
| Lwason, NW | 1 |
| Mills, NL | 1 |
| Ochsner, JL | 1 |
| de Antueno, J | 1 |
| Vinas, JC | 1 |
| Caviglia, C | 1 |
| Cortinas, JL | 1 |
| Darley, C | 1 |
| Heng, MC | 1 |
| Levine, S | 1 |
| Fine, H | 1 |
| Allen, SG | 1 |
| Heng, MK | 1 |
| Wilson, CL | 2 |
| Burge, SM | 1 |
| Dean, D | 1 |
| Jaworsky, C | 1 |
| Kligman, AM | 2 |
| Wollenberg, A | 1 |
| Heckmann, M | 1 |
| Tambwekar, SR | 1 |
| García Santos, JM | 1 |
| Climent, V | 1 |
| Bachynsky, T | 1 |
| Antonyshyn, OM | 1 |
| Nelson, BR | 3 |
| Gillard, M | 1 |
| Johnson, TM | 1 |
| Matloub, HS | 1 |
| Yousif, NJ | 1 |
| Ye, Z | 1 |
| Sanger, JR | 1 |
| Teshima, H | 1 |
| Urabe, A | 1 |
| Irie, M | 1 |
| Nakagawa, T | 1 |
| Nakayama, J | 2 |
| Hori, Y | 1 |
| Helm, TN | 1 |
| Benedetto, E | 1 |
| Pillar, T | 1 |
| Assay, B | 1 |
| David, M | 1 |
| Hitzig, GS | 2 |
| McDonagh, AJ | 1 |
| Laing, RW | 1 |
| Harrington, CI | 1 |
| Griffiths, RW | 1 |
| van Damme, PH | 1 |
| Arouete, J | 3 |
| Young, JW | 1 |
| Conte, ET | 1 |
| Leavitt, ML | 1 |
| Nafz, MA | 1 |
| Schroeter, AL | 1 |
| Jansen, T | 1 |
| Küppers, U | 1 |
| Plewig, G | 1 |
| Lemperle, G | 1 |
| Kostka, KH | 1 |
| Exner, K | 1 |
| Hodgins, MB | 1 |
| Choudhry, R | 1 |
| Parker, G | 1 |
| Oliver, RF | 1 |
| Jahoda, CA | 1 |
| Withers, AP | 1 |
| Brinkmann, AO | 1 |
| van der Kwast, TH | 1 |
| Boersma, WJ | 1 |
| Lammers, KM | 1 |
| Dumortier, M | 1 |
| Johnson, T | 2 |
| Natsuda, H | 1 |
| Muraki, Y | 1 |
| Kozima, H | 1 |
| Shibuya, A | 1 |
| Nagasawa, T | 1 |
| Abe, T | 1 |
| Levy, ML | 1 |
| Landsman, L | 1 |
| Welch, TB | 1 |
| Boyne, PJ | 1 |
| Arellano, A | 2 |
| Ramsay, ID | 2 |
| Norris, MJ | 2 |
| Gilkes, JJ | 2 |
| Taylor, BJ | 1 |
| Baker, BW | 1 |
| Davis, AL | 1 |
| Spearing, RL | 1 |
| Hart, DN | 1 |
| Heaton, DC | 1 |
| Beard, ME | 1 |
| Tószegi, A | 1 |
| Mehregan, AH | 1 |
| Mehregan, DA | 1 |
| Hillen, HF | 1 |
| Botman, CJ | 1 |
| Bulengo-Ransby, SM | 1 |
| Meirson, D | 1 |
| Reyes, BA | 1 |
| Geronemus, R | 1 |
| Velez, JR | 1 |
| Palou, J | 1 |
| Mascaro, JM | 1 |
| Cooper, RL | 1 |
| Brown, D | 1 |
| Ziv, R | 1 |
| Schewach-Millet, M | 1 |
| Trau, H | 1 |
| Ehrenfeld, M | 1 |
| Samra, Y | 1 |
| Asman, A | 1 |
| Madazimov, MM | 1 |
| Grishkevich, VM | 1 |
| Moroz, VIu | 1 |
| Vaganova, NA | 1 |
| Archer, CB | 1 |
| Smith, NP | 1 |
| Brou, J | 1 |
| Vu, T | 1 |
| McCauley, RL | 2 |
| Rutan, RL | 1 |
| Stenberg, B | 1 |
| Phillips, LG | 1 |
| Robson, MC | 2 |
| Jin, YT | 1 |
| Muller, SA | 4 |
| Toshitani, S | 1 |
| Yahata, T | 1 |
| Yasuda, M | 1 |
| Urabe, H | 1 |
| Dekio, S | 2 |
| Imaoka, C | 1 |
| Jidoi, J | 2 |
| Brown, MD | 1 |
| Swanson, NA | 1 |
| James, KC | 1 |
| Ortega, MT | 1 |
| Leyder, P | 1 |
| Devauchelle, B | 1 |
| Chabolle, F | 1 |
| Vaillant, JM | 1 |
| Galbraith, GM | 1 |
| Thiers, BH | 1 |
| Jensen, J | 1 |
| Hoehler, F | 1 |
| Barth, JH | 1 |
| Chavoin, JP | 1 |
| Rouge, D | 1 |
| Costagliola, M | 1 |
| Grattan, CE | 1 |
| Liddle, BJ | 1 |
| Willshaw, HE | 1 |
| Nagashima, T | 1 |
| Da Matta, A | 1 |
| Ai, YF | 1 |
| Goldfarb, MT | 1 |
| Nickoloff, BJ | 1 |
| Hamilton, TA | 1 |
| Ellis, CN | 1 |
| Voorhees, JJ | 1 |
| Bergner, T | 2 |
| Heilgemeir, GP | 1 |
| Künzler, A | 1 |
| Sailer, HF | 1 |
| Kroneisen, P | 1 |
| Fuse, Y | 1 |
| Tsukagoshi, E | 1 |
| Iizuka, S | 1 |
| Baran, R | 1 |
| Honig, LS | 2 |
| Hsia, SL | 2 |
| Moscona, R | 1 |
| Friedman-Birnbaum, R | 1 |
| Moss, RM | 1 |
| Swenson, RW | 2 |
| Schmidt, JB | 1 |
| Garland, LD | 1 |
| Konishi, Y | 1 |
| Kuroki, T | 1 |
| Heinberg, CE | 1 |
| Doyle, MA | 1 |
| Bennett, CS | 1 |
| Vozza, A | 1 |
| Uzzauto, MT | 1 |
| Pestana, A | 1 |
| Delong, ER | 1 |
| Murray, JC | 1 |
| Krull, EA | 1 |
| Schack, SH | 1 |
| Koranda, FC | 2 |
| Walsh-Kelly, C | 1 |
| Hemmer, KM | 1 |
| Marsh, JL | 1 |
| Picker, S | 1 |
| Ruzicka, T | 1 |
| Rubenstein, R | 1 |
| Masser, MR | 1 |
| Buhrer, DP | 1 |
| Yee, HW | 1 |
| Blackwell, SJ | 1 |
| Hing, DN | 1 |
| Buncke, HJ | 1 |
| Alpert, BS | 1 |
| Nordström, R | 1 |
| Pugash, E | 1 |
| Bertolino, AP | 1 |
| Kajiwara, H | 1 |
| Kohchi, M | 1 |
| Fuwa, I | 1 |
| Wada, H | 1 |
| Perevodchikova, NI | 1 |
| Denisov, LE | 1 |
| Orel, NF | 1 |
| Trofimova, NB | 1 |
| Iarygin, LM | 1 |
| Wagner, RF | 1 |
| Grande, DJ | 1 |
| Bekhor, PS | 1 |
| Cappas, A | 1 |
| Brigham, P | 1 |
| Roenigk, RK | 1 |
| Wheeland, RG | 1 |
| Pinski, JB | 1 |
| Pinski, KS | 1 |
| Adson, MH | 1 |
| Argenta, LC | 1 |
| Abramson, LJ | 1 |
| Strange, P | 1 |
| Berbis, P | 1 |
| Dor, AM | 1 |
| Niel-Bourrelly, RM | 1 |
| Benveniste, MJ | 1 |
| Devaux, J | 1 |
| Perrimond, H | 1 |
| Privat, Y | 1 |
| Au, VK | 1 |
| Wong, RK | 1 |
| Piotti, F | 1 |
| Gambaro, G | 1 |
| Mascetti, M | 1 |
| Tiwari, IN | 1 |
| Sandhir, RK | 1 |
| Prendiville, JS | 1 |
| Tierney, AJ | 1 |
| Kohn, G | 1 |
| Metzker, A | 1 |
| Geter, RK | 1 |
| Puckett, CL | 1 |
| Dowd, PM | 1 |
| Martin, H | 1 |
| Leighton, WD | 1 |
| Johnson, ML | 1 |
| Friedland, JA | 1 |
| Lamont, E | 1 |
| Kridel, RW | 1 |
| Krugman, ME | 1 |
| Mendoza, F | 1 |
| Freilich, IW | 1 |
| Brough, MD | 1 |
| Orton, CI | 1 |
| Krueger, GG | 1 |
| Pincelli, C | 1 |
| Girolomoni, G | 1 |
| Benassi, L | 1 |
| Astle, N | 1 |
| Burket, JM | 1 |
| Franz, TJ | 1 |
| Groveman, HD | 1 |
| Ganiats, T | 1 |
| Klauber, MR | 1 |
| Chen, WY | 1 |
| Earles, RM | 1 |
| Rizzetto-Stubel, A | 1 |
| Ellenbogen, R | 1 |
| Leonard, AG | 1 |
| Small, JO | 1 |
| Dickson, WA | 1 |
| Dickson, MG | 1 |
| Sharpe, DT | 1 |
| Imai, S | 1 |
| Phillips, JH | 1 |
| Smith, SL | 1 |
| Storer, JS | 1 |
| Goldman, PM | 1 |
| Wiles, JC | 1 |
| Hansen, RC | 1 |
| Klein, JA | 1 |
| Cole, G | 1 |
| Barr, RJ | 1 |
| Bartlow, G | 1 |
| Fulwider, C | 1 |
| Siemund, J | 1 |
| Herring, BD | 1 |
| Franks, D | 1 |
| Hall, V | 1 |
| Smallwood, J | 1 |
| Zhang, JQ | 1 |
| Wang, SY | 1 |
| Kazandzhiev, R | 1 |
| Sánchez-Pedreño Guillén, P | 1 |
| Rodriguez Pichardo, A | 1 |
| Camacho Martínez, F | 1 |
| Neuman, KM | 1 |
| Burnett, JW | 1 |
| Marion, RB | 1 |
| Wirth, G | 1 |
| Bindewald, I | 1 |
| Küster, W | 1 |
| Goerz, G | 1 |
| Beutner, KR | 1 |
| Bülow, J | 1 |
| Friberg, L | 1 |
| Gaardsting, O | 1 |
| Hansen, M | 1 |
| Kadanov, D | 1 |
| Dscherov, D | 1 |
| Toribio, J | 1 |
| Quiñones, PA | 1 |
| Allegra, F | 1 |
| Giacometti, L | 1 |
| Adachi, K | 3 |
| Sidi, E | 1 |
| Bourgeois-Spinasse, J | 1 |
| Raab, W | 1 |
| Maréchal, R | 1 |
| Fazekas, AG | 1 |
| Sandor, T | 1 |
| Jänner, M | 1 |
| Lippert, HD | 1 |
| Stolzenbach, G | 1 |
| Ishibashi, A | 1 |
| Chujo, T | 1 |
| Grosshans, E | 1 |
| Bohner, C | 1 |
| Weitzenblum, E | 1 |
| Rousselot, P | 1 |
| Maleville, J | 1 |
| Basset, A | 1 |
| Kano, M | 1 |
| Hauck, H | 1 |
| Schultka, O | 1 |
| Baudet, J | 1 |
| Lemaire, JM | 1 |
| Legroux, P | 1 |
| Vidal, L | 1 |
| Sargos, P | 1 |
| de Conninck, L | 1 |
| Goumain, AJ | 1 |
| Rudolph, RI | 1 |
| Schwartz, W | 1 |
| Leyden, JJ | 1 |
| Orentreich, N | 3 |
| Hight, DW | 1 |
| Anderton, RL | 1 |
| Fujino, T | 1 |
| Harashina, T | 1 |
| Tanino, R | 1 |
| Oshiro, T | 1 |
| Aoyagi, F | 1 |
| Griffiths, WA | 1 |
| Crovato, F | 2 |
| Moretti, G | 2 |
| Bertamino, R | 1 |
| Bingham, KD | 1 |
| Shaw, DA | 1 |
| Golitz, LE | 1 |
| Shapiro, L | 1 |
| Hurwitz, E | 1 |
| Stritzler, R | 1 |
| Guerrero-Santos, J | 1 |
| Casteñeda, A | 1 |
| Fernandez, JM | 1 |
| Ebner, H | 1 |
| Minars, N | 1 |
| Omori, K | 1 |
| Omori, S | 1 |
| Selmanowitz, VJ | 1 |
| Abu Jamra, F | 1 |
| Kadanoff, D | 1 |
| Cunningham, DS | 1 |
| Donaldson, RC | 1 |
| Purita, F | 1 |
| Montagna, W | 3 |
| Machida, H | 1 |
| Perkins, E | 1 |
| Takashima, I | 2 |
| Chaurasia, BD | 1 |
| Goswami, HK | 1 |
| Moyer, DG | 1 |
| Hori, H | 1 |
| Aron, R | 1 |
| Gordon, W | 1 |
| Shuster, S | 1 |
| Smith, TW | 1 |
| Puissant, A | 1 |
| Cherif Cheikh, JL | 2 |
| Medenica, M | 1 |
| Février, JC | 1 |
| Ginsberg, JE | 1 |
| Bruck, HG | 1 |
| Nakamura, I | 1 |
| Fujiki, T | 1 |
| Kikuchi, I | 1 |
| Eisenman, HT | 1 |
| Mikhail, GR | 1 |
| Rodermund, OE | 1 |
| Goenechea, S | 1 |
| Sellier, K | 1 |
| Morris, J | 1 |
| Ackerman, B | 1 |
| Koblenzer, PJ | 1 |
| Friedmann, E | 1 |
| Orfanos, C | 1 |
| Mahrle, G | 1 |
| Christenhusz, R | 1 |
| Souder, DE | 1 |
| Bercaw, BL | 1 |
| Mian, EU | 1 |
| Mühlbauer, WD | 1 |
| O'Brien, R | 1 |
| Zelson, JH | 1 |
| Schwartz, AD | 1 |
| Pearson, HA | 1 |
| Banerjee, AK | 1 |
| Roychowdhury, DS | 1 |
| Helson, L | 1 |
| Prager, D | 1 |
| Peachey, RD | 1 |
| Wells, RS | 1 |
| Berger, RA | 1 |
| Orentrich, N | 1 |
| Schweikert, HU | 1 |
| LoPresti, P | 1 |
| Papa, CM | 1 |
| Popchristov, P | 1 |
| Konstantinov, A | 1 |
| Obreshkova, E | 1 |
| Koziĭ, LM | 1 |
| Seltzer, AP | 1 |
| Sams, WM | 1 |
| Dobson, RL | 1 |
| Bleehen, SS | 1 |
| Muto, H | 1 |
| Fleming, JP | 1 |
| Preaux, J | 1 |
| Yarborough, JM | 2 |
| Burks, JW | 2 |
| Hairston, MA | 1 |
| Söltz-Szöts, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06651600 AND PF-06700841 IN SUBJECTS WITH MODERATE TO SEVERE ALOPECIA AREATA WITH A SINGLE-BLIND EXTENSION PERIOD AND A CROSS-OVER[NCT02974868] | Phase 2 | 142 participants (Actual) | Interventional | 2016-12-15 | Completed | ||
| Prospective, Multi-centre Trial to Evaluate Effectiveness of 45-min and 20-min Post-infusion Cooling Time for Patients Treated With Scalp Cooling to Prevent Paclitaxel-induced Alopecia[NCT03266185] | 91 participants (Actual) | Interventional | 2017-12-20 | Completed | |||
| A Proof of Concept Study to Evaluate the Efficacy, Safety and Tolerability of Secukinumab 300 mg Over 32 Weeks in Adult Patients With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical Therapies - PRELUDE[NCT04300296] | Phase 2 | 111 participants (Actual) | Interventional | 2020-07-27 | Completed | ||
| Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia: A Randomized, Double-blind Clinical Trial[NCT05296863] | Phase 3 | 37 participants (Actual) | Interventional | 2021-10-11 | Completed | ||
| Autologous Cellular Micro-graft in Surgical Treatment of Stable Resistant Vitiligo: A Randomized Self-controlled Trial[NCT05503368] | 20 participants (Anticipated) | Interventional | 2023-06-30 | Suspended (stopped due to lack of availability of the needed kits) | |||
| Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia: A Double-Blind, Randomized, Placebo Controlled Trial[NCT02074943] | 20 participants (Anticipated) | Interventional | 2014-04-30 | Recruiting | |||
| Using Indirect Cold Atmospheric Pressure Plasma (Plasma Activate Liquid) for the Treatment of Hair Loss[NCT04379752] | 14 participants (Actual) | Interventional | 2020-07-01 | Completed | |||
| Measuring the Efficacy of Paxman Scalp Cooling to Prevent Chemotherapy Induced Alopecia (CIA) in Black Patients With Stage I-III Breast or Gynecological Cancers[NCT04626895] | 15 participants (Actual) | Interventional | 2019-06-04 | Completed | |||
| Definitive Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation, Randomized Prospective Controlled Study[NCT06145672] | 40 participants (Anticipated) | Interventional | 2023-12-01 | Not yet recruiting | |||
| The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer[NCT04558034] | 14 participants (Actual) | Interventional | 2020-08-04 | Terminated (stopped due to Principal Investigator retired before study completed.) | |||
| The Efficacy of Combining 308 Nm-Excimer Light and Topical Steroid in the Treatment of Alopecia Areata[NCT04793945] | Phase 4 | 30 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | ||
| International Phase III, Multi Center, Randomized, Double Blind, Placebo and Active Controlled and Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female Patients With Androgenetic Alopecia[NCT05888922] | Phase 3 | 520 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
| Efficacy of Combined CO2 Fractional Laser With Bimatoprost 0.03% in Treatment of Alopecia Areata[NCT05600673] | Phase 1/Phase 2 | 30 participants (Actual) | Interventional | 2019-01-01 | Completed | ||
| A Study on the Efficacy and Safety of DIGNICAP™ System for Preventing Chemotherapy Induced Alopecia[NCT03712696] | 139 participants (Actual) | Interventional | 2014-07-18 | Completed | |||
| A Comparison of Different Scalp Cooling Systems for the Prevention of Chemotherapy Induced Alopecia[NCT01008774] | 239 participants (Actual) | Interventional | 2009-07-31 | Completed | |||
| The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.[NCT01437163] | 88 participants (Actual) | Interventional | 2011-09-30 | Completed | |||
| A Method of Calculating the Shortest Incision for Internal Fixation of Zygomatic Arch Fracture: Sideburns Mini Incision[NCT05381337] | 80 participants (Actual) | Interventional | 2021-01-01 | Completed | |||
| Therapeutic Drug Monitoring of Corticosteroids/β2-agonists in Hair in Asthmatic Patients: an Open-label Feasibility Study[NCT03691961] | 24 participants (Actual) | Interventional | 2018-09-20 | Active, not recruiting | |||
| Radiation- Induced Alopecia in Patients Undergoing Radiation Therapy to the Brain: A Prospective Clinical and Dosimetric Study of Primary and Metastatic Brain Tumour Patients[NCT03543020] | 25 participants (Actual) | Observational | 2017-07-17 | Terminated (stopped due to inadequate patient number) | |||
| A Randomized Controlled Trial to Evaluate Effectiveness of Cooling Cap to Prevent Permanent Chemotherapy-induced Alopecia Among Breast Cancer Patients[NCT04678544] | 170 participants (Actual) | Interventional | 2020-12-23 | Completed | |||
| Scalp Cooling for Alopecia Prevention (SCALP)[NCT01986140] | 236 participants (Actual) | Interventional | 2014-05-15 | Active, not recruiting | |||
| Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer[NCT01831024] | 110 participants (Anticipated) | Interventional | 2013-07-31 | Active, not recruiting | |||
| Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia[NCT01651689] | 50 participants (Anticipated) | Observational | 2010-10-31 | Enrolling by invitation | |||
| A Prospective, Single Center, Open Label, Proof of Principle Study to Assess the Efficacy and Safety of 150 Units of Botulinum Toxin-A Intra-Muscular Injection in the Prevention of Hair Loss in Men With Androgenetic Alopecia[NCT00965640] | Phase 2 | 0 participants | Interventional | 2002-12-31 | Completed | ||
| Use of Botulinum Toxin in the Treatment of Androgenic Alopecia[NCT05456087] | Phase 2 | 20 participants (Anticipated) | Interventional | 2022-08-12 | Recruiting | ||
| Influence of Creatine Monohydrate Supplementation on Androgens and Global Hair Assessments[NCT04298840] | 0 participants (Actual) | Interventional | 2020-04-30 | Withdrawn (stopped due to Sponsor indicated it was unable/unwilling to support project at the present time.) | |||
| Randomized Phase II Trial of Conventional vs IMRT Whole Brain Radiotherapy for Brain Metastases[NCT01890278] | 60 participants (Anticipated) | Interventional | 2013-06-30 | Recruiting | |||
| Cryotherapy Versus Intralesional Corticosteroid Injection In Treatment Of Alopecia Areata: Trichoscopic Evaluation[NCT03473600] | Phase 4 | 40 participants (Anticipated) | Interventional | 2018-11-30 | Not yet recruiting | ||
| A Pilot Study Comparing Cutaneous Scarring When Scalpel Versus Cautery is Used to Make Skin Incisions[NCT00803140] | 4 participants (Actual) | Interventional | 2008-11-30 | Terminated (stopped due to Slow accrual of subject enrollment.) | |||
| The Role of Cetirizine in Androgenetic Alopecia in Females[NCT04481412] | Phase 2/Phase 3 | 66 participants (Actual) | Interventional | 2020-07-25 | Completed | ||
| Barriers to Healthcare and Quality of Life for Central Centrifugal Cicatricial Alopecia Patients[NCT03044782] | 34 participants (Actual) | Observational [Patient Registry] | 2016-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. Score range: 0-100%. Higher score indicates more severe disease. Change from baseline is defined as the baseline value minus the value at a specific visit. Positive change from baseline signifies an improvement. Baseline is defined as the last measurement prior to first dosing (Day 1). (NCT02974868)
Timeframe: Baseline, Week24
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| PF-06651600 | 32.54 |
| PF-06700841 | 50.59 |
| Placebo | 1.41 |
"SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. Change from baseline is defined as the baseline value minus the value at a specific visit. Positive change from baseline implies an improvement. Alopecia totalis (AT): derived as SALT score = 100% at baseline only. Alopecia universalis (AU): derived as SALT score = 100% and both eyelash and eyebrow assessments were none at baseline." (NCT02974868)
Timeframe: Baseline, Week 24
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| PF-06651600-AT/AU | 27.59 |
| PF-06700841-AT/AU | 48.42 |
| Placebo-AT/AU | 1.81 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 30 response is a 30% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Baseline, Week 24
| Intervention | percentage of participants (Number) |
|---|---|
| PF-06651600 | 50.0 |
| PF-06700841 | 63.8 |
| Placebo | 2.1 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. The SALT score can vary from 0 to 100% with higher score indicates more severe disease. Baseline is defined as the last measurement prior to first dosing (Day 1). Change from baseline is defined as the baseline value minus the value at a specific visit. Positive change from baseline implies an improvement. Least Square Mean and 90% confidence interval in this outcome measurement is the LSM and 90%CI for difference from initial 24-week treatment period placebo respectively. (NCT02974868)
Timeframe: Weeks 30, 32, 34, 36, 40, 44, 48, 52 for non-responders, and AT Weeks 2, 4, 6, 8, 12, 16, 20, 24 for retreated responders.(AT=active treatment)
| Intervention | unit on a scale (Least Squares Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 30/ AT Week 2 | Week 32/ AT Week 4 | Week 34/ AT Week 6 | Week 36/ AT Week 8 | Week 40/ AT Week 12 | Week 44/ AT Week 16 | Week 48/ AT Week 20 | Week 52/ AT Week 24 | |
| Active Non-responders on PF-06651600 | 1.76 | 1.85 | 1.80 | 2.16 | 3.35 | 3.41 | 4.70 | 7.06 |
| Active Non-responders on PF-06700841 | 0.09 | 2.22 | 3.16 | 3.01 | 3.19 | 3.12 | 2.97 | 3.01 |
| Placebo Non-responders on PF-06651600 | 2.99 | 3.37 | 10.16 | 8.93 | 18.30 | 25.71 | 25.28 | 28.88 |
| Placebo Non-responders on PF-06700841 | -0.31 | 3.71 | 24.67 | 42.32 | 50.27 | 54.69 | 62.45 | 58.53 |
| Retreated PF-06651600 Responders in the Retreatment Segment | 25.04 | 27.63 | 33.78 | 38.80 | 43.70 | 48.93 | 53.74 | 55.94 |
| Retreated Responders on PF-06700841 in the Retreatment Segment | 19.83 | 15.66 | 20.09 | 27.35 | 39.28 | 50.58 | 53.79 | 58.37 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. The SALT score can vary from 0 to 100% with higher score indicates more severe disease. Baseline is defined as the last measurement prior to first dosing (Day 1). Change from baseline is defined as the baseline value minus the value at a specific visit. Positive change from baseline implies an improvement. Least Square Mean and 90% Confidence Interval of Arms (PF-06651600 and PF-06700841) are the Least Square Mean and 90% Confidence Interval for difference from placebo respectively. (NCT02974868)
Timeframe: Baseline, Weeks 2,4,6,8,12,16,20,24
| Intervention | units on a scale (Least Squares Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 6 | Week 8 | Week 12 | Week 16 | Week 20 | Week 24 | |
| PF-06651600 | -0.74 | 2.93 | 12.44 | 18.49 | 24.49 | 27.59 | 29.32 | 31.14 |
| PF-06700841 | -0.93 | 7.70 | 19.37 | 29.30 | 36.57 | 41.16 | 45.55 | 49.18 |
| Placebo | 1.18 | 0.85 | 1.32 | 1.77 | 1.62 | 1.61 | 1.62 | 1.41 |
Following laboratory parameters were assessed against pre-defined abnormality criteria: hematology(Hemoglobin, Hematocrit, RBC count, Reticulocyte count, Platelet count, WBC count with differential, Total neutrophils, Eosinophils, Monocytes, Basophils, Lymphocytes); serum chemistry (BUN and Creatinine, Cystatin C, Creatine Phosphokinase, Glucose , Na+, K+, Cl ,Ca++, Total CO2, AST, ALT, Total Indirect & Direct Bilirubin, Alkaline phosphatase, Uric acid, Albumin,Total protein, Fasting lipid Profile Panel; urinalysis(pH, Glucose, Protein, Nitrites, Leukocyte esterase, Microscopy culture);Other(HIV, HBsAg, HBcAb, HepB reflex (HbsAB), if applicable, HCVAb, Serum pregnancy test, Urine pregnancy test, FSH, QFT G or other IGRA, or PPD, EBV, CMV, HSV1, HSV2, VZV, Skin swab for herpetiform rash, Skin swab for potential drug related rash).Retest/discontinuation criteria are defined in Protocol Appendix 6.1 and 6.2 respectively. (NCT02974868)
Timeframe: Week 28 up to Week 52 for non-responders and responders in the withdrawal segment, AT day 1 up to AT Week 24 for retreatment segment (AT=active treatment)
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| With abnormalities without regard to baseline | Meeting Retest Criteria | Meeting Discontinuation Criteria | |
| Active Non-responders on PF-06651600 | 13 | 3 | 0 |
| Active Non-responders on PF-06700841 | 4 | 2 | 0 |
| Non-Retreated PF-06651600 Responders in the Withdrawal Segment | 6 | 2 | 0 |
| Non-Retreated PF-06700841 Responders in the Withdrawal Segment | 7 | 3 | 0 |
| Placebo Non-responders on PF-06651600 | 11 | 5 | 0 |
| Placebo Non-responders on PF-06700841 | 11 | 7 | 0 |
| Retreated PF-06651600 Responders in the Retreatment Segment | 11 | 4 | 1 |
| Retreated PF-06651600 Responders in the Withdrawal Segment | 9 | 0 | 0 |
| Retreated PF-06700841 Responders in the Withdrawal Segment | 10 | 2 | 0 |
| Retreated Responders on PF-06700841 in the Retreatment Segment | 14 | 4 | 0 |
Following laboratory parameters were assessed against pre-defined abnormality criteria: hematology(Hemoglobin, Hematocrit, RBC count, Reticulocyte count, Platelet count, WBC count with differential, Total neutrophils, Eosinophils, Monocytes, Basophils, Lymphocytes); serum chemistry (BUN and Creatinine, Cystatin C, Creatine Phosphokinase, Glucose , Na+, K+, Cl ,Ca++, Total CO2, AST, ALT, Total Indirect & Direct Bilirubin, Alkaline phosphatase, Uric acid, Albumin,Total protein, Fasting lipid Profile Panel; urinalysis(pH, Glucose, Protein, Nitrites, Leukocyte esterase, Microscopy culture);Other(HIV, HBsAg, HBcAb, HepB reflex (HbsAB), if applicable, HCVAb, Serum pregnancy test, Urine pregnancy test, FSH, QFT G or other IGRA, or PPD, EBV, CMV, HSV1, HSV2, VZV, Skin swab for herpetiform rash, Skin swab for potential drug related rash).Retest/discontinuation criteria are defined in Protocol Appendix 6.1 and 6.2 respectively. (NCT02974868)
Timeframe: Baseline up to Week 24
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| With abnormalities without regard to baseline | Meeting Safety Criteria | Meeting Retest Criteria | Meeting Discontinuation Criteria | |
| PF-06651600 | 35 | 12 | 5 | 0 |
| PF-06700841 | 36 | 29 | 18 | 3 |
| Placebo | 32 | 5 | 9 | 0 |
An AE (non-serious and serious) was any untoward medical occurrence in a participant who received study treatment without regard to possibility of causal relationship. Any such events with initial onset or increasing in severity after the first dose of study treatment were counted as treatment-emergent Adverse Event (TEAE). Treatment-related TEAE were determined by investigators. (NCT02974868)
Timeframe: COE day 1 up to end of study
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| TEAE (All Causalities) | TEAE (Treatment Related) | |
| COE-PF-06651600 | 4 | 2 |
| COE-PF-06700841 | 9 | 3 |
"An AE (non-serious and serious) was any untoward medical occurrence in a participant who received study treatment without regard to possibility of causal relationship. Any such events with initial onset or increasing in severity after the first dose of study treatment were counted as treatment-emergent Adverse Event (TEAE). Treatment-related TEAE were determined by investigators. Arms end with withdrawal Segment and retreatment segment described the same population while in different treatment segment .The reason why count on PF-06700841 differ by 1 participant is that 1 responder directly entered the retreatment segment and skipped the withdrawal segment." (NCT02974868)
Timeframe: Week 28 up to Week 52
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| TEAE (All Causalities) | TEAE (Treatment Related) | |
| Active Non-responders on PF-06651600 | 8 | 5 |
| Active Non-responders on PF-06700841 | 4 | 0 |
| Non-Retreated PF-06651600 Responders in the Withdrawal Segment | 4 | 0 |
| Non-Retreated PF-06700841 Responders in the Withdrawal Segment | 6 | 0 |
| Placebo Non-responders on PF-06651600 | 12 | 1 |
| Placebo Non-responders on PF-06700841 | 10 | 1 |
| Retreated PF-06651600 Responders in the Retreatment Segment | 11 | 2 |
| Retreated PF-06651600 Responders in the Withdrawal Segment | 3 | 1 |
| Retreated PF-06700841 Responders in the Withdrawal Segment | 9 | 3 |
| Retreated Responders on PF-06700841 in the Retreatment Segment | 9 | 2 |
An AE (non-serious and serious) was any untoward medical occurrence in a participant who received study treatment without regard to possibility of causal relationship. Any such events with initial onset or increasing in severity after the first dose of study treatment were counted as treatment-emergent Adverse Event (TEAE). Treatment-related TEAE were determined by investigators. (NCT02974868)
Timeframe: baseline up to Week 24
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| TEAE (All Causalities) | TEAE (Treatment Related) | |
| PF-06651600 | 32 | 13 |
| PF-06700841 | 36 | 20 |
| Placebo | 35 | 14 |
Following laboratory parameters were assessed against pre-defined abnormality criteria: hematology(Hemoglobin, Hematocrit, RBC count, Reticulocyte count, Platelet count, WBC count with differential, Total neutrophils, Eosinophils, Monocytes, Basophils, Lymphocytes); serum chemistry (BUN and Creatinine, Cystatin C, Creatine Phosphokinase, Glucose , Na+, K+, Cl ,Ca++, Total CO2, AST, ALT, Total Indirect & Direct Bilirubin, Alkaline phosphatase, Uric acid, Albumin,Total protein, Fasting lipid Profile Panel; urinalysis(pH, Glucose, Protein, Nitrites, Leukocyte esterase, Microscopy culture);Other(HIV, HBsAg, HBcAb, HepB reflex (HbsAB), if applicable, HCVAb, Serum pregnancy test, Urine pregnancy test, FSH, QFT G or other IGRA, or PPD, EBV, CMV, HSV1, HSV2, VZV, Skin swab for herpetiform rash, Skin swab for potential drug related rash).Retest/discontinuation criteria are defined in Protocol Appendix 6.1 and 6.2 respectively. (NCT02974868)
Timeframe: COE day 1 up to end of study
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| With abnormalities without regard to baseline | Meeting Retest Criteria | Meeting Discontinuation Criteria | |
| COE-PF-06651600 | 5 | 1 | 0 |
| COE-PF-06700841 | 11 | 6 | 0 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. The SALT score can vary from 0 to 100% with higher score indicates more severe disease. Baseline is defined as the last measurement prior to first dosing (Day 1). Percent change from baseline is defined as SALT baseline value minus SALT value at a specific visit divided by baseline and multiplying by 100. Positive change from baseline implies an improvement. Least Square Mean and 90% Confidence Interval of Arms (PF-06651600 and PF-06700841) are the Least Square Mean and 90% Confidence Interval for difference from placebo respectively. (NCT02974868)
Timeframe: Baseline, Weeks 2,4,6,8,12,16,20,24
| Intervention | percent change (Least Squares Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 6 | Week 8 | Week 12 | Week 16 | Week 20 | Week 24 | |
| PF-06651600 | -0.76 | 3.99 | 15.88 | 23.22 | 30.99 | 35.14 | 37.31 | 39.67 |
| PF-06700841 | -1.13 | 9.70 | 22.88 | 34.78 | 44.17 | 49.99 | 55.46 | 59.71 |
| Placebo | 1.26 | 0.53 | 1.02 | 1.31 | 0.99 | 0.86 | 0.91 | 0.43 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 100 response is a 100% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) in this outcome measurement is the percentage and 90% CI for difference from initial 24-week treatment period placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Weeks 30, 32, 34, 36, 40, 44, 48, 52 for non-responders, and AT Weeks 2, 4, 6, 8, 12, 16, 20, 24 for retreated responders.(AT=active treatment)
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 30/ AT Week 2 | Week 32/ AT Week 4 | Week 34/ AT Week 6 | Week 36/ AT Week 8 | Week 40/ AT Week 12 | Week 44/ AT Week 16 | Week 48/ AT Week 20 | Week 52/ AT Week 24 | |
| Active Non-responders on PF-06651600 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Active Non-responders on PF-06700841 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Placebo Non-responders on PF-06651600 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Placebo Non-responders on PF-06700841 | 0.0 | 0.0 | 0.0 | 0.0 | 8.3 | 8.3 | 8.3 | 8.3 |
| Retreated PF-06651600 Responders in the Retreatment Segment | 0.0 | 0.0 | 0.0 | 0.0 | 7.1 | 7.1 | 7.1 | 14.3 |
| Retreated Responders on PF-06700841 in the Retreatment Segment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.3 | 20.0 | 20.0 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 100 response is a 100% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) of Arms(PF-06651600 and PF-06700841) in this outcome measurement is the percentage and 90% CI for difference from placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Baseline, Weeks 2,4,6,8,12,16,20,24
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 6 | Week 8 | Week 12 | Week 16 | Week 20 | Week 24 | |
| PF-06651600 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 2.1 | 4.2 | 12.5 |
| PF-06700841 | 0.0 | 0.0 | 0.0 | 2.1 | 6.4 | 8.5 | 12.8 | 12.8 |
| Placebo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 30 response is a 30% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) in this outcome measurement is the percentage and 90% CI for difference from initial 24-week treatment period placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Weeks 30, 32, 34, 36, 40, 44, 48, 52 for non-responders, and AT Weeks 2, 4, 6, 8, 12, 16, 20, 24 for retreated responders.(AT=active treatment)
| Intervention | percent of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 30/ AT Week 2 | Week 32/ AT Week 4 | Week 34/ AT Week 6 | Week 36/ AT Week 8 | Week 40/ AT Week 12 | Week 44/ AT Week 16 | Week 48/ AT Week 20 | Week 52/ AT Week 24 | |
| Active Non-responders on PF-06651600 | 4.1 | 4.1 | 4.1 | 4.1 | 10.4 | 10.4 | 10.4 | 10.4 |
| Active Non-responders on PF-06700841 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 |
| Placebo Non-responders on PF-06651600 | 3.8 | 9.6 | 21.4 | 21.4 | 27.3 | 33.2 | 39.0 | 27.3 |
| Placebo Non-responders on PF-06700841 | -2.1 | 14.5 | 31.2 | 56.2 | 81.2 | 64.5 | 64.5 | 64.5 |
| Retreated PF-06651600 Responders in the Retreatment Segment | 47.9 | 62.2 | 69.3 | 69.3 | 62.2 | 62.2 | 69.3 | 55.0 |
| Retreated Responders on PF-06700841 in the Retreatment Segment | 31.2 | 11.2 | 31.2 | 44.5 | 51.2 | 51.2 | 51.2 | 51.2 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 30 response is a 30% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) of Arms(PF-06651600 and PF-06700841) in this outcome measurement is the percentage and 90% CI for difference from placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Baseline, Weeks 2,4,6,8,12,16,20,24
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 6 | Week 8 | Week 12 | Week 16 | Week 20 | Week 24 | |
| PF-06651600 | -2.1 | 6.2 | 18.7 | 25.0 | 39.5 | 45.8 | 47.9 | 47.9 |
| PF-06700841 | -2.1 | 12.8 | 27.7 | 38.3 | 48.9 | 55.3 | 59.6 | 61.7 |
| Placebo | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 50 response is a 50% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) in this outcome measurement is the percentage and 90% CI for difference from initial 24-week treatment period placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Weeks 30, 32, 34, 36, 40, 44, 48, 52 for non-responders, and AT Weeks 2, 4, 6, 8, 12, 16, 20, 24 for retreated responders.(AT=active treatment)
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 30/ AT Week 2 | Week 32/ AT Week 4 | Week 34/ AT Week 6 | Week 36/ AT Week 8 | Week 40/ AT Week 12 | Week 44/ AT Week 16 | Week 48/ AT Week 20 | Week 52/ AT Week 24 | |
| Active Non-responders on PF-06651600 | 0.0 | 0.0 | -2.1 | -2.1 | -2.1 | -2.1 | 4.1 | 4.1 |
| Active Non-responders on PF-06700841 | 0.0 | 0.0 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 |
| Placebo Non-responders on PF-06651600 | 0.0 | 0.0 | 9.6 | 3.8 | 15.5 | 21.4 | 27.3 | 27.3 |
| Placebo Non-responders on PF-06700841 | 0.0 | 0.0 | 31.2 | 56.2 | 56.2 | 64.5 | 64.5 | 64.5 |
| Retreated PF-06651600 Responders in the Retreatment Segment | 14.3 | 21.4 | 26.4 | 33.6 | 47.9 | 47.9 | 47.9 | 47.9 |
| Retreated Responders on PF-06700841 in the Retreatment Segment | 20.0 | 6.7 | 11.2 | 24.5 | 44.5 | 44.5 | 37.9 | 44.5 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 50 response is a 50% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) of Arms(PF-06651600 and PF-06700841) in this outcome measurement is the percentage and 90% CI for difference from placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Baseline, Weeks 2,4,6,8,12,16,20,24
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 6 | Week 8 | Week 12 | Week 16 | Week 20 | Week 24 | |
| PF-06651600 | 0.0 | 0.0 | 10.4 | 18.7 | 27.0 | 33.3 | 33.3 | 37.5 |
| PF-06700841 | 0.0 | 10.6 | 17.0 | 29.8 | 36.2 | 40.4 | 46.8 | 51.1 |
| Placebo | 0 | 0 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 75 response is a 75% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) in this outcome measurement is the percentage and 90% CI for difference from initial 24-week treatment period placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Weeks 30, 32, 34, 36, 40, 44, 48, 52 for non-responders, and AT Weeks 2, 4, 6, 8, 12, 16, 20, 24 for retreated responders.(AT=active treatment)
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 30/ AT Week 2 | Week 32/ AT Week 4 | Week 34/ AT Week 6 | Week 36/ AT Week 8 | Week 40/ AT Week 12 | Week 44/ AT Week 16 | Week 48/ AT Week 20 | Week 52/ AT Week 24 | |
| Active Non-responders on PF-06651600 | 0.0 | 0.0 | 0.0 | -2.1 | -2.1 | -2.1 | -2.1 | 4.1 |
| Active Non-responders on PF-06700841 | 0.0 | 0.0 | 0.0 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 |
| Placebo Non-responders on PF-06651600 | 0.0 | 0.0 | 0.0 | -2.1 | 3.8 | 15.5 | 15.5 | 27.3 |
| Placebo Non-responders on PF-06700841 | 0.0 | 0.0 | 8.3 | 22.9 | 39.5 | 56.2 | 64.5 | 64.5 |
| Retreated PF-06651600 Responders in the Retreatment Segment | 0.0 | 7.1 | 14.3 | 26.4 | 26.4 | 26.4 | 28.6 | 33.6 |
| Retreated Responders on PF-06700841 in the Retreatment Segment | 0.0 | 0.0 | 6.7 | 17.9 | 31.2 | 37.9 | 37.9 | 37.9 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 75 response is a 75% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) of Arms(PF-06651600 and PF-06700841) in this outcome measurement is the percentage and 90% CI for difference from placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Baseline, Weeks 2,4,6,8,12,16,20,24
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 6 | Week 8 | Week 12 | Week 16 | Week 20 | Week 24 | |
| PF-06651600 | 0.0 | 0.0 | 8.3 | 12.5 | 16.6 | 20.8 | 25.0 | 27.0 |
| PF-06700841 | 0.0 | 0.0 | 10.6 | 23.4 | 27.7 | 31.9 | 38.3 | 40.4 |
| Placebo | 0 | 0 | 0 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 90 response is a 90% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) in this outcome measurement is the percentage and 90% CI for difference from initial 24-week treatment period placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Weeks 30, 32, 34, 36, 40, 44, 48, 52 for non-responders, and AT Weeks 2, 4, 6, 8, 12, 16, 20, 24 for retreated responders.(AT=active treatment)
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 30/ AT Week 2 | Week 32/ AT Week 4 | Week 34/ AT Week 6 | Week 36/ AT Week 8 | Week 40/ AT Week 12 | Week 44/ AT Week 16 | Week 48/ AT Week 20 | Week 52/ AT Week 24 | |
| Active Non-responders on PF-06651600 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.1 | 0.0 |
| Active Non-responders on PF-06700841 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.1 | 0.0 |
| Placebo Non-responders on PF-06651600 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.8 | 17.6 |
| Placebo Non-responders on PF-06700841 | 0.0 | 0.0 | 0.0 | 8.3 | 25.0 | 33.3 | 47.9 | 50.0 |
| Retreated PF-06651600 Responders in the Retreatment Segment | 0.0 | 0.0 | 0.0 | 7.1 | 14.3 | 21.4 | 26.4 | 28.6 |
| Retreated Responders on PF-06700841 in the Retreatment Segment | 0.0 | 0.0 | 0.0 | 6.7 | 13.3 | 20.0 | 24.5 | 40.0 |
SALT is a quantitative assessment of alopecia areata (AA) severity based on the scalp hair loss. A SALT 90 response is a 90% or greater reduction from baseline in SALT score. The SALT score can vary from 0 to 100%, with higher scores representing increasing severity of disease. The analysis was done using FAS (full analysis set) based on Non-responder imputation (ie. set missing values to be non-responsive) data. The percentage(Number) and 90% confidence interval (CI) of Arms(PF-06651600 and PF-06700841) in this outcome measurement is the percentage and 90% CI for difference from placebo. The 90% CI was calculated using Chan and Zhang method. (NCT02974868)
Timeframe: Baseline, Weeks 2,4,6,8,12,16,20,24
| Intervention | percentage of participants (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Week 2 | Week 4 | Week 6 | Week 8 | Week 12 | Week 16 | Week 20 | Week 24 | |
| PF-06651600 | 0.0 | 0.0 | 0.0 | 4.2 | 10.4 | 16.7 | 18.7 | 25.0 |
| PF-06700841 | 0.0 | 0.0 | 6.4 | 12.8 | 25.5 | 27.7 | 29.8 | 34.0 |
| Placebo | 0 | 0 | 0 | 0 | 0 | 0 | 2.1 | 0 |
Time to re-treatment (weeks) = (date of re-treatment criteria met - date at Week 24 +1)/7. The calendar time to retreatment was calculated. Baseline is defined as Week 24 measurement. The duration in Drug Holiday #1 (ranging from 2-6 weeks) is counted in the Kaplan-Meier analysis. One subject directly entered the re-treatment period and hence is censored at baseline in the Kaplan-Meier analysis. (NCT02974868)
Timeframe: Week 24 up to Week 52
| Intervention | Weeks (Number) | ||
|---|---|---|---|
| Q1 time to retreatment (25th percentile of time) | Median time to retreatment | Q3 time to retreatment (75th percentile of time) | |
| PF-06651600 Responders | 10.1 | 16.1 | 21.1 |
| PF-06700841 Responders | 11.0 | 24.1 | NA |
The clinical evaluator of alopecia areata (AA) will perform an assessment of the overall improvement of AA and assign an Investigator Global Assessment (IGA) score(ranging from 0 to 5) with higher score representing higher regrowth rate. Baseline is defined as the last measurement prior to first dosing (Day 1). (NCT02974868)
Timeframe: baseline, Week 2,4,6,8,12,16,20,24
| Intervention | Participants (Count of Participants) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline72539794 | Baseline72539793 | Baseline72539795 | Week 272539793 | Week 272539794 | Week 272539795 | Week 472539793 | Week 472539794 | Week 472539795 | Week 672539793 | Week 672539794 | Week 672539795 | Week 872539793 | Week 872539795 | Week 872539794 | Week 1272539794 | Week 1272539795 | Week 1272539793 | Week 1672539793 | Week 1672539794 | Week 1672539795 | Week 2072539793 | Week 2072539794 | Week 2072539795 | Week 2472539793 | Week 2472539794 | Week 2472539795 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 0 (NO CHANGE OR FURTHER LOSS) | 1 (1-24% REGROWTH) | 2 (25-49% REGROWTH) | 3 (50-74% REGROWTH) | 4 (75-99% REGROWTH) | 5 (100% REGROWTH) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 47 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 47 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 33 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Placebo | 27 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06700841 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PF-06651600 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of treatment responders at week 16, where response is defined as an Investigator's Global Assessment (IGA) score of 2 or lower at Week 16. IGA is measured on a scale from 0 - 4 with 0 = Clear, 1 = Minimal; 2 = Mild; 3 = Moderate; and 4 = Severe with 0 being best score and 4 being worst score. CLP=Cutaneous lichen planus, MLP=Mucosal lichen planus, LPP=Lichen planopilaris. Posterior median and 95% credible interval (instead of 95% confidence interval) were derived using Bayesian method based on beta-binomial model. (NCT04300296)
Timeframe: Baseline up to week 16
| Intervention | percentage of participants (Median) |
|---|---|
| AIN457 300 mg Q4W - TP 1 - CLP Cohort | 44.0 |
| Placebo - TP 1 - CLP Cohort | 58.2 |
| AIN457 300 mg Q4W - TP 1 - MLP Cohort | 37.5 |
| Placebo - TP 1 - MLP Cohort | 23.1 |
| AIN457 300 mg Q4W - TP 1 - LPP Cohort | 37.6 |
| Placebo - TP 1 - LPP Cohort | 30.9 |
The Physician Assessment of Surface Area of Disease (PSAD) evaluates the extent of cutaneous lesions estimated by investigator or qualified designee. Assessment scores range from 0-5, with lower scores corresponding to lower percentages of surface area with disease: 0=clear, 1=<2%, 2=2-9%, 3=10-29%, 4=30-50%, 5=>50% of total body surface (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 2 0 score | Week 16 0 score | Week 16 1 score | Week 16 2 score | Week 16 3 score | Week 16 4 score | Week 16 5 score | Week 20 0 score | Week 20 1 score | Week 20 2 score | Week 20 3 score | Week 20 4 score | Week 20 5 score | Week 24 0 score | Week 24 1 score | Week 24 2 score | Week 24 3 score | Week 24 4 score | Week 24 5 score | Week 28 0 score | Week 28 1 score | Week 28 2 score | Week 28 3 score | Week 28 4 score | Week 28 5 score | Week 32 0 score | Week 32 1 score | Week 32 2 score | Week 32 3 score | Week 32 4 score | Week 32 5 score | |
| Placebo to AIN457 300 mg Q2W - TP 2 - CLP Cohort | 0 | 0 | 0 | 3 | 3 | 4 | 0 | 0 | 0 | 3 | 2 | 3 | 2 | 0 | 0 | 2 | 2 | 4 | 2 | 0 | 0 | 2 | 3 | 3 | 2 | 0 | 1 | 0 | 4 | 2 | 2 |
The Physician Assessment of Surface Area of Disease (PSAD) evaluates the extent of cutaneous lesions estimated by investigator or qualified designee. Assessment scores range from 0-5, with lower scores corresponding to lower percentages of surface area with disease: 0=clear, 1=<2%, 2=2-9%, 3=10-29%, 4=30-50%, 5=>50% of total body surface (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline 0 Score | Baseline 1 score | Baseline 2 score | Baseline 3 score | Baseline 4 score | Baseline 5 score | Week 2 0 score | Week 2 1 score | Week 2 2 score | Week 2 3 score | Week 2 4 score | Week 2 5 score | Week 4 0 score | Week 4 1 score | Week 4 2 score | Week 4 3 score | Week 4 4 score | Week 4 5 score | Week 8 0 score | Week 8 1 score | Week 8 2 score | Week 8 3 score | Week 8 4 score | Week 8 5 score | Week 12 0 score | Week 12 1 score | Week 12 2 score | Week 12 3 score | Week 12 4 score | Week 12 5 score | Week 16 0 score | Week 16 1 score | Week 16 2 score | Week 16 3 score | Week 16 4 score | Week 16 5 score | |
| Placebo - TP 1 - CLP Cohort | 0 | 0 | 0 | 3 | 6 | 3 | 0 | 0 | 1 | 3 | 5 | 3 | 0 | 0 | 0 | 3 | 5 | 3 | 0 | 1 | 1 | 2 | 4 | 3 | 0 | 1 | 2 | 0 | 7 | 2 | 0 | 2 | 3 | 3 | 4 | 0 |
The Physician Assessment of Surface Area of Disease (PSAD) evaluates the extent of cutaneous lesions estimated by investigator or qualified designee. Assessment scores range from 0-5, with lower scores corresponding to lower percentages of surface area with disease: 0=clear, 1=<2%, 2=2-9%, 3=10-29%, 4=30-50%, 5=>50% of total body surface (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline 0 Score | Baseline 1 score | Baseline 2 score | Baseline 3 score | Baseline 4 score | Baseline 5 score | Week 2 0 score | Week 2 1 score | Week 2 2 score | Week 2 3 score | Week 2 4 score | Week 2 5 score | Week 4 0 score | Week 4 1 score | Week 4 2 score | Week 4 3 score | Week 4 4 score | Week 4 5 score | Week 8 0 score | Week 8 1 score | Week 8 2 score | Week 8 3 score | Week 8 4 score | Week 8 5 score | Week 12 0 score | Week 12 1 score | Week 12 2 score | Week 12 3 score | Week 12 4 score | Week 12 5 score | Week 16 0 score | Week 16 1 score | Week 16 2 score | Week 16 3 score | Week 16 4 score | Week 16 5 score | Week 20 0 score | Week 20 1 score | Week 20 2 score | Week 20 3 score | Week 20 4 score | Week 20 5 score | Week 24 0 score | Week 24 1 score | Week 24 2 score | Week 24 3 score | Week 24 4 score | Week 24 5 score | Week 28 0 score | Week 28 1 score | Week 28 2 score | Week 28 3 score | Week 28 4 score | Week 28 5 score | Week 32 0 score | Week 32 1 score | Week 32 2 score | Week 32 3 score | Week 32 4 score | Week 32 5 score | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - CLP Cohort | 0 | 3 | 6 | 6 | 5 | 5 | 0 | 6 | 5 | 9 | 3 | 2 | 0 | 3 | 8 | 8 | 3 | 2 | 0 | 7 | 5 | 7 | 4 | 2 | 0 | 6 | 7 | 7 | 3 | 2 | 0 | 4 | 12 | 5 | 2 | 2 | 0 | 6 | 12 | 3 | 1 | 2 | 1 | 8 | 10 | 1 | 2 | 3 | 0 | 6 | 11 | 1 | 3 | 2 | 2 | 5 | 10 | 3 | 1 | 3 |
"The Dermatology Life Quality Index (DLQI) is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts. The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Baseline n=25,12,0 | Week 4 n=24,11,0 | Week 8 n=25,11,0 | Week 12 n=25,12,0 | Week 16 n=25,12,10 | |
| Placebo - TP 1 - CLP Cohort | 0 | 0 | 0 | 1 | 2 |
"The Dermatology Life Quality Index (DLQI) is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts. The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Week 16 n=25,12,10 | Week 20 n=24,0,10 | Week 24 n=25,0,10 | Week 28 n=23,0,10 | Week 32 n=25,0,9 | |
| Placebo to AIN457 300 mg Q2W - TP 2 - CLP Cohort | 2 | 1 | 1 | 1 | 1 |
"The Dermatology Life Quality Index (DLQI) is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts. The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline n=25,12,0 | Week 4 n=24,11,0 | Week 8 n=25,11,0 | Week 12 n=25,12,0 | Week 16 n=25,12,10 | Week 20 n=24,0,10 | Week 24 n=25,0,10 | Week 28 n=23,0,10 | Week 32 n=25,0,9 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - CLP Cohort | 0 | 2 | 2 | 3 | 3 | 3 | 4 | 3 | 2 |
"The DLQI is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts (Finlay and Khan 1994). The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Baseline n=24,13,0 | Week 4 n=24,13,0 | Week 8 n=24,13,0 | Week 12 n=24,13,0 | Week 16 n=24,13,13 | |
| Placebo - TP 1 - LPP Cohort | 0 | 1 | 1 | 2 | 1 |
"The DLQI is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts (Finlay and Khan 1994). The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Week 16 n=24,13,13 | Week 20 n=24,0,13 | Week 24 n=23,0,13 | Week 28 n=24,0,13 | Week 32 n=24,0,11 | |
| Placebo to AIN457 300 mg Q2W TP 2 - LPP Cohort | 1 | 3 | 3 | 2 | 3 |
"The DLQI is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts (Finlay and Khan 1994). The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline n=24,13,0 | Week 4 n=24,13,0 | Week 8 n=24,13,0 | Week 12 n=24,13,0 | Week 16 n=24,13,13 | Week 20 n=24,0,13 | Week 24 n=23,0,13 | Week 28 n=24,0,13 | Week 32 n=24,0,11 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - LPP Cohort | 0 | 3 | 3 | 2 | 2 | 4 | 2 | 2 | 1 |
"The DLQI is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts (Finlay and Khan 1994). The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Baseline n=24,13,0 | Week 4 n=24,13,0 | Week 8 n=24,13,0 | Week 12 n=24,13,0 | Week 16 n=24,13,11 | |
| Placebo - TP 1 - MLP Cohort | 0 | 1 | 1 | 2 | 3 |
"The DLQI is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts (Finlay and Khan 1994). The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Week 16 n=24,13,11 | Week 20 n=24,0,11 | Week 24 n=24,0,10 | Week 28 n=23,0,11 | Week 32 n=23,0,10 | |
| Placebo to AIN457 300 mg Q2W TP 2 - MLP Cohort | 2 | 2 | 3 | 2 | 2 |
"The DLQI is a 10-item general dermatology disability index designed to assess health-related quality of life (HRQoL) in adult subjects with skin diseases such as eczema, psoriasis, acne, and viral warts (Finlay and Khan 1994). The measure is self-administered and includes domains of daily activities, leisure, personal relationships, symptoms and feelings, treatment, and work/school. The recall period is the last week, and the instrument requires 1 to 2 minutes for completion. Each item has four response categories ranging from 0 (not at all) to 3 (very much). Not relevant is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions. Scores range from 0 to 30, with higher scores indicating greater HRQoL impairment." (NCT04300296)
Timeframe: Baseline, Weeks 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline n=24,13,0 | Week 4 n=24,13,0 | Week 8 n=24,13,0 | Week 12 n=24,13,0 | Week 16 n=24,13,11 | Week 20 n=24,0,11 | Week 24 n=24,0,10 | Week 28 n=23,0,11 | Week 32 n=23,0,10 | |
| AIN457 300 mg Q4W - TP 1 and TP 2- MLP Cohort | 0 | 2 | 4 | 4 | 5 | 7 | 7 | 3 | 4 |
Number of subjects with IGA of 2 or lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 2 IGA <=2 n=25,12,0 | Week 2 IGA improvement >=2 n=25,12,0 | Week 2 IGA 0/1 n=25,12,0 | Week 4 IGA <=2 n=24,11,0 | Week 4 IGA improvement. >=2 n=24,11,0 | Week 4 IGA 0/1 n=24,11,0 | Week 8 IGA <=2 n=25,11,0 | Week 8 IGA improvement. >=2 n=25,11,0 | Week 8 IGA 0/1 n=25,11,0 | Week 12 IGA <=2 n=25,12,0 | Week 12 IGA improvement. >=2 n=25,12,0 | Week 12 IGA 0/1 n=25,12,0 | Week16 IGA <=2 n=25,12,10 | Week 16 IGA improvement. >=2 n=25,12,10 | Week 16 IGA 0/1 n=25,12,10 | |
| Placebo - TP 1 - CLP Cohort | 1 | 0 | 0 | 2 | 0 | 0 | 3 | 1 | 1 | 4 | 2 | 1 | 7 | 3 | 2 |
Number of subjects with IGA of 2 or lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week16 IGA <=2 n=25,12,10 | Week 16 IGA improvement. >=2 n=25,12,10 | Week 16 IGA 0/1 n=25,12,10 | Week 20 IGA <=2 n=24,0,10 | Week 20 IGA improvement. >=2 n=24,0,10 | Week 20 IGA 0/1 n=24,0,10 | Week 24 IGA <=2 n=25,0,10 | Week 24 IGA improvement. >=2 n=25,0,10 | Week 24 IGA 0/1 n=25,0,10 | Week 28 IGA <=2 n=23,0,10 | Week 28 IGA improvement. >=2 n=23,0,10 | Week 28 IGA 0/1 n=23,0,10 | Week 32 IGA <=2 n=24,0,9 | Week 32 IGA improvement. >=2 n=24,0,9 | Week 32 IGA 0/1 n=24,0,9 | |
| Placebo to AIN457 300 mg Q2W - TP 2 - CLP Cohort | 5 | 1 | 0 | 1 | 1 | 1 | 3 | 2 | 1 | 4 | 1 | 1 | 2 | 2 | 1 |
Number of subjects with IGA of 2 or lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 2 IGA <=2 n=25,12,0 | Week 2 IGA improvement >=2 n=25,12,0 | Week 2 IGA 0/1 n=25,12,0 | Week 4 IGA <=2 n=24,11,0 | Week 4 IGA improvement. >=2 n=24,11,0 | Week 4 IGA 0/1 n=24,11,0 | Week 8 IGA <=2 n=25,11,0 | Week 8 IGA improvement. >=2 n=25,11,0 | Week 8 IGA 0/1 n=25,11,0 | Week 12 IGA <=2 n=25,12,0 | Week 12 IGA improvement. >=2 n=25,12,0 | Week 12 IGA 0/1 n=25,12,0 | Week16 IGA <=2 n=25,12,10 | Week 16 IGA improvement. >=2 n=25,12,10 | Week 16 IGA 0/1 n=25,12,10 | Week 20 IGA <=2 n=24,0,10 | Week 20 IGA improvement. >=2 n=24,0,10 | Week 20 IGA 0/1 n=24,0,10 | Week 24 IGA <=2 n=25,0,10 | Week 24 IGA improvement. >=2 n=25,0,10 | Week 24 IGA 0/1 n=25,0,10 | Week 28 IGA <=2 n=23,0,10 | Week 28 IGA improvement. >=2 n=23,0,10 | Week 28 IGA 0/1 n=23,0,10 | Week 32 IGA <=2 n=24,0,9 | Week 32 IGA improvement. >=2 n=24,0,9 | Week 32 IGA 0/1 n=24,0,9 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - CLP Cohort | 5 | 2 | 2 | 9 | 3 | 2 | 10 | 4 | 3 | 10 | 3 | 4 | 11 | 4 | 4 | 11 | 5 | 5 | 14 | 10 | 10 | 12 | 7 | 6 | 9 | 7 | 6 |
Number of subjects with IGA of 2 or lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 2 IGA <=2 n=24,13,0 | Week 2 IGA improvement >=2 n=24,13,0 | Week 2 IGA 0/1 n=24,13,0 | Week 4 IGA <=2 n=24,13,0 | Week 4 IGA improvement. >=2 n=24,13,0 | Week 4 IGA 0/1 n=24,13,0 | Week 8 IGA <=2 n=24,13,0 | Week 8 IGA improvement. >=2 n=24,13,0 | Week 8 IGA 0/1 n=24,13,0 | Week 12 IGA <=2 n=24,13,0 | Week 12 IGA improvement. >=2 n=24,13,0 | Week 12 IGA 0/1 n=24,13,0 | Week16 IGA <=2 n=24,13,13 | Week 16 IGA improvement. >=2 n=24,13,13 | Week 16 IGA 0/1 n=24,13,13 | |
| Placebo - TP 1 - LPP Cohort | 1 | 0 | 0 | 2 | 1 | 1 | 3 | 1 | 1 | 4 | 2 | 2 | 4 | 0 | 0 |
Number of subjects with IGA of 2 or lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week16 IGA <=2 n=24,13,13 | Week 16 IGA improvement. >=2 n=24,13,13 | Week 16 IGA 0/1 n=24,13,13 | Week 20 IGA <=2 n=24,0,13 | Week 20 IGA improvement. >=2 n=24,0,13 | Week 20 IGA 0/1 n=24,0,13 | Week 24 IGA <=2 n=23,0,13 | Week 24 IGA improvement. >=2 n=23,0,13 | Week 24 IGA 0/1 n=23,0,13 | Week 28 IGA <=2 n=24,0,13 | Week 28 IGA improvement. >=2 n=24,0,13 | Week 28 IGA 0/1 n=24,0,13 | Week 32 IGA <=2 n==24,0,11 | Week 32 IGA improvement. >=2 n==24,0,11 | Week 32 IGA 0/1 n==24,0,11 | |
| Placebo to AIN457 300 mg Q2W - TP 2- LPP Cohort | 4 | 0 | 0 | 6 | 1 | 0 | 8 | 3 | 2 | 9 | 4 | 3 | 7 | 5 | 4 |
Number of subjects with IGA of 2 or lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 2 IGA <=2 n=24,13,0 | Week 2 IGA improvement >=2 n=24,13,0 | Week 2 IGA 0/1 n=24,13,0 | Week 4 IGA <=2 n=24,13,0 | Week 4 IGA improvement. >=2 n=24,13,0 | Week 4 IGA 0/1 n=24,13,0 | Week 8 IGA <=2 n=24,13,0 | Week 8 IGA improvement. >=2 n=24,13,0 | Week 8 IGA 0/1 n=24,13,0 | Week 12 IGA <=2 n=24,13,0 | Week 12 IGA improvement. >=2 n=24,13,0 | Week 12 IGA 0/1 n=24,13,0 | Week16 IGA <=2 n=24,13,13 | Week 16 IGA improvement. >=2 n=24,13,13 | Week 16 IGA 0/1 n=24,13,13 | Week 20 IGA <=2 n=24,0,13 | Week 20 IGA improvement. >=2 n=24,0,13 | Week 20 IGA 0/1 n=24,0,13 | Week 24 IGA <=2 n=23,0,13 | Week 24 IGA improvement. >=2 n=23,0,13 | Week 24 IGA 0/1 n=23,0,13 | Week 28 IGA <=2 n=24,0,13 | Week 28 IGA improvement. >=2 n=24,0,13 | Week 28 IGA 0/1 n=24,0,13 | Week 32 IGA <=2 n==24,0,11 | Week 32 IGA improvement. >=2 n==24,0,11 | Week 32 IGA 0/1 n==24,0,11 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - LPP Cohort | 4 | 1 | 1 | 9 | 2 | 2 | 8 | 3 | 3 | 8 | 3 | 2 | 9 | 3 | 2 | 10 | 6 | 4 | 10 | 7 | 6 | 10 | 6 | 5 | 11 | 5 | 4 |
Number of subjects with IGA of 2 of lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 2 IGA <=2 n=24,12,0 | Week 2 IGA improvement >=2 n=24,12,0 | Week 2 IGA 0/1 n=24,12,0 | Week 4 IGA <=2 n=24,13,0 | Week 4 IGA improvement. >=2 n=24,13,0 | Week 4 IGA 0/1 n=24,13,0 | Week 8 IGA <=2 n=24,13,0 | Week 8 IGA improvement. >=2 n=24,13,0 | Week 8 IGA 0/1 n=24,13,0 | Week 12 IGA <=2 n=24,13,0 | Week 12 IGA improvement. >=2 n=24,13,0 | Week 12 IGA 0/1 n=24,13,0 | Week16 IGA <=2 n=24,13,11 | Week 16 IGA improvement. >=2 n=24,13,11 | Week 16 IGA 0/1 n=24,13,11 | |
| Placebo - TP 1 - MLP Cohort | 3 | 1 | 1 | 2 | 1 | 1 | 3 | 2 | 1 | 4 | 4 | 2 | 3 | 3 | 2 |
Number of subjects with IGA of 2 of lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week16 IGA <=2 n=24,13,11 | Week 16 IGA improvement. >=2 n=24,13,11 | Week 16 IGA 0/1 n=24,13,11 | Week 20 IGA <=2 n=24,0,11 | Week 20 IGA improvement. >=2 n=24,0,11 | Week 20 IGA 0/1 n=24,0,11 | Week 24 IGA <=2 n=24,0,10 | Week 24 IGA improvement. >=2 n=24,0,10 | Week 24 IGA 0/1 n=24,0,10 | Week 28 IGA <=2 n=23,0,11 | Week 28 IGA improvement. >=2 n=23,0,11 | Week 28 IGA 0/1 n=23,0,11 | Week 32 IGA <=2 n=23,0,10 | Week 32 IGA improvement. >=2 n=23,0,10 | Week 32 IGA 0/1 n=23,0,10 | |
| Placebo to AIN457 300 mg Q2W TP 2 - MLP Cohort | 1 | 1 | 0 | 3 | 2 | 1 | 4 | 2 | 0 | 4 | 3 | 0 | 2 | 1 | 0 |
Number of subjects with IGA of 2 of lower, improvement in the IGA score of at least 2 points, or IGA score of 0/1. IGA is measured on a scale from 0-4 with 0=Clear, 1=minimal, 2=mild, 3=moderate, and 4=severe with 0 being best score and 4 being worst score. (NCT04300296)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, and 32
| Intervention | Participants (Count of Participants) | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 2 IGA <=2 n=24,12,0 | Week 2 IGA improvement >=2 n=24,12,0 | Week 2 IGA 0/1 n=24,12,0 | Week 4 IGA <=2 n=24,13,0 | Week 4 IGA improvement. >=2 n=24,13,0 | Week 4 IGA 0/1 n=24,13,0 | Week 8 IGA <=2 n=24,13,0 | Week 8 IGA improvement. >=2 n=24,13,0 | Week 8 IGA 0/1 n=24,13,0 | Week 12 IGA <=2 n=24,13,0 | Week 12 IGA improvement. >=2 n=24,13,0 | Week 12 IGA 0/1 n=24,13,0 | Week16 IGA <=2 n=24,13,11 | Week 16 IGA improvement. >=2 n=24,13,11 | Week 16 IGA 0/1 n=24,13,11 | Week 20 IGA <=2 n=24,0,11 | Week 20 IGA improvement. >=2 n=24,0,11 | Week 20 IGA 0/1 n=24,0,11 | Week 24 IGA <=2 n=24,0,10 | Week 24 IGA improvement. >=2 n=24,0,10 | Week 24 IGA 0/1 n=24,0,10 | Week 28 IGA <=2 n=23,0,11 | Week 28 IGA improvement. >=2 n=23,0,11 | Week 28 IGA 0/1 n=23,0,11 | Week 32 IGA <=2 n=23,0,10 | Week 32 IGA improvement. >=2 n=23,0,10 | Week 32 IGA 0/1 n=23,0,10 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - MLP Cohort | 5 | 1 | 1 | 4 | 1 | 1 | 5 | 0 | 0 | 5 | 5 | 4 | 9 | 5 | 4 | 10 | 5 | 5 | 10 | 3 | 3 | 7 | 1 | 1 | 9 | 2 | 2 |
The LPPAI assesses symptoms (pruritus, pain, burning), signs (erythema, perifollicular erythema and scale), a measure of activity (pull test) and extension of disease. These subjective and objective measures are assigned numeric values to establish a disease activity score. The total score ranges from 0 to 10, with higher scores corresponding to higher disease activity (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |
|---|---|---|
| Baseline n=24,13,13 | Week 16 n=24,13,13 | |
| Placebo - TP 1 - LPP Cohort | 5.95 | -2.24 |
The LPPAI assesses symptoms (pruritus, pain, burning), signs (erythema, perifollicular erythema and scale), a measure of activity (pull test) and extension of disease. These subjective and objective measures are assigned numeric values to establish a disease activity score. The total score ranges from 0 to 10, with higher scores corresponding to higher disease activity (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||
|---|---|---|---|
| Baseline n=24,13,13 | Week 16 n=24,13,13 | Week 32 n=24,0,13 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - LPP Cohort | 5.92 | -1.44 | -2.44 |
| Placebo to AIN457 300 mg Q2W TP 2 - Lpp Cohort | 5.95 | -2.24 | -3.20 |
"Itch is assessed with the following questions: • Overall, how severe was your lichen planus-related itching during the past 24 hours? • How severe was your lichen planus-related itching at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related itching during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no itch and 10 meaning the worst itch imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Baseline - Question 1 | Week 16 Severity of itch during past 24 hours n=25,12,10 | Baseline- Question 2 | Week 16 How severe was itch at worst moment during past 24 hours n=25,12,10 | Baseline- Question 3 | Week 16 How bothered by Itch during past 24 hours n=25,12,10 | |
| Placebo - TP 1 - CLP Cohort | 5.7 | -2.3 | 6.3 | -2.7 | 6.1 | -2.7 |
"Itch is assessed with the following questions: • Overall, how severe was your lichen planus-related itching during the past 24 hours? • How severe was your lichen planus-related itching at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related itching during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no itch and 10 meaning the worst itch imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline - Question 1 | Week 16 Severity of itch during past 24 hours n=25,12,10 | Week 32 Severity of itch during past 24 hours n=25,0,9 | Baseline- Question 2 | Week 16 How severe was itch at worst moment during past 24 hours n=25,12,10 | Week 32 How severe was itch at worst moment during past 24 hours n=25,0,9 | Baseline- Question 3 | Week 16 How bothered by Itch during past 24 hours n=25,12,10 | Week 32 How bothered by Itch during past 24 hours n=25,0,9 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - CLP Cohort | 5.1 | -0.8 | -1.5 | 5.6 | -0.9 | -1.3 | 4.8 | -1.0 | -1.1 |
| Placebo to AIN457 300 mg Q2W TP 2 - CLP Cohort | 5.8 | -2.0 | -1.1 | 5.9 | -1.9 | -1.2 | 6.1 | -2.4 | -1.2 |
"Itch is assessed with the following questions: • Overall, how severe was your lichen planus-related itching during the past 24 hours? • How severe was your lichen planus-related itching at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related itching during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no itch and 10 meaning the worst itch imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Baseline - Question 1 n=24,13,13 | Week 16 Severity of itch during past 24 hours n=24,13,11 | Baseline - Question 2 n=24,13,13 | Week 16 How severe was itch at worst moment during past 24 hours n=24,13,13 | Baseline - Question 3 n=24,13,11 | Week 16 How bothered by Itch during past 24 hours n=24,13,13 | |
| Placebo - TP 1 - LPP Cohort | 3.8 | -1.1 | 4.2 | -1.3 | 3.2 | -1.2 |
"Itch is assessed with the following questions: • Overall, how severe was your lichen planus-related itching during the past 24 hours? • How severe was your lichen planus-related itching at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related itching during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no itch and 10 meaning the worst itch imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline - Question 1 n=24,13,13 | Week 16 Severity of itch during past 24 hours n=24,13,11 | Week 32 Severity of itch during past 24 hours n=24,0,11 | Baseline - Question 2 n=24,13,13 | Week 16 How severe was itch at worst moment during past 24 hours n=24,13,13 | Week 32 How severe was itch at worst moment during past 24 hours n=24,0,11 | Baseline - Question 3 n=24,13,11 | Week 16 How bothered by Itch during past 24 hours n=24,13,13 | Week 32 How bothered by Itch during past 24 hours n=24,0,11 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - LPP Cohort | 4.5 | -0.5 | -1.6 | 5.1 | -0.7 | -1.8 | 4.0 | -0.4 | -1.7 |
| Placebo to AIN457 300 mg Q2W - TP 2 - LPP Cohort | 3.8 | -1.1 | -2.4 | 4.1 | -1.3 | -2.6 | 3.2 | -1.2 | -2.2 |
"Itch is assessed with the following questions: • Overall, how severe was your lichen planus-related itching during the past 24 hours? • How severe was your lichen planus-related itching at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related itching during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no itch and 10 meaning the worst itch imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Baseline - Question 1 n=23,13,11 | Week 16 Severity of itch during past 24 hours n=23,13,11 | Baseline - Question 2 n=23,13,11 | Week 16 How severe was itch at worst moment during past 24 hours n=23,13,11 | Baseline - Question 3 n=24,13,11 | Week 16 How bothered by Itch during past 24 hours n=23,13,11 | |
| Placebo - TP 1 - MLP Cohort | 3.8 | -0.2 | 3.6 | 0.4 | 4.0 | 0.1 |
"Itch is assessed with the following questions: • Overall, how severe was your lichen planus-related itching during the past 24 hours? • How severe was your lichen planus-related itching at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related itching during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no itch and 10 meaning the worst itch imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline - Question 1 n=23,13,11 | Week 16 Severity of itch during past 24 hours n=23,13,11 | Week 32 Severity of itch during past 24 hours n=22,0,10 | Baseline - Question 2 n=23,13,11 | Week 16 How severe was itch at worst moment during past 24 hours n=23,13,11 | Week 32 How severe was itch at worst moment during past 24 hours n=22,0,10 | Baseline - Question 3 n=24,13,11 | Week 16 How bothered by Itch during past 24 hours n=23,13,11 | Week 32 How bothered by Itch during past 24 hours n=22,0,10 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - MLP Cohort | 2.5 | 0.3 | 0.1 | 2.4 | 0.8 | 0.3 | 3.4 | -0.5 | -0.2 |
| Placebo to AIN457 300 mg Q2W TP 2 - MLP Cohort | 4.3 | -0.3 | -0.4 | 4.1 | 0.4 | 0.4 | 4.5 | 0.0 | -0.4 |
"Pain is assessed with the following questions: • Overall, how severe was your lichen planus-related pain during the past 24 hours? • How severe was your lichen planus-related pain at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related pain during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no pain and 10 meaning the worst pain imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Baseline - Question 1 n=25,12,10 | Week 16 Severity of pain during past 24 hours n=25,12,10 | Baseline - Question 2 n=25,12,10 | Week 16 How severe was pain at worst moment during past 24 hours n=25,12,10 | Baseline - Question 3 n=25,12,10 | Week 16 How bothered by pain during past 24 hour n=25,12,10 | |
| Placebo - TP 1 - CLP Cohort | 3.4 | -0.8 | 3.9 | -1.2 | 3.7 | -0.6 |
"Pain is assessed with the following questions: • Overall, how severe was your lichen planus-related pain during the past 24 hours? • How severe was your lichen planus-related pain at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related pain during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no pain and 10 meaning the worst pain imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline - Question 1 n=25,12,10 | Week 16 Severity of pain during past 24 hours n=25,12,10 | Week 32 Severity of pain during past 24 hours n=25,0,9 | Baseline - Question 2 n=25,12,10 | Week 16 How severe was pain at worst moment during past 24 hours n=25,12,10 | Week 32 How severe was pain at worst moment during past 24 hours n=25,0,9 | Baseline - Question 3 n=25,12,10 | Week 16 How bothered by pain during past 24 hour n=25,12,10 | Week 32 How bothered by pain during past 24 hours n=25, 0,9 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - CLP Cohort | 1.09 | 0.2 | -0.3 | 2.2 | 0.1 | -0.4 | 2.1 | 0.1 | -0.2 |
| Placebo to AIN457 300 mg Q2W - TP 2 - CLP Cohort | 3.5 | -0.8 | -0.3 | 3.9 | -1.0 | -0.4 | 3.8 | 0.5 | -0.3 |
"Pain is assessed with the following questions: • Overall, how severe was your lichen planus-related pain during the past 24 hours? • How severe was your lichen planus-related pain at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related pain during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no pain and 10 meaning the worst pain imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Baseline - Question 1 n=24,13,12 | Week 16 Severity of pain during past 24 hours n=24,13,12 | Baseline - Question 2 24,13,12 | Week 16 How severe was pain at worst moment during past 24 hours n=24,13,12 | Baseline - Question 3 n=24,13,12 | Week 16 How bothered by pain during past 24 hour n=24,13,12 | |
| Placebo - TP 1 - LPP Cohort | 2.0 | -0.5 | 2.5 | -0.9 | 2.4 | -1.1 |
"Pain is assessed with the following questions: • Overall, how severe was your lichen planus-related pain during the past 24 hours? • How severe was your lichen planus-related pain at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related pain during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no pain and 10 meaning the worst pain imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline - Question 1 n=24,13,12 | Week 16 Severity of pain during past 24 hours n=24,13,12 | Week 32 Severity of pain during past 24 hours n=24,0,11 | Baseline - Question 2 24,13,12 | Week 16 How severe was pain at worst moment during past 24 hours n=24,13,12 | Week 32 How severe was pain at worst moment during past 24 hours n=24,0,11 | Baseline - Question 3 n=24,13,12 | Week 16 How bothered by pain during past 24 hour n=24,13,12 | Week 32 How bothered by pain during past 24 hours n=24,0,11 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - LPP Cohort | 2.5 | 0.3 | -0.6 | 2.8 | 0.2 | -0.8 | 2.7 | 0.0 | -0.8 |
| Placebo to AIN457 300 mg Q2W - TP 2 - LPP Cohort | 2.0 | -0.5 | -1.5 | 2.5 | -0.9 | -2.0 | 2.4 | -1.1 | -1.9 |
"Pain is assessed with the following questions: • Overall, how severe was your lichen planus-related pain during the past 24 hours? • How severe was your lichen planus-related pain at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related pain during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no pain and 10 meaning the worst pain imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Baseline - Question 1 n=24,13,11 | Week 16 Severity of pain during past 24 hours n=24,13,11 | Baseline - Question 2 n=24,13,11 | Week 16 How severe was pain at worst moment during past 24 hours n=24,13,11 | Baseline - Question 3 n=24,13,11 | Week 16 How bothered by pain during past 24 hour n=24,13,11 | |
| Placebo - TP 1 - MLP Cohort | 5.9 | -0.1 | 6.4 | -0.3 | 6.5 | -0.3 |
"Pain is assessed with the following questions: • Overall, how severe was your lichen planus-related pain during the past 24 hours? • How severe was your lichen planus-related pain at the worst moment during the past 24 hours? • Overall, how bothered were you by your lichen planus-related pain during the past 24 hours? Answers are given on a numeric rating scale (NRS) from 0 to 10, with 0 meaning no pain and 10 meaning the worst pain imaginable." (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline - Question 1 n=24,13,11 | Week 16 Severity of pain during past 24 hours n=24,13,11 | Week 32 Severity of pain during past 24 hours n=23,0,10 | Baseline - Question 2 n=24,13,11 | Week 16 How severe was pain at worst moment during past 24 hours n=24,13,11 | Week 32 How severe was pain at worst moment during past 24 hours n=23,0,10 | Baseline - Question 3 n=24,13,11 | Week 16 How bothered by pain during past 24 hour n=24,13,11 | Week 32 How bothered by pain during past 24 hours n=23,0,10 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - MLP Cohort | 5.1 | -0.5 | -0.3 | 5.4 | -0.5 | -0.3 | 5.5 | -0.8 | -0.5 |
| Placebo to AIN457 300 mg Q2W TP 2 - MLP Cohort | 6.3 | 0.0 | -0.6 | 6.7 | -0.2 | -0.5 | 6.8 | -0.1 | -0.9 |
Scalpdex is a self-administered, health-related quality of life instrument originally developed for scalp dermatitis. This survey includes 23 items, each item scored on a scale of 0-100, where 0=never, 25=rarely, 50=sometimes, 75=often and 100=all the time. The 23 items pertain to 3 domains: symptom, emotions and functioning. Subjects were asked to score themselves on how true each of the 23 statements has been for them over the past four weeks. the total score is the average of the scores of the 23 items. A higher total score indicated a higher impairment in quality of life. (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |
|---|---|---|
| Baseline n=24,13,12 | Week 16 n=24,13,12 | |
| Placebo - TP 1 - LPP Cohort | 54.01 | -6.94 |
Scalpdex is a self-administered, health-related quality of life instrument originally developed for scalp dermatitis. This survey includes 23 items, each item scored on a scale of 0-100, where 0=never, 25=rarely, 50=sometimes, 75=often and 100=all the time. The 23 items pertain to 3 domains: symptom, emotions and functioning. Subjects were asked to score themselves on how true each of the 23 statements has been for them over the past four weeks. the total score is the average of the scores of the 23 items. A higher total score indicated a higher impairment in quality of life. (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||
|---|---|---|---|
| Baseline n=24,13,12 | Week 16 n=24,13,12 | Week 32 n=24,0,11 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 -LPP Cohort | 55.75 | 1.86 | -4.26 |
| Placebo to AIN457 300 mg Q2W - TP 2 - LPP Cohort | 54.01 | -6.94 | -14.43 |
OLPSSM is a self-administered assessment of the symptom experience of subjects with oral LP in clinical studies. It includes 7 triggers contributing to soreness of oral lichen planus: Brushing teeth, eating food, drinking liquids, smiling, breathing through mouth, talking and touching. These 7 items contributed equally to a total OLP symptom severity score, ranging from 0 to 28, with higher scores indicating worse severity. (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |
|---|---|---|
| Baseline n=21,12,10 | Week 16 n=21,12,10 | |
| Placebo - TP 1 - MLP Cohort | 13.4 | 0.8 |
OLPSSM is a self-administered assessment of the symptom experience of subjects with oral LP in clinical studies. It includes 7 triggers contributing to soreness of oral lichen planus: Brushing teeth, eating food, drinking liquids, smiling, breathing through mouth, talking and touching. These 7 items contributed equally to a total OLP symptom severity score, ranging from 0 to 28, with higher scores indicating worse severity. (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||
|---|---|---|---|
| Baseline n=21,12,10 | Week 16 n=21,12,10 | Week 32 n=20,0,9 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - MLP Cohort | 11.0 | -1.0 | -1.8 |
| Placebo to AIN457 300 mg Q2W TP 2 - MLP Cohort | 13.9 | -0.4 | -0.7 |
REU measured disease severity based on 3 dimensions: reticulation, erythema and ulceration for all subjects in the MLP cohort who had an oral presentation of the disease. The total score ranged from 0-115 with higher values corresponding to higher activity of the disease. (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | |
|---|---|---|
| Baseline n=21,12,10 | Week 16 n=21,12,10 | |
| Placebo - TP 1 - MLP Cohort | 25.29 | -5.79 |
REU measured disease severity based on 3 dimensions: reticulation, erythema and ulceration for all subjects in the MLP cohort who had an oral presentation of the disease. The total score ranged from 0-115 with higher values corresponding to higher activity of the disease. (NCT04300296)
Timeframe: Baseline, Week 16 and Week 32
| Intervention | scores on a scale (Mean) | ||
|---|---|---|---|
| Baseline n=21,12,10 | Week 16 n=21,12,10 | Week 32 n=20,0,9 | |
| AIN457 300 mg Q4W - TP 1 and TP 2 - MLP Cohort | 21.31 | -4.83 | -6.08 |
| Placebo to AIN457 300 mg Q2W TP 2 - MLP Cohort | 26.95 | -4.10 | -2.17 |
206 reviews available for salicylic acid and Alopecia
| Article | Year |
|---|---|
Efficacy of scalp cooling for prevention of chemotherapy induced alopecia: a systematic review and meta-analysis.
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Randomized Controlled Trials as Topic | 2021 |
The hair follicle-psoriasis axis: Shared regulatory mechanisms and therapeutic targets.
Topics: Alopecia; Hair; Hair Follicle; Humans; Psoriasis; Scalp | 2022 |
Treatment of Alopecia in Children.
Topics: Alopecia; Biopsy; Child; Cicatrix; Hair; Humans; Scalp | 2022 |
[Frontal fibrosing alopecia-update].
Topics: Adolescent; Alopecia; Eyebrows; Female; Fibrosis; Humans; Inflammation; Lichen Planus; Male; Scalp | 2022 |
Alopecia in children undergoing chemotherapy, radiation, and hematopoietic stem cell transplantation: Scoping review and approach to management.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Child; Hair; Hematopoietic Stem Cell Trans | 2022 |
[Janus kinase inhibitors for the treatment of alopecia areata].
Topics: Alopecia; Alopecia Areata; Humans; Janus Kinase Inhibitors; Quality of Life; Scalp | 2022 |
Chemotherapy, Alopecia, and Scalp Cooling Systems.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2022 |
Minimally invasive procedures for the management of female pattern hair loss.
Topics: Alopecia; Female; Hair Follicle; Humans; Minimally Invasive Surgical Procedures; Quality of Life; Sc | 2022 |
Frontal Fibrosing Alopecia - a review and a practical guide for clinicians.
Topics: Alopecia; Child, Preschool; Female; Forehead; Humans; Hydroxychloroquine; Lichen Planus; Scalp | 2022 |
Natural results of scalp micropigmentation: A review.
Topics: Alopecia; Cicatrix; Humans; Scalp; Skin Transplantation | 2022 |
Platelet-Rich Plasma Monotherapies for Androgenetic Alopecia: A Network Meta-Analysis and Meta-Regression Study.
Topics: Alopecia; Female; Hair; Humans; Male; Network Meta-Analysis; Platelet-Rich Plasma; Scalp; Treatment | 2022 |
Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy-induced alopecia: A systematic review.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Communication; Female; Humans; Scalp | 2023 |
Treatment of erosive pustular dermatosis of the scalp: our experience and review of unconventional topical drugs.
Topics: Administration, Topical; Aged; Alopecia; Dapsone; Humans; Scalp; Scalp Dermatoses | 2023 |
EROSIVE PUSTULAR DERMATOSIS OF THE SCALP (EPDS) - A CASE SERIES AND SHORT REVIEW.
Topics: Aged; Alopecia; Cicatrix; Communicable Diseases; Humans; Scalp; Skin | 2023 |
Melatonin and the Human Hair Follicle.
Topics: Alopecia; Hair; Hair Follicle; Humans; Male; Melatonin; Scalp | 2023 |
Histopathology in the Diagnosis of Tinea Capitis: When to Do, How to Interpret?
Topics: Alopecia; Cellulitis; Humans; Psoriasis; Scalp; Tinea Capitis | 2023 |
[Scalp cooling for the prevention of chemotherapy-induced alopecia: systematic review and meta-analysis.]
Topics: Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Quality of | 2023 |
Commonly used hair oils in the Black community: a narrative review in their use to treat androgenetic alopecia.
Topics: Alopecia; Animals; Hair; Humans; Mice; Oils, Volatile; Scalp; Tea Tree Oil | 2023 |
Scarring Alopecia.
Topics: Alopecia; Cicatrix; Hair; Humans; Lupus Erythematosus, Discoid; Scalp | 2023 |
Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling.
Topics: Alopecia; Antineoplastic Agents; Cannabinoids; Cryotherapy; Drug-Related Side Effects and Adverse Re | 2023 |
The role of the scalp biopsy in the evaluation of alopecia.
Topics: Alopecia; Biopsy; Cicatrix; Hair; Humans; Scalp | 2023 |
Establishing baselines of hair density measurements: Variations across ethnicity, scalp region, and measurement techniques: A systematic review.
Topics: Alopecia; Ethnicity; Hair; Humans; Scalp; Scalp Dermatoses | 2023 |
Alopecia Areata: Current Treatments and New Directions.
Topics: Alopecia; Alopecia Areata; Hair Follicle; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; | 2023 |
Imaging Tools for Noninvasive Hair Assessment.
Topics: Alopecia; Biopsy; Hair; Humans; Photography; Scalp | 2023 |
Alopecia Areata: The Clinician and Patient Voice.
Topics: Alopecia; Alopecia Areata; Autoimmune Diseases; Hair Follicle; Humans; Recurrence; Scalp | 2023 |
Herbal preparations for the treatment of hair loss.
Topics: Alopecia; Androgens; Cholestenone 5 alpha-Reductase; Garlic; Hair; Humans; Male; Onions; Phytotherap | 2020 |
PPAR-γ signalling as a key mediator of human hair follicle physiology and pathology.
Topics: Alopecia; Animals; Cicatrix; Epithelial-Mesenchymal Transition; Hair; Hair Diseases; Hair Follicle; | 2020 |
Fibrosing alopecia in a pattern distribution.
Topics: Alopecia; Female; Fibrosis; Hair Follicle; Humans; Lichen Planus; Male; Middle Aged; Scalp | 2021 |
Hair Transplantation in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Systematic Review.
Topics: Alopecia; Dermoscopy; Hair; Humans; Lichen Planus; Scalp | 2021 |
Therapeutic options for erosive pustular dermatosis of the scalp: a systematic review.
Topics: Alopecia; Calcineurin Inhibitors; Humans; Prospective Studies; Scalp; Scalp Dermatoses | 2021 |
[Tinea capitis in children is an overlooked disease].
Topics: Alopecia; Antifungal Agents; Child; Humans; Pain; Pruritus; Scalp; Tinea Capitis | 2020 |
Hairline-Lowering Surgery.
Topics: Alopecia; Forehead; Hair; Humans; Patient Selection; Scalp; Skin Transplantation | 2020 |
Getting under the skin of hair aging: the impact of the hair follicle environment.
Topics: Alopecia; Animals; Cellular Microenvironment; Gonadal Steroid Hormones; Hair Follicle; Humans; Scalp | 2020 |
[Alopecia-keep a cool head].
Topics: Alopecia; Biopsy; Cicatrix; Humans; Scalp | 2020 |
Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: A systematic review of the literature.
Topics: Alopecia; Botulinum Toxins, Type A; Cosmetic Techniques; Humans; Scalp | 2020 |
Cephalgia Alopecia.
Topics: Alopecia; Botulinum Toxins, Type A; Headache; Humans; Neck Pain; Scalp | 2020 |
Management of chemotherapy-induced alopecia (CIA): A comprehensive review and future directions.
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Quality of Life; Scalp | 2020 |
Common causes of hair loss - clinical manifestations, trichoscopy and therapy.
Topics: Alopecia; Alopecia Areata; Hair Diseases; Humans; Lichen Planus; Scalp; Trichotillomania | 2021 |
Dermoscopy of discoid lupus erythematosus - a systematic review of the literature.
Topics: Alopecia; Dermatitis; Dermoscopy; Humans; Lupus Erythematosus, Discoid; Scalp | 2021 |
Male and female pattern hair loss: Treatable and worth treating.
Topics: Alopecia; Female; Hair; Humans; Male; Scalp | 2021 |
The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis.
Topics: Alopecia; Breast Neoplasms; Cross-Sectional Studies; Female; Humans; Hypothermia, Induced; Scalp | 2021 |
[Kerion Celsi due to Microsporum canis infection].
Topics: Alopecia; Antifungal Agents; Child; Humans; Male; Microsporum; Scalp; Tinea Capitis | 2021 |
Hair transplantation: Basic overview.
Topics: Alopecia; Female; Hair; Hair Follicle; Humans; Male; Scalp; Skin Transplantation; Tissue and Organ H | 2021 |
New Diagnostic Tools to Evaluate Hair Loss.
Topics: Alopecia; Dermoscopy; Hair Diseases; Humans; Scalp; Scalp Dermatoses | 2021 |
Oxidative stress and its impact on skin, scalp and hair.
Topics: Aging; Alopecia; Hair; Humans; Oxidative Stress; Reactive Oxygen Species; Scalp; Skin | 2021 |
TNF-inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy.
Topics: Adalimumab; Adult; Alopecia; Atrophy; Female; Humans; Middle Aged; Psoriasis; Scalp; Sebaceous Gland | 2017 |
Efficacy of topical caffeine in male androgenetic alopecia.
Topics: Administration, Topical; Alopecia; Caffeine; Hair; Hair Follicle; Humans; Male; Randomized Controlle | 2017 |
Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hypother | 2018 |
Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials.
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Randomized Controlled Trials as Topic | 2018 |
[Postmenopausal lichen planopilaris also known as fibrosing frontotemporal alopecia Kossard : An evidence-oriented practical guide to treatment from the University of the Saarland, Hair Research Center of the Dr. Rolf M. Schwiete Foundation].
Topics: Adult; Aged; Algorithms; Alopecia; Diagnosis, Differential; Evidence-Based Medicine; Female; Fibrosi | 2018 |
Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review.
Topics: Alopecia; Animals; Antihypertensive Agents; Antineoplastic Agents; Bimatoprost; Cryotherapy; Hair Fo | 2018 |
5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Breast Neoplasms; Depression; Dutasteride; Evidence-Based Me | 2018 |
Hairline Restoration: Difference in Men and Woman-Length and Shape.
Topics: Adult; Alopecia; Esthetics; Female; Hair; Humans; Male; Middle Aged; Scalp; Sex Factors; Surgery, Pl | 2018 |
Cicatricial alopecia.
Topics: Alopecia; Biopsy; Coloring Agents; Combined Modality Therapy; Delayed Diagnosis; Fluorescent Antibod | 2018 |
A proposed mechanism for central centrifugal cicatricial alopecia.
Topics: Alopecia; Cicatrix; Fibrosis; Humans; Kidney; Kidney Diseases; Lichen Planus; PPAR gamma; Scalp; Scl | 2020 |
The Significance of Scalp Involvement in Pemphigus: A Literature Review.
Topics: Alopecia; Desmogleins; Fluorescent Antibody Technique, Direct; Hair Follicle; Humans; Pemphigus; Sca | 2018 |
Morphea «En Coup De Sabre» at the Site of Healed Herpes Zoster Ophthalmicus.
Topics: Adult; Alopecia; Cicatrix; Facial Dermatoses; Female; Forehead; Herpes Zoster Ophthalmicus; Humans; | 2019 |
Androgens in women: Androgen-mediated skin disease and patient evaluation.
Topics: Acne Vulgaris; Adrenal Gland Neoplasms; Adrenal Glands; Alopecia; Androgens; Cholesterol; Endocrinol | 2019 |
Algorithmic approach to the treatment of frontal fibrosing alopecia: A systematic review.
Topics: Algorithms; Alopecia; Fibrosis; Humans; Scalp | 2021 |
Nonshaven Follicular Unit Extraction: Personal Experience.
Topics: Adult; Alopecia; Cicatrix; Esthetics; Female; Graft Survival; Hair; Hair Follicle; Humans; Male; Mid | 2019 |
Alopecia areata: A multifactorial autoimmune condition.
Topics: Adrenal Cortex Hormones; Alopecia; Alopecia Areata; Animals; Autoimmunity; Cell Movement; Gene-Envir | 2019 |
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Female; Humans; Hyperandrogenism; Low- | 2019 |
The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
Topics: Alopecia; Breast Neoplasms; Bridged-Ring Compounds; Cryotherapy; Female; Humans; Induction Chemother | 2019 |
Medical therapy for frontal fibrosing alopecia: A review and clinical approach.
Topics: 5-alpha Reductase Inhibitors; Adrenal Cortex Hormones; Alopecia; Anti-Inflammatory Agents; Fibrosis; | 2019 |
The role of the microbiome in scalp hair follicle biology and disease.
Topics: Alopecia; Alopecia Areata; Animals; Dermatitis, Seborrheic; Hair; Hair Follicle; Humans; Immune Syst | 2020 |
The Applications of Medical Tattooing in the Head and Neck Region.
Topics: Alopecia; Cicatrix; Humans; Quality of Life; Scalp; Tattooing | 2019 |
Herbal Medicines For Treatment of Androgenic Alopecia.
Topics: Alopecia; Finasteride; Herbal Medicine; Humans; Minoxidil; Phytotherapy; Plants, Medicinal; Scalp | 2020 |
Hair transplantation.
Topics: Alopecia; Hair Follicle; Humans; Patient Selection; Scalp; Tissue and Organ Harvesting | 2012 |
Graham-Little-Piccardi-Lasseur syndrome: case report and review of the syndrome in men.
Topics: Abnormalities, Multiple; Adult; Alopecia; Axilla; Cicatrix; Darier Disease; Eyebrows; Humans; Lichen | 2014 |
Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy; Female; Humans; Hypothermia, | 2013 |
Primary cicatricial alopecia: diagnosis and treatment.
Topics: Alopecia; Biopsy; Cicatrix; Diagnosis, Differential; Disease Management; Humans; Scalp | 2013 |
Extensive Darier's disease with pityriasis amiantacea, alopecia and congenital facial nerve palsy.
Topics: Acantholysis; Aged; Alopecia; Darier Disease; Facial Nerve Diseases; Humans; Isotretinoin; Male; Pit | 2013 |
Phenotype of normal hairline maturation.
Topics: Adolescent; Adult; Aging; Alopecia; Child; Female; Genetic Predisposition to Disease; Hair; Human De | 2013 |
Hairline design and frontal hairline restoration.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Esthetics; Hair; Hair Follicle; Hum | 2013 |
Graft harvesting and management of the donor site.
Topics: Alopecia; Cicatrix; Cosmetic Techniques; Dermatologic Surgical Procedures; Hair; Hair Follicle; Huma | 2013 |
Management of advanced hair loss patterns.
Topics: Age Factors; Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Hair; Humans; Male; Pa | 2013 |
Follicular unit extraction.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Esthetics; Hair; Hair Follicle; Hum | 2013 |
Management of the crown.
Topics: Age Factors; Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Hair; Humans; Male; Sc | 2013 |
Female hair restoration.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Esthetics; Female; Hair; Humans; Pa | 2013 |
Megasessions: surgical indications and technical perspectives.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Female; Graft Survival; Hair; Hair | 2013 |
Dense packing: surgical indications and technical considerations.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Esthetics; Hair; Hair Follicle; Hum | 2013 |
Optimal graft growth.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Graft Survival; Hair; Hair Follicle | 2013 |
Use of body hair and beard hair in hair restoration.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Eyebrows; Face; Hair; Hair Follicle | 2013 |
Hairline lowering.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Female; Forehead; Humans; Patient C | 2013 |
Scalp repair using tissue expanders.
Topics: Adult; Alopecia; Child; Cosmetic Techniques; Female; Hair; Humans; Male; Middle Aged; Scalp; Surgica | 2013 |
Scalp micropigmentation: a useful treatment for hair loss.
Topics: Alopecia; Humans; Patient Satisfaction; Patient Selection; Scalp; Tattooing; Treatment Outcome | 2013 |
Complications in hair-restoration surgery.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Surgical Procedures; Hair; Humans; Patient Care Planning | 2013 |
Androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Biopsy; Comorbidity; Contraindications | 2014 |
Hair loss in autoimmune systemic diseases.
Topics: Alopecia; Alopecia Areata; Autoimmune Diseases; Cicatrix; Connective Tissue Diseases; Hair Diseases; | 2014 |
Trichoscopy: an update.
Topics: Alopecia; Black People; Cicatrix; Dermoscopy; Hair; Hair Diseases; Humans; Lice Infestations; Refere | 2014 |
Additional methods for diagnosing alopecia and appraising their severity.
Topics: Alopecia; Biopsy; Hair; Humans; Microscopy; Photography; Physical Examination; Scalp; Stress, Mechan | 2014 |
Odd-looking hair and progressive alopecia in mother and son.
Topics: Adult; Alopecia; Biopsy, Needle; Disease Progression; Female; Follow-Up Studies; Hair; Heterozygote; | 2014 |
Follicular and scarring disorders in skin of color: presentation and management.
Topics: Alopecia; Cicatrix; Hair Follicle; Humans; Quality of Life; Racial Groups; Scalp; Skin Diseases; Ski | 2014 |
Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination.
Topics: Alopecia; Alopecia Areata; Beauty Culture; Diagnosis, Differential; Humans; Hyperandrogenism; Physic | 2014 |
[Your patient complains about hair loss. Contribution of a skin biopsy in noncicatricial alopecias].
Topics: Alopecia; Biopsy; Diagnosis, Differential; Humans; Scalp; Skin | 2014 |
The scalp biopsy for hair loss and its interpretation.
Topics: Alopecia; Biopsy, Needle; Humans; Scalp | 2015 |
Evaluation of hair loss.
Topics: Alopecia; Alopecia Areata; Biopsy; Dermatitis, Seborrheic; Dermoscopy; Female; Hair Diseases; Humans | 2015 |
Normal and aging hair biology and structure 'aging and hair'.
Topics: 5-alpha Reductase Inhibitors; Aging; Alopecia; Finasteride; Hair; Hair Follicle; Humans; Melanocytes | 2015 |
Scalp dermoscopy or trichoscopy.
Topics: Alopecia; Alopecia Areata; Cicatrix; Dermoscopy; Hair Diseases; Humans; Lupus Erythematosus, Discoid | 2015 |
Primary scarring alopecias.
Topics: Acne Keloid; Alopecia; Cellulitis; Cicatrix; Fibrosis; Folliculitis; Humans; Lichen Planus; Lupus Er | 2015 |
Trichodynia: a review of the literature.
Topics: Alopecia; Humans; Pain; Scalp; Sex Factors; Substance P | 2016 |
Special Stains and Immunohistochemical Stains in Hair Pathology.
Topics: Alopecia; Biopsy; Hair; Humans; Immunohistochemistry; Predictive Value of Tests; Scalp; Scalp Dermat | 2016 |
Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis.
Topics: Alopecia; Fibrosis; Humans; Scalp | 2016 |
Diagnostic value of horizontal versus vertical sections for scarring and non-scarring alopecia: a systematic review and meta-analysis.
Topics: Alopecia; Biopsy; Cicatrix; Humans; Microtomy; Scalp; Skin | 2016 |
Multi-therapies in androgenetic alopecia: review and clinical experiences.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Administration, Oral; Alopecia; Finasteride | 2016 |
Primary scalp alopecia: new histopathological tools, new concepts and a practical guide to diagnosis.
Topics: Alopecia; Cicatrix; Female; Humans; Male; Scalp | 2017 |
Platelet-Rich Plasma in Androgenic Alopecia: Indications, Technique, and Potential Benefits.
Topics: Alopecia; Humans; Platelet-Rich Plasma; Scalp | 2017 |
Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
Topics: Alopecia; Bimatoprost; Eyebrows; Eyelashes; Humans; Hypotrichosis; Scalp | 2017 |
Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cryotherapy; Female; Head | 2017 |
[Physiology of the scalp].
Topics: Alopecia; Animals; Humans; Hyperalgesia; Models, Biological; Scalp; Scalp Dermatoses; Skin; Touch | 2017 |
Hair transplantation for men.
Topics: Alopecia; Cicatrix; Cosmetic Techniques; Finasteride; Hair; Hair Follicle; Humans; Low-Level Light T | 2008 |
Follicular unit transplantation.
Topics: Alopecia; Female; Hair Follicle; Humans; Male; Scalp; Skin Transplantation; Tissue and Organ Harvest | 2008 |
Malignant eccrine spiradenoma of the scalp.
Topics: Adenoma, Sweat Gland; Adult; Alopecia; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; N | 2008 |
Alopecia in epidermolysis bullosa.
Topics: Alopecia; Epidermolysis Bullosa; Humans; Scalp | 2010 |
Hairpin-induced alopecia: case reports and a review of the literature.
Topics: Adolescent; Alopecia; Beauty Culture; Black People; Debridement; Female; Granulation Tissue; Humans; | 2010 |
From surgery to pharmacology to gene therapy: the past, present, and future of hair restoration.
Topics: Alopecia; Female; Finasteride; Forecasting; Genetic Therapy; Hair; Hair Follicle; Humans; Male; Mino | 2010 |
Iron deficiency and diffuse nonscarring scalp alopecia in women: more pieces to the puzzle.
Topics: Alopecia; Anemia, Iron-Deficiency; Animals; Cicatrix; Female; Humans; Iron; Scalp | 2010 |
Chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Female; Hair Follicle; Humans; Male; Minoxidil; Neoplasms; Scalp; V | 2010 |
Burn reconstruction.
Topics: Alopecia; Burns; Cicatrix; Contracture; Face; Humans; Lower Extremity; Mammaplasty; Perineum; Pigmen | 2011 |
[Effectiveness of scalp cooling in chemotherapy].
Topics: Alopecia; Antineoplastic Agents; Contraindications; Head Protective Devices; Humans; Hypothermia, In | 2011 |
[Scalp cooling for chemotherapy-induced alopecia].
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Neoplasms; Scalp; Treatment Outcome | 2011 |
Hair through the female life cycle.
Topics: Age of Onset; Aging; Alopecia; Attitude to Health; Female; Hair; Hair Color; Humans; Scalp; Scalp De | 2011 |
Linear lupus panniculitis of the scalp presenting as alopecia along Blaschko's lines: a distinct variant of lupus panniculitis in East Asians?
Topics: Adult; Alopecia; Asian People; Humans; Hydroxychloroquine; Male; Panniculitis, Lupus Erythematosus; | 2012 |
A review of scalp camouflaging agents and prostheses for individuals with hair loss.
Topics: Alopecia; Dermatologic Agents; Eyebrows; Female; Hair; Humans; Male; Prostheses and Implants; Scalp; | 2012 |
Sarcoidosis-induced alopecia.
Topics: Alopecia; Black or African American; Cicatrix; Female; Humans; Male; Middle Aged; Sarcoidosis; Scalp | 2012 |
Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
Topics: Adalimumab; Adult; Alopecia; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclona | 2012 |
Histopathology of scarring and nonscarring hair loss.
Topics: Alopecia; Biopsy; Cicatrix; Diagnosis, Differential; Hair Diseases; Hair Follicle; Humans; Microtomy | 2013 |
Hair transplantation update: procedural techniques, innovations, and applications.
Topics: Alopecia; Eyebrows; Eyelashes; Groin; Hair Follicle; Humans; Patient Satisfaction; Plastic Surgery P | 2013 |
Shampoos, conditioners, and camouflage techniques.
Topics: Alopecia; Hair; Hair Preparations; Humans; Patient Satisfaction; Scalp | 2013 |
Assessment of hair loss: clinical relevance of hair growth evaluation methods.
Topics: Alopecia; Biopsy; Female; Hair; Hair Follicle; Humans; Male; Photography; Scalp | 2002 |
Telogen effluvium.
Topics: Acute Disease; Alopecia; Chronic Disease; Female; Hair; Hair Follicle; Humans; Male; Scalp | 2002 |
[The hair follicle as a target for gene therapy].
Topics: Alopecia; Animals; Genetic Therapy; Hair Follicle; Humans; Mice; Scalp; Skin Diseases; Skin Physiolo | 2002 |
The art of repair in surgical hair restoration part I: basic repair strategies.
Topics: Alopecia; Dermatology; Esthetics; Hair; Humans; Reoperation; Scalp | 2002 |
The art of repair in surgical hair restoration--part II: the tactics of repair.
Topics: Alopecia; Dermatology; Esthetics; Hair Follicle; Humans; Scalp | 2002 |
Approach to the adult female patient with diffuse nonscarring alopecia.
Topics: Adult; Alopecia; Biopsy, Needle; Child, Preschool; Female; Humans; Immunohistochemistry; Incidence; | 2002 |
A philosophy and strategy for surgical hair restoration: a 10-year experience.
Topics: Alopecia; Hair; Humans; Postoperative Complications; Preoperative Care; Scalp; Surgical Flaps; Trans | 2002 |
Post-menopausal frontal fibrosing alopecia.
Topics: Aged; Alopecia; Female; Fibrosis; Hair Follicle; Humans; Postmenopause; Scalp | 2003 |
Androgens and alopecia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Alopecia; Androgens; Clinical T | 2002 |
Methods of evaluating hair growth.
Topics: Alopecia; Hair; Hair Follicle; Humans; Image Processing, Computer-Assisted; Microscopy, Video; Photo | 2003 |
Morphological approach to hair disorders.
Topics: Alopecia; Androgens; Biopsy; Hair Diseases; Hair Follicle; Humans; Molecular Biology; Mosaicism; Rep | 2003 |
[Baldness surgery].
Topics: Alopecia; Hair; Hair Follicle; Humans; Scalp; Surgery, Plastic; Surgical Flaps; Treatment Outcome | 2003 |
What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss?
Topics: Alopecia; Antineoplastic Agents; Cold Temperature; Europe; Humans; Hypothermia, Induced; Prevalence; | 2004 |
Natural hair patterns.
Topics: Alopecia; Esthetics; Hair; Humans; Male; Scalp; Transplantation, Autologous | 2004 |
[Paroxismal reactions of the scalp].
Topics: Acute Disease; Adult; Alopecia; Dermatitis, Seborrheic; Female; Humans; Lice Infestations; Male; Pos | 2004 |
Ant-induced alopecia: report of 2 cases and review of the literature.
Topics: Adult; Alopecia; Alopecia Areata; Animals; Ants; Appetitive Behavior; Bedding and Linens; Diagnosis, | 2004 |
Lipedematous scalp and lipedematous alopecia: a clinical and histologic analysis of 3 cases.
Topics: Adipose Tissue; Aged; Alopecia; Female; Humans; Lymphangiectasis; Middle Aged; Scalp; White People | 2005 |
Prevention of chemotherapy-induced hair loss by scalp cooling.
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Neoplasms; Scalp; Treatment Outcome | 2005 |
Transverse sections for diagnosis of alopecia?
Topics: Alopecia; Hair Follicle; Humans; Microtomy; Scalp | 2005 |
Vertical vs. transverse sections: both are valuable in the evaluation of alopecia.
Topics: Alopecia; Hair Follicle; Humans; Microtomy; Scalp | 2005 |
Hair transplantation for men and women.
Topics: Alopecia; Female; Hair Follicle; Humans; Male; Scalp; Tissue and Organ Harvesting | 2006 |
Review of scalp alopecia due to a clinically unapparent or minimally apparent neoplasm (SACUMAN).
Topics: Alopecia; Breast Neoplasms; Carcinoma, Basal Cell; Cicatrix; Hemangiosarcoma; Humans; Keloid; Lympho | 2006 |
Lipedematous scalp and lipedematous alopecia: report of three cases in white adults.
Topics: Adipose Tissue; Alopecia; Female; Humans; Male; Middle Aged; Scalp; Scalp Dermatoses | 2007 |
Pharmacologic interventions in aging hair.
Topics: Aging; Alopecia; Antioxidants; Hair; Hair Preparations; Humans; Scalp; Ultraviolet Rays | 2006 |
Cicatricial alopecia secondary to radiation therapy: case report and review of the literature.
Topics: Adult; Alopecia; Astrocytoma; Brain Neoplasms; Cicatrix; Female; Hair; Humans; Radiotherapy; Scalp | 2008 |
Cicatricial alopecia secondary to radiation therapy: case report and review of the literature.
Topics: Adult; Alopecia; Astrocytoma; Brain Neoplasms; Cicatrix; Female; Hair; Humans; Radiotherapy; Scalp | 2008 |
Cicatricial alopecia secondary to radiation therapy: case report and review of the literature.
Topics: Adult; Alopecia; Astrocytoma; Brain Neoplasms; Cicatrix; Female; Hair; Humans; Radiotherapy; Scalp | 2008 |
Cicatricial alopecia secondary to radiation therapy: case report and review of the literature.
Topics: Adult; Alopecia; Astrocytoma; Brain Neoplasms; Cicatrix; Female; Hair; Humans; Radiotherapy; Scalp | 2008 |
[Hair follicle regeneration].
Topics: Alopecia; Animals; Cell- and Tissue-Based Therapy; Dermis; Finasteride; Hair; Hair Follicle; Humans; | 2008 |
Lipedematous alopecia: an uncommon clinicopathologic variant of nonscarring but permanent alopecia.
Topics: Adolescent; Adult; Aged; Alopecia; Female; Hair; Hair Follicle; Humans; Male; Middle Aged; Scalp; Sc | 2008 |
Keratosis follicularis spinulosa decalvans. Report of two cases and literature review.
Topics: Adult; Alopecia; Atrophy; Biopsy; Darier Disease; Eyebrows; Female; Humans; Male; Scalp; Terminology | 1983 |
Prevention of chemotherapy-induced alopecia: a review of the literature.
Topics: Alopecia; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Humans; Hypothermia, Induced; Scalp; | 1984 |
Hair transplantation. The fourth decade.
Topics: Adolescent; Adult; Alopecia; Female; Hair; Humans; Male; Microsurgery; Middle Aged; Scalp; Surgical | 1995 |
Congenital cardiac malformations in Adams-Oliver syndrome.
Topics: Abnormalities, Multiple; Alopecia; Child; Child, Preschool; Female; Heart Defects, Congenital; Human | 1995 |
Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 1994 |
Scarring alopecia: a classification based on microscopic criteria.
Topics: Alopecia; Humans; Scalp | 1994 |
The transversely sectioned scalp biopsy specimen: the technique and an algorithm for its use in the diagnosis of alopecia.
Topics: Algorithms; Alopecia; Biopsy; Hair; Histocytological Preparation Techniques; Humans; Scalp | 1994 |
Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast carcinoma.
Topics: Adult; Alopecia; Alopecia Areata; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Scalp; | 1994 |
Advances in surgical hair restoration.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps; Tissue Expansion | 1993 |
Cutaneous fibrous dysplasia: an incomplete form of the McCune-Albright syndrome.
Topics: Alopecia; Biopsy, Needle; Cafe-au-Lait Spots; Diagnosis, Differential; Female; Fibrous Dysplasia, Po | 1996 |
Alopecia: histologic diagnosis by transverse sections.
Topics: Alopecia; Biopsy; Diagnosis, Differential; Humans; Microtomy; Scalp | 1996 |
[Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
Topics: Alopecia; Androgens; Dihydrotestosterone; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; | 1996 |
Arteriovenous fistula of the scalp secondary to punch autograft hair transplantation: angioarchitecture, histopathology, and endovascular and surgical therapy.
Topics: Alopecia; Angiography; Arteriovenous Fistula; Hair; Humans; Male; Middle Aged; Postoperative Complic | 1997 |
Concepts in scalp and forehead reconstruction.
Topics: Alopecia; Forehead; Humans; Scalp; Surgical Flaps; Tissue Expansion | 1997 |
Relationship between follicular nerve supply and alopecia.
Topics: Adult; Alopecia; Axons; Female; Humans; Immunohistochemistry; Male; Microscopy, Confocal; Microscopy | 1996 |
What's new in hair replacement surgery.
Topics: Aged; Aged, 80 and over; Alopecia; Anesthesia; Hair; Humans; Laser Therapy; Male; Middle Aged; Preop | 1996 |
[Cicatricial alopecias: diagnosis and therapy].
Topics: Alopecia; Biopsy; Cicatrix; Diagnosis, Differential; Hair Follicle; Humans; Prognosis; Scalp | 1997 |
Increased scalp skin and serum 5 alpha-reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Alopecia; Androgens; Disease Progression; Hair; Hair D | 1997 |
[Trichodynia].
Topics: Alopecia; Female; Humans; Neuropeptides; Pain; Scalp; Skin Diseases; Stress, Psychological; Substanc | 1997 |
Acquired scalp alopecia. Part I: A review.
Topics: Alopecia; Biopsy; Female; Hair; Humans; Male; Medical History Taking; Scalp | 1998 |
Novel agents for the treatment of alopecia.
Topics: Alopecia; Androgen Antagonists; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Scalp | 1998 |
Traumatic alopecia.
Topics: Alopecia; Diagnosis, Differential; Hair Follicle; Hot Temperature; Humans; Scalp; Trichotillomania | 1999 |
Human scalp hair growth and loss evaluation methods: is there simple and reliable method?
Topics: Alopecia; Dermatology; Hair; Humans; Scalp | 1999 |
Scalp cooling: a critical examination.
Topics: Alopecia; Antineoplastic Agents; Cryotherapy; Hair; Humans; Scalp | 1998 |
Lipedematous alopecia: a clinicopathologic, histologic and ultrastructural study.
Topics: Adipose Tissue; Adolescent; Alopecia; Biopsy; Humans; Lymphedema; Male; Microscopy, Electron; Scalp | 2000 |
Sarcoidosis of the scalp: a case series and review of the literature.
Topics: Adult; Alopecia; Female; Humans; Sarcoidosis; Scalp; Skin Diseases | 2000 |
Tissue expansion for frontal hairline restoration in severe alopecia in a child.
Topics: Alopecia; Burns; Child, Preschool; Esthetics; Follow-Up Studies; Humans; Injury Severity Score; Male | 2000 |
Lipedematous alopecia.
Topics: Adipose Tissue; Alopecia; Female; Hair; Humans; Middle Aged; Scalp | 2000 |
Clinical application of 5alpha-reductase inhibitors.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; I | 2001 |
Scarring alopecia and the dermatopathologist.
Topics: Alopecia; Biopsy; Cicatrix; Dermatology; Diagnosis, Differential; Humans; Scalp | 2001 |
Baldness. Medical solutions for men and women.
Topics: Alopecia; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; Scalp; Sex Factors; | 2001 |
Hair and cancer chemotherapy: consequences and nursing care--a literature study.
Topics: Alopecia; Antineoplastic Agents; Body Image; Humans; Hypothermia, Induced; Scalp; Self Care | 2001 |
Hair and cancer chemotherapy: consequences and nursing care--a literature study.
Topics: Alopecia; Antineoplastic Agents; Body Image; Humans; Hypothermia, Induced; Scalp; Self Care | 2001 |
Hair and cancer chemotherapy: consequences and nursing care--a literature study.
Topics: Alopecia; Antineoplastic Agents; Body Image; Humans; Hypothermia, Induced; Scalp; Self Care | 2001 |
Hair and cancer chemotherapy: consequences and nursing care--a literature study.
Topics: Alopecia; Antineoplastic Agents; Body Image; Humans; Hypothermia, Induced; Scalp; Self Care | 2001 |
Basal cell carcinoma originating from a nevus sebaceus on the scalp of a 7-year-old boy.
Topics: Alopecia; Carcinoma, Basal Cell; Child; Diagnostic Errors; Hamartoma; Head and Neck Neoplasms; Human | 2001 |
Congenital triangular alopecia: a case report and review.
Topics: Alopecia; Biopsy; Child; Diagnosis, Differential; Hair; Humans; Male; Scalp | 2002 |
Recent developments in alopecias.
Topics: Alopecia; Alopecia Areata; Androgens; Dihydrotestosterone; Female; Humans; Male; Protein-Energy Maln | 1978 |
Quantitative models for the study of hair growth in vivo.
Topics: Aging; Alopecia; Animals; Diazoxide; DNA Replication; Hair; Humans; Macaca; Minoxidil; Models, Biolo | 1991 |
Disorders of the hair and scalp in children.
Topics: Alopecia; Child; Cysts; Humans; Infant; Infant, Newborn; Nevus; Scalp; Scalp Dermatoses; Skin Neopla | 1991 |
Treatment of male pattern baldness and postoperative temporal baldness in men.
Topics: Alopecia; Esthetics; Hair; Humans; Male; Scalp; Surgery, Plastic; Surgical Flaps | 1991 |
Microsurgical free temporoparietal flaps in surgery for male pattern baldness.
Topics: Alopecia; Esthetics; Humans; Male; Microsurgery; Scalp; Surgical Flaps | 1991 |
Salvage of an avulsed expanded scalp flap to correct burn alopecia.
Topics: Accidents, Traffic; Adolescent; Alopecia; Burns; Debridement; Humans; Male; Scalp; Surgical Flaps; T | 1990 |
Expanded pedicle scalp flaps for baldness: is a delay necessary?
Topics: Alopecia; Elasticity; Humans; Male; Scalp; Skin Physiological Phenomena; Surgical Flaps; Time Factor | 1988 |
General evaluation of the patient with alopecia.
Topics: Alopecia; Biopsy; Genetic Counseling; Hair; Humans; Scalp | 1987 |
Hair replacement techniques. An overview.
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Surgical Flaps; Surgical Instruments | 1987 |
Scalp reduction in the treatment of androgenic alopecia.
Topics: Alopecia; Androgens; Humans; Methods; Postoperative Complications; Scalp | 1987 |
Contemporary approaches to scalp reduction and hair transplantation.
Topics: Alopecia; Hair; Humans; Male; Microsurgery; Scalp | 1987 |
Electric mixer-inflicted scalp injury: a case report and review of CPSC data.
Topics: Accidents, Home; Alopecia; Child, Preschool; Consumer Product Safety; Cooking and Eating Utensils; F | 1987 |
Common hair disorders.
Topics: Adult; Alopecia; Alopecia Areata; Child; Female; Humans; Male; Nevus, Pigmented; Scalp; Skin Neoplas | 1986 |
Topically applied minoxidil in baldness.
Topics: Administration, Topical; Alopecia; Animals; Biopsy; Double-Blind Method; Drug Evaluation; Drug Evalu | 1985 |
Alopecia: syndromes of genetic significance.
Topics: Abnormalities, Multiple; Adolescent; Adult; Age Factors; Alopecia; Alopecia Areata; Child; Child, Pr | 1973 |
Keratinization and hair growth.
Topics: Adrenal Cortex Hormones; Alopecia; Androgens; Animals; Antineoplastic Agents; Diet; Embryology; Fema | 1968 |
83 trials available for salicylic acid and Alopecia
| Article | Year |
|---|---|
Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers.
Topics: Alopecia; Alopecia Areata; Biomarkers; Humans; Janus Kinase Inhibitors; Protein Kinase Inhibitors; S | 2022 |
The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double-blind placebo-controlled trial.
Topics: Alopecia; Alopecia Areata; Double-Blind Method; Humans; Latanoprost; Scalp; Treatment Outcome | 2022 |
Safety and efficacy of Trimax-360 serum in healthy adult subjects with mild to moderate alopecia of scalp.
Topics: Adult; Alopecia; Female; Hair; Humans; Male; Scalp | 2022 |
Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2022 |
Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2023 |
Biomolecules of Fermented Tropical Fruits and Fermenting Microbes as Regulators of Human Hair Loss, Hair Quality, and Scalp Microbiota.
Topics: Adenosine Triphosphate; Alopecia; Female; Fermentation; Fruit; Hair; Humans; Male; Microbiota; Scalp | 2023 |
Electric hand warmer versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia prevention: a randomized study.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced; Middle Aged | 2023 |
The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial.
Topics: Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Head Protective Devices; Humans; Lo | 2023 |
Sequential Scalp Assessment in Hair Regeneration Therapy Using an Adipose-Derived Stem Cell-Conditioned Medium.
Topics: Adipose Tissue; Adult; Aged; Alopecia; Cell Culture Techniques; Culture Media, Conditioned; Female; | 2020 |
Monofilament threads in treatment of female hair loss.
Topics: Adult; Alopecia; Double-Blind Method; Female; Hair; Humans; Pilot Projects; Prospective Studies; Sca | 2021 |
Effect of a sphingolipid-mimetic compound on the promotion of hair growth: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Alopecia; Double-Blind Method; Hair; Humans; Scalp; Sphingolipids | 2020 |
"Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
Topics: Adult; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compounds; Ch | 2020 |
Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
Topics: Administration, Topical; Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; Scalp; Treatment Outc | 2020 |
Growth factor concentrations in platelet-rich plasma for androgenetic alopecia: An intra-subject, randomized, blinded, placebo-controlled, pilot study.
Topics: Adult; Alopecia; Blood Platelets; Female; Hair; Humans; Intercellular Signaling Peptides and Protein | 2020 |
Use of vibrating anesthetic device reduces the pain of mesotherapy injections: A randomized split-scalp study.
Topics: Alopecia; Alopecia Areata; Anesthetics; Child; Humans; Mesotherapy; Pain; Scalp | 2021 |
Comparison between single- versus double-spin prepared platelet-rich plasma injection in treatment of female pattern hair loss: clinical effect and relation to vascular endothelial growth factor.
Topics: Adult; Alopecia; Centrifugation; Female; Hair Follicle; Humans; Injections, Intradermal; Middle Aged | 2021 |
Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia.
Topics: Adult; Alopecia; Biopsy; Cell Count; Cell Proliferation; Combined Modality Therapy; Hair; Hair Folli | 2020 |
A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
Topics: Administration, Topical; Alopecia; Drug Therapy, Combination; Hair; Humans; Minoxidil; Scalp; Spiron | 2021 |
Tolerability of Six Months Indirect Cold (Physical) Plasma Treatment of the Scalp for Hair Loss.
Topics: Adult; Aged; Alopecia; Cryotherapy; Female; Humans; Male; Middle Aged; Pilot Projects; Plasma Gases; | 2020 |
Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double-Blind Half-Head Controlled Trial.
Topics: Alopecia; Double-Blind Method; Hair; Humans; Male; Minoxidil; Scalp; Treatment Outcome | 2021 |
The Effects of Lower vs Higher Cell Number of Platelet-Rich Plasma (PRP) on Hair Density and Diameter in Androgenetic Alopecia (AGA): A Randomized, Double-Blinded, Placebo, Parallel-Group Half-Scalp IRB-Approved Study.
Topics: Alopecia; Cell Count; Ethics Committees, Research; Female; Humans; Male; Platelet-Rich Plasma; Prosp | 2021 |
Digital Innovation in Oncological Primary Treatment for Well-Being of Patients: Psychological Caring as Prompt for Enhancing Quality of Life.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hypothermia, Induced; Qual | 2021 |
Scalp application of the antioxidant piroctone olamine reduces hair shedding in an 8-week randomized, double-blind, placebo-controlled clinical study.
Topics: Administration, Topical; Adult; Aged; Alopecia; Antioxidants; Double-Blind Method; Drug Combinations | 2021 |
Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24-week randomized, double-blind, placebo-controlled clinical trial.
Topics: Administration, Topical; Adult; Aged; Alopecia; Antioxidants; Biomarkers; Double-Blind Method; Hair | 2021 |
Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Animals; Breast Neoplasms; Carboplatin; Docetaxel; Female; | 2018 |
Selective Scalp Nerve Block: A Useful Technique With Tissue Expansion in Postburn Pediatric Alopecia.
Topics: Alopecia; Burns; Child; Dermatologic Surgical Procedures; Female; Follow-Up Studies; Humans; Male; N | 2018 |
Styling without shedding: Novel topical formula reduces hair shedding by contracting the arrector pili muscle.
Topics: Administration, Topical; Adolescent; Adrenergic alpha-1 Receptor Agonists; Adult; Alopecia; Blood Pr | 2018 |
Therapeutic efficacy and safety of a 1927-nm fractionated thulium laser on pattern hair loss: an evaluator-blinded, split-scalp study.
Topics: Adult; Aged; Alopecia; Animals; Hair; Humans; Intercellular Signaling Peptides and Proteins; Lasers, | 2018 |
A pilot split-scalp study of combined fractional radiofrequency microneedling and 5% topical minoxidil in treating male pattern hair loss.
Topics: Administration, Topical; Adult; Alopecia; Combined Modality Therapy; Cosmetic Techniques; Humans; Ma | 2018 |
Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 2019 |
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2019 |
Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cryotherapy | 2019 |
The effect of platelet-rich plasma injection in the treatment of androgenetic alopecia.
Topics: Adult; Alopecia; Blood Transfusion, Autologous; Dermoscopy; Hair Follicle; Humans; Injections; Male; | 2019 |
A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Alopecia; Combined Modality Therapy; Glas | 2019 |
"Miliacin encapsulated by polar lipids stimulates cell proliferation in hair bulb and improves telogen effluvium in women".
Topics: Administration, Oral; Adult; Alopecia; Cell Proliferation; Double-Blind Method; Drug Carriers; Femal | 2020 |
Treatment of Postsurgical Scalp Scar Deformity Using Follicular Unit Hair Transplantation.
Topics: Adolescent; Adult; Alopecia; Cicatrix; Female; Hair Follicle; Humans; Male; Scalp | 2019 |
Preliminary results of the use of scalp microneedling in different types of alopecia.
Topics: Adult; Alopecia; Dermoscopy; Dry Needling; Erythema; Female; Follow-Up Studies; Hair; Humans; Male; | 2020 |
Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Humans; Hy | 2013 |
The growth of human scalp hair mediated by visible red light laser and LED sources in males.
Topics: Adolescent; Adult; Alopecia; Double-Blind Method; Follow-Up Studies; Hair; Humans; Light; Low-Level | 2013 |
A prostaglandin D-synthase-positive mast cell gradient characterizes scalp patterning.
Topics: Alopecia; Female; Humans; Intramolecular Oxidoreductases; Lipocalins; Male; Mast Cells; Scalp | 2014 |
The growth of human scalp hair in females using visible red light laser and LED sources.
Topics: Adolescent; Adult; Alopecia; Double-Blind Method; Female; Hair; Humans; Low-Level Light Therapy; Mid | 2014 |
Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis.
Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia; Controlled Before-After Studies; Dermatologi | 2015 |
The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Causality; Cohort | 2015 |
Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Administration, Topical; Adolescent; Adult; Aged; Alopecia; Dihydrotes | 2016 |
α1 -AR agonist induced piloerection protects against the development of traction alopecia.
Topics: Adolescent; Adrenergic alpha-1 Receptor Agonists; Adult; Alopecia; Barbering; Female; Humans; Phenyl | 2016 |
Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Docetaxel; Drug-Related Side Effect | 2016 |
Robotic Follicular Unit Graft Selection.
Topics: Alopecia; Hair Follicle; Humans; Male; Robotics; Scalp; Tissue and Organ Harvesting; Transplantation | 2016 |
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compoun | 2017 |
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compoun | 2017 |
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compoun | 2017 |
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compoun | 2017 |
Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Body Image; Breast Neoplasms; Female; Huma | 2009 |
Impact of alopecia and scalp cooling on the well-being of breast cancer patients.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Anxiety Disorders; Body Image; Breast Neop | 2010 |
Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp.
Topics: Aged; Aged, 80 and over; Alopecia; Aminoquinolines; Face; Female; Half-Life; Humans; Imiquimod; Kera | 2010 |
Treatment of male pattern baldness with botulinum toxin: a pilot study.
Topics: Adult; Alopecia; Botulinum Toxins, Type A; Drug Administration Schedule; Humans; Injections; Male; M | 2010 |
Clinical evaluation of alopecias using a handheld dermatoscope.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Biopsy; Child; Dermoscopy; Epidermis; Female; | 2012 |
Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 2002 |
Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Automation | 2003 |
A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy.
Topics: Adult; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced; Midd | 2004 |
Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention.
Topics: Alopecia; Antineoplastic Agents; Head and Neck Neoplasms; Humans; Hypothermia, Induced; Neoplasms; S | 2006 |
Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; | 2006 |
Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG).
Topics: Administration, Topical; Alopecia; bcl-2-Associated X Protein; Catechin; Cells, Cultured; Dermis; Ge | 2007 |
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Antagonists; Azasteroids; Dihydrotestosteron | 2006 |
Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography.
Topics: Administration, Topical; Adult; Aged; Alopecia; Blood Flow Velocity; Clinical Trials as Topic; Doubl | 1984 |
The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss.
Topics: Adult; Aged; Alopecia; Clinical Trials as Topic; Doxorubicin; Female; Humans; Hypothermia, Induced; | 1984 |
[Prevention of chemotherapy-induced alopecia in cancer patients by scalp hypothermia (author's transl)].
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combinati | 1982 |
Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 1994 |
The use of retention sutures and tensed Silastic-Dacron strips for the prevention of stretch-back after alopecia-reducing procedures.
Topics: Adult; Alopecia; Humans; Male; Middle Aged; Polyethylene Terephthalates; Scalp; Silicone Elastomers; | 1994 |
The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Dihydrotestosterone; Double-Blind Method; Finasteride | 1994 |
Comparative evaluation of scalp hair by phototrichogram and unit area trichogram analysis within the same subjects.
Topics: Adult; Aged; Alopecia; Female; Hair; Hair Color; Humans; Male; Middle Aged; Scalp | 1993 |
Consecutive wide and long single hair-bearing transposition flaps in combination with hair transplantation for the management of slot formation after alopecia reducing surgery.
Topics: Alopecia; Cicatrix; Esthetics; Hair; Hair Diseases; Humans; Postoperative Complications; Scalp; Surg | 1996 |
Dissecting microscope versus magnifying loupes with transillumination in the preparation of follicular unit grafts. A bilateral controlled study.
Topics: Alopecia; Anesthesia, Local; Dissection; Hair Follicle; Humans; Lenses; Male; Microscopy; Microsurge | 1998 |
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Alopecia; Androgens; Androstane-3,17-diol; Dihydrot | 1999 |
Prevention of chemotherapy-induced alopecia using an effective scalp cooling system.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; | 2000 |
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
Topics: Administration, Oral; Adult; Alopecia; Biopsy; Disease Progression; Double-Blind Method; Enzyme Inhi | 2000 |
Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent.
Topics: Administration, Cutaneous; Adult; Alopecia; Antioxidants; Biflavonoids; Catechin; Double-Blind Metho | 2000 |
The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent.
Topics: Administration, Cutaneous; Adult; Alopecia; Biflavonoids; Catechin; Hair; Humans; Male; Middle Aged; | 2001 |
A comparative clinical and histologic study of hair transplantation using Er:YAG, Er:YAG/CO2, and standard punch techniques.
Topics: Adult; Alopecia; Follow-Up Studies; Hair; Humans; Laser Therapy; Male; Middle Aged; Postoperative Co | 2001 |
Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined C | 2002 |
Contrast enhanced phototrichogram pinpoints scalp hair changes in androgen sensitive areas of male androgenetic alopecia.
Topics: Adolescent; Adult; Alopecia; Colorimetry; Hair; Hair Follicle; Humans; Image Enhancement; Male; Midd | 2002 |
Doxorubicin-induced hair loss and possible modification by scalp cooling.
Topics: Alopecia; Breast Neoplasms; Cryotherapy; Doxorubicin; Female; Humans; Scalp | 1977 |
Expression of the L-fucose moiety on infrainfundibular follicular keratinocytes of terminal follicles, its decreased expression on vellus and indeterminate follicles of androgenetic alopecia, and re-expression in drug-induced hair regrowth.
Topics: Adult; Aged; Alopecia; Binding Sites; Biopsy; Fucose; Hair; Humans; Keratinocytes; Lectins; Middle A | 1992 |
Treatment of female androgenetic alopecia with minoxidil 2%.
Topics: Administration, Topical; Adult; Alopecia; Double-Blind Method; Female; Humans; Minoxidil; Scalp | 1992 |
A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis.
Topics: Adult; Alopecia; Biopsy, Needle; Clinical Trials as Topic; Double-Blind Method; Female; Hair; Humans | 1987 |
Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness.
Topics: Adult; Alopecia; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Humans; Male; | 1987 |
Lack of efficacy of polysorbate 60 in the treatment of male pattern baldness.
Topics: Adult; Aged; Alopecia; Clinical Trials as Topic; Double-Blind Method; Hair; Humans; Male; Middle Age | 1985 |
1372 other studies available for salicylic acid and Alopecia
| Article | Year |
|---|---|
Alopecia in association with severe seborrhoeic dermatitis following combination antiretroviral therapy for acute retroviral syndrome.
Topics: Administration, Topical; Adult; Alopecia; Antiretroviral Therapy, Highly Active; Betamethasone; Coco | 2005 |
[Postmenopausal bleeding following the application of an estrogen-containing hair lotion--concomitant endocrine changes].
Topics: Age Factors; Aged; Alopecia; Dermatologic Agents; Drug Combinations; Estradiol; Female; Hair Prepara | 1984 |
Pityriasis amiantacea: a report of two cases in adults.
Topics: Administration, Topical; Adult; Alopecia; Female; Humans; Male; Pityriasis; Salicylic Acid; Scalp | 1999 |
Treatment of androgenetic alopecia in females in reproductive age with topical estradiolbenzoate, prednisolon and salicylic acid.
Topics: Administration, Topical; Adolescent; Adult; Alopecia; Drug Therapy, Combination; Estradiol; Female; | 2000 |
Device for serial photography of the scalp.
Topics: Alopecia; Humans; Photography; Scalp | 2023 |
Evidence for lymphocytic inflammation in non-lesional scalp of folliculitis decalvans: an observational study of 25 patients.
Topics: Alopecia; Folliculitis; Humans; Inflammation; Scalp; Scalp Dermatoses | 2022 |
Identifying Barriers and Facilitators to Scalp Cooling Therapy Through a National Survey of the Awareness, Practice Patterns, and Attitudes of Oncologists.
Topics: Alopecia; Attitude; Humans; Hypothermia, Induced; Oncologists; Scalp; United States | 2022 |
Disseminated Coccidioidomycosis as the First Presentation of a C-Terminal NFKB2 Pathogenic Variant: A Case Report and Review of the Literature.
Topics: Alopecia; Antifungal Agents; Child; Coccidioidomycosis; Codon, Nonsense; Female; Humans; NF-kappa B | 2022 |
Characterizing the willingness to undergo treatment in patients with alopecia areata.
Topics: Administration, Topical; Alopecia; Alopecia Areata; Hair; Humans; Scalp | 2022 |
Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom?
Topics: Alopecia; Alopecia Areata; Female; Ferritins; Hemoglobins; Humans; Male; Retrospective Studies; Scal | 2022 |
Evaluating the association of central centrifugal cicatricial alopecia (CCCA) and fibroproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Black or African American; Body Mass Index; Cicatrix; Fema | 2021 |
A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Female; Hair; Humans; Male; Nail Diseases; Patient Rep | 2022 |
Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early-stage breast cancer-The COOL study.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2022 |
Novel splicing-site mutation in DCAF17 gene causing Woodhouse-Sakati syndrome in a large consanguineous family.
Topics: Adolescent; Alopecia; Arrhythmias, Cardiac; Basal Ganglia Diseases; Child; Consanguinity; Diabetes M | 2022 |
Effect of minoxidil formulations on human scalp skin xenotransplants on SCID mice: A novel pre-clinical in vivo assay for androgenetic alopecia research.
Topics: Administration, Topical; Alopecia; Animals; Hair; Humans; Mice; Mice, SCID; Minoxidil; Scalp; Treatm | 2022 |
Gene expression profiling suggests severe, extensive central centrifugal cicatricial alopecia may be both clinically and biologically distinct from limited disease subtypes.
Topics: Alopecia; Cicatrix; Dermatitis; Female; Gene Expression Profiling; Hair; Humans; Microarray Analysis | 2022 |
The Emperor Has No Platelets: Minimal Effects in an Alopecia Split-Scalp Study Unsurprising as Platelet-Rich Plasma Was Actually Platelet-Poor.
Topics: Alopecia; Blood Platelets; Humans; Platelet-Rich Plasma; Scalp | 2022 |
Alopecia areata - Current understanding and management.
Topics: Alopecia; Alopecia Areata; Humans; Immunotherapy; Quality of Life; Recurrence; Scalp | 2022 |
A Novel Needleless Delivery System for Scalp Platelet-Rich Plasma: Pilot Study.
Topics: Alopecia; Humans; Pilot Projects; Platelet-Rich Plasma; Scalp | 2022 |
Plasma Cell-Predominant Lichen Planopilaris.
Topics: Alopecia; Hair Follicle; Humans; Lichen Planus; Male; Middle Aged; Plasma Cells; Scalp | 2022 |
Efficacy of botulinum toxin A injection in the treatment of androgenic alopecia: A Comparative Controlled Study.
Topics: Alopecia; Botulinum Toxins, Type A; Hair; Humans; Mesotherapy; Scalp; Treatment Outcome | 2022 |
The presence of mast cells in lichen planopilaris and discoid lupus erythematosus of the scalp: A quantitative study.
Topics: Alopecia; Cell Count; Humans; Lichen Planus; Lupus Erythematosus, Discoid; Mast Cells; Scalp | 2022 |
Efficacy assessment for low-level laser therapy in the treatment of androgenetic alopecia: a real-world study on 1383 patients.
Topics: Adolescent; Adult; Alopecia; Dandruff; Exanthema; Humans; Low-Level Light Therapy; Male; Scalp; Trea | 2022 |
Effects of watercress extract fraction on R-spondin 1-mediated growth of human hair.
Topics: Alopecia; Female; Hair; Hair Follicle; Humans; Male; Plant Extracts; Scalp | 2022 |
Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany.
Topics: Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2022 |
Different levels of EGF, VEGF, IL-6, MCP-1, MCP-3, IP-10, Eotaxin and MIP-1α in the adipose-derived stem cell secretome in androgenetic alopecia.
Topics: Adipose Tissue; Alopecia; Chemokine CCL3; Chemokine CXCL10; Epidermal Growth Factor; Hair Follicle; | 2022 |
Giant cutaneous squamous cell carcinoma of the scalp arising in the setting of folliculitis decalvans.
Topics: Alopecia; Carcinoma, Squamous Cell; Folliculitis; Head and Neck Neoplasms; Humans; Male; Scalp; Skin | 2022 |
Dermatologist awareness of scalp cooling for chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2023 |
Early onset female pattern hair loss: A case-control study for analyzing clinical features and genetic variants.
Topics: Adult; Alopecia; Case-Control Studies; Female; Hair; Humans; Polymorphism, Single Nucleotide; Scalp | 2022 |
Low temperature mitigating the paclitaxel-induced damages in mouse cell and hair follicle model.
Topics: Alopecia; Animals; Antineoplastic Agents; Breast Neoplasms; Female; Hair Follicle; Humans; Hypotherm | 2022 |
Scalp reduction surgery does not reactivate frontal fibrosing alopecia: A case report.
Topics: Alopecia; Humans; Lichen Planus; Plastic Surgery Procedures; Scalp | 2022 |
Chemotherapy-Induced Alopecia: Examining Patient Perceptions and Adherence to Home Haircare Recommendations.
Topics: Alopecia; Antineoplastic Agents; Cross-Sectional Studies; Humans; Hypothermia, Induced; Scalp | 2022 |
Risk factors of long-term alopecia after pulsed-dye laser treatment for infantile scalp hemangiomas: A retrospective study.
Topics: Alopecia; Female; Hemangioma; Humans; Infant; Lasers, Dye; Male; Retrospective Studies; Risk Factors | 2022 |
Short sequence repeats of the intergenic spacer regions of ribosomal RNA genes in Malassezia globosa and Malassezia restricta colonizing the scalps of male individuals with and without androgenetic alopecia.
Topics: Alopecia; DNA, Intergenic; Genes, rRNA; Humans; Malassezia; Male; Scalp | 2022 |
Comment on scalp neuropathy in androgenetic alopecia.
Topics: Alopecia; Hair Follicle; Humans; Peripheral Nervous System Diseases; Scalp | 2022 |
A prospective pilot study of narrowband UV-B treatment of lichen planopilaris.
Topics: Alopecia; Humans; Lichen Planus; Pilot Projects; Prospective Studies; Scalp | 2022 |
Adalimumab-Induced Psoriasis with Severe Alopecia.
Topics: Adalimumab; Alopecia; Crohn Disease; Female; Humans; Middle Aged; Psoriasis; Scalp | 2022 |
A pediatric case of corticosteroid-resistant erosive pustular dermatosis of scalp-like alopecia treated successfully with oral indomethacin, doxycycline, and topical tacrolimus.
Topics: Adrenal Cortex Hormones; Alopecia; Child; Doxycycline; Humans; Indomethacin; Male; Scalp; Scalp Derm | 2022 |
Nonmelanoma skin cancer in the setting of erosive pustular dermatosis of the scalp: A case series and comment on management implications.
Topics: Aged, 80 and over; Alopecia; Humans; Scalp; Scalp Dermatoses; Skin Diseases, Vesiculobullous; Skin N | 2022 |
Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2022 |
Localized alopecia with itching on the scalp.
Topics: Alopecia; Dermoscopy; Diagnosis, Differential; Humans; Pruritus; Scalp; Scalp Dermatoses | 2022 |
Percutaneous collagen induction (microneedling) for scarring alopecia in discoid lupus erythematosus of the scalp.
Topics: Alopecia; Cicatrix; Humans; Lupus Erythematosus, Discoid; Scalp | 2022 |
Alopecia of the crown and midline scalp.
Topics: Alopecia; Hair; Humans; Scalp | 2023 |
Response to the article, "Evaluation of standardized scalp photography on patient perception of hair loss severity, anxiety, and treatment," by Pathoulas et al.
Topics: Alopecia; Anxiety; Humans; Perception; Photography; Scalp | 2022 |
Treatment of hereditary hypotrichosis simplex of the scalp with oral minoxidil and growth factors.
Topics: Alopecia; Humans; Hypotrichosis; Intercellular Signaling Peptides and Proteins; Minoxidil; Scalp | 2022 |
A rare manifestation of scalp sarcoidosis.
Topics: Alopecia; Humans; Sarcoidosis; Scalp | 2023 |
Reply to "Response to Pathoulas et al's 'Evaluation of standardized scalp photography on patient perception of hair loss severity, anxiety, and treatment'".
Topics: Alopecia; Anxiety; Humans; Perception; Photography; Scalp | 2022 |
Effectiveness, Safety, and Tolerance of Scalp Cooling for Chemotherapy-Induced Alopecia.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Scalp | 2022 |
Inflammatory complications after hair transplantation: Report of 10 cases.
Topics: Alopecia; Eczema; Female; Hair; Humans; Lichen Planus; Male; Scalp | 2022 |
Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2022 |
[A child with a bald spot on her scalp].
Topics: Alopecia; Ectodermal Dysplasia; Family; Female; Humans; Infant; Rare Diseases; Scalp | 2022 |
Leucoderma secondary to wig wearing.
Topics: Alopecia; Hair; Humans; Scalp | 2022 |
An Arts-Based Workshop Using Scalp Tattoos to Connect Students with Cancer Patients' Experiences of Chemotherapy and Hair Loss.
Topics: Alopecia; Humans; Neoplasms; Scalp; Students, Medical; Tattooing | 2022 |
A Presentation of New-onset Hair Loss in a 7-year-old.
Topics: Alopecia; Child; Humans; Scalp | 2023 |
Response to: The Emperor Has No Platelets: Minimal Effects in an Alopecia Split-Scalp Study Unsurprising as Platelet-Rich Plasma Was Actually Platelet-Poor.
Topics: Alopecia; Blood Platelets; Humans; Platelet-Rich Plasma; Scalp | 2022 |
Depth control in follicular unit excision: A new classification from a detailed analysis of 30 patients undergoing FUE technique for hair restoration.
Topics: Alopecia; Hair; Hair Follicle; Humans; Male; Scalp; Tissue and Organ Harvesting; Transplantation, Au | 2022 |
Type 2 diabetes mellitus and central centrifugal cicatricial alopecia severity.
Topics: Alopecia; Cicatrix; Dermatitis; Diabetes Mellitus, Type 2; Humans; Scalp | 2022 |
Intermediate Hair Follicles from Patients with Female Pattern Hair Loss Are Associated with Nutrient Insufficiency and a Quiescent Metabolic Phenotype.
Topics: Alopecia; Female; Hair Follicle; Humans; Nutrients; Phenotype; Scalp | 2022 |
A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia.
Topics: Alopecia; Cross-Sectional Studies; Dermoscopy; Humans; Melanoma; Proto-Oncogene Proteins B-raf; Retr | 2022 |
Rare Concurrence of Alopecia Areata in the Setting of the Lipedematous Scalp.
Topics: Alopecia; Alopecia Areata; Glycyrrhizic Acid; Humans; Lipedema; Minoxidil; Scalp; Vitamin D | 2022 |
Changing spectrum of hair and scalp disorders over the last decade in a tertiary medical centre.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Alopecia Areata; Child; Child, Preschool; Fema | 2023 |
Erythematous alopecic plaques on the scalp of an adult female.
Topics: Adult; Alopecia; Female; Humans; Scalp; Scalp Dermatoses | 2023 |
In Vitro and In Vivo Scalp Retention and Penetration of 99mTc-Minoxidil Solution.
Topics: Administration, Topical; Alopecia; Excipients; Humans; Minoxidil; Propylene Glycol; Scalp; Skin; Ski | 2023 |
Annular plaque over the scalp with patchy alopecia.
Topics: Alopecia; Alopecia Areata; Humans; Scalp; Scalp Dermatoses | 2023 |
IL-17 Expression in the Perifollicular Fibrosis in Biopsies From Lichen Planopilaris.
Topics: Alopecia; Biopsy; Cicatrix; Fibrosis; Humans; Interleukin-17; Lichen Planus; Retrospective Studies; | 2022 |
A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss.
Topics: Alopecia; Attitude; Dihydrotestosterone; Female; Humans; Male; Minoxidil; Scalp; Treatment Outcome | 2022 |
Sebaceous gland atrophy in seborrheic dermatitis of the scalp; a pilot study.
Topics: Alopecia; Atrophy; Dermatitis, Seborrheic; Humans; Pilot Projects; Psoriasis; Retrospective Studies; | 2022 |
Efficacy of Percutaneous Superficial Temporal Arterial Hyaluronidase Injection for Hyaluronic Acid Filler-Induced Necrosis of Frontotemporal Skin and/or the Ipsilateral Scalp With Subsequent Alopecia.
Topics: Alopecia; Dermal Fillers; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Necrosis; Retrospective | 2023 |
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Topics: Adult; Alopecia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2022 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Male; Scalp; United States | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
The efficacy of LED microneedle patch on hair growth in mice.
Topics: Alopecia; Animals; Hair Follicle; Male; Mice; Mice, Inbred C57BL; Scalp; Skin | 2023 |
Tinea capitis.
Topics: Alopecia; Dermoscopy; Female; Hair; Humans; Lymphadenopathy; Male; Scalp; Tinea Capitis | 2022 |
Tinea capitis.
Topics: Alopecia; Dermoscopy; Female; Hair; Humans; Lymphadenopathy; Male; Scalp; Tinea Capitis | 2022 |
Tinea capitis.
Topics: Alopecia; Dermoscopy; Female; Hair; Humans; Lymphadenopathy; Male; Scalp; Tinea Capitis | 2022 |
Tinea capitis.
Topics: Alopecia; Dermoscopy; Female; Hair; Humans; Lymphadenopathy; Male; Scalp; Tinea Capitis | 2022 |
Automating Hair Loss Labels for Universally Scoring Alopecia From Images: Rethinking Alopecia Scores.
Topics: Adult; Alopecia; Alopecia Areata; Child; Female; Hair; Humans; Male; Retrospective Studies; Scalp | 2023 |
Automating Hair Loss Labels for Universally Scoring Alopecia From Images: Rethinking Alopecia Scores.
Topics: Adult; Alopecia; Alopecia Areata; Child; Female; Hair; Humans; Male; Retrospective Studies; Scalp | 2023 |
Automating Hair Loss Labels for Universally Scoring Alopecia From Images: Rethinking Alopecia Scores.
Topics: Adult; Alopecia; Alopecia Areata; Child; Female; Hair; Humans; Male; Retrospective Studies; Scalp | 2023 |
Automating Hair Loss Labels for Universally Scoring Alopecia From Images: Rethinking Alopecia Scores.
Topics: Adult; Alopecia; Alopecia Areata; Child; Female; Hair; Humans; Male; Retrospective Studies; Scalp | 2023 |
Retrospective cohort study of scalp cooling in breast cancer patients.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2023 |
Low temperature upregulating HSP70 expression to mitigate the paclitaxel-induced damages in NHEK cell.
Topics: Alopecia; HSP70 Heat-Shock Proteins; Humans; Keratinocytes; Paclitaxel; Reactive Oxygen Species; Sca | 2023 |
A Scalp Dose Threshold for Preventing Permanent Alopecia in Scalp-Avoidance Whole-Brain Irradiation With Volumetric Modulated Arc Radiation Therapy for Pediatric Patients With Medulloblastomas.
Topics: Alopecia; Brain; Cerebellar Neoplasms; Child; Humans; Medulloblastoma; Organs at Risk; Radiotherapy | 2023 |
Scalp biopsy influences diagnostic accuracy and treatment in Black women with alopecia: A retrospective study.
Topics: Alopecia; Biopsy; Cicatrix; Female; Hair; Humans; Retrospective Studies; Scalp | 2023 |
The efficacy of learning programmes on hairstylists and barbers in the early detection of alopecia and scalp disorders in South Africa.
Topics: Alopecia; Humans; Scalp; Skin Diseases; South Africa | 2023 |
Scalp hair loss is not random across follicular units: A new insight into human hair ageing.
Topics: Aging; Alopecia; Cross-Sectional Studies; Female; Hair; Hair Follicle; Humans; Male; Retrospective S | 2023 |
Osteoma cutis of the scalp on a background of hair loss surgeries.
Topics: Alopecia; Humans; Ossification, Heterotopic; Scalp; Skin Diseases, Genetic; Skin Neoplasms | 2023 |
[Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients].
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2023 |
A Scalp Scar-Reducing Procedure for the Hair Transplant Donor Area Using a Columnar Trichophytic Suture: A Case Report.
Topics: Adult; Alopecia; Cicatrix; Hair; Humans; Male; Scalp; Sutures; Tissue Donors; Young Adult | 2023 |
The Efficacy of Anterior Capsulotomy and Basal Capsulectomy Adherent to Expanded Scalp Flap During Alopecia Reconstruction in Pediatric Burned Patients.
Topics: Adolescent; Adult; Alopecia; Burns; Case-Control Studies; Child; Child, Preschool; Humans; Quality o | 2023 |
Protein profiling of forehead epidermal corneocytes distinguishes frontal fibrosing from androgenetic alopecia.
Topics: Alopecia; Epidermis; Fibrosis; Forehead; Humans; Lichen Planus; Scalp; Skin | 2023 |
A split scalp study to evaluate the effects of platelet rich plasma prepared by two different methods in androgenetic alopecia.
Topics: Alopecia; Humans; Platelet-Rich Plasma; Scalp; Treatment Outcome | 2023 |
Alopecia in Patients with Collagen VI-Related Myopathies: A Novel/Unrecognized Scalp Phenotype.
Topics: Alopecia; Collagen; Folliculitis; Humans; Muscular Diseases; Phenotype; Pruritus; Scalp | 2023 |
Comparative histopathological analyses of non-scarring alopecia in systemic lupus erythematosus patients in Lagos Nigeria.
Topics: Alopecia; Cross-Sectional Studies; Hair; Humans; Lupus Erythematosus, Systemic; Nigeria; Scalp | 2023 |
Experience on biocompatible artificial hair implant.
Topics: Adult; Aged; Alopecia; Female; Hair; Humans; Male; Middle Aged; Prostheses and Implants; Prosthesis | 2023 |
Redefining the "crown": Approaching chemotherapy-induced alopecia among Black patients with breast cancer.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Black or African Am | 2023 |
A case of scarring and nonscarring alopecia secondary to vascular occlusion with dermal filler.
Topics: Alopecia; Cicatrix; Dermal Fillers; Humans; Scalp; Vascular Diseases | 2023 |
Male pattern hair loss: Can developmental origins explain the pattern?
Topics: Alopecia; Hair; Hair Follicle; Humans; Male; Scalp; Skin | 2023 |
Sarcoidosis Coexisting With Distinct Forms of Alopecia on the Scalp: A Case Series.
Topics: Alopecia; Alopecia Areata; Cicatrix; Humans; Lichen Planus; Sarcoidosis; Scalp | 2023 |
The histopathologic diagnosis of traction alopecia: An evidence-based model.
Topics: Alopecia; Biopsy; Cicatrix; Hair Follicle; Humans; Scalp; Traction | 2023 |
Increase in subcutaneous adipose tissue in the frontal scalp may be associated with androgenetic alopecia and metabolic syndrome.
Topics: Adult; Alopecia; Cross-Sectional Studies; Diabetes Mellitus; Humans; Metabolic Syndrome; Scalp | 2023 |
Scalp Nodule Associated With Hair Loss.
Topics: Alopecia; Hair; Humans; Scalp | 2023 |
Minimizing Bias in Alopecia Diagnosis in Skin of Color Patients.
Topics: Alopecia; Humans; Quality of Life; Scalp; Skin; Skin Pigmentation | 2023 |
Application of Autologous Hair Transplantation Technique in Children with Cicatricial Alopecia.
Topics: Alopecia; Child; Cicatrix; Female; Hair; Hair Follicle; Humans; Male; Scalp; Skin Transplantation; T | 2023 |
Central centrifugal cicatricial alopecia in males.
Topics: Adult; Alopecia; Black or African American; Cicatrix; Dermatitis; Diabetes Mellitus, Type 2; Female; | 2023 |
Diagnosis and differential diagnosis of tertiary androgenetic alopecia with severe alopecia areata based on high-resolution MRI.
Topics: Alopecia; Alopecia Areata; Diagnosis, Differential; Hair Follicle; Humans; Magnetic Resonance Imagin | 2023 |
Follicular Unit Excision in Patients of African Descent: A Skin-Responsive Technique.
Topics: Alopecia; Black People; Female; Hair; Hair Follicle; Humans; Male; Retrospective Studies; Scalp; Tis | 2023 |
Localized alopecic myxedema of the scalp.
Topics: Alopecia; Biopsy; Graves Disease; Hashimoto Disease; Humans; Myxedema; Scalp | 2023 |
What Do We Know About Hair Growth Induced by Wounding and Its Therapeutic Applications?
Topics: Alopecia; Hair; Hair Follicle; Humans; Hypertrichosis; Scalp; Skin Diseases | 2023 |
Response to "Lack of association between comorbidities and central centrifugal cicatricial alopecia: a retrospective cohort study of 153 patients".
Topics: Alopecia; Dermatitis; Humans; Retrospective Studies; Scalp | 2023 |
Central centrifugal cicatricial alopecia: Beyond the hot comb.
Topics: Alopecia; Cicatrix; Dermatitis; Humans; Scalp | 2023 |
Hairline Correction by Hair Transplantation for Reducing Apparent Face Length in Long-Face Women.
Topics: Alopecia; Female; Hair; Hair Follicle; Humans; Scalp; Skin Transplantation | 2023 |
Hypotrichosis and Hair Loss on the Occipital Scalp.
Topics: Alopecia; Hair; Humans; Hypotrichosis; Pedigree; Scalp | 2023 |
Establishment and characterization of matched immortalized human frontal and occipital scalp dermal papilla cell lines from androgenetic alopecia.
Topics: Alopecia; Androgens; Cell Line; Hair Follicle; Humans; Male; Scalp | 2023 |
Frontal Fibrosing Alopecia Involving the Limbs Shows Inflammatory Pattern on Histology: A Review of 13 Cases.
Topics: Alopecia; Extremities; Folliculitis; Humans; Male; Scalp | 2020 |
Creating slits to the right depth: Innovative use of micropore tape for depth control on an 18-gauge needle in hair restoration surgery.
Topics: Alopecia; Cosmetic Techniques; Hair Follicle; Humans; Needles; Scalp; Transplantation, Autologous | 2021 |
Pressure alopecia in pediatric and adult patients: Clinical and trichoscopic findings in 12 cases.
Topics: Adolescent; Adult; Aged; Alopecia; Child; Child, Preschool; Dermoscopy; Female; Hair; Humans; Infant | 2019 |
A Case of Secondary Osteoma Cutis Associated with Lichen Planopilaris.
Topics: Alopecia; Bone Diseases, Metabolic; Clobetasol; Female; Glucocorticoids; Humans; Hydroxychloroquine; | 2019 |
Histologic and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease.
Topics: Adult; Aged; Alopecia; Biopsy; Chronic Disease; Cross-Sectional Studies; Female; Graft vs Host Disea | 2019 |
Experience of Replantation and Reconstruction in Total Scalp, Partial Forehead, and Ear Avulsions.
Topics: Adolescent; Adult; Alopecia; Anastomosis, Surgical; Debridement; Ear; Female; Forehead; Hair; Humans | 2019 |
In silico analysis of gene expression data from bald frontal and haired occipital scalp to identify candidate genes in male androgenetic alopecia.
Topics: Adult; Aged; Alopecia; Biopsy; Computational Biology; Datasets as Topic; Down-Regulation; Gene Expre | 2019 |
Comment on: "Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines".
Topics: Alopecia; Anthracyclines; Breast Neoplasms; Humans; Prospective Studies; Scalp | 2019 |
Reply to Comments on: "Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines."
Topics: Alopecia; Anthracyclines; Breast Neoplasms; Humans; Prospective Studies; Scalp | 2019 |
Pattern hair loss: Assessment of inflammation and fibrosis on histologic sections.
Topics: Adult; Aged; Alopecia; Female; Fibrosis; Humans; Inflammation; Male; Middle Aged; Scalp | 2020 |
Dermoscopy and confocal microscopy for different chemotherapy-induced alopecia (CIA) phases characterization: Preliminary study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Dermoscopy; Female; Humans; Image Interpretation, Comp | 2020 |
Frontal fibrosing alopecia: histopathological, immunohistochemical and hormonal study of clinically unaffected scalp areas.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Female; Humans; Immunohistochemistry; Middle Aged; Scalp | 2020 |
Chemotherapy-induced alopecia-A potentially preventable side effect with scalp cooling.
Topics: Alopecia; Antineoplastic Agents; Hair Diseases; Humans; Neoplasms; Scalp | 2020 |
Frontal fibrosing alopecia in Asians: a retrospective clinical study.
Topics: 5-alpha Reductase Inhibitors; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alopecia; Asi | 2020 |
Progenitor-cell-enriched micrografts as a novel option for the management of androgenetic alopecia.
Topics: Alopecia; Female; Hair Follicle; Humans; Male; Regeneration; Scalp; Stem Cell Transplantation; Time | 2020 |
Clinical-histopathological profile of the frontal fibrosing alopecia: a retrospective study of 16 cases of a university hospital.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Biopsy; Dermoscopy; Female; Fibrosis; Hair Follicle; Hospi | 2019 |
The flambeau sign - A new dermoscopy finding in a case of marginal traction alopecia.
Topics: Adult; Alopecia; Female; Hair; Humans; Scalp; Traction | 2020 |
Case of intractable scalp pustulosis with alopecia diagnosed with amicrobial pustulosis of the folds.
Topics: Administration, Oral; Alopecia; Antibodies, Antinuclear; Back; Biopsy; Female; Humans; Middle Aged; | 2020 |
The peptide AC 2 isolated from Bacillus-treated Trapa japonica fruit extract rescues DHT (dihydrotestosterone)-treated human dermal papilla cells and mediates mTORC1 signaling for autophagy and apoptosis suppression.
Topics: Alopecia; Apoptosis; Autophagy; Bacillus; Cells, Cultured; Cytoprotection; Dermis; Dihydrotestostero | 2019 |
Dilation of Multiple Eccrine Ducts as a Highly Specific Marker for Cicatricial Alopecia.
Topics: Alopecia; Biopsy; Cicatrix; Databases, Factual; Diagnosis, Differential; Dilatation, Pathologic; Ecc | 2019 |
Observations of tissue reactions following neuroradiology interventional procedures.
Topics: Adult; Aged; Alopecia; Female; Humans; Male; Middle Aged; Neurology; Radiation Dosage; Radiology, In | 2020 |
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hypother | 2020 |
Global expression profile and global genome methylation signatures in male patients with androgenetic alopecia.
Topics: Adolescent; Adult; Alopecia; Biopsy; Case-Control Studies; DNA Methylation; Humans; Male; Middle Age | 2020 |
Profiling the human hair follicle immune system in lichen planopilaris and frontal fibrosing alopecia: can macrophage polarization differentiate these two conditions microscopically?
Topics: Alopecia; Hair Follicle; Humans; Lichen Planus; Macrophages; Scalp | 2020 |
Significant relationship between temporal hair loss and other scalp areas in female pattern hair loss.
Topics: Adolescent; Adult; Alopecia; Dermoscopy; Female; Hair; Humans; Middle Aged; Photography; Republic of | 2020 |
Androgenetic alopecia is associated with increased scalp hardness.
Topics: Alopecia; Case-Control Studies; Dermis; Epidermis; Female; Hardness; Humans; Male; Scalp | 2020 |
Erosive pustular dermatosis of the scalp: a multicentre study.
Topics: Alopecia; Female; Humans; Male; Middle Aged; Retrospective Studies; Scalp; Scalp Dermatoses; Tacroli | 2020 |
The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Hair; Humans; Scalp | 2020 |
Cell Enriched Autologous Fat Grafts to Follicular Niche Improves Hair Regrowth in Early Androgenetic Alopecia.
Topics: Alopecia; Double-Blind Method; Hair; Humans; Male; Scalp; Transplantation, Autologous | 2020 |
Study validity depends on the study design and bias. Comment on "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia" by Bajpai et al. (The Breast. 2019 December 12. Doi: 10.1016/j.breast.2019.12.004 [Epub ahea
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Humans; Scalp; Taxoids | 2020 |
Synthetic hair reactions and treatment of complications: Case reports.
Topics: Alopecia; Folliculitis; Hair; Humans; Scalp; Scalp Dermatoses | 2020 |
Use of Giemsa staining in the evaluation of central centrifugal cicatricial alopecia.
Topics: Alopecia; Azure Stains; Cicatrix; Hair Follicle; Humans; Scalp; Staining and Labeling | 2020 |
Autologous Micrografts from Scalp Tissue: Trichoscopic and Long-Term Clinical Evaluation in Male and Female Androgenetic Alopecia.
Topics: Adult; Alopecia; Female; Hair; Hair Follicle; Humans; Male; Scalp; Skin Transplantation; Transplants | 2020 |
Correspondence in response to the letter "Study validity depends on the study design and bias. Comment on "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Humans; Scalp; Taxoids | 2020 |
Evaluation of Hair Density and Hair Diameter in the Adult Thai Population Using Quantitative Trichoscopic Analysis.
Topics: Adult; Age Factors; Aged; Alopecia; Asian People; Female; Hair; Humans; Male; Middle Aged; Scalp; Th | 2020 |
Development of the Scalp Hair Assessment PRO™ measure for alopecia areata.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Hair; Humans; North America; Patient Reported Outcome | 2020 |
Response to 'Folliculitis decalvans-like pustular plaques on the limbs sparing the scalp'.
Topics: Alopecia; Folliculitis; Humans; Scalp | 2020 |
Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing.
Topics: Alopecia; Alopecia Areata; Humans; Janus Kinase 3; Lichen Planus; Quality of Life; Scalp | 2020 |
Optical Coherence Tomography in the Evaluation of the Scalp and Hair: Common Features and Clinical Utility.
Topics: Adult; Aged; Alopecia; Hair; Humans; Middle Aged; Pilot Projects; Reproducibility of Results; Scalp; | 2021 |
Dexpanthenol may be a novel treatment for male androgenetic alopecia: Analysis of nine cases.
Topics: Administration, Cutaneous; Alopecia; Hair; Humans; Male; Pantothenic Acid; Scalp | 2020 |
Eosinophilic folliculitis of the scalp associated with PD-1/PDL1 inhibitors.
Topics: Alopecia; Folliculitis; Humans; Immune Checkpoint Inhibitors; Lichen Planus; Programmed Cell Death 1 | 2020 |
Integral characterization of normal and alopecic hair at different degeneration stages by in-situ visible and chemical imaging.
Topics: Adult; Alopecia; Hair; Humans; Lipids; Lipoproteins; Male; Microscopy, Electron, Scanning; Phosphate | 2020 |
Report of two cases of mucous membrane pemphigoid with frontal fibrosing alopecia: a variant of lichen planus pemphigoides or an incidental finding?
Topics: Aged; Alopecia; Female; Gingivitis; Humans; Lichen Planus; Mouth Diseases; Mouth Mucosa; Pemphigoid, | 2020 |
Comment on 'Androgenetic alopecia is associated with increased scalp hardness': role of phosphodiesterase inhibitors?
Topics: Alopecia; Hardness; Humans; Phosphodiesterase Inhibitors; Scalp | 2020 |
A case of delayed-onset scarring alopecia in a 75-year-old woman.
Topics: Aged; Alopecia; Anastrozole; Aromatase Inhibitors; Biopsy; Bone Density Conservation Agents; Breast | 2020 |
Cicatricial pattern hair loss is not a variant of lichen planopilaris.
Topics: Alopecia; Humans; Lichen Planus; Scalp | 2020 |
MR Imaging of Hair and Scalp for the Evaluation of Androgenetic Alopecia.
Topics: Adult; Alopecia; Hair; Hair Follicle; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Scalp | 2021 |
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hum | 2021 |
Mixed-pattern syphilitic alopecia of the scalp associated with uveitis and asymptomatic neurosyphilis.
Topics: Alopecia; Humans; Neurosyphilis; Scalp; Syphilis, Cutaneous; Uveitis | 2020 |
Thermal Injury in a Patient Using a Scalp Cooling System to Prevent Chemotherapy-Induced Alopecia.
Topics: Alopecia; Antineoplastic Agents; Burns; Humans; Hypothermia, Induced; Scalp | 2020 |
Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab.
Topics: Alopecia; Antibodies, Monoclonal, Humanized; Cicatrix; Fibrosis; Humans; Lichen Planus; Scalp | 2020 |
Enhanced Follicular Delivery of Finasteride to Human Scalp Skin Using Heat and Chemical Penetration Enhancers.
Topics: Administration, Topical; Alopecia; Cadaver; Drug Compounding; Finasteride; Hair Follicle; Hot Temper | 2020 |
Favorable effects of microneedling on long-standing androgenetic alopecia in an elderly man: A case report.
Topics: Aged; Alopecia; Erythema; Hair; Humans; Male; Minoxidil; Scalp; Treatment Outcome | 2021 |
The study of hair follicle counts from scalp histopathology in the Thai population.
Topics: Alopecia; Hair; Hair Follicle; Humans; Iran; Scalp; Thailand | 2020 |
Adalimumab-induced scalp psoriasis with severe alopecia as a paradoxical effect in a patient with Crohn's disease successfully treated with ustekinumab.
Topics: Adalimumab; Alopecia; Crohn Disease; Humans; Psoriasis; Scalp; Ustekinumab | 2020 |
A new treatment of alopecia induced by palbociclib: Topical cetirizine.
Topics: Administration, Topical; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cetirizine; Cyclin | 2021 |
A new self-reported measure of disease severity of scalp hair loss in alopecia areata.
Topics: Alopecia; Alopecia Areata; Hair; Humans; Scalp; Self Report; Severity of Illness Index | 2020 |
Do not forget to check the scalp in systemic light-chain amyloidosis.
Topics: Alopecia; Amyloidosis; Biopsy; Dermoscopy; Hair Follicle; Humans; Scalp | 2021 |
Quantitative analysis of the anatomical changes in the scalp and hair follicles in androgenetic alopecia using magnetic resonance imaging.
Topics: Alopecia; Hair; Hair Follicle; Humans; Magnetic Resonance Imaging; Scalp | 2021 |
Dermatoscopic Evaluation of Central Centrifugal Cicatricial Alopecia Beyond the Vertex Scalp.
Topics: Adult; Alopecia; Cross-Sectional Studies; Dermoscopy; Female; Humans; Middle Aged; Scalp; Scalp Derm | 2020 |
Geographic disparities in access to scalp cooling for the prevention of chemotherapy-induced alopecia in the United States.
Topics: Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2021 |
Dosimetric study of whole-brain irradiation with high-energy photon beams for dose reduction to the scalp.
Topics: Alopecia; Brain Neoplasms; Humans; Photons; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, | 2020 |
Probable association between increased systemic recurrence and the use of scalp cooling in breast cancer patients receiving (neo)adjuvant chemotherapy.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; | 2021 |
Inhibition of Shh Signaling through MAPK Activation Controls Chemotherapy-Induced Alopecia.
Topics: Alopecia; Animals; Antineoplastic Agents; Cells, Cultured; Disease Models, Animal; Down-Regulation; | 2021 |
A female patient with a receding hairline.
Topics: Alopecia; Female; Humans; Scalp | 2021 |
Caffeine relaxes hair follicles in androgenetic alopecia.
Topics: Adrenocorticotropic Hormone; Alopecia; Androgens; Caffeine; Corticotropin-Releasing Hormone; Hair Fo | 2021 |
Features of classic lichen planopilaris and frontal fibrosing alopecia in reflectance confocal microscopy: A preliminary study.
Topics: Alopecia; Hair Follicle; Humans; Lichen Planus; Microscopy, Confocal; Scalp | 2021 |
Central Centrifugal Cicatricial Alopecia.
Topics: Administration, Oral; Adult; Alopecia; Black or African American; Cicatrix; Female; Glucocorticoids; | 2020 |
Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer.
Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia; Central Nervous System Neoplasms; Child; | 2020 |
Prevention of impending scalp necrosis by topical nitroglycerine in hair transplant surgery.
Topics: Alopecia; Hair; Humans; Necrosis; Scalp; Skin | 2021 |
A Timosaponin B-II containing scalp care solution for improvement of scalp hydration, dandruff reduction, and hair loss prevention: A comparative study on healthy volunteers before and after application.
Topics: Alopecia; Dandruff; Healthy Volunteers; Humans; Saponins; Scalp; Steroids | 2021 |
Characterization and classification of different female hairline patterns in the Thai population.
Topics: Adult; Alopecia; Face; Female; Hair; Humans; Middle Aged; Scalp; Thailand; Young Adult | 2021 |
Characteristics of healthy and androgenetic alopecia scalp microbiome: Effect of Lindera strychnifolia roots extract as a natural solution for its modulation.
Topics: Alopecia; Bacteria; Fungi; Humans; Lindera; Male; Microbiota; Middle Aged; Plant Extracts; Plant Roo | 2020 |
Outbreak of Trichophyton soudanense causing tinea capitis in an orphanage in Myanmar.
Topics: Alopecia; Animals; Arthrodermataceae; Child; Child, Orphaned; Disease Outbreaks; Dog Diseases; Dogs; | 2020 |
Exome sequencing reveals novel candidate gene variants associated with clinical characteristics in alopecia areata patients.
Topics: Acyltransferases; Adolescent; Age of Onset; Alopecia; Alopecia Areata; Child; Chloride Channels; Exo | 2020 |
Considerations for the Use of Scalp Cooling Devices in Black Patients.
Topics: Alopecia; Black or African American; Breast Neoplasms; Female; Hair Follicle; Humans; Hypothermia, I | 2020 |
Evaluating Areas of Preferred Hair Loss: Potential Implications for Rating Alopecia Severity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Female; Humans; Male; Middle Aged; Patient Pre | 2020 |
Erosive pustular dermatosis of the scalp.
Topics: Alopecia; Anti-Inflammatory Agents; Female; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Mo | 2020 |
Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
Topics: Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Prot | 2021 |
Crusted, ulcerated plaques on the scalp and face.
Topics: Adrenal Cortex Hormones; Aged; Alopecia; Biopsy; Defibrillators; Face; Humans; Lost to Follow-Up; Ma | 2021 |
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced | 2021 |
Combining Deep Learning With Optical Coherence Tomography Imaging to Determine Scalp Hair and Follicle Counts.
Topics: Alopecia; Deep Learning; Hair; Hair Follicle; Humans; Scalp; Tomography, Optical Coherence | 2021 |
[Design and clinical application of specialized protective cap for patients with alopecia after autologous hair transplantation].
Topics: Adult; Alopecia; Female; Humans; Male; Middle Aged; Prospective Studies; Scalp; Skin Transplantation | 2020 |
Scalp sarcoidosis with alopecia areata showing Renbök phenomenon.
Topics: Alopecia; Alopecia Areata; Humans; Psoriasis; Sarcoidosis; Scalp | 2020 |
Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alopecia; Dose-Response Relationship, Drug; Du | 2021 |
Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A Case Series.
Topics: Aged; Alopecia; Alopecia Areata; Biological Factors; Female; Hair; Humans; Male; Middle Aged; Platel | 2020 |
Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2021 |
Square alopecia on the vertex scalp.
Topics: Alopecia; Hair; Humans; Scalp | 2021 |
Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients.
Topics: Alopecia; Clobetasol; Female; Humans; Lichen Planus; Male; Retrospective Studies; Scalp | 2021 |
High-frequency ultrasonography of the scalp - Comparison of ultrasound and trichoscopic images in healthy individuals.
Topics: Adult; Alopecia; Dermoscopy; Female; Hair; Humans; Male; Scalp; Ultrasonography | 2021 |
Accuracy of clinical diagnosis and videodermoscopy in female pattern hair loss.
Topics: Alopecia; Female; Hair; Hair Diseases; Humans; Scalp; Scalp Dermatoses | 2021 |
Frontal fibrosing alopecia sparing a vascular naevus: the Renbök phenomenon.
Topics: Aged; Alopecia; Female; Fibrosis; Head and Neck Neoplasms; Humans; Nevus; Scalp; Skin Neoplasms | 2021 |
Combination Hair Restoration Techniques in the Treatment of Severe Cutis Verticis Gyrata.
Topics: Adult; Alopecia; Cicatrix; Esthetics; Hair Follicle; Humans; Male; Postoperative Complications; Scal | 2021 |
Co-localization of alopecia areata and lichen planopilaris in a patient receiving immunosuppressants: A rare case.
Topics: Adult; Alopecia; Alopecia Areata; Female; Hair Follicle; Humans; Immunosuppressive Agents; Lichen Pl | 2021 |
Enlarging Alopecic Plaque on the Scalp: A Quiz.
Topics: Alopecia; Humans; Scalp; Scalp Dermatoses; Skin Abnormalities | 2021 |
[A premature baby with hair loss].
Topics: Alopecia; Birth Injuries; Craniocerebral Trauma; Humans; Infant, Newborn; Infant, Premature; Male; S | 2020 |
Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemothe | 2021 |
Occipital alopecia in a young man.
Topics: Adipose Tissue; Adult; Alopecia; Humans; Lymphocytes; Male; Scalp; Subcutaneous Tissue; White People | 2020 |
Frontal fibrosing alopecia with involvement of the central hair part: distribution of hair loss corresponding to areas of sunscreen application.
Topics: Adult; Alopecia; Female; Humans; Scalp; Sunscreening Agents | 2020 |
A response to "Male balding is a major risk factor for severe COVID-19".
Topics: Alopecia; COVID-19; Humans; Male; Risk Factors; SARS-CoV-2; Scalp | 2021 |
Autologous whole fat injection stimulates hair growth in resistant Androgenetic Alopecia: Report of nine cases.
Topics: Alopecia; Female; Hair; Hair Follicle; Humans; Male; Scalp; Transplantation, Autologous | 2021 |
Drug-induced psoriasiform alopecia associated with interleukin-17 inhibitor therapy.
Topics: Alopecia; Antibodies, Monoclonal, Humanized; Biopsy; Diagnosis, Differential; Drug-Related Side Effe | 2021 |
Evaluation of standardized scalp photography on patient perception of hair loss severity, anxiety, and treatment.
Topics: Alopecia; Anxiety; Humans; Perception; Photography; Scalp | 2021 |
Frontal Fibrosing Alopecia: Successfully Treated with Methotrexate or Just the Natural Disease Progression?
Topics: Alopecia; Dermatologic Agents; Disease Progression; Female; Fibrosis; Humans; Methotrexate; Middle A | 2020 |
Colour Doppler ultrasound study in patients with frontal fibrosing alopecia.
Topics: Alopecia; Cross-Sectional Studies; Female; Fibrosis; Humans; Lichen Planus; Scalp; Ultrasonography, | 2021 |
Scalp neuropathy in androgenetic alopecia.
Topics: Alopecia; Humans; Peripheral Nervous System Diseases; Scalp | 2022 |
Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium.
Topics: Alopecia; Alopecia Areata; Female; Hair; Humans; Italy; Male; Middle Aged; Scalp | 2021 |
Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Black or African Am | 2021 |
SARS-CoV-2 & androgenic alopecia: exploring links!
Topics: Alopecia; COVID-19; Humans; SARS-CoV-2; Scalp | 2021 |
The role of prostaglandins in androgenetic alopecia.
Topics: Adult; Alopecia; Female; Hair; Hair Follicle; Humans; Male; Prostaglandins; Scalp | 2021 |
Aplasia cutis congenita with dermal melanocytosis.
Topics: Alopecia; Child; Ectodermal Dysplasia; Female; Genetic Diseases, X-Linked; Humans; Scalp | 2021 |
[A new treatment for androgenetic alopecia : platelet-rich plasma injections].
Topics: Alopecia; Female; Humans; Male; Minoxidil; Platelet-Rich Plasma; Scalp; Treatment Outcome | 2021 |
Temporal triangular alopecia confined to the frontal scalp.
Topics: Alopecia; Ectodermal Dysplasia; Hair; Humans; Scalp; Skin | 2021 |
Effective strategies to reduce pain during platelet-rich plasma scalp injections: A randomized split-scalp study.
Topics: Alopecia; Hair; Humans; Pain; Pain Management; Platelet-Rich Plasma; Scalp; Treatment Outcome | 2022 |
Transcriptome Profiling of Pilosebaceous Units in Male Androgenetic Alopecia Reveals Altered Junctional Networks.
Topics: Adherens Junctions; Alopecia; Biopsy; Desmosomes; Gene Expression Profiling; Hair; Humans; Male; Sca | 2021 |
Corrective strategies for poor appearance after tissue expansion for temporal and sideburn cicatricial alopecia.
Topics: Alopecia; Cicatrix; Hair; Hair Follicle; Humans; Scalp; Skin Transplantation; Tissue Expansion | 2021 |
Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; | 2021 |
Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo
Topics: Adult; Aged; Alopecia; Female; Hair; Humans; Injections, Intradermal; Male; Middle Aged; Prospective | 2021 |
Erosive Pustular Dermatosis of the Scalp: Clinicopathological Correlation Leading to a Definition of Diagnostic Criteria.
Topics: Aged; Aged, 80 and over; Alopecia; Humans; Scalp; Scalp Dermatoses | 2021 |
Multiple alopecic patches in the hairy scalp area of a 28-year-old female patient.
Topics: Adult; Alopecia; Female; Hair; Humans; Scalp | 2021 |
Case Report: Scarring Alopecia After Scalp Avulsion.
Topics: Alopecia; Amputation, Traumatic; Cicatrix; Humans; Risk Factors; Scalp | 2023 |
Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth Activity.
Topics: Alopecia; Biomarkers; Humans; Low-Level Light Therapy; Male; MicroRNAs; Minoxidil; Scalp; Treatment | 2021 |
Hair Transplantation in Burn Scar Alopecia After Combined Non-Ablative Fractional Laser and Microfat Graft Treatment.
Topics: Alopecia; Cicatrix; Hair; Hair Follicle; Humans; Lasers; Scalp; Skin Transplantation | 2021 |
A well-defined, firm, yellowish-orange alopecic plaque with multiple whitish papules on the scalp.
Topics: Aged, 80 and over; Alopecia; Female; Head and Neck Neoplasms; Humans; Neoplasms, Adnexal and Skin Ap | 2021 |
Scalp Biophysical Characteristics in Males with Androgenetic Alopecia: A Comparative Study with Healthy Controls.
Topics: Adult; Alopecia; Case-Control Studies; Epidermis; Hair; Humans; Lipids; Male; Middle Aged; Scalp; Se | 2021 |
Following historical "tracks" of hair follicle miniaturisation in patterned hair loss: Are elastin bodies the forgotten aetiology?
Topics: Alopecia; Elastin; Female; Hair; Hair Follicle; Humans; Male; Miniaturization; Scalp | 2022 |
Confronting frontal fibrosing alopecia.
Topics: Alopecia; Fibrosis; Humans; Scalp | 2021 |
Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement.
Topics: Alopecia; Alopecia Areata; Biomarkers; Cross-Sectional Studies; Female; Fibrosis; Humans; Lichen Pla | 2022 |
Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG).
Topics: Alopecia; Cicatrix; Clinical Trials as Topic; Consensus; Guidelines as Topic; Humans; Lichen Planus; | 2021 |
Genotype-Phenotype Correlation in Trichilemmal Cysts.
Topics: Adult; Alleles; Alopecia; Epidermal Cyst; Female; Genetic Association Studies; Genetic Variation; Hu | 2021 |
Clinicopathological insight into self-reported hair loss with no findings: How do we manage this enigmatic condition?
Topics: Alopecia; Female; Hair; Humans; Middle Aged; Retrospective Studies; Scalp; Self Report | 2021 |
Alterations of collagen type 1, skin fibroblasts, and macrophages in the scalp following the treatment of 1550-nm erbium glass fractional laser for androgenetic alopecia.
Topics: Alopecia; Collagen Type I; Erbium; Fibroblasts; Humans; Laser Therapy; Lasers, Solid-State; Macropha | 2022 |
[25-year-old man with alopecia].
Topics: Adult; Alopecia; Humans; Male; Scalp | 2021 |
Commentary on: The Effects of Lower vs Higher Cell Number of Platelet-Rich Plasma (PRP) in Hair Density and Diameter in Androgenetic Alopecia (AGA): A Randomized, Double-Blinded, Placebo, Parallel-Group Half-Scalp IRB Study.
Topics: Alopecia; Cell Count; Ethics Committees, Research; Humans; Platelet-Rich Plasma; Scalp | 2021 |
Scalp demodicosis developing in a patient with frontal fibrosing alopecia: a clinical and trichoscopic mimicker of active disease.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Scalp | 2022 |
A novel automated approach to rapid and precise in vivo measurement of hair morphometrics using a smartphone.
Topics: Alopecia; Hair; Hair Diseases; Humans; Scalp; Smartphone | 2021 |
Autologous Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: Results of a 54-Patient Prospective Study.
Topics: Alopecia; Female; Hair; Humans; Male; Platelet-Rich Plasma; Prospective Studies; Scalp; Treatment Ou | 2021 |
Fluorescence advanced videodermoscopy: a new method of hairs and scalp evaluation. Comparison with trichoscopy.
Topics: Alopecia; Dermoscopy; Diagnosis, Differential; Hair; Humans; Scalp | 2021 |
Acute onset traction-associated ulceration and alopecia.
Topics: Alopecia; Child; Female; Hair; Hair Follicle; Humans; Scalp; Traction | 2021 |
Flushing episodes in the context of frontal fibrosing alopecia with facial papules.
Topics: Alopecia; Female; Forehead; Humans; Lichen Planus; Retrospective Studies; Scalp | 2021 |
Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study.
Topics: Alopecia; Alopecia Areata; Female; Humans; Lichen Planus; Middle Aged; Retrospective Studies; Scalp; | 2021 |
Alopecia in hereditary mucoepithelial dysplasia.
Topics: Adolescent; Alopecia; Biopsy; Humans; Keratosis; Male; Mucous Membrane; Scalp; Skin Abnormalities | 2022 |
Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia
.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Breast Neoplasms; Education, Nursin | 2017 |
Frontal fibrosing alopecia in a 46-year-old man.
Topics: Alopecia; Fibrosis; Humans; Male; Middle Aged; Scalp; Scalp Dermatoses | 2016 |
Reversible Alopecia with Localized Scalp Necrosis After Accidental Embolization of the Parietal Artery with Hyaluronic Acid.
Topics: Adult; Alopecia; Arterial Occlusive Diseases; Arteries; Biopsy, Needle; Cosmetic Techniques; Dermal | 2017 |
Breast and pleuropulmonary metastasis of multirecurrent scalp dermatofibrosarcoma protuberans: a case report.
Topics: Adult; Alopecia; Antigens, CD34; Antineoplastic Agents; Biopsy; Breast Neoplasms; Cough; Dermatofibr | 2017 |
Alopecia neoplastica.
Topics: Agraphia; Alopecia; Brain Neoplasms; Fatal Outcome; Female; Head and Neck Neoplasms; Humans; Languag | 2017 |
A Retrospective Review of Treatment Results for Patients With Central Centrifugal Cicatrical Alopecia.
Topics: Administration, Topical; Adult; Alopecia; Biopsy; Black or African American; Black People; Cicatrix; | 2017 |
Dissecting Cellulitis of the Scalp with Excellent Response to Isotretinoin.
Topics: Adolescent; Alopecia; Cellulitis; Humans; Isotretinoin; Male; Scalp; Scalp Dermatoses; Skin Diseases | 2017 |
Adipocyte-myofibroblast transition as a possible pathophysiological step in androgenetic alopecia.
Topics: Adipocytes; Alopecia; Androgens; Animals; Female; Fibrosis; Hair Follicle; Humans; Male; Mice; Model | 2017 |
A case of multifocal scarring alopecia.
Topics: Alopecia; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cicatrix; Fatal Outcome; Fema | 2017 |
An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
Topics: Administration, Topical; Adolescent; Adult; Alopecia; Gene Expression Profiling; Gene Expression Reg | 2017 |
Baldness and scalp melanoma.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; M | 2017 |
Elastic Fibers in Scars and Alopecia.
Topics: Alopecia; Biopsy, Needle; Cicatrix; Elastic Tissue; Humans; Immunohistochemistry; Scalp; Sensitivity | 2017 |
Tumor necrosis factor-induced alopecia: alternative pathology and therapy.
Topics: Alopecia; Crohn Disease; Dermatologic Agents; Female; Humans; Infliximab; Scalp; Tumor Necrosis Fact | 2017 |
[A baby with progressive skin lesions on the scalp].
Topics: Alopecia; Antifungal Agents; Exanthema; Female; Humans; Infant; Scalp; Tinea Capitis | 2017 |
RF-Scalp cooling.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cryotherapy; | 2017 |
Alopecia developed in a transitional case from pemphigus foliaceus to pemphigus vulgaris.
Topics: Alopecia; Desmogleins; Female; Humans; Middle Aged; Pemphigus; Scalp; Skin | 2017 |
Frontal fibrosing alopecia among men: A clinicopathologic study of 7 cases.
Topics: Adult; Aged; Alopecia; Anti-Inflammatory Agents; Cheek; Cicatrix; Clobetasol; Dermatologic Agents; E | 2017 |
Thermal imaging and dermoscopy for detecting inflammation in frontal fibrosing alopecia.
Topics: Aged; Aged, 80 and over; Alopecia; Biopsy; Dermoscopy; Female; Fibrosis; Humans; Inflammation; Middl | 2018 |
Hair transplantation for the treatment of lichen planopilaris and frontal fibrosing alopecia: A report of two cases.
Topics: Adult; Alopecia; Female; Fibrosis; Forehead; Hair; Humans; Lichen Planus; Middle Aged; Scalp | 2018 |
Hair loss associated with imatinib treatment: a dermoscopic study.
Topics: Alopecia; Antineoplastic Agents; Dermoscopy; Female; Humans; Imatinib Mesylate; Middle Aged; Scalp | 2017 |
Scalp Cooling: The Prevention of Chemotherapy-Induced Alopecia
.
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Neoplasms; Scalp | 2017 |
Double whammy: a tale of two malignancies.
Topics: Alopecia; Carcinoma, Basal Cell; Cerebellar Neoplasms; Female; Humans; Medulloblastoma; Middle Aged; | 2017 |
Progressive hair loss.
Topics: Administration, Topical; Aged; Alopecia; Female; Glucocorticoids; Humans; Injections, Intralesional; | 2017 |
Elastic Staining in Differentiating Between Follicular Streamers and Follicular Scars in Horizontal Scalp Biopsy Sections.
Topics: Alopecia; Biopsy; Cicatrix; Elastic Tissue; Hair Follicle; Humans; Scalp; Staining and Labeling | 2018 |
Mycosis fungoides with CD30-positive large-cell transformation clinically mimicking scarring alopecia.
Topics: Alopecia; Biopsy; Cell Transformation, Neoplastic; Diagnosis, Differential; Humans; Ki-1 Antigen; Mi | 2017 |
Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals' attitudes to and experience with scalp cooling.
Topics: Adult; Alopecia; Attitude of Health Personnel; Australia; Female; Humans; Male; Middle Aged; Qualita | 2018 |
Optical coherence tomography for the investigation of frontal fibrosing alopecia.
Topics: Adult; Aged; Alopecia; Arm; Cicatrix; Epidermis; Eyebrows; Female; Fibrosis; Forehead; Humans; Middl | 2018 |
Hereditary hypotrichosis simplex of the scalp.
Topics: Alopecia; Child; Diagnosis, Differential; Female; Humans; Hypotrichosis; Pedigree; Scalp | 2017 |
Systemic photodynamic therapy in folliculitis decalvans.
Topics: Adult; Alopecia; Anti-Bacterial Agents; Dihematoporphyrin Ether; Folliculitis; Humans; Male; Photoch | 2018 |
The doll hairline: A clue for the diagnosis of frontal fibrosing alopecia.
Topics: Alopecia; Fibrosis; Humans; Scalp | 2017 |
[Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
Topics: Adalimumab; Alopecia; Crohn Disease; Diagnosis, Differential; Female; Folliculitis; Humans; Injectio | 2017 |
Alopecic and aseptic nodule of the scalp in a girl.
Topics: Administration, Topical; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Humans; I | 2017 |
Dramatic effect of hydroxychloroquine on lupus alopecia.
Topics: Administration, Oral; Adult; Alopecia; Antirheumatic Agents; Biopsy; Dermatitis, Atopic; Female; Hum | 2018 |
Scalp melanoma after antihair loss mesotherapy.
Topics: Alopecia; Female; Humans; Melanoma; Mesotherapy; Middle Aged; Scalp; Skin Neoplasms | 2018 |
Real-world use of scalp cooling to reduce chemotherapy-related hair loss.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2017 |
Is there a pathogenetic link between frontal fibrosing alopecia, androgenetic alopecia and fibrosing alopecia in a pattern distribution?
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Cicatrix; Dermoscopy; Female; Fibrosis; Humans; Menopause; | 2018 |
Centrifugal lipodystrophy of the scalp manifesting as centrifugal lipodystrophic alopecia.
Topics: Alopecia; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Humans; Lipodystrophy; Mag | 2018 |
Knockout of p16INK4a promotes aggregative growth of dermal papilla cells.
Topics: Alopecia; Cell Aggregation; Cell Cycle; Cell Proliferation; Cells, Cultured; Cellular Senescence; De | 2017 |
Establishment and characterization of five immortalized human scalp dermal papilla cell lines.
Topics: A549 Cells; Alopecia; Animals; Biglycan; Biomarkers; Bone Morphogenetic Protein 4; Carcinogenesis; C | 2018 |
Primary scarring alopecia: A retrospective study of 89 patients in Taiwan.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alopecia; Cicatrix; Female; Hair Follicle; | 2018 |
Cicatricial Alopecia Research Foundation meeting, May 2016: Progress towards the diagnosis, treatment and cure of primary cicatricial alopecias.
Topics: Alopecia; Animals; Cicatrix; Disease Models, Animal; Dogs; Fibrosis; Humans; Lichen Planus; Mice; Sc | 2018 |
Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient.
Topics: Adenocarcinoma; Aged, 80 and over; Alopecia; Anilides; Antineoplastic Combined Chemotherapy Protocol | 2018 |
SnapshotDx Quiz: February 2018.
Topics: Adult; Alopecia; Chemokine CXCL10; Chemokine CXCL9; Female; Humans; Lupus Erythematosus, Discoid; Sc | 2018 |
Facial Papules in Frontal Fibrosing Alopecia: Good Response to Isotretinoin.
Topics: Adult; Alopecia; Dermatologic Agents; Facial Dermatoses; Female; Fibrosis; Humans; Isotretinoin; Mid | 2018 |
A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors.
Topics: Alopecia; Androgens; Biomarkers; Dihydrotestosterone; Disease Progression; Estrogens; Female; Fibros | 2018 |
The ethics of medical marijuana in dermatology.
Topics: Alopecia; Dermatology; Drug Prescriptions; Female; Fibrosis; Humans; Medical Marijuana; Middle Aged; | 2018 |
Buschke-Ollendorff syndrome due to a novel LEMD3 mutation - an unusual case of alopecia.
Topics: Alopecia; Biopsy; Diagnosis, Differential; DNA Mutational Analysis; DNA-Binding Proteins; Female; Hu | 2018 |
Adalimumab-related alopecia in a patient affected by psoriasis.
Topics: Adalimumab; Alopecia; Alopecia Areata; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Hu | 2017 |
Donor Site Assessment for Female Hairline Restoration in Southeast Asians.
Topics: Adult; Age Factors; Alopecia; Asian People; Female; Forehead; Hair; Humans; Middle Aged; Scalp; Thai | 2018 |
Scalp as a donor site in children: Is it really the best option?
Topics: Alopecia; Black People; Burns; Child; Child, Preschool; Cicatrix; Cicatrix, Hypertrophic; Cohort Stu | 2018 |
Introducing Platelet-Rich Stroma: Platelet-Rich Plasma (PRP) and Stromal Vascular Fraction (SVF) Combined for the Treatment of Androgenetic Alopecia.
Topics: Adult; Aged; Alopecia; Hair Follicle; Humans; Injections, Intradermal; Male; Mesenchymal Stem Cell T | 2018 |
The timing and distribution of nonscalp hair loss in patients with lichen planopilaris and frontal fibrosing alopecia: A survey-based study.
Topics: Alopecia; Female; Fibrosis; Humans; Lichen Planus; Middle Aged; Scalp; Self Report; Time Factors | 2021 |
Detection of titanium nanoparticles in the hair shafts of a patient with frontal fibrosing alopecia.
Topics: Aged; Alopecia; Female; Fibrosis; Hair; Humans; Microscopy, Electron, Scanning; Nanoparticles; Scalp | 2018 |
Bibbidi bobbidi bald: Two "hairowing" tales of Princess Package hairstyles.
Topics: Alopecia; Child, Preschool; Cicatrix; Female; Glucaric Acid; Hair; Humans; Minoxidil; Scalp; United | 2018 |
Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
Topics: Alopecia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2018 |
Coexistence of chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.
Topics: Alopecia; Biopsy; Dermoscopy; Female; Fibrosis; Humans; Lichenoid Eruptions; Lupus Erythematosus, Di | 2018 |
At the Root: Cutaneous Langerhans Cell Histiocytosis.
Topics: Adult; Alopecia; Diagnosis, Differential; Female; Histiocytosis, Langerhans-Cell; Humans; Scalp; Ski | 2018 |
Frontal fibrosing alopecia: is the melanocyte of the upper hair follicle the antigenic target?
Topics: Aged; Alopecia; Autoimmune Diseases; Female; Fibrosis; Forehead; Hair Follicle; Humans; Male; Melano | 2018 |
A novel insertion mutation of CDSN responsible for hypotrichosis simplex of scalp in a Chinese family.
Topics: Alopecia; China; Genetic Variation; Glycoproteins; Humans; Hypotrichosis; Intercellular Signaling Pe | 2018 |
Visual Diagnosis: A Ring of Long, Dark, Coarse Hair on the Scalp of a 5-month-old Girl.
Topics: Alopecia; Female; Hair; Humans; Infant; Scalp | 2018 |
Trichostasis spinulosa arising in isolated collagenoma of the scalp.
Topics: Alopecia; Child; Female; Hair Diseases; Head and Neck Neoplasms; Humans; Keratosis; Nevus; Pruritus; | 2018 |
The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Scalp | 2018 |
White and yellow dots as new trichoscopic signs of severe female androgenetic alopecia in dark skin phototypes.
Topics: Adolescent; Adult; Age of Onset; Alopecia; Dermoscopy; Female; Hair; Hair Follicle; Humans; Middle A | 2018 |
Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2018 |
Atrophic and Annular Scarring Alopecia of the Scalp as a Finding in Underlying Systemic Sarcoidosis.
Topics: Aged; Alopecia; Atrophy; Cicatrix; Humans; Male; Sarcoidosis; Scalp | 2017 |
Harvested vs estimated follicular units in hair transplantation.
Topics: Adult; Age Factors; Alopecia; Hair Follicle; Humans; Male; Middle Aged; Retrospective Studies; Scalp | 2019 |
Measurements of tension on wound edges after strip harvest surgery.
Topics: Adult; Alopecia; Cicatrix; Hair Follicle; Humans; Male; Scalp; Skin; Skin Transplantation; Suture Te | 2019 |
Utility of Horizontal Sections of Scalp Biopsies in Differentiating between Androgenetic Alopecia and Alopecia Areata.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Biopsy; Cross-Sectional Studies; Female; Hair Follicle | 2018 |
Thermal modelling of controlled scalp hypothermia using a thermoelectric cooling cap.
Topics: Alopecia; Antineoplastic Agents; Body Temperature; Female; Hair Follicle; Humans; Hypothermia, Induc | 2018 |
Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66-patient case series and proposal of classification.
Topics: Abscess; Acne Vulgaris; Adult; Alopecia; Cellulitis; Comorbidity; Female; Granulation Tissue; Humans | 2018 |
A unique case of pressure-induced alopecia following EEG monitoring.
Topics: Alopecia; Child; Electroencephalography; Hair Follicle; Humans; Male; Pressure; Scalp | 2018 |
Reflectance confocal microscopy of tinea capitis: comparing images with results of dermoscopy and mycological exams.
Topics: Alopecia; Child, Preschool; Dermoscopy; Hair; Humans; Male; Microscopy, Confocal; Microsporum; Scalp | 2019 |
Pseudodidymosis: nevus psiloliparus with aplasia cutis congenita, an initial manifestation of Haberland syndrome.
Topics: Adipose Tissue; Alopecia; Child; Ectodermal Dysplasia; Eye Diseases; Genetic Pleiotropy; Humans; Lip | 2018 |
Scalp Cooling: Implementation of a Program at a Multisite Organization.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2018 |
Feature characterization of scarring and non-scarring types of alopecia by multiphoton microscopy.
Topics: Alopecia; Cicatrix; Hair Follicle; Humans; Male; Microscopy, Confocal; Pilot Projects; Prospective S | 2019 |
Tofacitinib for the treatment of lichen planopilaris: A case series.
Topics: Administration, Oral; Adult; Aged; Alopecia; Dermatologic Agents; Drug Administration Schedule; Fema | 2018 |
Study on Hair Distribution in Healthy Males for Hair Restoration Design.
Topics: Adolescent; Adult; Alopecia; Anatomic Landmarks; China; Dermoscopy; Hair; Hair Follicle; Humans; Mal | 2018 |
Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Biopsy; Case-Control Studies; Dermoscopy; Female; Hair | 2020 |
Extracellular proteoglycan decorin maintains human hair follicle stem cells.
Topics: Adult; Adult Stem Cells; Aged; Aged, 80 and over; Aging; Alopecia; Biopsy; Cell Differentiation; Cel | 2018 |
Bold to do - bald to be? Outcomes decades after harvesting the scalp in burned children.
Topics: Adolescent; Adult; Alopecia; Burns; Child; Child, Preschool; Cicatrix, Hypertrophic; Female; Follow- | 2019 |
Lipedematous alopecia of the scalp in a Caucasian man: an atypical presentation.
Topics: Alopecia; Humans; Lipedema; Male; Scalp; Scalp Dermatoses; White People | 2021 |
A liposome-based formulation containing equol, dihomo-γ-linolenic acid and propionyl-l-carnitine to prevent and treat hair loss: A prospective investigation.
Topics: 8,11,14-Eicosatrienoic Acid; Administration, Cutaneous; Adult; Alopecia; Carnitine; Drug Combination | 2019 |
[43/m with alopecia and suberythroderma : Preparation for the specialist examination: part 9].
Topics: Alopecia; Humans; Scalp | 2018 |
"Normal-appearing" scalp areas are also affected in lichen planopilaris and frontal fibrosing alopecia: An observational histopathologic study of 40 patients.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Biopsy; Dermatology; Female; Fibrosis; Humans; Inflammatio | 2020 |
Evidence for neurogenic inflammation in lichen planopilaris and frontal fibrosing alopecia pathogenic mechanism.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Biopsy; Calcitonin Gene-Related Peptide; Chronic Disease; | 2020 |
Lichen Planus Pigmentosus and Frontal Fibrosing Alopecia Mimicking Discoid Lupus Erythematosus.
Topics: Aged; Alopecia; Diagnosis, Differential; Female; Fibrosis; Humans; Lichen Planus; Lupus Erythematosu | 2019 |
Shaved hair style scalp medical tattooing technique for treatment of advanced male pattern baldness patients.
Topics: Adult; Aged; Alopecia; Hair Removal; Humans; Male; Middle Aged; Patient Satisfaction; Scalp; Surveys | 2019 |
Scalp Sarcoidosis Presenting as Cicatricial Alopecia.
Topics: Alopecia; Cicatrix; Female; Humans; Middle Aged; Sarcoidosis; Scalp | 2018 |
Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation
Topics: Alopecia; Case-Control Studies; Dietary Supplements; Female; Follow-Up Studies; Hair Follicle; Human | 2018 |
A method for more precise sampling of the scalp and eyebrows in frontal fibrosing alopecia.
Topics: Alopecia; Biopsy; Dermoscopy; Epidermis; Fibrosis; Hair Follicle; Humans; Lymphocytes; Microtomy; Pa | 2019 |
A semiquantitative grading scale for frontal and vertex of androgenetic alopecia.
Topics: Adolescent; Adult; Alopecia; Dermoscopy; Female; Hair; Humans; Male; Middle Aged; Photography; Repro | 2019 |
Staged reconstructive treatment for extensive irregular cicatricial alopecia after burn.
Topics: Adolescent; Adult; Alopecia; Burns; Child; Cicatrix; Dermatologic Surgical Procedures; Esthetics; Fe | 2018 |
Trichophytic closure for cicatricial alopecia on the scalp.
Topics: Adolescent; Adult; Alopecia; Cicatrix; Craniotomy; Humans; Scalp; Surgical Wound; Wound Closure Tech | 2019 |
New pattern hair loss in young Turkish women; What's wrong in their daily life?
Topics: Adult; Alopecia; Beauty Culture; Cosmetic Techniques; Dermoscopy; Female; Hair; Hot Temperature; Hum | 2019 |
Characteristic findings by phototrichogram in southern Chinese women with Female pattern hair loss.
Topics: Adult; Alopecia; Asian People; Cell Count; Female; Hair; Hair Follicle; Humans; Middle Aged; Scalp; | 2019 |
Adipose Infiltration of the Dermis, Involving the Arrector Pili Muscle, and Dermal Displacement of Eccrine Sweat Coils: New Histologic Observations in Frontal Fibrosing Alopecia.
Topics: Adipose Tissue; Alopecia; Biopsy; Dermis; Eccrine Glands; Fibrosis; Forehead; Hair Follicle; Humans; | 2019 |
A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Hair; Humans; Mi | 2019 |
Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls.
Topics: Adult; Alopecia; Case-Control Studies; Cross-Sectional Studies; Dermoscopy; Female; Hair; Hematologi | 2019 |
Alopecic patches of the scalp: a variant of primary cutaneous follicle centre B-cell lymphoma reported in a series of 14 cases.
Topics: Alopecia; Female; Hair Follicle; Head and Neck Neoplasms; Humans; Lymphoma, B-Cell; Male; Retrospect | 2019 |
Lichenoid folliculitis of the scalp in four patients with ichthyosiform skin disorders and cicatricial alopecia.
Topics: Adolescent; Adult; Alopecia; Chondrodysplasia Punctata; Female; Folliculitis; Humans; Scalp | 2019 |
En coup de sabre.
Topics: Aged; Alopecia; Face; Female; Humans; Nervous System Diseases; Scalp; Scleroderma, Localized | 2019 |
Oral lichen planus and lichen planopilaris complicated with thymoma.
Topics: Aged; Alopecia; Biopsy; Cobalt; Female; Hair Follicle; Humans; Lichen Planus; Lichen Planus, Oral; M | 2019 |
Variant
Topics: Adolescent; Adult; Age of Onset; Alopecia; Black or African American; Chi-Square Distribution; Cicat | 2019 |
Frontal fibrosing alopecia: A new autoimmune entity?
Topics: Adult; Aged; Alopecia; Animals; Autoimmune Diseases; Cicatrix; Female; Fibrosis; Humans; Lichen Plan | 2019 |
Extensive tinea capitis and corporis in a child caused by Trichophyton verrucosum.
Topics: Alopecia; Antifungal Agents; Child, Preschool; Humans; Itraconazole; Male; Random Amplified Polymorp | 2019 |
Expression Level of Prostaglandin D2 Receptor 2 Regulates Hair Regression.
Topics: Alopecia; Biopsy; Gene Knockdown Techniques; Hair Follicle; Humans; Middle Aged; Primary Cell Cultur | 2019 |
Effective treatment with guselkumab for psoriatic alopecia as paradoxical reaction.
Topics: Aged; Alopecia; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Administration Schedule | 2019 |
Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma - with or without concurrent bimatoprost and/or minoxidil.
Topics: Administration, Cutaneous; Alopecia; Bimatoprost; Combined Modality Therapy; Drug Delivery Systems; | 2019 |
The mechanism of activated platelet-rich plasma supernatant promotion of hair growth by cultured dermal papilla cells.
Topics: Alopecia; Blood Transfusion, Autologous; Cell Proliferation; Cells, Cultured; Culture Media; Down-Re | 2019 |
Types of hairline recession in androgenetic alopecia and perceptions of aging in Asian males.
Topics: Adult; Age Factors; Aging; Alopecia; Asian People; Delphi Technique; Face; Hair; Humans; Image Proce | 2019 |
Successful Treatment of Keratosis Follicularis Spinulosa Decalvans With an 800-nm Diode Laser.
Topics: Alopecia; Biopsy; Genetic Diseases, X-Linked; Humans; Ichthyosis; Lasers, Semiconductor; Low-Level L | 2020 |
The innovative use of a click counter for counting the number of slits prepared during hair transplantation.
Topics: Alopecia; Hair; Hair Follicle; Humans; Scalp; Tissue and Organ Harvesting | 2023 |
Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a "drug dependency" and a post-finasteride "rebound effect".
Topics: Administration, Oral; Alopecia; Dermatologic Agents; Finasteride; Hair; Hair Follicle; Humans; Male; | 2019 |
Scalp Cooling: Implementing a Cold Cap Program at a Community Breast Health Center.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Community Health Centers | 2019 |
A preliminary study on ultrasound techniques applied to cicatricial alopecia.
Topics: Adult; Alopecia; Cicatrix; Feasibility Studies; Humans; Middle Aged; Scalp; Skin; Ultrasonography; Y | 2019 |
Alternate coronal and sagittal slits in recipient area of hair transplantation to ensure the correct graft implantation by assisting surgeon.
Topics: Alopecia; Esthetics; Hair Follicle; Humans; Scalp; Treatment Outcome | 2020 |
Faster calculation of scalp area in androgenetic alopecia before platelet-rich plasma therapy using the mobile application ImageMeter.
Topics: Alopecia; Humans; Mobile Applications; Platelet-Rich Plasma; Scalp | 2021 |
Filler-induced alopecia.
Topics: Administration, Topical; Alopecia; Cosmetic Techniques; Dermal Fillers; Drug Therapy, Combination; F | 2019 |
Viable terminal scalp hair follicles constitute a necessary and sufficient biological end-organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles.
Topics: Adult; Alopecia; Dermatologic Agents; Finasteride; Hair; Hair Follicle; Humans; Male; Scalp; Treatme | 2019 |
Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp fibroblasts of a male patient with androgenetic alopecia.
Topics: Alopecia; Cell Line; Cellular Reprogramming Techniques; Fibroblasts; Humans; Induced Pluripotent Ste | 2019 |
Graham-Little-Piccardi-Lassueur syndrome.
Topics: Alopecia; Axilla; Cicatrix; Female; Groin; Hair Diseases; Humans; Middle Aged; Scalp; Syndrome | 2019 |
Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
Topics: Administration, Topical; Adult; Alopecia; Alopecia Areata; Child; Combined Modality Therapy; Female; | 2019 |
Distribution of polyamines may be altered in different scalp regions of patients with hair loss.
Topics: Alopecia; Cell Division; Chromatography, Liquid; Female; Hair; Humans; Male; Mass Spectrometry; Orga | 2019 |
Inhibition of ATP binding cassette transporter B1 sensitizes human hair follicles to chemotherapy-induced damage.
Topics: Alopecia; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Cult | 2019 |
Nevus sebaceous.
Topics: Alopecia; Female; Head and Neck Neoplasms; Humans; Infant; Nevus; Scalp; Skin Neoplasms | 2019 |
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.
Topics: Adult; Aged; Alopecia; Anthracyclines; Breast Neoplasms; Cold Temperature; Female; Humans; Middle Ag | 2019 |
Deciphering the molecular morphology of the human hair cycle: Wnt signalling during the telogen-anagen transformation.
Topics: Alopecia; Animals; Hair; Hair Follicle; Humans; Mice; Scalp; Wnt Proteins; Wnt Signaling Pathway | 2020 |
Blink sign in dermatoscopy of cicatricial alopecia.
Topics: Alopecia; Cicatrix; Dermoscopy; Diagnosis, Differential; Fibrosis; Humans; Scalp; Skin | 2019 |
Adalimumab-induced scalp psoriasis with severe alopecia.
Topics: Adalimumab; Adult; Alopecia; Anti-Inflammatory Agents; Dermatologic Agents; Female; Humans; Injectio | 2019 |
Temporary Hair Loss With An Increase of Telogen Hairs After Filler Migration Into the Scalp.
Topics: Alopecia; Dermal Fillers; Female; Forehead; Hair; Humans; Hyaluronic Acid; Middle Aged; Scalp | 2020 |
Successful treatment of frontal fibrosing alopecia with alitretinoin.
Topics: Administration, Oral; Alitretinoin; Alopecia; Biopsy; Dermatologic Agents; Disease Progression; Dose | 2019 |
Dermoscopic features of lichen planopilaris in Northern Iran: a prospective observational study.
Topics: Adult; Alopecia; Biopsy; Cicatrix; Dermoscopy; Feasibility Studies; Female; Hair; Hair Diseases; Hum | 2019 |
Follicular density and ratios in scarring and nonscarring alopecia.
Topics: Adult; Alopecia; Biopsy; Cicatrix; Cytodiagnosis; Female; Hair Follicle; Humans; Male; Scalp | 2013 |
Prospective histologic examinations in patients who practice traumatic hairstyling.
Topics: Adult; Alopecia; Beauty Culture; Biopsy; Black or African American; Cicatrix; Female; Fibrosis; Hair | 2013 |
Unique presentations of epidermal growth factor receptor inhibitor-induced papulopustular eruption related to bacterial superinfection.
Topics: Aged; Alopecia; Anti-Bacterial Agents; Antineoplastic Agents; Drug Resistance, Bacterial; ErbB Recep | 2013 |
Yellow light gone wild: a tale of permanent laser hair removal with a 595-nm pulsed-dye laser.
Topics: Alopecia; Child, Preschool; Face; Humans; Lasers, Solid-State; Male; Port-Wine Stain; Scalp | 2013 |
[Traction alopecias].
Topics: Alopecia; Beauty Culture; Cicatrix; Diagnosis, Differential; Folliculitis; Humans; Scalp; Stress, Me | 2013 |
Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Female; Fo | 2013 |
Scalp eschar and neck lymphadenopathy caused by Rickettsia massiliae.
Topics: Adolescent; Alopecia; Animals; Bacterial Typing Techniques; Base Sequence; Cicatrix; Dermacentor; DN | 2013 |
Localised alopecia -- a case study.
Topics: Alopecia; Child; Diagnosis, Differential; Follow-Up Studies; Humans; Male; Scalp | 2013 |
A comprehensive approach to hair pathology of horizontal sections.
Topics: Alopecia; Association Learning; Biopsy; Hair; Histocytological Preparation Techniques; Humans; Memor | 2013 |
Images in clinical medicine. A receding hairline.
Topics: Alopecia; Eyebrows; Female; Forehead; Humans; Middle Aged; Postmenopause; Scalp | 2013 |
Microarray analysis of androgenetic and senescent alopecia: comparison of gene expression shows two distinct profiles.
Topics: Adult; Alopecia; Androgens; Biopsy; Gene Expression Profiling; Gene Expression Regulation; Hair; Hai | 2013 |
Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Cryotherapy; Female; Head and Neck Neoplasms; Hum | 2013 |
Transversely sectioned biopsies in the diagnosis of end-stage traction alopecia.
Topics: Adult; Alopecia; Beauty Culture; Black or African American; Cicatrix; Female; Hair; Hair Preparation | 2013 |
Elastin staining patterns in primary cicatricial alopecia.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Elastic Tissue; Elastin; Female; Fibrosis; Humans; Male; M | 2013 |
Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cost-Be | 2014 |
Hyaluronic acid-induced alopecia: a novel complication.
Topics: Alopecia; Cosmetic Techniques; Dermatologic Agents; Female; Humans; Hyaluronic Acid; Middle Aged; Ne | 2013 |
Partial reversal of androgenetic alopecia with methotrexate therapy for psoriasis.
Topics: Alopecia; Dermatologic Agents; Hair; Hair Follicle; Humans; Male; Methotrexate; Middle Aged; Psorias | 2013 |
Lung cancer-associated scalp hair loss: a rare cause of secondary alopecia neoplastica.
Topics: Adenocarcinoma; Aged; Alopecia; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Scalp; Skin N | 2013 |
[Slowly enlarging space-occupying lesion of the posterior head with loss of hair].
Topics: Alopecia; Diagnosis, Differential; Eccrine Porocarcinoma; Head and Neck Neoplasms; Humans; Magnetic | 2014 |
Homozygous missense mutation in the LIPH gene causing autosomal recessive hypotrichosis simplex in a Chinese patient.
Topics: Alopecia; Asian People; Child; China; Homozygote; Humans; Hypotrichosis; Lipase; Male; Mutation, Mis | 2014 |
Micropigmentation: camouflaging scalp alopecia and scars in Korean patients.
Topics: Adult; Alopecia; Asian People; Cicatrix; Female; Humans; Male; Middle Aged; Retrospective Studies; S | 2014 |
Congenital triangular alopecia.
Topics: Alopecia; Child, Preschool; Dermoscopy; Diagnosis, Differential; Female; Hair; Humans; Scalp | 2014 |
Editor's invited commentary: Micropigmentation: camouflaging scalp alopecia and scars in Korean patients.
Topics: Alopecia; Cicatrix; Female; Humans; Male; Scalp; Tattooing | 2014 |
Morphological and morphometric study of the androgenetic alopecic scalp using two- and three-dimensional analysis comparing regional differences.
Topics: Aged; Aged, 80 and over; Alopecia; Cadaver; Hair Follicle; Humans; Image Processing, Computer-Assist | 2014 |
Successful treatment of discoid lupus erythematosus with chloroquine.
Topics: Administration, Oral; Administration, Topical; Adult; Alopecia; Anti-Inflammatory Agents; Antirheuma | 2013 |
Immunohistochemical patterns in the interfollicular Caucasian scalps: influences of age, gender, and alopecia.
Topics: Adult; Aged; Aging; Alopecia; Biopsy; Epidermis; Factor XIIIa; Female; Humans; Male; Middle Aged; Pr | 2013 |
Insulin-like growth factor-1: roles in androgenetic alopecia.
Topics: Adult; Alopecia; Cells, Cultured; Hair Follicle; Humans; Insulin-Like Growth Factor Binding Protein | 2014 |
Partial alopecia due to scalp massage.
Topics: Alopecia; Humans; Massage; Scalp | 1950 |
Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.
Topics: Alopecia; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Drug Eruptions; Female; | 2015 |
Potential relationship between the canonical Wnt signalling pathway and expression of the vitamin D receptor in alopecia.
Topics: Adult; Alopecia; Female; Hair Follicle; Humans; Keratinocytes; Middle Aged; Receptors, Calcitriol; S | 2014 |
Reconstruction of large alopecia with old technique: V-Y-S plasty.
Topics: Adult; Alopecia; Burns; Hair; Humans; Male; Plastic Surgery Procedures; Scalp; Surgical Flaps; Tissu | 2016 |
[Frontal fibrosing alopecia].
Topics: Alopecia; Dermoscopy; Diagnosis, Differential; Disease Progression; Europe; Eyebrows; Female; Fibros | 2014 |
Follicular unit extraction with the Artas robotic hair transplant system system: an evaluation of FUE yield.
Topics: Alopecia; Hair Follicle; Humans; Robotics; Scalp; Tissue and Organ Harvesting; Transplantation, Auto | 2014 |
The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation.
Topics: Adult; Alopecia; Cell Proliferation; Epidermis; Hair Follicle; Humans; Injections; Keratinocytes; Ma | 2014 |
Survey about the use of scalp cooling to prevent alopecia during breast cancer chemotherapy treatment in Canada.
Topics: Adult; Alopecia; Antineoplastic Agents; Breast Neoplasms; Canada; Data Collection; Female; Health Kn | 2014 |
Ischaemic scalp ulceration and hair loss.
Topics: Alopecia; Female; Humans; Middle Aged; Scalp; Skin Ulcer; Subclavian Steal Syndrome | 2014 |
Congenital triangular alopecia.
Topics: Alopecia; Genetic Diseases, X-Linked; Humans; Infant; Scalp; Skin | 2014 |
Platelet-rich plasma for androgenetic alopecia: a pilot study.
Topics: Adult; Alopecia; Cytokines; Female; Humans; Leukocytes; Male; Photography; Pilot Projects; Platelet- | 2014 |
Histopathological investigation of clinically non-affected perilesional scalp in alopecias detected unexpected spread of disease activities.
Topics: Adult; Aged; Alopecia; Asian People; Female; Hair; Humans; Japan; Male; Middle Aged; Reference Value | 2014 |
Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis.
Topics: Adolescent; Adult; Aged; Alopecia; Case-Control Studies; Chronic Disease; Female; Hair Follicle; Hum | 2014 |
Pathologic diagnosis of central centrifugal cicatricial alopecia on horizontal sections.
Topics: Adolescent; Adult; Alopecia; Biopsy; Black or African American; Cicatrix; Female; Hair Follicle; Hum | 2014 |
A mathematical proof of how the outgrowth angle of hair follicles influences the injury to the donor area in FUE harvesting.
Topics: Alopecia; Hair Follicle; Humans; Mathematics; Scalp; Skin; Sodium Chloride; Tissue and Organ Harvest | 2014 |
Repigmentation of vitiligo using the follicular unit extraction technique.
Topics: Alopecia; Child; Hair Follicle; Humans; Male; Orbit; Scalp; Scrotum; Vitiligo | 2014 |
[Alopecia reconstruction by expansion after a scalp burn injury caused by Taser(®): a case report].
Topics: Alopecia; Burns, Electric; Cicatrix; Conducted Energy Weapon Injuries; Equipment Design; Esthetics; | 2014 |
Absence of HLA-DR1 positivity in 2 familial cases of frontal fibrosing alopecia.
Topics: Alopecia; Antibodies; Female; Fibrosis; HLA-DR1 Antigen; Humans; Lichen Planus; Middle Aged; Scalp; | 2014 |
Our experiences on the reconstruction of lateral scalp burn alopecia with tissue expanders.
Topics: Adolescent; Adult; Algorithms; Alopecia; Burns; Child; Child, Preschool; Cohort Studies; Humans; Mal | 2015 |
Newly described features resulting from high-magnification dermoscopy of tinea capitis.
Topics: Alopecia; Child; Child, Preschool; Dermoscopy; Female; Hair; Humans; Male; Microscopy; Microsporum; | 2015 |
Trichoscopy and ultrasonography features of aseptic and alopecic nodules of the scalp.
Topics: Adult; Alopecia; Dermoscopy; Diagnosis, Differential; Follow-Up Studies; Humans; Male; Scalp; Scalp | 2016 |
Bar code-like hair: dermoscopic marker of tinea capitis and tinea of the eyebrow.
Topics: Aged; Alopecia; Dermoscopy; Eyebrows; Female; Humans; Microsporum; Scalp; Tinea Capitis | 2015 |
Characteristics of nonbalding scalp zones of androgenetic alopecia in East Asians.
Topics: Adult; Age Distribution; Aged; Alopecia; Case-Control Studies; Hair; Humans; Male; Middle Aged; Scal | 2015 |
Is TrichoScan a new diagnostic method for diffuse hair loss?
Topics: Adolescent; Adult; Alopecia; Anemia, Iron-Deficiency; Female; Ferritins; Hair; Humans; Image Interpr | 2014 |
Lichen planopilaris with foreign-body granuloma.
Topics: Alopecia; Biopsy; Fibrosis; Granuloma, Foreign-Body; Hair Follicle; Humans; Lichen Planus; Male; Mid | 2015 |
Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia.
Topics: Adult; Alopecia; Biopsy, Needle; Case-Control Studies; Catalase; Cell Movement; Cells, Cultured; Cel | 2015 |
Zigzag skin incision effectively camouflages the scar and alopecia for moyamoya disease: technical note.
Topics: Adolescent; Adult; Alopecia; Cerebral Revascularization; Child; Cicatrix; Craniotomy; Female; Humans | 2015 |
Can long-term alopecia occur after appropriate pulsed-dye laser therapy in hair-bearing sites? Pediatric dermatologists weigh in.
Topics: Alopecia; Child; Dermatology; Eyebrows; Health Care Surveys; Humans; Incidence; Lasers, Dye; Low-Lev | 2015 |
Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; | 2015 |
Steatocystoma multiplex with hair shaft abnormalities.
Topics: Adult; Alopecia; Female; Hair; Humans; Keratin-17; Scalp; Steatocystoma Multiplex | 2015 |
Sarcoidosis presenting as non-scarring non-scalp alopecia.
Topics: Adult; Alopecia; Biopsy, Needle; Cicatrix; Diagnosis, Differential; Humans; Immunohistochemistry; Lo | 2016 |
Childhood follicular mucinosis co-existed with alopecia universalis.
Topics: Alopecia; Child; Female; Humans; Mucinosis, Follicular; Scalp; Torso | 2015 |
[Ischemic hair loss].
Topics: Alopecia; Brain Ischemia; Diagnosis, Differential; Female; Humans; Ischemia; Magnetic Resonance Angi | 2015 |
Cronkhite-Canada syndrome: A rare disease presenting with dermatological and gastrointestinal manifestations.
Topics: Abdominal Pain; Aged; Alopecia; Anorexia; Diarrhea; Female; Humans; Intestinal Polyposis; Lethargy; | 2016 |
A case of Graham-Little-Piccardi-Lasseur syndrome.
Topics: Aged; Alopecia; Axilla; Female; Groin; Humans; Lichen Planus; Scalp; Syndrome | 2015 |
Assessment of tissue levels of dickkopf-1 in androgenetic alopecia and alopecia areata.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Case-Control Studies; Female; Humans; Intercellular Si | 2016 |
Prevalence and types of androgenetic alopecia in north Anatolian population: A community-based study.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Alopecia; Female; Humans; Male; Middle Aged; Preva | 2015 |
Double-Opposing Unilobar Rotation Flaps in the Reconstruction of Moderate-to-Large Defects of the Scalp.
Topics: Aged; Alopecia; Blood Loss, Surgical; Carcinoma, Squamous Cell; Child; Cicatrix; Female; Graft Survi | 2015 |
No prevention of radiotherapy-induced alopecia by scalp cooling.
Topics: Alopecia; Brain Neoplasms; Female; Humans; Hypothermia, Induced; Male; Pilot Projects; Radiation Inj | 2015 |
Setting reference values in trichology.
Topics: Alopecia; Child; Child, Preschool; Female; Hair; Hair Follicle; Humans; Male; Reference Values; Samp | 2016 |
Acute alopecia with underlying pruritic erythema.
Topics: Adult; Alopecia; Erythema; Facial Dermatoses; Facial Neoplasms; Forehead; Head and Neck Neoplasms; H | 2015 |
Recipient Site Necrosis After Tumescent Infiltration with Adrenaline in Hair Transplantation.
Topics: Adult; Alopecia; Anesthetics, Local; Epinephrine; Hair; Humans; Male; Necrosis; Prilocaine; Scalp; V | 2015 |
Gender differences in scalp hair growth rates are maintained but reduced in pattern hair loss compared to controls.
Topics: Adolescent; Alopecia; Female; Hair; Humans; Image Interpretation, Computer-Assisted; Male; Photograp | 2016 |
Postoperative permanent pressure alopecia.
Topics: Alopecia; Anesthesia, General; Female; Humans; Middle Aged; Postoperative Period; Pressure; Risk Fac | 2016 |
Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.
Topics: Alopecia; Brain Neoplasms; Cranial Irradiation; Hippocampus; Humans; Radiation Injuries; Radiometry; | 2015 |
What's eating you? ant-induced alopecia (pheidole).
Topics: Adolescent; Alopecia; Animals; Ants; Diagnosis, Differential; Humans; Male; Scalp | 2015 |
Factors affecting the severity of central centrifugal cicatricial alopecia.
Topics: Adult; Alopecia; Black or African American; Cross-Sectional Studies; Female; Hair Preparations; Huma | 2016 |
Alopecia in general medicine.
Topics: Adult; Alopecia; Female; Humans; Male; Scalp | 2016 |
Alterations in Hair Follicle Morphology and Hair Shaft Production After Follicular Unit Transplantation.
Topics: Adult; Alopecia; Biopsy; Fluorescent Antibody Technique; Hair Follicle; Humans; Male; Microscopy, El | 2016 |
Simulation of scalp cooling by external devices for prevention of chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Body Temperature; Hair Follicle; Humans; Hypothermia, Induced; Mode | 2016 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Scalp Cooling System To Reduce the Likelihood of Chemotherapy-Induced Alopecia. Final order.
Topics: Alopecia; Cryotherapy; Device Approval; Humans; Scalp; United States; United States Food and Drug Ad | 2016 |
The Use of Anti-Keratin 903 Antibodies to Visualize Colloid Bodies and Diagnose Lichen Planopilaris.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antibodies; Antibodies, Monoclonal, Murine-Derived; Biomar | 2016 |
Histopathologic diagnosis of multifactorial alopecia.
Topics: Alopecia; Biopsy; Female; Humans; Male; Scalp | 2016 |
Demodex Folliculitis of the Scalp: Clinicopathological Study of an Uncommon Entity.
Topics: Adolescent; Adult; Aged; Alopecia; Animals; Female; Folliculitis; Hair Follicle; Humans; Male; Middl | 2016 |
Anagen Effluvium Caused by Thallium Poisoning.
Topics: Adult; Alopecia; Biopsy, Needle; Dermoscopy; Diagnosis, Differential; Humans; Male; Scalp; Skin; Tha | 2016 |
Hair "regrowth" during chemotherapy after scalp cooling technique.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cryotherapy; Female; Hair; Humans; Middle | 2016 |
Response to "Hair 'regrowth' during chemotherapy after scalp cooling technique".
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cryotherapy; Hair; Humans; Quality of Life | 2016 |
Differential Expression between Human Dermal Papilla Cells from Balding and Non-Balding Scalps Reveals New Candidate Genes for Androgenetic Alopecia.
Topics: Alopecia; Androgens; Biopsy; Carrier Proteins; Cell Line; Cell Nucleus; Cluster Analysis; Dermis; Ge | 2016 |
Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer.
Topics: Alopecia; Australia; Breast Neoplasms; Female; Focus Groups; Humans; Hypothermia, Induced; Perceptio | 2016 |
Focal Photodamage on the Occipital Scalp.
Topics: Aged; Alopecia; Humans; Male; Occipital Bone; Photosensitivity Disorders; Protective Clothing; Scalp | 2016 |
Tick Bite Alopecia: A Report and Review.
Topics: Adolescent; Alopecia; Biopsy; Child; Child, Preschool; Female; Humans; Male; Mucinosis, Follicular; | 2016 |
Experience of high-frequency ultrasound in rare skin scalp pathology.
Topics: Adult; Aged; Alopecia; Female; Humans; Lipedema; Male; Scalp; Scalp Dermatoses; Skin Diseases; Ultra | 2016 |
Body Hair Transplant by Follicular Unit Extraction: My Experience With 122 Patients.
Topics: Adult; Aged; Alopecia; Hair Follicle; Humans; Los Angeles; Middle Aged; Patient Satisfaction; Retros | 2016 |
Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient.
Topics: Alopecia; Fibrosis; Humans; Lichen Planus; Scalp | 2016 |
When trichoscopy enlightens clinics.
Topics: Adult; Alopecia; Dermoscopy; Female; Hair; Humans; Lupus Erythematosus, Discoid; Scalp; Tinea | 2016 |
Asymmetry of the Receding Hairline in Men With Early Androgenetic Alopecia.
Topics: Adult; Alopecia; Disease Progression; Hair; Humans; Male; Middle Aged; Scalp | 2016 |
Cocking the eyebrows to find the missing hairline in frontal fibrosing alopecia: A useful clinical maneuver.
Topics: Aged; Alopecia; Eyebrows; Female; Fibrosis; Forehead; Humans; Muscle Contraction; Muscle, Skeletal; | 2016 |
The arrector pili muscle, the bridge between the follicular stem cell niche and the interfollicular epidermis.
Topics: Actins; Alopecia; Anatomy; Basement Membrane; Epidermis; Hair Follicle; Humans; Muscle, Smooth; Phal | 2017 |
Patch of hair loss on the scalp.
Topics: Alopecia; Child; Diagnosis, Differential; Female; Humans; Scalp | 2016 |
Scalp Tissue Expansion Above a Custom-Made Hydroxyapatite Cranial Implant to Correct Sequelar Alopecia on a Transposition Flap.
Topics: Adult; Alopecia; Craniotomy; Dermatofibrosarcoma; Durapatite; Head and Neck Neoplasms; Humans; Male; | 2016 |
Using Feily's method prevented scalp necrosis in three patients incline to the scalp recipient necrosis; what is new in prevention of scalp necrosis?
Topics: Adult; Alopecia; Hair Follicle; Humans; Male; Middle Aged; Necrosis; Reperfusion Injury; Risk Factor | 2017 |
A New Subtype of Lichen Planopilaris Affecting Vellus Hairs and Clinically Mimicking Androgenetic Alopecia.
Topics: Adult; Aged; Alopecia; Biopsy; Cross-Sectional Studies; Diagnosis, Differential; Female; Hair Follic | 2016 |
Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2016 |
[Reply to "frontal fibrosing alopecia: Three pediatric cases"].
Topics: Alopecia; Humans; Scalp | 2016 |
Two Annular Alopecic Lesions on the Scalp in a Young Asian Man: A Quiz.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Alopecia; Biop | 2017 |
An unusual case of folliculitis spinulosa decalvans.
Topics: Adult; Alopecia; Anti-Infective Agents; Clarithromycin; Dermatologic Agents; Diagnosis, Differential | 2016 |
Study of frontal hairline patterns for natural design and restoration.
Topics: Alopecia; Anatomic Landmarks; Female; Forehead; Hair; Humans; Male; Photography; Scalp; Turkey; Youn | 2017 |
Increased cutaneous stimulation is required for C-fiber sensory perception in alopecia areata: A double-blind study.
Topics: Adolescent; Adult; Aged; Alopecia; Case-Control Studies; Double-Blind Method; Female; Humans; Male; | 2016 |
Hair pull test: Evidence-based update and revision of guidelines.
Topics: Adolescent; Adult; Aged; Alopecia; Asian People; Black People; Evidence-Based Medicine; Female; Hair | 2017 |
Frontal fibrosing alopecia.
Topics: Aged; Alopecia; Female; Fibrosis; Hair Preparations; Humans; Laser Therapy; Lichen Planus; Male; Sca | 2017 |
Alopecia Following Bicoronal Incisions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Cautery; Child; Child, Preschool; Female; Hemo | 2017 |
Commentary on Association Between Scalp Laxity, Elasticity, and Glidability and Donor Strip Scar Width in Hair Transplantation and a New Elasticity Measuring Method.
Topics: Alopecia; Cicatrix; Elasticity; Hair; Humans; Scalp; Skin | 2017 |
Do the Data on Scalp Cooling for Patients With Breast Cancer Warrant Broad Adoption?
Topics: Alopecia; Breast Neoplasms; Female; Humans; Scalp | 2017 |
Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Humans; Hypothermia, Induced; Induction Chemother | 2017 |
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2017 |
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2017 |
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2017 |
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2017 |
Chemotherapy and Hair Loss.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced; Scalp | 2017 |
Scalp cooling and hair loss during breast cancer chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Clinical Trials, Phase III as Topic; Equipment De | 2017 |
Infundibular protein and RNA microarray analyses from affected and clinically non-affected scalp in male androgenetic alopecia patients.
Topics: Alopecia; Biomarkers; Disease Progression; DNA Methylation; Gene Expression Profiling; Gene Expressi | 2017 |
Squamous cell carcinoma arising within folliculitis decalvans.
Topics: Adult; Alopecia; Carcinoma, Squamous Cell; Folliculitis; Head and Neck Neoplasms; Humans; Male; Scal | 2008 |
Standardizing the 60-second hair count.
Topics: Adult; Alopecia; Hair; Humans; Male; Middle Aged; Reference Values; Scalp | 2008 |
A histologic review of 27 patients with lichen planopilaris.
Topics: Adult; Aged; Alopecia; Biopsy; Cicatrix; Female; Humans; Lichen Planus; Male; Middle Aged; Retrospec | 2008 |
The composite galeal frontalis pericranial flap designed for anterior skull base surgery.
Topics: Alopecia; Cranial Fossa, Anterior; Dissection; Humans; Microsurgery; Plastic Surgery Procedures; Pos | 2008 |
The use of micrografts and minigrafts together with advancement of temporalis fascia and its periosteum on the treatment of burn alopecia.
Topics: Adult; Alopecia; Burns; Cicatrix; Fascia; Graft Survival; Hair; Humans; Male; Microsurgery; Muscle, | 2008 |
Baldness may be caused by the weight of the scalp: gravity as a proposed mechanism for hair loss.
Topics: Alopecia; Female; Gravitation; Humans; Male; Models, Theoretical; Organ Size; Pressure; Scalp | 2008 |
Hair transplantation: standard guidelines of care.
Topics: Alopecia; Ambulatory Surgical Procedures; Hair; Hair Follicle; Humans; Scalp; Tissue and Organ Harve | 2008 |
Determinants of marginal traction alopecia in African girls and women.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alopecia; Black People; Child; Female; Hair | 2008 |
Trichoscopy.
Topics: Alopecia; Dermoscopy; Hair; Hair Diseases; Humans; Microscopy, Video; Scalp; Scalp Dermatoses | 2008 |
Postoperative alopecia following orthognathic surgery.
Topics: Adult; Alopecia; Chin; Female; Hair Follicle; Humans; Mandibular Advancement; Maxilla; Oral Surgical | 2008 |
A draping technique for scalp operations.
Topics: Alopecia; Asepsis; Bedding and Linens; Humans; Intraoperative Care; Scalp | 2009 |
Big head? Bald head! Skull expansion: alternative model for the primary mechanism of AGA.
Topics: Alopecia; Head; Humans; Male; Models, Biological; Models, Neurological; Receptors, Androgen; Scalp; | 2009 |
The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unit.
Topics: Alopecia; Androgens; Biopsy; Female; Hair Follicle; Humans; Scalp | 2008 |
Frontal fibrosing alopecia: clinical presentations and prognosis.
Topics: Adult; Aged; Alopecia; Cicatrix; Disease Progression; Eyebrows; Female; Fibrosis; Forehead; Hair Fol | 2009 |
Cicatricial marginal alopecia: is it all traction?
Topics: Adolescent; Adult; Alopecia; Biopsy; Cicatrix; Diagnosis, Differential; Female; Hair Follicle; Human | 2009 |
Alopecic and aseptic nodules of the scalp.
Topics: Adolescent; Adult; Alopecia; Anti-Bacterial Agents; Child; Cysts; Doxycycline; Humans; Male; Scalp; | 2009 |
Hair extensions: a concerning cause of hair disorders.
Topics: Alopecia; Barbering; Female; Hair Diseases; Humans; Scalp; Traction | 2009 |
Tissue expanded scalp flaps in alopecia: advancement, rotation or transposition?
Topics: Alopecia; Hair; Humans; Scalp; Surgical Flaps; Tissue Expansion | 2009 |
Hair restoration.
Topics: Alopecia; Hair Follicle; Humans; Scalp | 2008 |
Hairline design in hair replacement surgery.
Topics: Alopecia; Esthetics; Female; Forehead; Hair Follicle; Humans; Male; Scalp; Skin Transplantation; Sur | 2008 |
Follicular unit extraction.
Topics: Alopecia; Female; Hair Follicle; Humans; Male; Scalp; Skin Transplantation; Tissue and Organ Harvest | 2008 |
Understanding and management of female pattern alopecia.
Topics: Alopecia; Female; Hair Follicle; Humans; Scalp; Skin Transplantation; Tissue and Organ Harvesting; T | 2008 |
Scalp reconstruction and repair.
Topics: Adolescent; Adult; Alopecia; Child; Female; Hair Follicle; Humans; Male; Middle Aged; Plastic Surger | 2008 |
Hair restoration complications: an approach to the unnatural-appearing hair transplant.
Topics: Alopecia; Cicatrix; Esthetics; Female; Hair Follicle; Humans; Male; Scalp; Skin Transplantation; Tis | 2008 |
Postmenopausal frontal fibrosing alopecia in a Japanese woman with Sjögren's syndrome.
Topics: Aged; Alopecia; Asian People; Female; Humans; Japan; Postmenopause; Scalp; Sjogren's Syndrome | 2008 |
Tinea capitis mimicking cicatricial alopecia: what host and dermatophyte factors lead to this unusual clinical presentation?
Topics: Abscess; Adolescent; Alopecia; Child; Cicatrix; Dermatitis, Atopic; Diagnosis, Differential; Female; | 2009 |
Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling.
Topics: Adult; Alopecia; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, A | 2009 |
Hair control: a quick and simple method--reply to 'A draping technique for scalp operations' and 'Secure sterile head drape for head and neck surgery'.
Topics: Alopecia; Asepsis; Bedding and Linens; Hair; Humans; Intraoperative Care; Scalp | 2010 |
Cutaneous metastasis of breast carcinoma presenting as alopecia neoplastica.
Topics: Adenocarcinoma; Alopecia; Breast Neoplasms; Female; Humans; Middle Aged; Risk Factors; Scalp; Skin N | 2009 |
Cutaneous metastases from breast cancer.
Topics: Alopecia; Breast Neoplasms; Female; Humans; Risk Factors; Scalp; Skin Neoplasms | 2009 |
Scalp dermoscopy of androgenetic alopecia in Asian people.
Topics: Adolescent; Adult; Aged; Alopecia; Asian People; Dermoscopy; Female; Hair; Humans; Male; Middle Aged | 2009 |
[Breakdancer's "Headspin Hole" - first description of a common overuse syndrome].
Topics: Adolescent; Adult; Alopecia; Athletic Injuries; Child; Cumulative Trauma Disorders; Dancing; Female; | 2009 |
The expanded "flying-wings" scalp flap for aesthetic hemiscalp alopecia reconstruction in children.
Topics: Alopecia; Child; Child, Preschool; Female; Humans; Male; Plastic Surgery Procedures; Scalp; Surgical | 2009 |
Epidermal field carcinogenesis in bald-headed: An attempt at finetuning early non-invasive detection.
Topics: Age Factors; Alopecia; Cell Transformation, Neoplastic; Head and Neck Neoplasms; Humans; Male; Middl | 2009 |
The role of dermoscopy in the diagnosis of cicatricial marginal alopecia.
Topics: Adult; Aged; Alopecia; Cicatrix; Dermoscopy; Female; Hair Follicle; Humans; Middle Aged; Scalp | 2009 |
Androgenic alopecia: a counterproductive outcome of the anabolic effect of androgens.
Topics: Alopecia; Anabolic Agents; Androgens; Hair; Humans; Models, Biological; Scalp | 2009 |
The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control study.
Topics: Adolescent; Adult; Aged; Alopecia; Case-Control Studies; Depressive Disorder; Female; Folic Acid; Hu | 2009 |
Hair counts in scalp biopsy of males and females with androgenetic alopecia compared with normal subjects.
Topics: Adult; Aged; Alopecia; Biopsy; Female; Hair; Humans; Iran; Male; Middle Aged; Retrospective Studies; | 2009 |
Cysts and erythematous plaques on the face and scalp.
Topics: Aged; Alopecia; Facial Neoplasms; Follicular Cyst; Head and Neck Neoplasms; Humans; Male; Mycosis Fu | 2009 |
Androgenetic alopecia in males: a histopathological and ultrastructural study.
Topics: Adult; Age Factors; Aged; Alopecia; Biopsy; Case-Control Studies; Collagen; Fibrosis; Hair Follicle; | 2009 |
JAAD Grand Rounds quiz. Woman with hyperpigmented plaque and alopecia.
Topics: Adult; Alopecia; Diagnosis, Differential; Female; Forehead; Humans; Hyperpigmentation; Scalp; Sclero | 2009 |
Weathering of the hairless scalp: a study using skin capacitance imaging and ultraviolet light-enhanced visualization.
Topics: Alopecia; Humans; Male; Middle Aged; Scalp; Skin Aging; Skin Pigmentation; Sunlight; Ultraviolet Ray | 2010 |
Cytokeratin 75 expression in central, centrifugal, cicatricial alopecia--new observations in normal and diseased hair follicles.
Topics: Alopecia; Hair Follicle; Humans; Immunohistochemistry; Keratins, Hair-Specific; Keratins, Type II; S | 2010 |
Scarring alopecia: clinical and pathologic study of 54 African-American women.
Topics: Adult; Aged; Alopecia; Biopsy; Black or African American; Cicatrix; Female; Hair Follicle; Hair Prep | 2009 |
Occipital involvement in female pattern hair loss: histopathological evidences.
Topics: Adolescent; Adult; Alopecia; Cell Count; Female; Follow-Up Studies; Hair Follicle; Humans; Middle Ag | 2010 |
Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp.
Topics: Alopecia; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Cell Degranulation; Female; Hai | 2010 |
Loose anagen hair syndrome: an unusual cause of alopecia of cosmetic importance only.
Topics: Alopecia; Child, Preschool; Cosmetics; Female; Hair; Hair Diseases; Humans; Remission, Spontaneous; | 2009 |
Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray.
Topics: Alopecia; Animals; Biopsy; Cluster Analysis; False Positive Reactions; Gene Expression; Gene Express | 2010 |
A study of serial vertical sectioning of scalp biopsies to increase the histological diagnostic yield in alopecias.
Topics: Adolescent; Adult; Aged; Alopecia; Biopsy; Child; Child, Preschool; Epidermis; Female; Hair Follicle | 2010 |
Halo scalp ring with purulent drainage in a newborn.
Topics: Alopecia; Craniocerebral Trauma; Diagnosis, Differential; Follow-Up Studies; Humans; Infant, Newborn | 2010 |
Combining scalp tissue expansion with porous polyethylene total ear reconstruction in burned patients.
Topics: Adolescent; Alopecia; Burns; Child; Ear, External; Facial Injuries; Humans; Male; Plastic Surgery Pr | 2010 |
Management of primary cutis verticis gyrata with tissue expansion and hairline lowering foreheadplasty.
Topics: Adolescent; Alopecia; Female; Forehead; Humans; Rhytidoplasty; Scalp; Skin Abnormalities; Tissue Exp | 2010 |
Absence of pathological scarring in the donor site of the scalp in burns: an analysis of 295 cases.
Topics: Adolescent; Adult; Aged; Alopecia; Burns; Child; Child, Preschool; Cicatrix, Hypertrophic; Epitheliu | 2010 |
Scalp problems.
Topics: Alopecia; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Medical Illustration; Photography; Psor | 2010 |
Adhesive depilation for scalp graft hair removal.
Topics: Alopecia; Foreign-Body Reaction; Hair; Hair Removal; Humans; Postoperative Complications; Scalp; Sur | 2010 |
Alopecia and severe parasthesia of scalp, associated with amenorrhea.
Topics: Alopecia; Amenorrhea; Female; Humans; Paresthesia; Scalp | 1946 |
Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients.
Topics: Adolescent; Adult; Age of Onset; Alopecia; Biopsy; Diagnosis, Differential; Enzyme Inhibitors; Femal | 2010 |
Acute hair loss on the limbs in frontal fibrosing alopecia: a clinicopathological study of two cases.
Topics: Acute Disease; Adult; Alopecia; Biopsy; Eyebrows; Female; Fibrosis; Hair Follicle; Humans; Middle Ag | 2010 |
Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplat | 2010 |
Picture of the month--quiz case. Halo scalp ring.
Topics: Alopecia; Birth Injuries; Humans; Infant, Newborn; Male; Scalp | 2010 |
Scarring alopecia followed by a progressive eruption.
Topics: Alopecia; Biopsy; Cicatrix; Disease Progression; Humans; Male; Middle Aged; Scalp | 2010 |
Acquired nonscarring diffuse hair loss in a 3-year-old girl.
Topics: Alopecia; Child, Preschool; Dermoscopy; Female; Hair; Humans; Microscopy, Electron, Scanning; Monile | 2011 |
Chronic telogen effluvium is due to a reduction in the variance of anagen duration.
Topics: Alopecia; Chronic Disease; Computer Simulation; Female; Hair; Humans; Models, Biological; Scalp | 2010 |
Frontal fibrosing alopecia associated with generalized hair loss.
Topics: Aged; Alopecia; Eyebrows; Female; Fibrosis; Hair; Humans; Lichen Planus; Middle Aged; Postmenopause; | 2010 |
Frontal fibrosing alopecia: a clinical review of 36 patients.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Anti-Bacterial Agents; Cohort Studies; Dermatologic Agents | 2010 |
Hair casts are a dermoscopic clue for the diagnosis of traction alopecia.
Topics: Adult; Aged; Alopecia; Barbering; Dermoscopy; Hair; Humans; Middle Aged; Scalp; Traction | 2010 |
[The Adams-Oliver syndrome. A case report].
Topics: Abnormalities, Multiple; Alopecia; Ectodermal Dysplasia; Female; Finger Phalanges; Foot Deformities, | 2010 |
An algorithmic approach for reconstruction of burn alopecia.
Topics: Adolescent; Adult; Algorithms; Alopecia; Burns; Child; Child, Preschool; Facial Injuries; Female; Ha | 2010 |
[Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur].
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2010 |
Expanding the spectrum of frontal fibrosing alopecia: a unifying concept.
Topics: Adult; Age Distribution; Aged; Alopecia; Biopsy, Needle; Cohort Studies; Diagnosis, Differential; Di | 2010 |
Alopecia of the scalp after ineffective treatment of Bowen's disease using red light 5-aminolevulinic acid photodynamic therapy: two case reports.
Topics: Aged; Alopecia; Aminolevulinic Acid; Bowen's Disease; Female; Humans; Mohs Surgery; Photochemotherap | 2010 |
Graham-Little syndrome.
Topics: Alopecia; Female; Glucocorticoids; Humans; Keratosis; Middle Aged; Prednisone; Scalp; Scalp Dermatos | 2010 |
Morphometric analysis of the human scalp hair follicle: practical implications for the hair transplant surgeon and hair regeneration studies.
Topics: Adult; Aged; Alopecia; Female; Hair Follicle; Humans; Immunochemistry; Male; Middle Aged; Scalp; Ski | 2011 |
Expanded flap and hair follicle transplantation for reconstruction of postburn scalp alopecia.
Topics: Abscess; Adolescent; Adult; Alopecia; Burns; Burns, Electric; Child; Child, Preschool; Cicatrix; Dev | 2010 |
Evaluation of apoptosis regulatory markers in androgenetic alopecia.
Topics: Adolescent; Adult; Aged; Alopecia; Analysis of Variance; Apoptosis; bcl-2-Associated X Protein; Biom | 2010 |
Physiological changes in scalp, facial and body hair after the menopause: a cross-sectional population-based study of subjective changes.
Topics: Aged; Aged, 80 and over; Aging; Alopecia; Cross-Sectional Studies; Face; Female; Hair; Humans; Middl | 2011 |
Improved hair restoration method for burns.
Topics: Adult; Alopecia; Burns; Eyebrows; Face; Female; Hair; Hair Follicle; Humans; Male; Scalp; Tissue and | 2011 |
Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells.
Topics: Alopecia; Animals; Antigens, CD; Antigens, CD34; Hair Follicle; Humans; Integrin alpha6; Keratin-15; | 2011 |
Trichoscopy as a clue to the diagnosis of scalp sarcoidosis.
Topics: Alopecia; Biopsy; Dermoscopy; Female; Hair; Hair Diseases; Humans; Middle Aged; Sarcoidosis; Scalp; | 2011 |
Severe kerion celsi due to Trichophyton mentagrophytes: a case report.
Topics: Alopecia; Child, Preschool; Female; Humans; Scalp; Tinea Capitis; Trichophyton | 2011 |
Classification of the female hairline and refined hairline correction techniques for Asian women.
Topics: Adult; Alopecia; Asian People; Female; Forehead; Hair Follicle; Humans; Scalp; Skin Transplantation; | 2011 |
Primary cutaneous follicle centre cell lymphoma of the scalp presenting with scarring alopecia.
Topics: Alopecia; Biopsy; Cicatrix; Female; Head and Neck Neoplasms; Humans; Lymphoma, Follicular; Middle Ag | 2011 |
Osteophyte-induced rupture of a scalp tissue expander.
Topics: Alopecia; Child; Female; Hamartoma; Humans; Osteophyte; Scalp; Tissue Expansion | 2011 |
Commentary: hair transplantation and female hairlines.
Topics: Alopecia; Female; Forehead; Hair Follicle; Humans; Scalp; Skin Transplantation | 2011 |
Gas chromatography/mass spectrometry based hair steroid profiling may reveal pathogenesis in hair follicles of the scalp.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Biomarkers; Dihydrotestosterone; Dutasteride; G | 2011 |
Massive tufted hair folliculitis associated with chronic use of systemic corticosteroids.
Topics: Adult; Alopecia; Anti-Bacterial Agents; Chronic Disease; Dermoscopy; Disease Progression; Female; Fo | 2011 |
Frontal fibrosing alopecia occurring on scalp vitiligo: report of four cases.
Topics: Adult; Aged; Alopecia; Female; Fibrosis; Humans; Middle Aged; Scalp; Scalp Dermatoses; Vitiligo | 2011 |
The α-lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: a pilot study.
Topics: Administration, Topical; Alopecia; Animals; Antineoplastic Agents; Antioxidants; Cytarabine; Hair Fo | 2011 |
Facilitated scalp measuring using phototrichogram with a headband and tapeline.
Topics: Alopecia; Female; Hair; Humans; Male; Scalp | 2011 |
Activation of transient receptor potential vanilloid-3 inhibits human hair growth.
Topics: Alopecia; Anti-Infective Agents; Apoptosis; Boron Compounds; Calcium; Cell Division; Cells, Cultured | 2011 |
Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy.
Topics: Adolescent; Adult; Alopecia; Antineoplastic Agents; Clothing; Female; Humans; Hypothermia, Induced; | 2011 |
Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution.
Topics: Alopecia; Amides; Bimatoprost; Cloprostenol; Female; Humans; Injections, Intradermal; Middle Aged; P | 2011 |
Necrosis of the donor site after hair restoration with follicular unit extraction (FUE): a case report.
Topics: Alopecia; Cicatrix; Hair Follicle; Humans; Male; Necrosis; Postoperative Complications; Scalp; Trans | 2012 |
The follicular triad: a pathological clue to the diagnosis of early frontal fibrosing alopecia.
Topics: Alopecia; Early Diagnosis; Fibrosis; Forehead; Humans; Lichen Planus; Middle Aged; Scalp | 2012 |
The latest innovations in hair transplantation.
Topics: Alopecia; Eyebrows; Eyelashes; Hair; Hair Follicle; Humans; Low-Level Light Therapy; Male; Organ Pre | 2011 |
Tactile and thermal detection thresholds of the scalp skin.
Topics: Adult; Alopecia; Cold Temperature; Hot Temperature; Humans; Male; Pain Measurement; Pain Threshold; | 2011 |
Dihydrotestosterone-inducible IL-6 inhibits elongation of human hair shafts by suppressing matrix cell proliferation and promotes regression of hair follicles in mice.
Topics: Alopecia; Androgens; Animals; Cell Division; Cells, Cultured; Cytokine Receptor gp130; Dermis; Dihyd | 2012 |
Temporal triangular alopecia: trichoscopic diagnosis.
Topics: Alopecia; Child; Child, Preschool; Dermoscopy; Female; Hair; Hair Follicle; Humans; Scalp | 2012 |
Vertical vs. transverse sections of scalp biopsy specimens: a pilot study on the comparison of the diagnostic value of two techniques in alopecia.
Topics: Adolescent; Adult; Aged; Alopecia; Biopsy; Female; Humans; Male; Middle Aged; Pilot Projects; Prospe | 2011 |
JAAD Grand Rounds quiz. Fixed focal alopecia for 20 years.
Topics: Adult; Alopecia; Alopecia Areata; Diagnosis, Differential; Hair Follicle; Humans; Male; Scalp | 2011 |
Erosive pustular dermatosis of the scalp from topical minoxidil 5% solution.
Topics: Aged; Alopecia; Dermatologic Agents; Drug Eruptions; Female; Humans; Minoxidil; Scalp; Scalp Dermato | 2013 |
Field melanin mapping of the hairless scalp.
Topics: Aged; Alopecia; Humans; Male; Melanins; Middle Aged; Reproducibility of Results; Scalp; Sensitivity | 2012 |
Factors influencing postoperative hyperesthesia in hair restoration surgery.
Topics: Adult; Alopecia; Confidence Intervals; Cosmetic Techniques; Female; Hair; Hair Follicle; Humans; Hyp | 2011 |
Hormonal changes in menopause: do they contribute to a 'midlife hair crisis' in women?
Topics: Alopecia; Estrogens; Female; Hair; Hair Follicle; Humans; Menopause; Middle Aged; Scalp; Scalp Derma | 2011 |
Association of nevus of Jadassohn, sebaceoma and trichoblastoma in a scalp lesion.
Topics: Aged; Alopecia; Head and Neck Neoplasms; Humans; Male; Nevus, Sebaceous of Jadassohn; Scalp; Skin Ne | 2011 |
Hair follicle stem cell differentiation is inhibited through cross-talk between Wnt/β-catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia.
Topics: Alopecia; Androgens; Cell Differentiation; Cells, Cultured; Dermis; Dihydrotestosterone; DNA, Comple | 2012 |
Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Female; Humans; Hypothe | 2012 |
'A detective look' at hair biopsies from African-American patients.
Topics: Alopecia; Biopsy; Black or African American; Hair; Hair Follicle; Humans; Lupus Erythematosus, Disco | 2012 |
The transplanted hairline: leg room for improvement.
Topics: Adult; Alopecia; Forehead; Hair; Hair Follicle; Humans; Leg; Male; Scalp; Surgery, Plastic | 2012 |
Cutaneous mastocytosis associated with congenital alopecia.
Topics: Administration, Cutaneous; Administration, Oral; Adrenal Cortex Hormones; Alopecia; Biopsy; Child, P | 2012 |
Baseline sebum IL-1α is higher than expected in afro-textured hair: a risk factor for hair loss?
Topics: Adult; Alopecia; Baths; Black People; Cytokines; Female; Guanidines; Hair; Hair Preparations; Humans | 2012 |
Caspase-1 level is higher in the scalp in androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aged, 80 and over; Alopecia; Androgens; Caspase 1; Cells, | 2012 |
Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia.
Topics: Alopecia; Animals; Epidermis; Female; Gene Expression Profiling; Hair; Hair Follicle; Humans; Kerati | 2012 |
Dermoscopy guided scalp biopsy in cicatricial alopecia.
Topics: Alopecia; Biopsy; Dermoscopy; Folliculitis; Hair Follicle; Humans; Lupus Erythematosus, Discoid; Sca | 2013 |
[Localized inflammatory alopecia of the scalp: an unusual presentation of tularemia].
Topics: Alopecia; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Lymphatic | 2012 |
Moth-eaten alopecia: a sign of secondary syphilis.
Topics: Adult; Alopecia; Diagnosis, Differential; Humans; Male; Scalp; Syphilis | 2013 |
[Clinical investigation of a Chinese family with hypotrichosis simplex of the scalp and mutational analysis of CDSN gene].
Topics: Alopecia; China; Codon, Nonsense; Female; Glycoproteins; Humans; Hypotrichosis; Intercellular Signal | 2012 |
Scalp hair loss after transsphenoidal adenomectomy in patients with acromegaly.
Topics: Acromegaly; Adenoma; Adult; Aged; Alopecia; Female; Glucose Tolerance Test; Growth Hormone; Humans; | 2013 |
Temporary alopecia after embolization of an arteriovenous malformation.
Topics: Adult; Alopecia; Arteriovenous Malformations; Combined Modality Therapy; Craniotomy; Embolization, T | 2012 |
The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias.
Topics: Administration, Topical; Adult; Alopecia; Amides; Animals; Antihypertensive Agents; Base Sequence; B | 2013 |
[Dermatoscopy of hair and scalp].
Topics: Adolescent; Adult; Aged; Alopecia; Dermoscopy; Diagnosis, Differential; Female; Hair; Hair Diseases; | 2012 |
Disseminated dermatophytic pseudomycetoma caused by Microsporum species.
Topics: Aged; Alopecia; Antifungal Agents; Dermatomycoses; Facial Dermatoses; Female; Humans; Immunocompromi | 2012 |
Reducing chemotherapy-induced alopecia with scalp cooling.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Cold Temperature; Female; Humans; Hypothermia, In | 2012 |
Hair mass index obtained by cross-section trichometry: an objective and clinically useful parameter to quantify hair in chemotherapy-induced alopecia.
Topics: Aged; Alopecia; Case-Control Studies; Clothing; Female; Hair; Humans; Hypothermia, Induced; Male; Mi | 2013 |
A scalp disorder: dermatoscopy as a useful diagnostic tool.
Topics: Alopecia; Child, Preschool; Dermatology; Dermoscopy; Female; Humans; Scalp; Trichotillomania | 2013 |
Erosive lichen planus of the scalp and hepatitis C infection.
Topics: Alopecia; Biopsy; Glucocorticoids; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Lichen | 2013 |
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Anti-Bacterial Agents; Azasteroids; Cicatrix; D | 2013 |
[Kossard frontal fibrosing alopecia in a man].
Topics: Aged; Alopecia; Biopsy; Fibrosis; Hair Follicle; Humans; Lichen Planus; Male; Scalp; Sex Factors | 2002 |
Complete osseous regeneration of a large skull defect in a patient with cutis aplasia: a conservative approach.
Topics: Administration, Cutaneous; Administration, Oral; Alopecia; Anti-Infective Agents; Anti-Infective Age | 2002 |
Surgical treatment of aplasia cutis congenita of the scalp associated with bilateral coronal synostosis.
Topics: Alopecia; Bone Transplantation; Cicatrix; Craniosynostoses; Ectodermal Dysplasia; Follow-Up Studies; | 2002 |
New treatment of a visible linear scar in the scalp: multiple hair-bearing flap technique.
Topics: Adolescent; Adult; Alopecia; Child; Cicatrix; Female; Hair; Humans; Male; Plastic Surgery Procedures | 2002 |
Follicular unit extraction: minimally invasive surgery for hair transplantation.
Topics: Alopecia; Hair Follicle; Humans; Male; Minimally Invasive Surgical Procedures; Scalp; Treatment Outc | 2002 |
[Interactive clinical cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Female; Hair Diseases; Humans; Male; Mi | 2002 |
An evaluation system to enhance patient selection for alopecia-reducing surgery.
Topics: Age Factors; Alopecia; Hair; Humans; Outcome Assessment, Health Care; Patient Selection; Scalp; Woun | 2002 |
Validation and clinical relevance of a novel scalp coverage scoring method.
Topics: Alopecia; Calibration; Computer Systems; Equipment Design; Follow-Up Studies; Hair; Humans; Male; Ph | 2003 |
Postmenopausal frontal fibrosing alopecia.
Topics: Adult; Aged; Alopecia; Biopsy; Female; Fibrosis; Glucocorticoids; Humans; Postmenopause; Scalp | 2003 |
Computerized morphometry and three-dimensional image reconstruction in the evaluation of scalp biopsy from patients with non-cicatricial alopecias.
Topics: Adolescent; Adult; Aged; Alopecia; Alopecia Areata; Biopsy; Female; Hair Follicle; Humans; Image Pro | 2003 |
An investigation of apoptosis in androgenetic alopecia.
Topics: Alopecia; Apoptosis; Cell Cycle; Hair Follicle; Humans; Immunohistochemistry; In Situ Nick-End Label | 2003 |
Algorithm of hair restoration surgery in children.
Topics: Adolescent; Alopecia; Child; Child, Preschool; Cicatrix; Female; Hair; Humans; Male; Radiation Injur | 2003 |
Delayed wound healing after three different treatments for widespread actinic keratosis on the atrophic bald scalp.
Topics: Aged; Aged, 80 and over; Alopecia; Atrophy; Chemexfoliation; Cryosurgery; Humans; Keratosis; Laser T | 2003 |
Scalp thickness and the fat-loss theory of balding.
Topics: Alopecia; Head; Humans; Scalp | 1954 |
[Isolated scleroderma in small superficial elements of the scalp; its status among cicatricial alopecias].
Topics: Alopecia; Basidiomycota; Disease; Head; Humans; Scalp; Scleroderma, Localized; Scleroderma, Systemic | 1955 |
Familial congenital defect of the scalp.
Topics: Alopecia; Humans; Scalp | 1957 |
Familial congenital defect of the scalp.
Topics: Alopecia; Humans; Scalp | 1957 |
Familial congenital defect of the scalp.
Topics: Alopecia; Humans; Scalp | 1957 |
Familial congenital defect of the scalp.
Topics: Alopecia; Humans; Scalp | 1957 |
Some disorders of the scalp.
Topics: Alopecia; Disease; Head; Humans; Scalp | 1957 |
[Plastic surgery in certain partial alopecias of the scalp].
Topics: Alopecia; Humans; Plastic Surgery Procedures; Scalp; Surgery, Plastic | 1957 |
[Partial limited alopecia of the scalp].
Topics: Alopecia; Humans; Scalp | 1957 |
[Technics of distribution of undamaged pilous tissue in partial alopecia of the scalp].
Topics: Alopecia; Humans; Scalp | 1957 |
Influence of the salt intake on the loss of scalp hair.
Topics: Alopecia; Hair; Humans; Scalp; Sodium Chloride | 1957 |
[Pseudopelade; statistics of 109 new cases; findings on lichen planus of the scalp].
Topics: Alopecia; Biometry; Humans; Lichen Planus; Scalp | 1957 |
Alopecia areata and other common scalp problems.
Topics: Alopecia; Alopecia Areata; Disease; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Scalp; Skin Di | 1958 |
Keratodermatitis follicularis decalvans.
Topics: Alopecia; Darier Disease; Disease; Humans; Medical Records; Scalp; Skin Diseases | 1958 |
Noncicatrizing alopecias; with special reference to alopecia areata.
Topics: Adrenal Cortex Hormones; Adult; Alopecia; Alopecia Areata; Dermatologic Agents; Female; Glucocortico | 1958 |
Alopecia mucinosa: report of a case with a grouped papular eruption and alopecia of the scalp.
Topics: Alopecia; Humans; Medical Records; Mucinosis, Follicular; Musculoskeletal Diseases; Scalp | 1958 |
Geometric relationships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp.
Topics: Alopecia; Dermis; Hair; Hair Follicle; Humans; Scalp | 1958 |
Vitamins and loss of scalp hair.
Topics: Alopecia; Hair; Humans; Scalp; Vitamins | 1959 |
[On 2 cases of favus of the scalp treated 4 times with roentgen epilation without definite hair loss].
Topics: Alopecia; Disease; Hair; Hair Removal; Scalp; Skin Diseases; Tinea; Tinea Favosa | 1961 |
[Traumatic alopecias].
Topics: Alopecia; Humans; Scalp | 1961 |
[The problem of premature alopecia: its surgical treatment].
Topics: Alopecia; Humans; Scalp; Skin Transplantation | 1961 |
[Data on vascular spasm in the pathogenesis of various cases of alopecia areata].
Topics: Alopecia; Alopecia Areata; Cardiovascular System; Humans; Scalp; Spasm; Vascular Diseases | 1961 |
Nerve network of the hair follicle in alopecia areata.
Topics: Alopecia; Alopecia Areata; Hair Follicle; Humans; Scalp | 1960 |
[Circumscribed lichenification of the hair of the head with simultaneous reversible alopecia].
Topics: Alopecia; Alopecia Areata; Disease; Hair; Head; Humans; Scalp; Skin Diseases | 1960 |
[Geotrichosis of the scalp simulating folliculitis decalvans].
Topics: Alopecia; Disease; Folliculitis; Geotrichosis; Humans; Mycoses; Scalp | 1959 |
[Lupus erythematosus of the scalp with characteristics of alopecia areata].
Topics: Alopecia; Alopecia Areata; Disease; Humans; Lupus Erythematosus, Systemic; Medical Records; Scalp; S | 1961 |
Circulatory changes in alopecia. Preliminary report, with a summary of the cutaneous circulation of the normal scalp.
Topics: Alopecia; Humans; Scalp | 1961 |
Lipedematous alopecia.
Topics: Alopecia; Humans; Scalp | 1961 |
[Hair loss in typical baldness in males].
Topics: Alopecia; Dermatitis; Dermatitis, Seborrheic; Disease; Hair; Humans; Male; Pityriasis; Scalp | 1962 |
Diffuse loss of scalp hair in women.
Topics: Alopecia; Female; Hair; Humans; Scalp; Women | 1962 |
Multiple embolisms in the fundus of an eye after an injection in the scalp.
Topics: Alopecia; Emaciation; Embolism; Fundus Oculi; Humans; Retinal Vessels; Scalp | 1963 |
[Apropos of a case of chronic trichophytosis of the scalp, of pseudo-pelada type, due to Trichophyton verrucosum].
Topics: Alopecia; Alopecia Areata; Humans; Scalp; Tinea; Tinea Capitis; Trichophyton | 1962 |
FLUOCINOLONE ACETONIDE IN PROPYLENE GLYCOL.
Topics: Adrenal Cortex Hormones; Alopecia; Alopecia Areata; Dermatitis; Dermatitis, Atopic; Dermatitis, Sebo | 1963 |
THE RESULTS OF FRONTAL GALEOTOMIES FOR LOSS OF HAIR; A PRELIMINARY REPORT.
Topics: Alopecia; Headache; Humans; Scalp; Surgical Procedures, Operative | 1963 |
NON-ANEMIC IRON DEFICIENCY AS AN ETIOLOGIC FACTOR IN DIFFUSE LOSS OF HAIR OF THE SCALP IN WOMEN.
Topics: Alopecia; Blood Chemical Analysis; Deficiency Diseases; Female; Hair; Humans; Iron; Scalp | 1963 |
MALIGNANT TUMORS OF THE SCALP. I. ANALYSIS OF 92 CASES OF MALIGNANT EPITHELIAL AND SOMATIC TUMORS OF THE SCALP.
Topics: Adenocarcinoma; Adolescent; Alopecia; Anatomy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chil | 1964 |
SURGICAL TREATMENT OF THE RECEDING HAIRLINE. REPORT OF A CASE.
Topics: Alopecia; Humans; Plastics; Scalp; Skin Transplantation; Surgery, Plastic | 1964 |
[FUNCTIONAL PHYSIOLOGY AND PATHOLOGY OF THE HAIR AND ITS FOLLICLE].
Topics: Alopecia; Dermatitis; Dermatitis, Seborrheic; Hair; Humans; Pathology; Physiology; Scalp; Sebaceous | 1963 |
[REACTIVITY OF THE SCALP TO NEURO-HORMONAL SUBSTANCES AND BIOLOGICALLY ACTIVE POLYPEPTIDES].
Topics: Alopecia; Angiotensins; Bradykinin; Epinephrine; Histamine; Nerve Endings; Norepinephrine; Peptides; | 1963 |
[STUDIES ON THE DEPILATION OF SCALP HAIR AND SCURF. 3. EFFECT OF HEAD BINDING].
Topics: Alopecia; Dandruff; Hair; Hair Removal; Humans; Lipids; Pityriasis; Scalp; Seasons; Temporal Arterie | 1964 |
[RARE CONGENITAL SCALP ABNORMALITY TREATED BY PLASTIC SURGERY].
Topics: Alopecia; Congenital Abnormalities; Humans; Infant; Plastic Surgery Procedures; Scalp; Skin Transpla | 1964 |
[ATROPHODERMIA OF THE LEFT HEMIFRONTAL REGION ASSOCIATED WITH CORRESPONDING ALOPECIA OF THE SCALP AND THE LEFT EYEBROW. SCLERODERMA WITH ATYPICAL BANDS?].
Topics: Alopecia; Eyebrows; Humans; Scalp; Scleroderma, Localized; Scleroderma, Systemic; Skin Diseases | 1964 |
AN UNUSUAL MALFORMATION OF THE SCALP CORRECTED BY PLASTIC SURGERY.
Topics: Alopecia; Congenital Abnormalities; Hair; Humans; Infant; Plastic Surgery Procedures; Scalp; Skin Tr | 1965 |
TREATMENT OF ALOPECIA CICATRICANS USING AN ARTERY FLAP.
Topics: Alopecia; Cicatrix; Humans; Scalp; Temporal Arteries; Vascular Surgical Procedures | 1965 |
ATROPHIC ALOPECIA DUE TO GRANULOMATOUS INFILTRATION OF SCALP IN SYSTEMIC SARCOIDOSIS.
Topics: Alopecia; Diagnosis; Granuloma; Humans; Pathology; Prednisone; Sarcoidosis; Scalp | 1965 |
[CIRCUMSCRIBED NONMYCOTIC ALOPECIA-LIKE DISEASES OF THE SCALP IN CHILDREN].
Topics: Alopecia; Alopecia Areata; Child; Classification; Humans; Scalp; Scalp Dermatoses | 1965 |
Microsporum canis infection of the scalp in an adult with cicatricial alopecia.
Topics: Adult; Alopecia; Disease; Head; Humans; Microsporum; Scalp; Tinea | 1955 |
[Preliminary note on a new treatment of essential alopecia. (Subcutaneous injection of trophic substances into the scalp].
Topics: Alopecia; Humans; Injections, Subcutaneous; Nutritional Status; Scalp | 1960 |
Pseudopelade.
Topics: Alopecia; Disease; Humans; Scalp; Skin Diseases | 1960 |
[Unusual sclero-artophic alopecizing development of pityriasiform dermoepidermitis (so-called seborrhoic dermatitis) of the scalp of a woman].
Topics: Alopecia; Dermatitis; Dermatitis, Seborrheic; Female; Humans; Medical Records; Scalp; Sebaceous Glan | 1960 |
Scarring alopecia associated with mastocytosis.
Topics: Alopecia; Cicatrix; Diagnosis, Differential; Female; Humans; Mast Cells; Mastocytosis, Cutaneous; Mi | 2003 |
[Hair loss].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alopecia; Alopecia Areata; Biopsy; Child; Clinical Tria | 2003 |
Primary cutaneous follicle center cell lymphoma of the scalp successfully treated with anti CD20 monoclonal antibody and CHOP combination therapy with no subsequent permanent loss of hair.
Topics: Adult; Alopecia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb | 2003 |
Parietal/occipital ratio of the hair diameter as a measure of baldness severity in men.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Cohort Studies; Hair; Humans; Male; Middle Age | 2003 |
Deep plane fixation in integumental surgery.
Topics: Alopecia; Biomechanical Phenomena; Elasticity; Humans; Plastic Surgery Procedures; Scalp; Stress, Me | 2004 |
Histological features of peripilar signs associated with androgenetic alopecia.
Topics: Adult; Alopecia; Biopsy; Female; Hair; Hair Follicle; Humans; Male; Middle Aged; Scalp | 2004 |
Pressure alopecia in living donors for liver transplantation.
Topics: Alopecia; Anti-Inflammatory Agents; Humans; Liver Transplantation; Living Donors; Massage; Mometason | 2004 |
Tinea capitis in a 17 year old soldier (residual infection?); alopecia areata associated with tinea capitis?
Topics: Alopecia; Alopecia Areata; Humans; Microsporum; Military Personnel; Scalp; Tinea; Tinea Capitis | 1950 |
Recurrent peptic ulcers with general hypertrichosis including growth of hair on the bald scalp and later development of signs suggesting adrenal failure.
Topics: Alopecia; Hair; Humans; Hypertrichosis; Peptic Ulcer; Scalp | 1951 |
[Therapy of pityriasis of the scalp; pityriasis simplex, dry scales].
Topics: Alopecia; Dandruff; Humans; Pityriasis; Scalp | 1952 |
Three patients with actinic keratoses on atrophic balding scalps who experienced delayed healing after treatment.
Topics: Alopecia; Atrophy; Chemexfoliation; Cryosurgery; Humans; Keratosis; Laser Therapy; Scalp; Scalp Derm | 2004 |
Two brothers with trichiasis, entropion and corneal scarring, sensorineural hearing loss, progressive thinning of scalp hair, mild learning difficulties and distinct facial features. A new syndrome?
Topics: Adolescent; Alopecia; Entropion; Face; Hearing Loss, Sensorineural; Humans; Male; Scalp; Siblings; S | 2004 |
Oculo-ectodermal syndrome: a new tumour predisposition syndrome.
Topics: Alopecia; Child, Preschool; Female; Follow-Up Studies; Genetic Predisposition to Disease; Granuloma, | 2004 |
Familial localized connective tissue nevus of the scalp with alopecia (report of a very unusual case).
Topics: Alopecia; Biopsy, Needle; Connective Tissue Diseases; Diagnosis, Differential; Follow-Up Studies; Ha | 2004 |
Videodermatoscopy enhances diagnostic capability in some forms of hair loss.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Child; Child, Preschool; Female; Hair; Hair Follicle; | 2004 |
Delayed wound healing after three different treatments for widespread actinic keratosis on the atrophic bald scalp.
Topics: Alopecia; Atrophy; Humans; Keratosis; Scalp; Scalp Dermatoses; Time Factors; Ultraviolet Rays; Wound | 2004 |
Weathering of hair in trichoteiromania.
Topics: Aged; Alopecia; Behavior Therapy; Female; Hair; Humans; Patient Education as Topic; Scalp; Trichotil | 2004 |
Evaluation of inflammatory infiltrate and fibrogenic cytokines in pseudopelade of Brocq suggests the involvement of T-helper 2 and 3 cytokines.
Topics: Adult; Aged; Alopecia; Cytokines; Female; Fibroblast Growth Factor 2; Humans; Immunohistochemistry; | 2004 |
The "silicone suture" for tissue expansion without an expander: a new device for repair of soft-tissue defects after burns.
Topics: Abdomen; Adolescent; Adult; Alopecia; Burns; Cicatrix; Dermatologic Surgical Procedures; Female; Hum | 2004 |
The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women.
Topics: Adolescent; Adult; Aged; Alopecia; Analysis of Variance; Biopsy, Needle; Chronic Disease; Female; Hu | 2004 |
Scarring alopecia in discoid lupus erythematosus: a clinical, histopathologic and immunopathologic study.
Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Antinuclear; Diagnosis, Differential; Female; Humans; | 2004 |
[Identification of geophilic and zoophilic dermatophytes in siblings with tinea capitis. A pathogenic factor or contamination?].
Topics: Alopecia; Animals; Biopsy; Cattle; Child, Preschool; Diagnosis, Differential; Eritrea; Female; Germa | 2004 |
Alopecia treatment with scalp expansion: some surgical fine points and a simple modification to improve the results.
Topics: Adolescent; Adult; Alopecia; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Plastic Sur | 2004 |
[Treatment of the scalp with percutine].
Topics: Alopecia; Humans; Scalp | 1950 |
[Circumscribed alopecia following furunculosis].
Topics: Alopecia; Alopecia Areata; Animals; Furunculosis; Humans; Scalp | 1950 |
Hair deformities.
Topics: Adult; Alopecia; Burns; Child; Female; Hair; Hair Diseases; Humans; Iatrogenic Disease; Male; Middle | 2004 |
Alopecia neoplastica due to metastatic breast carcinoma vs. extramammary Paget's disease: mimicry in epidermotropic carcinoma.
Topics: Aged; Aged, 80 and over; Alopecia; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Different | 2004 |
Circumscribed scalp hair loss following multiple hair-cutter ant invasion.
Topics: Adult; Alopecia; Animals; Ants; Ectoparasitic Infestations; Female; Humans; Scalp | 2004 |
Chest hair micrografts display extended growth in scalp tissue: a case report.
Topics: Aged; Alopecia; Graft Survival; Hair; Humans; Male; Microsurgery; Scalp; Tissue and Organ Harvesting | 2004 |
Validity of self reported male balding patterns in epidemiological studies.
Topics: Adult; Aged; Alopecia; Humans; Male; Middle Aged; Observation; Observer Variation; Scalp; Self Conce | 2004 |
Frontal fibrosing alopecia in postmenopausal women.
Topics: Aged; Alopecia; Eyebrows; Female; Fibrosis; Forehead; Humans; Middle Aged; Postmenopause; Scalp | 2005 |
Chronic telogen effluvium: a study of 5 patients over 7 years.
Topics: Adolescent; Adult; Alopecia; Biopsy; Chronic Disease; Diagnosis, Differential; Female; Follow-Up Stu | 2005 |
More research on facial hair.
Topics: Alopecia; Ethnicity; Face; Female; Hair; Humans; Male; Odorants; Scalp | 2005 |
Androgenetic alopecia in children: report of 20 cases.
Topics: Age of Onset; Alopecia; Biopsy; Child; Dermoscopy; Female; Genetic Predisposition to Disease; Humans | 2005 |
Frontal fibrosing alopecia developing after hair transplantation for androgenetic alopecia.
Topics: Aged; Alopecia; Fibrosis; Hair; Humans; Male; Postoperative Complications; Scalp | 2005 |
The lack of significant changes in scalp hair follicle density with advancing age.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alopecia; Biopsy; Female; Hair Follicle; Humans; | 2005 |
Ichthyosis follicularis with alopecia and photophobia in a girl with cataract: histological and electron microscopy findings.
Topics: Abnormalities, Multiple; Alopecia; Biopsy; Cataract; Child, Preschool; Corneal Neovascularization; F | 2005 |
Eyebrow reconstruction following burn injury.
Topics: Adult; Alopecia; Burns; Eyebrows; Female; Humans; Male; Plastic Surgery Procedures; Scalp; Surgical | 2005 |
A possible chemical burn to the scalp following hair highlights.
Topics: Adult; Alopecia; Burns, Chemical; Female; Hair Dyes; Humans; Scalp; Skin Ulcer | 2005 |
[Frontal fibrosing alopecia is not always post-menopausal].
Topics: Adolescent; Adult; Age of Onset; Aged; Alopecia; Disease Progression; Female; Fibrosis; Humans; Midd | 2005 |
Pseudocyst of the scalp.
Topics: Adult; Alopecia; Biopsy, Needle; Cysts; Female; Follow-Up Studies; Humans; Immunohistochemistry; Jap | 2005 |
Hair loss with chemotherapy: at a loss over its management?
Topics: Adaptation, Psychological; Adult; Alopecia; Attitude of Health Personnel; Attitude to Health; Cold T | 2005 |
Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
Topics: Administration, Topical; Aged; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Female; Human | 2005 |
[Incomplete tonsure like alopecia].
Topics: Adult; Alopecia; Biopsy; Diagnosis, Differential; Female; Hair Follicle; Humans; Scalp; Trichotillom | 2006 |
Medical Pearl: Comparing crown part width to occipital part width to diagnose female pattern hair loss.
Topics: Alopecia; Female; Humans; Scalp | 2005 |
Lipedematous alopecia: an unusual sequela of discoid lupus, or other co-conspirators at work?
Topics: Alopecia; Biopsy; Black or African American; Female; Humans; Lupus Erythematosus, Discoid; Middle Ag | 2005 |
[Repair of large cicatricial alopecia with skin soft-tissue expansion].
Topics: Adolescent; Adult; Alopecia; Child; Child, Preschool; Cicatrix; Female; Follow-Up Studies; Humans; M | 2005 |
Development of multiple tumours arising in a nevus sebaceus of Jadassohn.
Topics: Adenoma, Sweat Gland; Aged; Alopecia; Biopsy, Needle; Female; Follow-Up Studies; Humans; Immunohisto | 2005 |
[Two cases of frontal fibrosing alopecia in postmenopausal women].
Topics: Administration, Topical; Adrenal Cortex Hormones; Aged; Alopecia; Female; Fibrosis; Forehead; Humans | 2004 |
[Scalp surgery in children: principles and therapeutic aspects].
Topics: Adolescent; Alopecia; Child; Child, Preschool; Cicatrix; Craniocerebral Trauma; Ectodermal Dysplasia | 2005 |
Atypical fibroxanthoma on a bald scalp.
Topics: Aged, 80 and over; Alopecia; Head and Neck Neoplasms; Histiocytoma, Benign Fibrous; Humans; Male; Sc | 2005 |
Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective.
Topics: Alopecia; Black or African American; Cicatrix; Female; Fibrosis; Hair Follicle; Humans; Scalp | 2005 |
Substantial sex-dependent differences in the response of human scalp hair follicles to estrogen stimulation in vitro advocate gender-tailored management of female versus male pattern balding.
Topics: Alopecia; Estradiol; Estrogen Receptor beta; Estrogens; Female; Gene Expression Profiling; Gene Expr | 2005 |
Dermatopathology workshop summary, Berlin 2004.
Topics: Adolescent; Adult; Aged; Alopecia; Child; Female; Hair Follicle; Humans; Male; Middle Aged; Scalp; S | 2005 |
Female pattern hair loss, sebum excretion and the end-organ response to androgens.
Topics: Adolescent; Adult; Alopecia; Androgens; Body Mass Index; Female; Hair; Hirsutism; Humans; Middle Age | 2006 |
Large, nonhealing scalp ulcer associated with scarring alopecia and sclerodermatous change in a patient with porphyria cutanea tarda.
Topics: Alanine Transaminase; Alopecia; Aspartate Aminotransferases; Blood Sedimentation; Cicatrix; Hepatiti | 2005 |
Photo quiz. Painful scalp lesions and hair loss.
Topics: Adult; Alopecia; Anti-Bacterial Agents; Diagnosis, Differential; Drainage; Folliculitis; Humans; Mal | 2006 |
Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
Topics: Alopecia; Animals; Autocrine Communication; Biological Factors; Cell Division; Cells, Cultured; Cult | 2006 |
Hair transplantation: new concepts in 2005.
Topics: Alopecia; Hair Follicle; Humans; Scalp; Tissue and Organ Harvesting | 2005 |
Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study.
Topics: Aged; Aged, 80 and over; Alopecia; Apoptosis; Biopsy; Female; Fibrosis; Fluorescent Antibody Techniq | 2006 |
Permanent pressure alopecia after microsurgical breast reconstruction.
Topics: Alopecia; Breast Neoplasms; Equipment and Supplies, Hospital; Equipment Design; Female; Humans; Intr | 2006 |
Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride.
Topics: Alopecia; Finasteride; Hair; Humans; Male; Scalp | 2006 |
Reply to the letter to the editor on 'Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention', by C. Christodoulou, G. Tsakalos, E. Galani & D. V. Skarlos (doi:10.1093/annonc/mdj008).
Topics: Alopecia; Antineoplastic Agents; Humans; Scalp; Skin Neoplasms; Treatment Outcome | 2006 |
Recurrent blistering of the scalp with scarring.
Topics: Alopecia; Biopsy; Humans; Male; Middle Aged; Pemphigoid, Benign Mucous Membrane; Recurrence; Scalp; | 2006 |
Autosomal dominant atretic cephalocele with phenotype variability: report of a Brazilian family with six affected in four generations.
Topics: Adult; Aged; Alopecia; Brazil; Child; Child, Preschool; Encephalocele; Family Characteristics; Femal | 2006 |
Higher levels of steroidogenic acute regulatory protein and type I 3beta-hydroxysteroid dehydrogenase in the scalp of men with androgenetic alopecia.
Topics: 17-Hydroxysteroid Dehydrogenases; Alopecia; Cells, Cultured; Humans; Male; Phosphoproteins; Reverse | 2006 |
A nonadherent dressing for aplasia cutis congenita.
Topics: Alopecia; Bandages; Ectodermal Dysplasia; Female; Humans; Infant, Newborn; Scalp; Treatment Outcome | 2006 |
The triple rotation scalp flap revisited: a case of reconstruction of cicatricial pressure alopecia.
Topics: Adult; Alopecia; Humans; Male; Rotation; Scalp; Surgical Flaps; Treatment Outcome | 2006 |
Supragaleal placement of tissue expander for post-burn alopecia.
Topics: Adult; Alopecia; Burns; Female; Humans; Retrospective Studies; Scalp; Tissue Expansion Devices | 2006 |
Stem cell apoptosis in HIV-1 alopecia.
Topics: Adult; Alopecia; Apoptosis; Case-Control Studies; Female; Hair Follicle; HIV Infections; HIV-1; Huma | 2006 |
Follicular miniaturization in female pattern hair loss: clinicopathological correlations.
Topics: Alopecia; Biopsy; Cross-Sectional Studies; Female; Hair Follicle; Humans; Scalp; Severity of Illness | 2006 |
Follicular unit transplantation for male-pattern hair loss: Evaluation of 120 patients.
Topics: Adult; Age Distribution; Aged; Alopecia; Esthetics; Hair Color; Hair Follicle; Humans; Male; Middle | 2006 |
Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease.
Topics: Alopecia; Antiparkinson Agents; Benzothiazoles; Female; Hair Follicle; Humans; Middle Aged; Parkinso | 2006 |
[Hair darkening close to a patch of frontal fibrosing alopecia].
Topics: Aged; Alopecia; Female; Fibrosis; Hair Color; Humans; Scalp | 2006 |
Female-patterned alopecia in teenage brothers with unusual histologic features.
Topics: Adolescent; Alopecia; Diagnosis, Differential; Hair; Hair Follicle; Humans; Male; Scalp; Sex Charact | 2006 |
Temporary alopecia after subarachnoid haemorrhage.
Topics: Adult; Alopecia; Cerebral Angiography; Embolization, Therapeutic; Fluoroscopy; Humans; Intracranial | 2007 |
A patch of alopecia in a 70-year-old woman.
Topics: Aged; Alopecia; Biopsy; Female; Hair Follicle; Humans; Scalp; Tinea Capitis; Trichophyton | 2007 |
Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro.
Topics: Adult; Alopecia; Androgens; Biopsy; Caffeine; Hair Follicle; Humans; Immunohistochemistry; In Vitro | 2007 |
Alopecia neoplastica due to metastatic colon adenocarcinoma.
Topics: Adenocarcinoma; Alopecia; Colonic Neoplasms; Female; Humans; Middle Aged; Scalp; Skin Neoplasms | 2007 |
[Prevention and treatment of postoperative complications after skin soft tissue expansion for scar alopecia].
Topics: Adolescent; Adult; Alopecia; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Postoperati | 2006 |
Cervical cancer metastasis to the scalp presenting as alopecia neoplastica.
Topics: Alopecia; Female; Head and Neck Neoplasms; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Squa | 2007 |
Scalp biopsy specimens: transverse vs vertical sections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Biopsy; Child; Female; Hair Follicle; Humans; | 2007 |
Evolution of techniques in hair transplantation: a 12-year perspective.
Topics: Adult; Alopecia; Cosmetic Techniques; Disease Progression; Enzyme Inhibitors; Female; Finasteride; F | 2007 |
Male pattern androgenetic alopecia in an Indian context: a perspective study.
Topics: Adolescent; Adult; Age of Onset; Alopecia; Disease Progression; Hair; Hair Preparations; Humans; Ind | 2007 |
Expression of sex-determining genes in the scalp of men with androgenetic alopecia.
Topics: Adult; Alopecia; DAX-1 Orphan Nuclear Receptor; DNA-Binding Proteins; Genes, sry; High Mobility Grou | 2007 |
[Tissue expansion in surgical treatment of burn scars of the scalp].
Topics: Adolescent; Alopecia; Burns; Child; Child, Preschool; Cicatrix; Humans; Male; Scalp; Tissue Expansio | 2007 |
[A "silicone suture" technique aided to scalp reduction for the treatment of scarring alopecia].
Topics: Adolescent; Adult; Alopecia; Cicatrix; Female; Humans; Male; Scalp; Silicones; Sutures; Young Adult | 2007 |
Staged hair transplantation in cicatricial alopecia after carbon dioxide laser-assisted scar tissue remodeling.
Topics: Adult; Alopecia; Cicatrix; Female; Hair; Humans; Laser Therapy; Male; Scalp; Transplantation, Autolo | 2007 |
Lassueur-Graham-Little-Piccardi syndrome.
Topics: Alopecia; Axilla; Biopsy; Cicatrix; Diagnosis, Differential; Follow-Up Studies; Humans; Male; Middle | 2007 |
[Skin expansion in cicatricial alopecia of the scalp: 18 cases].
Topics: Adolescent; Adult; Aged; Alopecia; Burns; Cicatrix; Female; Humans; Male; Middle Aged; Plastic Surge | 2007 |
Cross-sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopecia.
Topics: Adolescent; Adult; Aged; Alopecia; Cicatrix; Cross-Sectional Studies; Female; Humans; Korea; Lupus E | 2007 |
Alopecia associated with birth injury.
Topics: Adult; Alopecia; Birth Injuries; Edema; Female; Hair; Humans; Infant, Newborn; Male; Plastic Surgery | 2007 |
An unusual case of lipedematous alopecia.
Topics: Adipose Tissue; Alopecia; Biopsy; Epidermis; Female; Humans; Middle Aged; Scalp | 2007 |
Hair loss in children in South-East Nigeria: common and uncommon cases.
Topics: Adolescent; Age Distribution; Alopecia; Alopecia Areata; Child; Child, Preschool; Female; Humans; In | 2007 |
Endovascular treatment of AVF after hair transplantation.
Topics: Adult; Alopecia; Angiography; Arteriovenous Fistula; Diagnosis, Differential; Embolization, Therapeu | 2008 |
Long-term hair repigmentation following a hair transplant for frontal scarring alopecia.
Topics: Alopecia; Cicatrix; Female; Hair Color; Hair Follicle; Humans; Middle Aged; Scalp; Transplantation, | 2007 |
Transverse sectioning of the scalp (Headington technique) in the 19th century.
Topics: Alopecia; History, 19th Century; History, 20th Century; Humans; Microscopy; Scalp; Skin Diseases | 2008 |
Histological study of human scalps exhibiting various degrees of non-specific baldness.
Topics: Alopecia; Humans; Scalp | 1949 |
TrichoScan, a GCP-validated tool to measure hair growth.
Topics: Alopecia; Biopsy, Needle; Diagnosis, Computer-Assisted; Hair; Humans; Scalp; Software | 2008 |
Successful surgical management of lipoedematous alopecia.
Topics: Aged; Alopecia; Female; Fibrosis; Humans; Scalp; Scalp Dermatoses; Skin; Subcutaneous Fat | 2008 |
Aesthetic considerations in scalp reconstruction.
Topics: Alopecia; Cicatrix; Esthetics; Hair; Hair Follicle; Head and Neck Neoplasms; Humans; Microcirculatio | 2008 |
No association between serum ferritin levels >10 microg/l and hair loss activity in women.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alopecia; Anemia, Iron-Deficiency; Female; | 2008 |
Tick-borne lymphadenopathy/dermacentor-borne necrosis erythema lymphadenopathy: an infectious cause of cicatricial alopecia.
Topics: Alopecia; Animals; Child, Preschool; Cicatrix; Dermacentor; Erythema; Humans; Lymphatic Diseases; Ma | 2008 |
Influence of scalp hypothermia on doxorubicin related alopecia.
Topics: Adult; Alopecia; Doxorubicin; Female; Humans; Hypothermia, Induced; Male; Scalp; Skin Temperature | 1980 |
Scalp cooling by thermocirculator.
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Neoplasms; Scalp | 1982 |
[Proposal for a topographical approach to hair transplantation and scalp reduction].
Topics: Alopecia; Female; Hair; Humans; Male; Scalp; Surgery, Plastic | 1984 |
[Kinetics of the scalp in reduction operations for male alopecia].
Topics: Adult; Alopecia; Humans; Kinetics; Male; Middle Aged; Postoperative Period; Scalp | 1984 |
The effect of the antiandrogen II alpha-hydroxyprogesterone on sebum production and cholesterol concentration of sebum.
Topics: Adult; Alopecia; Androgen Antagonists; Cholesterol; Dermatitis, Seborrheic; Female; Humans; Hydroxyp | 1982 |
[Comparative morphometric study of the sebaceous and sweat glands in alopecia areata, chronic diffuse and seborrheic baldness].
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Biopsy; Child; Chronic Disease; Dermatitis, Seborrheic | 1982 |
[Hypothermia: scalp cooling for the prevention of cytostatic-induced hair loss].
Topics: Adolescent; Adult; Aged; Alopecia; Doxorubicin; Evaluation Studies as Topic; Female; Humans; Hypothe | 1982 |
[Follicular psoriasis with cicatricial alopecia. Piccardi-Lassueur-Graham Little syndrome of a psoriatic nature].
Topics: Adult; Alopecia; Cicatrix; Etretinate; Female; Foot; Humans; Pregnancy; Pregnancy Complications; Pso | 1983 |
Complications of scalp reductions.
Topics: Alopecia; Anesthesia; Cicatrix; Esthetics; Foreign Bodies; Hair; Humans; Intraoperative Complication | 1983 |
The preservation of hair in burns of the scalp.
Topics: Adult; Alopecia; Burns; Hair; Humans; Male; Methods; Scalp; Skin Transplantation | 1983 |
A new method of donor site harvesting.
Topics: Alopecia; Hair; Humans; Methods; Scalp; Suture Techniques | 1984 |
Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis).
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Antibodies, Monoclonal; Child; Child, Preschool; Femal | 1984 |
[Spinocellular cancer at the site of chronic discoid lupus erythematosus].
Topics: Alopecia; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Female; Fluorescent Antibody Te | 1984 |
[Prevention of hair loss during adriamycin treatment].
Topics: Alopecia; Doxorubicin; Humans; Hypothermia, Induced; Scalp | 1983 |
[How are the Blaschko lines arranged on the scalp?].
Topics: Abnormalities, Multiple; Alopecia; Female; Hair; Humans; Infant, Newborn; Orofaciodigital Syndromes; | 1984 |
Sideburn reconstruction for postrhytidectomy deformity.
Topics: Aged; Alopecia; Face; Female; Humans; Middle Aged; Reoperation; Scalp; Surgery, Plastic; Surgical Fl | 1984 |
Surgical treatment for frontal baldness: the long temporal vertical flap.
Topics: Adolescent; Alopecia; Humans; Postoperative Complications; Scalp; Surgery, Plastic; Surgical Flaps | 1984 |
Scalp reduction surgery.
Topics: Alopecia; Humans; Scalp; Surgery, Plastic | 1984 |
Alopecia reduction by scalp expansion.
Topics: Alopecia; Humans; Male; Methods; Scalp; Surgical Flaps | 1984 |
Hair transplantation with microsurgical free scalp flap.
Topics: Adult; Alopecia; Burns; Child, Preschool; Cicatrix; Female; Hair; Humans; Male; Microsurgery; Scalp; | 1984 |
The Y-shaped pattern of alopecia reduction and its variations.
Topics: Adult; Alopecia; Humans; Male; Methods; Scalp; Surgical Flaps; Sutures | 1984 |
Scalp kinetics in multiple excisions for correction of male pattern baldness.
Topics: Adult; Alopecia; Humans; Kinetics; Male; Middle Aged; Postoperative Complications; Postoperative Per | 1984 |
Halo scalp ring: a form of localized scalp injury associated with caput succedaneum.
Topics: Alopecia; Birth Injuries; Female; Humans; Infant; Infant, Newborn; Male; Scalp | 1984 |
[Pneumatic cold cap for the prevention of doxorubicin-induced alopecia].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxoru | 1984 |
[Prophylactic effect of scalp cooling to prevent chemotherapy-induced hair loss].
Topics: Alopecia; Antineoplastic Agents; Cryotherapy; Humans; Scalp | 1984 |
Cosmetic correction of alopecia.
Topics: Adult; Alopecia; Esthetics; Hair; Humans; Male; Postoperative Complications; Punctures; Scalp; Surgi | 1983 |
Alopecia totalis as a presentation of cutaneous metastasis (alopecia neoplastica).
Topics: Adenocarcinoma; Aged; Alopecia; Breast Neoplasms; Female; Humans; Scalp; Skin Neoplasms | 1983 |
Alopecia ichthyotica. A characteristic feature of congenital ichthyosis.
Topics: Adolescent; Adult; Alopecia; Female; Genes, Recessive; Humans; Ichthyosis; Scalp; Terminology as Top | 1983 |
Baldness surgery--reduction versus flap.
Topics: Adult; Alopecia; Humans; Male; Methods; Middle Aged; Scalp; Surgical Flaps | 1983 |
Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopecia.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-R | 1983 |
"Stretch-back" in scalp reductions for male pattern baldness.
Topics: Alopecia; Humans; Male; Postoperative Complications; Scalp; Surgery, Plastic | 1984 |
[Status of the microcirculation of the skin in patients undergoing reflexotherapy for alopecia].
Topics: Acupuncture Therapy; Adult; Alopecia; Female; Humans; Male; Microcirculation; Scalp | 1984 |
Transverse microscopic anatomy of the human scalp. A basis for a morphometric approach to disorders of the hair follicle.
Topics: Adult; Alopecia; Biopsy; Hair; Humans; Male; Scalp; Scalp Dermatoses | 1984 |
Scalp cooling and cytotoxic drugs.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cryotherapy; Humans; Methods; Scalp | 1984 |
[Therapeutic strategy in the repair of temporoparietal alopecia: value of the median or paramedian sagittal flap. Apropos of 6 cases].
Topics: Adult; Alopecia; Burns; Child; Humans; Methods; Scalp; Surgical Flaps; Time Factors | 1984 |
The postauricular vertical hair-bearing transposition flap.
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Surgical Flaps | 1984 |
[Prevention of hair loss during cancer chemotherapy].
Topics: Alopecia; Antineoplastic Agents; Cryotherapy; Doxorubicin; Female; Humans; Male; Scalp; Vasoconstric | 1984 |
Surgical management of the burned scalp.
Topics: Alopecia; Burns; Child; Child, Preschool; Female; Hair; Humans; Infant; Male; Scalp; Skin Transplant | 1982 |
Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Carcinoid Tumor; Doxorubicin; Female; Gels; Humans; Hypothe | 1981 |
Prevention of doxorubicin-induced alopecia.
Topics: Alopecia; Doxorubicin; Female; Humans; Hypothermia, Induced; Scalp | 1981 |
[Prevention of adriamycin-induced alopecia].
Topics: Alopecia; Cryotherapy; Doxorubicin; Humans; Scalp | 1981 |
Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling.
Topics: Alopecia; Breast Neoplasms; Cryotherapy; Doxorubicin; Female; Humans; Scalp; Time Factors | 1982 |
Change of direction of hair growth.
Topics: Alopecia; Hair; Humans; Methods; Scalp | 1983 |
Scalp reduction for baldness.
Topics: Alopecia; Humans; Male; Scalp | 1983 |
Surface temperature of bald and hairy scalp in reference to leprosy affection.
Topics: Adult; Alopecia; Female; Humans; Leprosy; Male; Middle Aged; Scalp; Skin Temperature | 1983 |
[Therapy of cicatricial alopecia caused by burns in the child].
Topics: Alopecia; Burns; Child; Child, Preschool; Cicatrix; Female; Humans; Male; Scalp; Surgical Flaps | 1983 |
Preventing chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Scalp; Skin Neoplasms; Tourniquets | 1983 |
[Cooling of the scalp as a preventive measure for alopecia during cytostatic therapy].
Topics: Alopecia; Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Female; Freezing; Humans; M | 1983 |
Bent scalpel and facelift scissors to facilitate scalp reduction.
Topics: Alopecia; Humans; Scalp; Surgical Instruments | 1983 |
Scalp tourniquets for chemotherapy-induced alopecia.
Topics: Alopecia; Cyclophosphamide; Evaluation Studies as Topic; Humans; Scalp; Tourniquets | 1980 |
Alopecia and chemotherapy.
Topics: Alopecia; Androgens; Antineoplastic Agents; Bandages; Drug-Related Side Effects and Adverse Reaction | 1980 |
Scalp hypothermia to prevent adriamycin-induced hair loss.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Carcinoid Tumor; Doxorubicin; Female; Humans; Hypothermia, | 1982 |
[Immunofluorescence studies on Clq in the mast cells (author's transl)].
Topics: Adolescent; Adult; Alopecia; Child; Complement Activating Enzymes; Complement C1q; Female; Humans; M | 1981 |
Fiber implantation for pattern baldness. Review of complications in forty-one patients.
Topics: Acrylates; Adult; Alopecia; Cicatrix; Edema; Female; Foreign-Body Reaction; Hair; Humans; Male; Post | 1981 |
Subtle clues to diagnosis by immunopathology. Scarring alopecia.
Topics: Alopecia; Fluorescent Antibody Technique; Humans; Lichen Planus; Lupus Erythematosus, Systemic; Scal | 1980 |
Complications of fiber implantation for baldness.
Topics: Adult; Alopecia; Cicatrix; Foreign-Body Reaction; Graft Rejection; Hair; Humans; Male; Polymers; Sca | 1981 |
Role of scalp reduction in the treatment of male pattern baldness.
Topics: Adult; Alopecia; Hair; Humans; Male; Middle Aged; Postoperative Complications; Scalp; Surgery, Plast | 1982 |
Short flaps-their use and abuse in the treatment of male pattern baldness.
Topics: Alopecia; Hair; Humans; Male; Postoperative Complications; Scalp; Surgery, Plastic; Surgical Flaps | 1982 |
Updating reduction and flap procedures for baldness.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgery, Plastic; Surgical Flaps | 1982 |
[Tonsural bald spot reduction, an adjunct to transplantation in common baldness].
Topics: Alopecia; Humans; Methods; Scalp | 1982 |
Hair autotransplant into the skull--experimental study in the pig with reference to burn alopecia.
Topics: Alopecia; Animals; Burns; Hair; Scalp; Skull; Swine | 1982 |
Surgical treatment for baldness.
Topics: Alopecia; Hair; Humans; Male; Postoperative Care; Scalp; Surgery, Plastic | 1982 |
An alternative flap in the treatment of baldness.
Topics: Alopecia; Humans; Scalp; Surgery, Plastic; Surgical Flaps | 1982 |
Surgical treatment of cicatricial alopecia of the scalp.
Topics: Adult; Alopecia; Burns; Child; Child, Preschool; Cicatrix; Female; Hair; Humans; Infant; Male; Middl | 1982 |
The punch scalp graft.
Topics: Alopecia; Anesthesia; Female; Hair; Humans; Male; Postoperative Care; Preoperative Care; Scalp; Tran | 1982 |
Square scalp grafts.
Topics: Alopecia; Anesthetics, Local; Hair; Humans; Postoperative Care; Scalp; Surgical Instruments; Transpl | 1982 |
The strip scalp graft.
Topics: Adult; Alopecia; Hair; Humans; Male; Middle Aged; Postoperative Period; Scalp; Transplantation, Auto | 1982 |
The lateral scalp flap for anterior hairline reconstruction.
Topics: Adult; Alopecia; Hair; Humans; Male; Methods; Middle Aged; Postoperative Care; Postoperative Complic | 1982 |
Temporo-parieto-occipital flap for the treatment of baldness.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps | 1982 |
Application of microvascular free flaps to scalp defects.
Topics: Alopecia; Humans; Infant; Male; Microsurgery; Middle Aged; Scalp; Surgical Flaps | 1982 |
Scalp reduction.
Topics: Adult; Alopecia; Child; Female; Humans; Male; Methods; Middle Aged; Postoperative Care; Postoperativ | 1982 |
Familial occurrence of aplasia cutis congenita.
Topics: Adult; Alopecia; Female; Humans; Infant; Male; Pedigree; Scalp; Skin Abnormalities | 1982 |
Angiosarcoma (angioendothelioma) of the scalp. An unusual case of scarring alopecia.
Topics: Aged; Alopecia; Cicatrix; Female; Hemangiosarcoma; Humans; Scalp; Skin Neoplasms | 1980 |
Scalp reduction as an adjunct to hair transplantation. Review of relevant literature and presentation of an improved technique.
Topics: Alopecia; Hair; Humans; Lidocaine; Male; Methylprednisolone; Middle Aged; Scalp; Surgery, Plastic; S | 1980 |
The use of small punches in hair-transplant surgery.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps | 1980 |
Psychiatric observations on patients who seek and undergo hair transplantation.
Topics: Alopecia; Gender Identity; Hair; Humans; Male; Mental Disorders; Patients; Psychosexual Development; | 1980 |
Two new methods for treating baldness: temporo-parieto-occipito-parietal pedicled flap and temporo-parieto-occipital free flap.
Topics: Alopecia; Humans; Microsurgery; Scalp; Surgical Flaps | 1981 |
The surgical treatment of temporal and sideburn alopecia.
Topics: Adult; Alopecia; Child; Female; Humans; Male; Methods; Middle Aged; Scalp; Surgical Flaps | 1981 |
Alopecia neoplastica--a rare form of cutaneous metastasis.
Topics: Alopecia; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Scalp; Skin Neoplasms | 1981 |
Short vs long scalp flaps in the treatment of male pattern baldness.
Topics: Age Factors; Alopecia; Hair; Hospitalization; Humans; Male; Methods; Postoperative Complications; Sc | 1981 |
Predicting hair growth for hair transplantations.
Topics: Alopecia; Cicatrix; Evaluation Studies as Topic; Hair; Hemorrhage; Humans; Postoperative Complicatio | 1981 |
Eosinophilic cellulitis. (Well's syndrome) in a child.
Topics: Alopecia; Cellulitis; Child; Dermatitis; Eosinophilia; Granuloma; Humans; Male; Scalp; Skin; Syndrom | 1981 |
Treatment of baldness in Brazil.
Topics: Alopecia; Hair; Humans; Scalp; Surgical Flaps; Transplantation, Autologous | 1981 |
[Surgical treatment in some types of alopecia (author's transl)].
Topics: Adult; Alopecia; Alopecia Areata; Female; Humans; Male; Scalp | 1981 |
Aesthetic aspects of reconstructive scalp surgery.
Topics: Alopecia; Esthetics; Humans; Scalp; Surgery, Plastic; Surgical Flaps | 1981 |
[The Juri flap: our problems].
Topics: Alopecia; Humans; Male; Methods; Scalp; Surgical Flaps | 1981 |
[Prevention of alopecia, induced by cytostatic drugs, using hypothermia on the scalp].
Topics: Adult; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cryotherapy; Female; Humans; Lung Neoplasm | 1981 |
Erosive pustular dermatosis of the scalp.
Topics: Aged; Alopecia; Female; Humans; Scalp; Scalp Dermatoses | 1981 |
Free scalp flap.
Topics: Adolescent; Adult; Alopecia; Burns; Female; Humans; Male; Methods; Scalp; Surgical Flaps | 1980 |
Autosomal recessive inheritance of atrichia congenita.
Topics: Alopecia; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Female; Genes, Rece | 1980 |
Closure of the donor site in hair transplantation by a cluster technique.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgery, Plastic; Transplantation, Autologous | 1980 |
Transposition flaps for the correction of baldness: a practical office procedure.
Topics: Adult; Alopecia; Ambulatory Surgical Procedures; Female; Humans; Male; Methods; Scalp; Surgical Flap | 1980 |
Reduction of male pattern baldness in multiple stages: a retrospective study.
Topics: Adult; Aged; Alopecia; Elasticity; Humans; Male; Middle Aged; Postoperative Complications; Scalp; Ti | 1980 |
Occult syringomas of scalp associated with progressive hair loss.
Topics: Adenoma; Alopecia; Female; Humans; Middle Aged; Scalp; Sweat Gland Neoplasms | 1980 |
[Alopecia].
Topics: Adult; Alopecia; Alopecia Areata; Child; Female; Hair; Humans; Lupus Erythematosus, Systemic; Male; | 1980 |
Dangers of synthetic fiber implantation for male pattern baldness.
Topics: Alopecia; Foreign Bodies; Humans; Male; Prostheses and Implants; Scalp | 1980 |
Reconstruction of scalp hemicircumference.
Topics: Alopecia; Humans; Methods; Scalp; Surgical Flaps; Time Factors | 1980 |
Free scalp flap surgery.
Topics: Adolescent; Adult; Alopecia; Child, Preschool; Female; Humans; Male; Scalp; Surgical Flaps | 1980 |
Monopedicled transposition flap for the treatment of traumatic scalp alopecias.
Topics: Adolescent; Adult; Alopecia; Burns; Child; Female; Humans; Radiation Injuries; Scalp; Surgical Flaps | 1980 |
Permanent baldness following caput succedaneum.
Topics: Adolescent; Alopecia; Birth Injuries; Hemorrhage; Humans; Male; Scalp | 1980 |
Quantification of hair follicle parameters using computer image analysis: a comparison of androgenetic alopecia with normal scalp biopsies.
Topics: Adult; Alopecia; Biopsy; Female; Hair Follicle; Humans; Image Processing, Computer-Assisted; Male; M | 1995 |
Laser hair transplantation. Tissue effects of laser parameters.
Topics: Adult; Alopecia; Evaluation Studies as Topic; Hair; Humans; Laser Therapy; Male; Middle Aged; Necros | 1995 |
Mini-slit graft hair transplantation using the Ultrapulse carbon dioxide laser handpiece.
Topics: Adult; Alopecia; Cicatrix; Female; Follow-Up Studies; Hair; Humans; Laser Therapy; Male; Postoperati | 1995 |
Linear transverse forehead incision for patients with alopecia praematura--technical note.
Topics: Adult; Aged; Alopecia; Brain; Brain Neoplasms; Craniotomy; Humans; Male; Middle Aged; Scalp; Surgery | 1995 |
A concentric method for mini-micrografting extensively bald patients.
Topics: Alopecia; Hair; Humans; Male; Methods; Preoperative Care; Scalp; Time Factors | 1995 |
Presuturing--a technique for closing congenital vertex aplasia.
Topics: Alopecia; Child, Preschool; Humans; Male; Methods; Scalp; Suture Techniques | 1995 |
Human scalp hair follicle development from birth to adulthood: statistical study with special regard to putative stem cells in the bulge and proliferating cells in the matrix.
Topics: Adolescent; Adult; Age Factors; Alopecia; Cell Division; Child; Child, Preschool; Epidermal Cells; E | 1995 |
New aspects in hair transplantation for females.
Topics: Adult; Alopecia; Esthetics; Eyebrows; Female; Groin; Hair; Humans; Male; Microsurgery; Middle Aged; | 1995 |
Scalp reductions.
Topics: Alopecia; Cicatrix; Humans; Laser Therapy; Scalp; Surgery, Plastic | 1995 |
The Burow's triangle scalp reduction. A new and improved technique for paramedian scalp reduction.
Topics: Alopecia; Humans; Scalp; Surgery, Plastic | 1995 |
Extensive head burns corrected by scalp extension.
Topics: Adult; Alopecia; Burns; Female; Humans; Scalp; Tissue Expansion | 1995 |
"Chignon alopecia": a distinctive type of nonmarginal traction alopecia.
Topics: Alopecia; Female; Humans; Middle Aged; Scalp | 1995 |
Alopecia: an unfavorable result of using a skin-stretching device.
Topics: Adolescent; Alopecia; Humans; Male; Postoperative Complications; Scalp; Surgery, Plastic; Tissue Exp | 1995 |
Laser hair transplantation II.
Topics: Alopecia; Blood Loss, Surgical; Carbon Dioxide; Equipment Design; Evaluation Studies as Topic; Follo | 1995 |
New devices for scalp reduction. Intraoperative and prolonged scalp extension.
Topics: Alopecia; Cicatrix; Dermatology; Equipment Design; Humans; Intraoperative Care; Male; Postoperative | 1995 |
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adenocarcinoma; Aging; Alopecia; Animals; Brain; CHO Cells; C | 1993 |
A scalp garment for prestretching prior to alopecia-reducing procedures.
Topics: Alopecia; Humans; Preoperative Care; Scalp | 1995 |
Noninvasive undermining. An innovative adjunct to scalp surgery [ comment].
Topics: Alopecia; Humans; Preoperative Care; Scalp | 1995 |
T-cell receptor repertoire V beta in alopecia areata.
Topics: Alopecia; Alopecia Areata; Case-Control Studies; Gene Expression; Genetic Variation; Hair; Humans; L | 1995 |
Glucocorticoid regulation of hair growth in alopecia areata.
Topics: Alopecia; Alopecia Areata; Calcium; Calmodulin; Case-Control Studies; Glucocorticoids; Hair; Humans; | 1995 |
A case of alopecia universalis without the involvement of scalp hairs.
Topics: Alopecia; Extremities; Eyebrows; Genitalia, Male; Hair; Humans; Male; Middle Aged; Scalp; Skin | 1995 |
Hair. Don't stop thinking about tomorrow--it'll soon be here.
Topics: Alopecia; Hair; Humans; Scalp; Tissue Expansion Devices; Transplantation, Autologous | 1995 |
[Scarring psoriatic alopecia].
Topics: Adult; Alopecia; Cicatrix; Diagnosis, Differential; Female; Hair; Humans; Psoriasis; Scalp; Scalp De | 1995 |
Minimal expansion for correction of male pattern baldness.
Topics: Adult; Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps; Time Factors; Tissue Expansion | 1995 |
The Mercedes incision in hair restoration.
Topics: Alopecia; Hair; Humans; Scalp; Transplantation | 1995 |
Aplasia cutis congenita of the scalp in five successive generations of one family.
Topics: Adult; Alopecia; Congenital Abnormalities; Family; Female; Humans; Scalp | 1995 |
[Surgical classification of androgenetic baldness and its therapeutic implications].
Topics: Alopecia; Elasticity; Hair; Humans; Male; Scalp; Surgical Flaps | 1994 |
[Complications of synthetic hair implantation].
Topics: Adult; Alopecia; Bacterial Infections; Biocompatible Materials; Cicatrix; Expert Testimony; Follicul | 1995 |
A redefinition of male pattern baldness and its treatment implications. A position paper.
Topics: Adult; Alopecia; Attitude of Health Personnel; Attitude to Health; Esthetics; Hair; Humans; Male; Me | 1995 |
[Congenital cutaneous aplasia. Apropos of 3 new cases located in the vertex].
Topics: Abnormalities, Multiple; Alopecia; Humans; Infant, Newborn; Male; Scalp; Skin Abnormalities; Surgery | 1993 |
Radiation-induced temporary epilation after a neuroradiologically guided embolization procedure.
Topics: Adult; Alopecia; Angiography, Digital Subtraction; Embolization, Therapeutic; Female; Fluoroscopy; H | 1994 |
[Implantation of synthetic hair is not risk-free].
Topics: Adult; Alopecia; Hair; Humans; Male; Prostheses and Implants; Risk Factors; Scalp; Scalp Dermatoses | 1994 |
Metabolism of 5 alpha-androstane-3 beta,17 beta-diol in bald and hairy areas of the scalp.
Topics: Alopecia; Androstane-3,17-diol; Androsterone; Dihydrotestosterone; Etiocholanolone; Gas Chromatograp | 1994 |
Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution.
Topics: Aged; Alopecia; Cicatrix; Female; Fibrosis; Humans; Middle Aged; Postmenopause; Scalp | 1994 |
Cell kinetics of anagen scalp hairs under physiological and pathological conditions.
Topics: Alopecia; Cell Cycle; Cell Division; DNA; Female; Flow Cytometry; Hair; Hair Diseases; Hirsutism; Hu | 1994 |
The phototrichogram: analysis of some technical factors of variation.
Topics: Alopecia; Female; Hair; Humans; Male; Photography; Scalp | 1994 |
Hair cycle and alopecia.
Topics: Adult; Aging; Alopecia; Hair; Humans; Male; Middle Aged; Photography; Scalp | 1994 |
Alopecia neoplastica without alopecia: a unique presentation of breast carcinoma scalp metastasis.
Topics: Adenocarcinoma; Aged; Alopecia; Breast Neoplasms; Female; Humans; Scalp; Skin Neoplasms | 1994 |
Clinical and histologic findings in temporal triangular alopecia.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Biopsy; Diagnosis, Differential; Female; Hair; Humans; | 1994 |
[Cross transposition of expanded scalp flaps for the treatment of postburn cicatricial alopecia].
Topics: Adolescent; Adult; Alopecia; Burns; Cicatrix; Female; Humans; Male; Scalp; Surgical Flaps; Tissue Ex | 1994 |
Scalp lifting. Anatomic and technical considerations.
Topics: Alopecia; Analgesia; Anesthesia; Arteries; Hemostasis, Surgical; Humans; Ligation; Male; Occipital B | 1994 |
Guanylate cyclase activity in male pattern baldness. Stimulating effect of 3-beta-androstanediol.
Topics: Alopecia; Androstane-3,17-diol; Cyclic AMP; Cyclic GMP; Cytosol; Dihydrotestosterone; Guanylate Cycl | 1993 |
Application of electrosurgery in scalp reduction. Experience with an ultrasharp tungsten needle electrode.
Topics: Alopecia; Electrodes; Electrosurgery; Humans; Needles; Scalp; Tungsten | 1994 |
Immunocytochemical localization of androgen receptors in the scalp of the stumptail macaque monkey, a model of androgenetic alopecia.
Topics: Alopecia; Animals; Disease Models, Animal; Female; Immunohistochemistry; Macaca; Male; Receptors, An | 1994 |
Circumferential scalp reduction. The application of the principles of extensive scalp-lifting for the improvement of scalp reduction surgery.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps | 1994 |
Male pattern baldness.
Topics: Alopecia; Hair; Humans; Male; Minoxidil; Scalp; Surgical Flaps | 1994 |
Post-thermal burn alopecia and its treatment using extensive horizontal scalp reduction in combination with a Juri flap.
Topics: Adolescent; Adult; Alopecia; Burns; Humans; Male; Scalp; Surgical Flaps | 1994 |
A case of Goltz syndrome presenting as congenital incomplete alopecia.
Topics: Alopecia; Child; Female; Focal Dermal Hypoplasia; Humans; Scalp | 1994 |
Quantitative study of the human hair follicle in normal scalp and androgenetic alopecia.
Topics: Adult; Aged; Alopecia; Hair; Humans; Male; Middle Aged; Scalp | 1993 |
Syringomatous carcinoma of the scalp presenting as a slowly enlarging patch of alopecia.
Topics: Alopecia; Carcinoma; Diagnosis, Differential; Female; Humans; Middle Aged; Scalp; Skin Neoplasms | 1993 |
Scalp lifting. An 8-year experience with over 1,230 cases.
Topics: Alopecia; Female; Humans; Ligation; Male; Necrosis; Postoperative Complications; Scalp; Surgical Fla | 1993 |
The scalp. To lift or not to lift--is that really the question?
Topics: Alopecia; Humans; Male; Scalp | 1993 |
A preliminary report on a strategy for treatment of male pattern baldness: bilateral vertical flaps plus tissue expansion.
Topics: Alopecia; Humans; Male; Scalp; Surgical Flaps; Tissue Expansion | 1993 |
[Alopecia psoriatica. Characteristics of an up to now neglected disease picture].
Topics: Alopecia; Diagnosis, Differential; Hair; Humans; Prognosis; Psoriasis; Scalp | 1993 |
[Baldness: indications].
Topics: Adult; Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps; Tissue Expansion Devices | 1993 |
Intraoperative expander-assisted scalp reduction.
Topics: Alopecia; Analgesia; Anesthesia, Local; Humans; Intraoperative Care; Male; Scalp; Surgical Flaps; Ti | 1993 |
The expanded "BAT" flap for treatment of male pattern baldness.
Topics: Adult; Alopecia; Hair; Humans; Male; Scalp; Surgery, Plastic; Surgical Flaps | 1993 |
[Forum on tissue expansion. Expansion of the scalp. Surgical techniques and clinical applications].
Topics: Adolescent; Adult; Alopecia; Burns; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Scal | 1993 |
[Forum on tissue expansion. Conclusion. How to master expansion...].
Topics: Alopecia; Burns; Female; Humans; Male; Scalp; Surgical Flaps; Tissue Expansion; Tissue Expansion Dev | 1993 |
[A case for diagnosis: cutaneous metastasis of breast carcinoma].
Topics: Adenocarcinoma; Alopecia; Breast Neoplasms; Female; Humans; Middle Aged; Scalp; Skin Neoplasms | 1993 |
Spotted cicatricial alopecia in dark skin. A dermoscopic clue to fibrous tracts.
Topics: Adult; Alopecia; Black People; Cicatrix; Female; Hair; Humans; Scalp; Skin Pigmentation | 1993 |
Scarring alopecia in neonates as a consequence of hypoxaemia-hypoperfusion.
Topics: Acidosis; Alopecia; Extracorporeal Membrane Oxygenation; Female; Humans; Hypoxia; Infant, Newborn; M | 1993 |
Factors affecting the development of skin cancer after scalp irradiation.
Topics: Adolescent; Alopecia; Child; Female; Head; Heliotherapy; Humans; Male; Neck; Neoplasms, Radiation-In | 1993 |
A radiation accident at an industrial accelerator facility.
Topics: Accidents, Occupational; Adult; Alopecia; Amputation, Surgical; Fingers; Humans; Male; Particle Acce | 1993 |
Hair today, gone tomorrow.
Topics: Alopecia; Hair; Humans; Scalp; Tissue Expansion | 1993 |
Scalp extension.
Topics: Alopecia; Equipment Design; Fasciotomy; Humans; Male; Pain, Postoperative; Scalp; Silicone Elastomer | 1993 |
Advanced use of tissue adhesive in hair transplantation.
Topics: Alopecia; Cyanoacrylates; Esthetics; Hair; Humans; Male; Postoperative Complications; Scalp; Surgica | 1993 |
[A case from practice (275). Lupus vulgaris with scar-forming alopecia in florid pulmonary tuberculosis].
Topics: Aged; Alopecia; Humans; Lupus Vulgaris; Male; Scalp; Tuberculosis, Pulmonary | 1993 |
[Keratosis follicularis spinulosa decalvans. Therapy with isotretinoin and etretinate in the inflammatory stage].
Topics: Administration, Oral; Adult; Alopecia; Darier Disease; Dose-Response Relationship, Drug; Drug Admini | 1993 |
Night-grinding.
Topics: Age Factors; Alopecia; Bruxism; Humans; Scalp; Stress, Psychological | 1993 |
Hair replacement surgery for male pattern alopecia.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps | 1993 |
Tufted hair folliculitis. A study of four cases.
Topics: Adult; Alopecia; Female; Folliculitis; Hair; Humans; Male; Scalp; Staphylococcus aureus | 1993 |
Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia; Biopsy; Collagen; Female; Fibrosis; Fo | 1993 |
A clinicopathological study of scarring alopecia.
Topics: Adult; Alopecia; Child; Child, Preschool; Female; Fibrin; Fluorescent Antibody Technique; Humans; Li | 1993 |
Chemically induced cosmetic alopecia.
Topics: Adult; Alopecia; Female; Hair; Hair Preparations; Humans; Middle Aged; Scalp | 1993 |
The penetration enhancer SEPA augments stimulation of scalp hair growth by topical minoxidil in the balding stumptail macaque.
Topics: Administration, Topical; Alopecia; Animals; Drug Delivery Systems; Female; Hair; Macaca mulatta; Min | 1995 |
Clinical and histopathologic features of hair loss in patients with HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Alopecia; Apoptosis; Female; Hair; HIV-1; Humans; Keratinocytes; | 1996 |
Hair restoration: answered questions.
Topics: Alopecia; Humans; Scalp; Skin Transplantation | 1996 |
Basaloid folliculolymphoid hyperplasia with alopecia as an expression of mycosis fungoides (CTCL).
Topics: Aged; Alopecia; Female; Hair Follicle; Humans; Hyperplasia; Immunohistochemistry; Lymphocytes; Micro | 1995 |
Circumferential scalp reduction with a suture-in-place Silastic-Dacron extender.
Topics: Alopecia; Humans; Polyethylene Terephthalates; Prostheses and Implants; Scalp; Silicone Elastomers; | 1996 |
How "safe" is safe enough?
Topics: Adult; Alopecia; Hair; Humans; Male; Scalp | 1996 |
Transcutaneous PO2 of the scalp in male pattern baldness: a new piece to the puzzle.
Topics: Adolescent; Adult; Alopecia; Blood Gas Monitoring, Transcutaneous; Frontal Bone; Hair; Humans; Hypox | 1996 |
Alopecia and sure-closure.
Topics: Alopecia; Humans; Scalp; Surgery, Plastic | 1996 |
Transverse scalp sections: a proposed method for laboratory processing.
Topics: Adipose Tissue; Alopecia; Biopsy; Coloring Agents; Cost-Benefit Analysis; Fluorescent Antibody Techn | 1996 |
Scalp cooling to prevent hair loss in chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Cryotherapy; Female; Humans; Male; Middle Aged; Patien | 1996 |
Alopecia of the unburned scalp.
Topics: Adult; Aged; Alopecia; Bedding and Linens; Burns; Craniocerebral Trauma; Female; Follow-Up Studies; | 1996 |
A comparison of the culture and growth of dermal papilla cells from hair follicles from non-balding and balding (androgenetic alopecia) scalp.
Topics: Adult; Alopecia; Cell Culture Techniques; Cell Division; Cells, Cultured; Hair Follicle; Humans; Mal | 1996 |
[Full-load expansion techniques and preliminary clinical application].
Topics: Alopecia; Humans; Scalp; Surgical Flaps; Tissue Expansion | 1995 |
Glutathione, glutathione S-transferase and reactive oxygen species of human scalp sebaceous glands in male pattern baldness.
Topics: Adult; Alopecia; Glutathione; Glutathione Transferase; Humans; Hydrogen-Ion Concentration; Immunoenz | 1996 |
Pseudopelade: an inherited alopecia.
Topics: Adult; Alopecia; Female; Humans; Male; Scalp | 1996 |
[Postmenopausal frontal fibrosing alopecia].
Topics: Aged; Alopecia; Climacteric; Diagnosis, Differential; Female; Hair Follicle; Humans; Lichen Sclerosu | 1996 |
Chronic telogen effluvium: increased scalp hair shedding in middle-aged women.
Topics: Adolescent; Adult; Aged; Alopecia; Biopsy; Chronic Disease; Female; Hair; Hair Follicle; Humans; Mal | 1996 |
Telomerase activity concentrates in the mitotically active segments of human hair follicles.
Topics: Adult; Aged; Aging; Alopecia; Hair Follicle; Humans; Male; Middle Aged; Mitosis; Scalp; Telomerase | 1997 |
Expanded free scalp flap.
Topics: Accidents, Traffic; Adolescent; Alopecia; Female; Humans; Scalp; Surgical Flaps; Tissue Expansion | 1996 |
Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alopecia; Antimalarials; Biopsy; Chloroquine; Dermato | 1997 |
Tinea capitis in adults: misdiagnosis or reappearance?
Topics: Adult; Age Factors; Aged; Alopecia; Diagnosis, Differential; Female; Hair; Humans; Immunocompromised | 1997 |
Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site.
Topics: Aged; Aged, 80 and over; Alopecia; Aminolevulinic Acid; Carcinoma, Squamous Cell; Follow-Up Studies; | 1997 |
Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Case-Control Studies; Female; Humans; Hypothermia | 1997 |
Anchor scalp reduction.
Topics: Alopecia; Humans; Male; Scalp; Surgery, Plastic; Treatment Outcome | 1996 |
[Tufted hair folliculitis].
Topics: Adult; Alopecia; Anti-Bacterial Agents; Drug Therapy, Combination; Folliculitis; Hair Diseases; Huma | 1997 |
Sideburn reconstruction with an expanded supraauricular trapezoidal flap.
Topics: Alopecia; Anesthesia, General; Burns; Ear, External; Female; Humans; Male; Scalp; Surgical Flaps; Ti | 1997 |
Experience with a make-it-yourself scalp extender with hooks.
Topics: Alopecia; Humans; Male; Middle Aged; Scalp; Silicones; Tissue Expansion; Tissue Expansion Devices | 1997 |
Tension and flap advancement in the human scalp.
Topics: Adult; Alopecia; Biomechanical Phenomena; Compliance; Humans; Male; Scalp; Surgical Flaps; Surgical | 1997 |
A comparison of the scalp kinetics in scalp-lifting with and without an intact occipital neurovascular bundle.
Topics: Adult; Alopecia; Humans; Male; Scalp; Surgery, Plastic | 1997 |
Follicular mucinosis associated with scarring alopecia, oligoclonal T-cell receptor V beta expansion, and Staphylococcus aureus: when does follicular mucinosis become mycosis fungoides?
Topics: Adult; Alopecia; Biopsy; Cicatrix; Diagnosis, Differential; Female; Gene Rearrangement, beta-Chain T | 1997 |
Micrograft and minigraft megasession hair transplantation results after a single session.
Topics: Adult; Aged; Alopecia; Anesthesia, Intravenous; Anesthesia, Local; Conscious Sedation; Cysts; Esthet | 1997 |
A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice.
Topics: Alopecia; Androgen Antagonists; Animals; Female; Hair; Humans; Imidazoles; Male; Mice; Mice, Nude; N | 1997 |
Frontal fibrosing alopecia in a postmenopausal woman.
Topics: Alopecia; Cicatrix; Diagnosis, Differential; Female; Humans; Middle Aged; Postmenopause; Scalp | 1997 |
Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp.
Topics: Adult; Alopecia; Androgens; Binding, Competitive; Cells, Cultured; Female; Fibroblasts; Hair Follicl | 1998 |
Diffuse alopecia of the scalp in borderline-lepromatous leprosy in an Indian patient.
Topics: Alopecia; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy, Borderline; | 1997 |
Nevocellular nevus associated with alopecia presenting as aplasia cutis congenita.
Topics: Alopecia; Child; Diagnosis, Differential; Ectodermal Dysplasia; Humans; Male; Nevus; Scalp; Scalp De | 1998 |
Undermining of the scalp: quantitative effects.
Topics: Adult; Alopecia; Elasticity; Evaluation Studies as Topic; Fasciotomy; Humans; Male; Methods; Nylons; | 1998 |
Acquired ichthyosis, alopecia and loss of hair pigment associated with leiomyosarcoma.
Topics: Aged; Alopecia; Biopsy, Needle; Female; Follow-Up Studies; Hair Color; Humans; Ichthyosis; Leiomyosa | 1998 |
Woman with new-onset boggy scalp.
Topics: Alopecia; Edema; Female; Humans; Middle Aged; Scalp; Skin Diseases; Ultrasonography | 1998 |
Cronkhite-Canada syndrome: report of two cases, biopsy findings in the associated alopecia, and a new treatment option.
Topics: Aged; Alopecia; Female; Glucocorticoids; Humans; Intestinal Polyps; Nail Diseases; Prednisone; Ranit | 1998 |
Rhomboid minigrafts in hair restoration surgery.
Topics: Adult; Alopecia; Graft Survival; Hair; Humans; Male; Scalp; Skin Transplantation | 1998 |
[Lichen planopilaris simulating postmenopausal frontal fibrosing alopecia (Kossard)].
Topics: Aged; Alopecia; Diagnosis, Differential; Female; Fibrosis; Hair Follicle; Humans; Lichen Planus; Mid | 1998 |
Conversion from tridimensional surface to a plane for measuring expanded skin area with computer aid.
Topics: Adult; Alopecia; Burns; Double-Blind Method; Humans; Image Processing, Computer-Assisted; Male; Pape | 1998 |
Effects of galeotomies on scalp flaps.
Topics: Adult; Alopecia; Biomechanical Phenomena; Humans; Male; Scalp; Surgical Flaps | 1998 |
[Surgical treatment strategies for baldness].
Topics: Adult; Aged; Alopecia; Clinical Protocols; Female; Hair; Humans; Male; Middle Aged; Scalp; Surgical | 1998 |
The microdissection cautery needle versus the cold scalpel in bicoronal incisions.
Topics: Alopecia; Cicatrix; Craniosynostoses; Dissection; Electrocoagulation; Electrosurgery; Esthetics; Hem | 1998 |
Localised alopecia of the scalp. Common causes.
Topics: Adolescent; Alopecia; Alopecia Areata; Child; Humans; Infant, Newborn; Scalp; Tinea Capitis; Trichot | 1998 |
[Pseudopelade Brocq--possible sequela of stage III borrelia infection?].
Topics: Alopecia; Biopsy; Cefotaxime; Diagnosis, Differential; Female; Humans; Lyme Disease; Middle Aged; Sc | 1998 |
The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women.
Topics: Adult; Alopecia; Female; Humans; Physical Examination; Scalp | 1999 |
Scalp extension--a quantitative study.
Topics: Alopecia; Elasticity; Elective Surgical Procedures; Humans; Male; Postoperative Period; Scalp; Tatto | 1999 |
Hormones and hair patterning in men: a role for insulin-like growth factor 1?
Topics: Aged; Alopecia; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Gonadal Steroid | 1999 |
Outcome of scalp donor sites in 450 consecutive pediatric burn patients.
Topics: Alopecia; Analysis of Variance; Burns; Child; Chronic Disease; Female; Folliculitis; Follow-Up Studi | 1999 |
Prevention and treatment of wide scar and alopecia in the scalp: wedge excision and double relaxation suture.
Topics: Adolescent; Adult; Alopecia; Child; Cicatrix; Female; Humans; Male; Plastic Surgery Procedures; Scal | 1999 |
Minoxidil increases 17 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity of cultured human dermal papilla cells from balding scalp.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Aged; Al | 1999 |
Hair loss: does anything really help?
Topics: Alopecia; Female; Hair Follicle; Hair Preparations; Humans; Male; Minoxidil; Scalp; Surgical Flaps | 1996 |
Pityriasis amiantacea.
Topics: Alopecia; Child; Diagnosis, Differential; Elbow; Female; Humans; Pityriasis; Pruritus; Scalp | 1999 |
Serial scalp reductions: a biomechanical approach.
Topics: Adult; Alopecia; Biomechanical Phenomena; Humans; Male; Methods; Scalp; Surgical Flaps | 1999 |
POEMS syndrome: cicatricial alopecia as an unusual cutaneous manifestation associated with an underlying plasmacytoma.
Topics: Adult; Alopecia; Castleman Disease; Cicatrix; Hair Diseases; Humans; Male; Movement Disorders; Paran | 1999 |
Temporal triangular alopecia acquired in adulthood.
Topics: Adult; Alopecia; Diagnosis, Differential; Female; Hair; Humans; Scalp | 1999 |
[Usefulness of galea suturing method for scalp closure].
Topics: Alopecia; Humans; Scalp; Surgical Procedures, Operative; Surgical Staplers; Suture Techniques | 1999 |
[Measurement of skin area of expansion and defect on scalp].
Topics: Adult; Alopecia; Anthropometry; Burns; Cicatrix; Female; Humans; Scalp; Tissue Expansion | 1997 |
[Prevention and treatment of postoperative complications following skin soft tissue expansion].
Topics: Adolescent; Adult; Alopecia; Burns; Child; Child, Preschool; Cicatrix; Face; Female; Humans; Male; M | 1998 |
Update on hair transplantation techniques.
Topics: Alopecia; Dermatology; Hair; Hair Follicle; Humans; Scalp; Surgical Flaps; Transplantation, Autologo | 1999 |
Substance P (SP) in innervated and non-innervated blood vessels in the skin of patients with symptomatic scalp.
Topics: Adult; Alopecia; Blood Vessels; Female; Humans; Nervous System Physiological Phenomena; Pain; Scalp; | 1999 |
Immunohistochemical localization of types 1 and 2 5alpha-reductase in human scalp.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Alopecia; Animals; Antibodies, Monoclonal; Hair Follic | 1999 |
Regarding propofol-ketamine and propofol-fentanyl sedation technique.
Topics: Alopecia; Hair Follicle; Humans; Scalp; Skin Transplantation | 1999 |
An experience of pubic hair reconstruction using free temporoparietal fasciocutaneous flap with needle epilation.
Topics: Adult; Alopecia; Burns; Female; Hair Removal; Humans; Scalp; Surgical Flaps | 1999 |
Revision surgical hair restoration: repair of undesirable results.
Topics: Adult; Alopecia; Hair; Humans; Male; Middle Aged; Plastic Surgery Procedures; Reoperation; Scalp; Su | 1999 |
New topical antiandrogenic formulations can stimulate hair growth in human bald scalp grafted onto mice.
Topics: Administration, Topical; Alopecia; Androgen Antagonists; Animals; Finasteride; Flutamide; Hair Folli | 2000 |
Alopecia neoplastica in a patient with gastric carcinoma.
Topics: Adult; Alopecia; Carcinoma, Signet Ring Cell; Female; Humans; Scalp; Skin Neoplasms; Stomach Neoplas | 1999 |
[PCR detected Borrelia burgdorferi DNA in a tissue sample in pseudopelade Brocq].
Topics: Adult; Alopecia; Borrelia burgdorferi Group; Borrelia Infections; DNA, Bacterial; Female; Humans; Po | 1999 |
Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Age Factors; Alopecia; Biopsy; Enzyme Inhibitors; F | 1999 |
Lichen planopilaris-like changes arising within an epidermal nevus: does this case suggest clues to the etiology of lichen planopilaris?
Topics: Adolescent; Alopecia; Humans; Lichen Planus; Male; Nevus, Intradermal; Scalp; Skin Neoplasms | 2000 |
Pseudopelade of Brocq in beard area.
Topics: Adult; Alopecia; Face; Humans; Male; Scalp | 2000 |
Acne keloidalis is a form of primary scarring alopecia.
Topics: Acne Keloid; Adolescent; Adult; Alopecia; Biopsy, Needle; Cicatrix; Hair; Humans; Male; Prospective | 2000 |
Roles of testosterone in the growth of keratinocytes through bald frontal dermal papilla cells.
Topics: Alopecia; Animals; Blotting, Northern; Cell Division; Coculture Techniques; Culture Media, Condition | 1999 |
Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3.
Topics: Aged; Aged, 80 and over; Alopecia; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Lik | 2000 |
Multifactorial classification of male and female androgenetic alopecia.
Topics: Alopecia; Female; Hair; Humans; Male; Scalp; Sex Characteristics | 2000 |
[GAPO syndrome].
Topics: Alopecia; Anodontia; Child; Dilatation, Pathologic; Facies; Growth Disorders; Hemangioma; Hernia, Um | 2000 |
A pilot study to assess the feasibility of prior scalp cooling with palliative whole brain radiotherapy.
Topics: Adult; Aged; Alopecia; Brain Neoplasms; Cranial Irradiation; Cryotherapy; Feasibility Studies; Femal | 2000 |
Modeling the dynamics of human hair cycles by a follicular automaton.
Topics: Alopecia; Hair Follicle; Humans; Male; Models, Biological; Scalp | 2000 |
[Physiopathology of scalp disorders].
Topics: Alopecia; Androgens; Hair Follicle; Humans; Scalp | 2000 |
Regional choroidal atrophy and alopecia. A new syndrome.
Topics: Adult; Alopecia; Child; Child, Preschool; Electrooculography; Female; Fluorescein Angiography; Gyrat | 1988 |
A case of lipedematous alopecia occurring in a male patient.
Topics: Adipose Tissue; Adult; Alopecia; Diagnosis, Differential; Humans; Lipoma; Male; Scalp | 2000 |
Er:YAG laser-assisted hair transplantation in cicatricial alopecia.
Topics: Alopecia; Cicatrix; Female; Hair; Humans; Laser Therapy; Male; Scalp; Transplantation, Autologous | 2000 |
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors.
Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 2001 |
Telogen effluvium after allergic contact dermatitis of the scalp.
Topics: Acute Disease; Adult; Alopecia; Dermatitis, Allergic Contact; Female; Hair Dyes; Humans; Middle Aged | 2001 |
[Progressive cicatricial psoriatic alopecia in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Alopecia; Biopsy; Cicatrix; Humans; Male; Scalp; Scalp De | 2000 |
The "Nordstrom suture" to enhance scalp reductions.
Topics: Alopecia; Equipment Design; Hair; Humans; Male; Scalp; Suture Techniques; Tissue Expansion; Treatmen | 2001 |
Functional analysis of the stratum corneum of scalp skin: studies in patients with alopecia areata and androgenetic alopecia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Alopecia Areata; Cheek; Child; Female; Forearm | 2000 |
Hair density, hair diameter and the prevalence of female pattern hair loss.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alopecia; Female; Hair; Hair Color; Humans; Middl | 2001 |
A peculiar pattern of alopecia.
Topics: Alopecia; Female; Fibrosis; Hair Follicle; Humans; Middle Aged; Postmenopause; Scalp; Scalp Dermatos | 2001 |
Folliculitis decalvans and tufted folliculitis are specific infective diseases that may lead to scarring, but are not a subset of central centrifugal scarring alopecia.
Topics: Alopecia; Cicatrix; Folliculitis; Humans; Scalp; Staphylococcal Infections | 2001 |
The feasibility of quantitative analysis of androgen metabolism by use of single dermal papillae from human hair follicles.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Alopecia; Androgens; Biopsy; Feasibility Studies; Female; Hai | 2001 |
[Multiple pigmented basalioma of the scalp in a patient with Curschmann-Steinert myotonia dystrophica. Confirmation of a rare symptom constellation].
Topics: Alopecia; Carcinoma, Basal Cell; Female; Head and Neck Neoplasms; Humans; Middle Aged; Myotonic Dyst | 2001 |
[Treating cicatricial baldness with scalp expanding and hair autografting].
Topics: Adolescent; Adult; Alopecia; Cicatrix; Female; Hair; Humans; Male; Middle Aged; Scalp; Tissue Expans | 2001 |
Nomenclature proposal for the zones and landmarks of the balding scalp.
Topics: Alopecia; Hair; Humans; Male; Scalp; Terminology as Topic | 2001 |
Scalp cooling therapy and cytotoxic treatment.
Topics: Adolescent; Alopecia; Antineoplastic Agents; Humans; Hypothermia, Induced; Leukemia; Male; Scalp | 2001 |
Tinea capitis.
Topics: Alopecia; Biopsy; Chronic Disease; Female; Humans; Middle Aged; Scalp; Tinea Capitis | 2001 |
Laser-assisted autologous hair transplantation with the Er:YAG laser.
Topics: Alopecia; Erbium; Hair; Humans; Laser Therapy; Male; Middle Aged; Scalp; Transplantation, Autologous | 1999 |
5 alpha-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro.
Topics: Adult; Alopecia; Cells, Cultured; Cholestenone 5 alpha-Reductase; Connective Tissue; Connective Tiss | 2001 |
Improved scalp surgery results by controlling tension vector forces in the tissues by galea to pericranium fixation sutures.
Topics: Alopecia; Hair; Humans; Plastic Surgery Procedures; Scalp; Suture Techniques; Treatment Outcome | 2001 |
Adams-Oliver syndrome: further evidence for autosomal recessive inheritance.
Topics: Abnormalities, Multiple; Alopecia; Calcinosis; Child; Epilepsy; Female; Genes, Recessive; Humans; Li | 2001 |
[Determination of scalp ER and AR of patients with male pattern baldness and the effects of hair transplantation on them].
Topics: Adult; Alopecia; Hair; Humans; Male; Receptors, Androgen; Receptors, Estrogen; Scalp | 2000 |
Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A.
Topics: Alopecia; Axilla; Back; Cyclosporine; Erythema; Female; Humans; Immunosuppressive Agents; Middle Age | 2001 |
Galea fixation in alopecia reduction surgery.
Topics: Alopecia; Hair; Humans; Laser Therapy; Male; Scalp; Suture Techniques | 2001 |
Painful, itchy, symptomatic scalp.
Topics: Adult; Alopecia; Biopsy; Case-Control Studies; Diagnosis, Differential; Female; Humans; Male; Micros | 1999 |
[Warning against the ice hat].
Topics: Alopecia; Antineoplastic Agents; Cold Temperature; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurr | 2002 |
The follicular automaton model: effect of stochasticity and of synchronization of hair cycles.
Topics: Alopecia; Animals; Hair; Humans; Male; Mammals; Models, Biological; Scalp | 2002 |
Clinical and molecular diagnostic criteria of congenital atrichia with papular lesions.
Topics: Alopecia; Child; Diagnosis, Differential; DNA Mutational Analysis; Family Health; Female; Genetic Te | 2001 |
Clinical and molecular diagnostic criteria of congenital atrichia with papular lesions.
Topics: Algorithms; Alopecia; Child; DNA Mutational Analysis; Female; Humans; Pedigree; Proteins; Scalp; Tra | 2002 |
[The clinical application of scalp expansion in the repair of cicatricial baldness in children].
Topics: Adolescent; Alopecia; Burns; Child; Cicatrix; Female; Humans; Male; Scalp; Tissue Expansion | 1999 |
Synchronous balding of scalp and hair-bearing grafts of scalp transplanted to the skin of the arm in male pattern baldness.
Topics: Adult; Alopecia; Arm; Dermatologic Surgical Procedures; Hair; Humans; Male; Scalp; Time Factors; Tra | 1979 |
[Comparative study of 5 alpha-reductase activity in the prostate and the human scalp].
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Alopecia; Humans; Male; Oxidoreductases; Prostate; Prostatic | 1979 |
[Histological studies of the scalp at the hair parting and crown in seborrheic alopecia].
Topics: Adolescent; Adult; Age Factors; Aged; Alopecia; Child; Dermatitis, Seborrheic; Elastic Tissue; Epith | 1975 |
[Morpho-histochemical characteristics of the scalp in person with premature alopecia in connection with the problem of hair transplantation].
Topics: Alopecia; Glycogen; Glycosaminoglycans; Hair; Humans; Scalp; Sulfhydryl Compounds; Transplantation, | 1975 |
Angiolymphoid hyperplasia with follicular mucinosis.
Topics: Alopecia; Female; Humans; Hyperplasia; Lymphatic System; Middle Aged; Mucinosis, Follicular; Scalp | 1978 |
[Angiolymphoid hyperplasia with follicular mucinosis].
Topics: Adult; Alopecia; Arterioles; Female; Granuloma; Humans; Hyperplasia; Mucinosis, Follicular; Scalp; S | 1979 |
New treatment for seborrheic alopecia: the ligature of the arteries of the scalp.
Topics: Alopecia; Arteries; Dermatitis, Seborrheic; Female; Humans; Ligation; Middle Aged; Scalp; Sebum; Tem | 1977 |
Extensive cicatrical alopecia following scalp vein infusion.
Topics: Adolescent; Alopecia; Bicarbonates; Cicatrix; Drug Eruptions; Fluid Therapy; Humans; Male; Scalp | 1979 |
Congenital midline porencephaly: a new brain malformation associated with scalp anomaly.
Topics: Agenesis of Corpus Callosum; Alopecia; Brain; Cerebral Angiography; Cerebral Cortex; Cerebral Ventri | 1979 |
Obliteration of alopecia by hair-lifting: a new concept and technique.
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Sex Factors; Skin Transplantation; Transplantation, Au | 1977 |
Juri flap procedure for the treatment of baldness. Two-year experience.
Topics: Adult; Alopecia; Hair; Humans; Male; Scalp; Surgery, Plastic; Suture Techniques; Transplantation, Au | 1979 |
Transfer of a large, single temporo-occipital flap for treatment of baldness.
Topics: Alopecia; Humans; Male; Postoperative Care; Scalp; Surgery, Plastic | 1979 |
Synthetic hair implantations continue; serious complications result.
Topics: Alopecia; Hair; Humans; Postoperative Complications; Scalp; Surgical Wound Infection | 1979 |
Reconstruction of a sideburn by a rotated flap.
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1979 |
Planning in hair transplantation.
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1979 |
Strip and punch grafting for alopecia of the eyebrow.
Topics: Alopecia; Eyebrows; Female; Hair; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1979 |
Innovative adjuncts in hair transplantation.
Topics: Adult; Alopecia; Hair; Humans; Hygiene; Male; Patient Care Planning; Scalp; Surgical Instruments; Tr | 1979 |
Scalp reduction for alopecia.
Topics: Adolescent; Alopecia; Cicatrix; Hair; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1979 |
[Congenital hereditary hypotrychosis. Generalized autosomal dominant hypotrichosis with pili torti (hypotrichosis congenita hereditaria Marie Unna)].
Topics: Adolescent; Alopecia; Chromosome Aberrations; Chromosome Disorders; Genes, Dominant; Hair; Humans; H | 1979 |
Prevention of doxorubicin-induced hair loss with scalp hypothermia.
Topics: Alopecia; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Hypothermia, Ind | 1979 |
Surgical treatment of baldness by hair transplantation.
Topics: Alopecia; Evaluation Studies as Topic; Female; Hair; Humans; Male; Scalp; Transplantation, Autologou | 1977 |
[Etiology and surgical treatment of alopecia in children].
Topics: Alopecia; Burns; Child; Cicatrix; Hair; Humans; Scalp; Transplantation, Autologous | 1977 |
Experiences with parieto-occipital flaps in hair transplantation.
Topics: Adult; Aged; Alopecia; Child, Preschool; Female; Hair; Humans; Male; Middle Aged; Motivation; Postop | 1978 |
Use of rotation scalp flaps for treatment of occipital baldness.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgery, Plastic; Transplantation, Autologous | 1978 |
Arteriovenous fistula after hair transplantation.
Topics: Adult; Alopecia; Arteriovenous Fistula; Hair; Humans; Male; Postoperative Complications; Scalp; Tran | 1978 |
Adriamycin, alopecia, and the scalp tourniquet.
Topics: Alopecia; Doxorubicin; Female; Humans; Scalp; Tourniquets | 1978 |
Scalp tourniquet in the prevention of chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Humans; Scalp; Tourniquets | 1978 |
[Alopecia induced by oncostatic drug therapy: prevention by pneumatic head band].
Topics: Alopecia; Antineoplastic Agents; Humans; Methods; Pressure; Scalp | 1978 |
[A case of congenital hypotrichosis with hair abnormalities, scar-like changes of the scalp, corneal changes and a congenital heart defect].
Topics: Abnormalities, Multiple; Alopecia; Child, Preschool; Female; Hair; Heart Defects, Congenital; Humans | 1978 |
Scalp tourniquet in cancer therapy.
Topics: Alopecia; Antineoplastic Agents; Female; Humans; Scalp; Tourniquets | 1978 |
Management of alopecia of the scalp by a combination of excisions and transplantations.
Topics: Alopecia; Hair; Humans; Scalp; Transplantation, Autologous | 1978 |
Diagnosing the common alopecias.
Topics: Alopecia; Alopecia Areata; Biopsy; Humans; Lupus Erythematosus, Discoid; Scalp; Tinea Capitis; Trich | 1978 |
Persistent gynecomastia resulting from scalp inunction of estradiol: a model for persistent gynecomastia.
Topics: Alopecia; Estradiol; Gynecomastia; Humans; Male; Middle Aged; Models, Biological; Scalp; Time Factor | 1978 |
[Scalp flaps. The mesh flap (proposal of a personal procedure)].
Topics: Alopecia; Humans; Male; Scalp; Surgery, Plastic | 1978 |
[Comparative study of hair transplant (author's transl)].
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1978 |
[Complications from scalp flaps used for the treatment of baldness (author's transl)].
Topics: Adult; Alopecia; Hair; Humans; Male; Necrosis; Scalp; Transplantation, Autologous | 1978 |
[Alopecia associated with macular retinal degeneration].
Topics: Adolescent; Adult; Alopecia; Child; Electroretinography; Female; Hair; Humans; Macular Degeneration; | 1978 |
Male pattern alopecia a histopathologic and histochemical study.
Topics: Adult; Alopecia; Capillaries; Connective Tissue; Cytological Techniques; Elastic Tissue; Endothelium | 1975 |
The tunnel graft procedure for attachment of a hairpiece.
Topics: Alopecia; Hair; Humans; Scalp; Skin Transplantation; Transplantation, Autologous | 1976 |
Histochemical quantification of glucose-6-phosphate dehydrogenase activity in human hair follicles.
Topics: Alopecia; Formazans; Glucosephosphate Dehydrogenase; Hair; Histocytochemistry; Humans; In Vitro Tech | 1977 |
The strip graft as a means of hairline replacement.
Topics: Alopecia; Hair; Humans; Male; Scalp; Transplantation, Autologous | 1977 |
Pityriasis amiantacea: a clinical and histopathological investigation.
Topics: Adolescent; Adult; Alopecia; Child; Child, Preschool; Female; Humans; Male; Pityriasis; Scalp; Scalp | 1977 |
Use of square scalp grafts for male pattern baldness.
Topics: Alopecia; Humans; Male; Scalp; Surgery, Plastic; Transplantation, Autologous | 1977 |
Traumatic alopecia in trichotillomania: a pathogenic interpretation of histologic lesions in the pilosebaceous unit.
Topics: Alopecia; Epidermis; Hair; Humans; Obsessive-Compulsive Disorder; Scalp; Sebaceous Glands; Sweat Gla | 1977 |
Lateral scalp flaps for instant results in male pattern baldness.
Topics: Adult; Alopecia; Hair; Humans; Male; Middle Aged; Scalp; Surgery, Plastic; Transplantation, Autologo | 1977 |
Burn alopecia.
Topics: Adult; Alopecia; Burns; Child; Female; Hair; Humans; Male; Scalp; Surgery, Plastic; Transplantation, | 1977 |
Single-stage rotation of arterialized scalp flaps for male pattern baldness: case report.
Topics: Alopecia; Arteries; Humans; Male; Methods; Middle Aged; Scalp; Transplantation, Autologous | 1977 |
[Critical study of scalp transplantations and proposal of an approach].
Topics: Alopecia; Humans; Scalp; Transplantation, Autologous | 1976 |
The esthetics of hair transplantation.
Topics: Alopecia; Hair; Humans; Methods; Scalp; Transplantation, Autologous | 1976 |
Hair transplantation. The use of hairbearing compound grafts for correction of alopecia due to chronic discoid lupus erythematosus, traumatic alopecia, and male pattern baldness.
Topics: Adult; Alopecia; Female; Hair; Humans; Lupus Erythematosus, Discoid; Male; Methods; Middle Aged; Sca | 1976 |
Phenotypic heterogeneity among the pilosebaceous dysplasias.
Topics: Adolescent; Alopecia; Child; Ectodermal Dysplasia; Female; Hair; Humans; Male; Orofaciodigital Syndr | 1975 |
[The linear sebaceous nevus syndrome. Feuerstein-Mims' syndrome].
Topics: Adolescent; Alopecia; Epilepsy; Humans; Male; Neck; Nevus; Scalp; Sebaceous Gland Neoplasms; Syndrom | 1975 |
[A case of epithelioma dyskeratoticum segregans of the scalp].
Topics: Alopecia; Humans; Male; Middle Aged; Scalp; Skin Neoplasms | 1975 |
Occipital alopecia following cardiopulmonary bypass.
Topics: Adult; Alopecia; Anesthesia, Endotracheal; Cardiopulmonary Bypass; Child; Extracorporeal Circulation | 1976 |
Reconstruction of the sideburn for alopecia after rhytidectomy.
Topics: Alopecia; Face; Female; Hair; Humans; Scalp; Surgery, Plastic; Transplantation, Autologous | 1976 |
Forehead rhytidoplasty and brow lifting.
Topics: Alopecia; Dermabrasion; Eyebrows; Face; Female; Hematoma; Humans; Male; Postoperative Complications; | 1976 |
Congenital inclusion dermoid cysts of the scalp.
Topics: Alopecia; Child; Child, Preschool; Cicatrix; Dermoid Cyst; Female; Humans; Male; Scalp; Skin Neoplas | 1992 |
Scarring alopecia in discoid lupus erythematosus.
Topics: Adolescent; Adult; Aged; Alopecia; Chronic Disease; Female; Humans; Immunohistochemistry; Keratins; | 1992 |
Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis.
Topics: Adult; Aged; Alopecia; Cell Degranulation; Female; Fibroblasts; Hair; HLA-D Antigens; Humans; Immuno | 1992 |
Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis.
Topics: Adult; Aged; Alopecia; Cell Degranulation; Female; Fibroblasts; Hair; HLA-D Antigens; Humans; Immuno | 1992 |
Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis.
Topics: Adult; Aged; Alopecia; Cell Degranulation; Female; Fibroblasts; Hair; HLA-D Antigens; Humans; Immuno | 1992 |
Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis.
Topics: Adult; Aged; Alopecia; Cell Degranulation; Female; Fibroblasts; Hair; HLA-D Antigens; Humans; Immuno | 1992 |
[Erosive pustular dermatosis of the scalp after zoster ophthalmicus and trauma].
Topics: Aged; Alopecia; Biopsy; Diagnosis, Differential; Female; Herpes Zoster Ophthalmicus; Humans; Male; M | 1992 |
Hair growth following scalp microvascular flap transfer for baldness due to burn injury.
Topics: Alopecia; Burns; Child; Female; Humans; Microsurgery; Scalp; Surgical Flaps | 1992 |
A scalp lesion over an extracerebral mass: a sign of a radiation-induced meningioma.
Topics: Adult; Alopecia; Cicatrix; Female; Hemangioma; Humans; Meningeal Neoplasms; Meningioma; Neoplasms, R | 1992 |
Dissecting folliculitis of the scalp. A case report of combined treatment using tissue expansion, radical excision, and isotretinoin.
Topics: Adult; Alopecia; Combined Modality Therapy; Folliculitis; Follow-Up Studies; Humans; Isotretinoin; M | 1992 |
The paramedian scalp reduction with posterior Z-plasty. A technique to minimize the "slot" defect.
Topics: Alopecia; Hair; Humans; Methods; Scalp | 1992 |
The occipital artery flap for transfer of hair-bearing tissue.
Topics: Adult; Alopecia; Arteries; Cadaver; Humans; Male; Scalp; Surgical Flaps; Wounds, Gunshot | 1992 |
Alopecia universalis treated with oral cyclosporine A and prednisolone: immunologic studies.
Topics: Administration, Oral; Adolescent; Adult; Alopecia; Child; Cyclosporine; Drug Therapy, Combination; F | 1992 |
Occult syringoma associated with alopecia.
Topics: Adenoma; Alopecia; Female; Humans; Middle Aged; Scalp; Sweat Gland Neoplasms | 1992 |
Extensive scalp lifting. Decrease in complications utilizing unilateral occipital artery ligation and other modifications.
Topics: Alopecia; Arteries; Humans; Ligation; Male; Necrosis; Postoperative Complications; Scalp; Surgical F | 1992 |
Extensive scalp lifting as a reconstructive tool for a large scalp defect.
Topics: Alopecia; Carcinoma, Squamous Cell; Eyebrows; Humans; Male; Middle Aged; Postoperative Complications | 1992 |
Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice.
Topics: Alopecia; Animals; Autoimmune Diseases; Complement System Proteins; Disease Models, Animal; Female; | 1992 |
The pulley suture. Utilization in scalp reduction surgery.
Topics: Alopecia; Humans; Male; Scalp; Suture Techniques | 1992 |
Giant alopecic nodule of the scalp: unusual presentation of a cellular blue naevus in an adult.
Topics: Adult; Alopecia; Humans; Male; Nevus, Pigmented; Scalp; Skin Neoplasms | 1992 |
Hair transplantation in females.
Topics: Alopecia; Cicatrix; Female; Hair; Humans; Scalp; Time Factors; Transplantation, Autologous | 1992 |
[Surgical treatment of cicatricial alopecia of the hairy scalp using tissue expansion].
Topics: Alopecia; Humans; Osteolysis; Scalp; Tissue Expansion | 1992 |
[Correction of baldness using a grafting method].
Topics: Alopecia; Humans; Male; Scalp; Surgery, Plastic; Surgical Instruments; Transplantation, Homologous | 1990 |
[High pedicle scalp flaps].
Topics: Adult; Alopecia; Esthetics; Humans; Male; Middle Aged; Retrospective Studies; Scalp; Surgical Flaps | 1990 |
Cutaneous immunopathology of androgenetic alopecia.
Topics: Adult; Alopecia; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulins; Male; | 1991 |
[Pomade crust of the scalp simulating cornu cutaneum].
Topics: Alopecia; Diagnosis, Differential; Female; Hair Preparations; Humans; Middle Aged; Postoperative Com | 1991 |
[Surgical treatment of male baldness using Juri's crescent flap].
Topics: Adult; Alopecia; Humans; Male; Middle Aged; Scalp; Surgery, Plastic; Surgical Flaps; Surgical Staple | 1991 |
Androgen receptors in dermal papilla cells of scalp hair follicles in male pattern baldness.
Topics: Adult; Aged; Alopecia; Cell Nucleus; Cells, Cultured; Hair; Humans; Immunoenzyme Techniques; Male; M | 1991 |
Reduced linear hair growth rates of vellus and of terminal hairs produced by human balding scalp grafted onto nude mice.
Topics: Alopecia; Animals; Female; Hair; Humans; Mice; Mice, Nude; Scalp; Skin Transplantation; Transplantat | 1991 |
Hair transplantation in advanced male pattern alopecia. The role of incisional slit grafting.
Topics: Alopecia; Female; Hair; Humans; Male; Methods; Microsurgery; Scalp; Time Factors | 1991 |
[Adult T cell lymphoma/leukemia with alopecia, huge tumors of scalp and wide destruction of cerebral bone].
Topics: Adult; Alopecia; Female; Humans; Leukemia, T-Cell; Scalp; Skin Neoplasms; Skull Neoplasms | 1991 |
Adjuncts to scalp reduction surgery. Intraoperative tissue expanders and hyaluronidase.
Topics: Alopecia; Anesthesia, Local; Humans; Hyaluronoglucosaminidase; Male; Scalp; Tissue Expansion | 1991 |
The management of traumatic scalp injuries: report of cases.
Topics: Adolescent; Adult; Alopecia; Female; Humans; Male; Scalp; Surgical Flaps; Surgical Wound Infection | 1991 |
A new scalp flap for baldness.
Topics: Adult; Aged; Alopecia; Esthetics; Female; Humans; Male; Middle Aged; Scalp; Skin Transplantation; Su | 1991 |
Natural progression of male pattern baldness in young men.
Topics: Adult; Alopecia; Hair; Humans; Male; Scalp; Time Factors | 1991 |
The effectiveness of occipital artery ligations as a priming procedure for extensive scalp-lifting.
Topics: Adult; Alopecia; Arteries; Humans; Ligation; Male; Methods; Middle Aged; Retrospective Studies; Scal | 1991 |
Incisional slit grafting.
Topics: Alopecia; Hair; Humans; Male; Methods; Microsurgery; Scalp; Surgical Instruments; Time Factors | 1991 |
Hairline design and placement.
Topics: Alopecia; Hair; Humans; Male; Scalp | 1991 |
Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth.
Topics: Adolescent; Adult; Alopecia; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; F | 1991 |
[The patient and the physician].
Topics: Alopecia; Antineoplastic Agents; Humans; Hungary; Physician-Patient Relations; Scalp; Vasoconstricti | 1991 |
Syringoma-like sweat duct proliferation in scalp alopecias.
Topics: Adenoma; Adult; Aged; Alopecia; Female; Humans; Male; Middle Aged; Scalp; Sweat Gland Neoplasms; Swe | 1990 |
Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced; Scalp; Temp | 1990 |
Regional scalp differences of the androgenic metabolic pattern in subjects affected by male pattern baldness.
Topics: 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Alopecia; Androgens; Biotran | 1990 |
Pseudopelade of Brocq in a child.
Topics: Alopecia; Child, Preschool; Female; Humans; Hydroxychloroquine; Scalp | 1990 |
Triple rhomboid flap for crown alopecia correction.
Topics: Alopecia; Humans; Scalp; Surgical Flaps | 1990 |
Presuturing in alopecia reductions.
Topics: Alopecia; Humans; Postoperative Complications; Scalp; Suture Techniques | 1990 |
[Metastatic alopecia].
Topics: Adenocarcinoma; Alopecia; Breast Neoplasms; Female; Humans; Middle Aged; Scalp; Skin Neoplasms | 1990 |
Pretransfer tissue expansion of a scalp free flap for burn alopecia reconstruction in a child: a case report.
Topics: Alopecia; Burns; Child; Humans; Male; Scalp; Skin Transplantation; Tissue Expansion | 1990 |
Alopecia universalis in a patient with Marfan's syndrome.
Topics: Adult; Alopecia; Humans; Male; Marfan Syndrome; Scalp | 1990 |
[Treatment of cicatricial alopecia by the method of tissue expansion].
Topics: Alopecia; Burns; Cicatrix; Female; Hair; Humans; Male; Scalp; Tissue Expansion | 1990 |
Alopecia neoplastica responsive to tamoxifen.
Topics: Alopecia; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Scalp; Skin Neoplasms; Tamoxifen | 1990 |
The scalp as a donor site: revisited.
Topics: Adolescent; Adult; Alopecia; Burns; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn | 1990 |
[Scalp expansion in the treatment of cicatricial alopecia].
Topics: Adolescent; Adult; Alopecia; Child; Cicatrix; Female; Humans; Male; Scalp; Tissue Expansion | 1990 |
A new method for correction of the vertical scar observed following scalp reduction for extensive alopecia.
Topics: Alopecia; Cicatrix; Humans; Scalp; Surgical Flaps | 1990 |
Trichotillomania: a histopathologic study in sixty-six patients.
Topics: Adolescent; Adult; Aged; Alopecia; Basement Membrane; Biopsy; Child; Child, Preschool; Diagnosis, Di | 1990 |
A new apparatus for hair regrowth in male-pattern baldness.
Topics: Adult; Aged; Alopecia; Dermatology; Female; Hair; Humans; Male; Middle Aged; Regional Blood Flow; Sc | 1990 |
Proliferating trichilemmal tumor with apocrine sweat glands.
Topics: Adult; Alopecia; Apocrine Glands; Epidermal Cyst; Humans; Male; Scalp; Skin Diseases; Sweat Glands | 1990 |
Extensive keloids following hair transplantation.
Topics: Alopecia; Hair; Humans; Keloid; Male; Middle Aged; Postoperative Complications; Scalp | 1990 |
Biochemical and trichological characterization of diffuse alopecia in women.
Topics: Adolescent; Adult; Age Factors; Alopecia; Androgens; Female; Ferritins; Hair; Humans; Middle Aged; S | 1990 |
[Closing of vast losses of substance of the scalp: use of a paramedian frontal flap].
Topics: Adolescent; Adult; Alopecia; Child, Preschool; Esthetics; Forehead; Humans; Male; Neck; Scalp; Surgi | 1985 |
Focal naevoid hypotrichosis.
Topics: Alopecia; Child, Preschool; Humans; Hypotrichosis; Male; Nevus, Pigmented; Scalp; Skin Neoplasms | 1987 |
[One-stage axial temporo-occipital flap for alopecia with Doppler detection. Apropos of a homogeneous series of 21 cases].
Topics: Adult; Alopecia; Humans; Male; Middle Aged; Scalp; Surgical Flaps; Suture Techniques; Ultrasonics | 1987 |
[Tonsure reduction. Principles and innovation: scalp lift].
Topics: Alopecia; Esthetics; Humans; Male; Scalp; Surgery, Plastic; Suture Techniques | 1989 |
Reconstructive surgery of the scalp.
Topics: Adult; Alopecia; Burns; Child; Child, Preschool; Cicatrix; Female; Hair; Humans; Male; Middle Aged; | 1989 |
Atrophic alopecia in the Hallermann-Strieff syndrome.
Topics: Alopecia; Atrophy; Child, Preschool; Craniofacial Dysostosis; Hallermann's Syndrome; Humans; Male; S | 1989 |
Hypotrichosis with keratosis pilaris: electrophoretical study of hair fibrous proteins from a patient.
Topics: Adult; Alopecia; Amino Acids; Darier Disease; Electrophoresis, Gel, Two-Dimensional; Hair; Humans; H | 1989 |
Reconstruction of postburn sequelae with expanded flaps.
Topics: Adolescent; Alopecia; Burns; Child; Female; Humans; Male; Postoperative Complications; Scalp; Surgic | 1989 |
[Planning of a local flap of expanded scalp for repair of alopecia cicatrisata].
Topics: Adolescent; Adult; Alopecia; Burns; Child; Child, Preschool; Cicatrix; Female; Humans; Male; Middle | 1989 |
A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia.
Topics: Adult; Alopecia; Atrophy; Biopsy; Female; Hair; Humans; Male; Middle Aged; Psoriasis; Scalp; Sebaceo | 1989 |
[The Brocq pseudopelade--a disease picture or disease entity].
Topics: Adolescent; Adult; Aged; Alopecia; Child; Child, Preschool; Cicatrix; Diagnosis, Differential; Femal | 1989 |
[Experiences with transplantation of artificial hair in the replacement of scalp hair and beard hair].
Topics: Alopecia; Face; Humans; Male; Nylons; Prostheses and Implants; Scalp | 1989 |
[Psoriatic alopecia manifestation, course and therapy in 34 patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Female; Follow-Up Studies; Humans; Male | 1989 |
[Nursing of cancer patients undergoing chemotherapy. Management of alopecia from chemotherapy--introduction of scalp cooling treatment].
Topics: Alopecia; Antineoplastic Agents; Cryotherapy; Humans; Neoplasms; Scalp | 1989 |
Explosive eruption of pyogenic granuloma on the scalp due to topical combination therapy of minoxidil and retinoic acid.
Topics: Alopecia; Drug Combinations; Hemangioma; Humans; Male; Middle Aged; Minoxidil; Scalp; Skin Neoplasms | 1989 |
A new technique for curvilinear scalp reduction.
Topics: Alopecia; Humans; Methods; Scalp | 1989 |
The modified bitemporal flap for the treatment of bitemporal recessions.
Topics: Alopecia; Humans; Male; Scalp; Surgical Flaps | 1989 |
Topical minoxidil, scalp hair, and vasodilatation.
Topics: Administration, Topical; Alopecia; Ethics, Medical; Humans; Male; Minoxidil; Rheology; Scalp; Vasodi | 1987 |
Increased androgen binding capacity in sebaceous glands in scalp of male-pattern baldness.
Topics: Adult; Alopecia; Androgens; Cell Nucleus; Centrifugation, Density Gradient; Cytosol; Dissection; Hum | 1989 |
New concepts in hair replacement.
Topics: Alopecia; Hair; Humans; Methods; Prostheses and Implants; Scalp; Surgical Flaps | 1989 |
Postirradiation extensive cicatricial scalp alopecia treated by tissue expansion.
Topics: Adult; Alopecia; Cicatrix; Female; Humans; Prostheses and Implants; Scalp; Surgery, Plastic; Tinea C | 1989 |
[Endocrine constellation in androgenetic alopecia in the female].
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Alopecia; Androgens; Cell Nucleus; Cytosol; Estradi | 1987 |
delta 5-3 beta-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male-pattern baldness.
Topics: 3-Hydroxysteroid Dehydrogenases; Adult; Alopecia; Androgens; Humans; Hydrogen-Ion Concentration; In | 1988 |
[Pilar physiopathology].
Topics: Alopecia; Animals; Hair; Humans; Mitosis; Rats; Scalp | 1988 |
[Prevention of adriamycin-induced alopecia by scalp hypothermia with a deep-frozen Duncool-Cap].
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Doxorubicin; Female; Freezing; Humans; Hypothermia, Induced | 1988 |
Extensive scalp-lifting.
Topics: Alopecia; Humans; Male; Scalp; Surgical Flaps | 1988 |
The use of tissue expanders in scalp alopecia.
Topics: Adult; Alopecia; Child; Child, Preschool; Female; Humans; Male; Scalp; Sodium Chloride; Surgery, Pla | 1988 |
[Aplasia cutis in 2 sisters].
Topics: Alopecia; Child; Child, Preschool; Female; Humans; Scalp; Xeroradiography | 1988 |
Treatment of male baldness.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps | 1986 |
Tissue expansion and flaps for surgical correction of male pattern baldness.
Topics: Alopecia; Elasticity; Humans; Male; Scalp; Surgical Flaps; Tissue Expansion; Tissue Expansion Device | 1988 |
Aids to scalp reduction surgery.
Topics: Alopecia; Humans; Methods; Scalp; Surgical Staplers; Suture Techniques | 1988 |
One variety of a long, nondelayed temporo-parieto-occipital flap.
Topics: Alopecia; Arteries; Hair; Humans; Male; Methods; Occipital Bone; Scalp; Skin; Skin Transplantation; | 1988 |
Calvarial erosion after scalp expansion.
Topics: Alopecia; Bone Transplantation; Brain Edema; Child, Preschool; Cicatrix; Craniotomy; Hematoma, Subdu | 1987 |
[Erosive pustulous dermatitis of the scalp].
Topics: Alopecia; Chronic Disease; Dermatitis, Atopic; Female; Fluorescent Antibody Technique; Humans; Middl | 1987 |
Combined scalp reduction and autologous fat implant treatment of localized soft tissue defects.
Topics: Adipose Tissue; Adolescent; Adult; Alopecia; Female; Forehead; Humans; Male; Scalp; Scleroderma, Loc | 1988 |
The modified major scalp reduction.
Topics: Alopecia; Humans; Methods; Scalp | 1988 |
A twin tissue expander used in the elimination of alopecia.
Topics: Adult; Alopecia; Equipment Design; Humans; Male; Reoperation; Scalp; Surgery, Plastic | 1988 |
Advantages of the paramedian scalp reduction.
Topics: Alopecia; Humans; Methods; Scalp | 1988 |
Treatment of burn alopecia with tissue expanders in children.
Topics: Adolescent; Alopecia; Burns; Child; Child, Preschool; Female; Humans; Male; Prostheses and Implants; | 1988 |
Use of the temporoparietal free fascial flap in the upper extremity.
Topics: Adolescent; Adult; Alopecia; Arm; Fascia; Female; Hand; Humans; Male; Masticatory Muscles; Methods; | 1988 |
Tissue expansion and flaps for surgical correction of male pattern baldness.
Topics: Adult; Alopecia; Humans; Male; Methods; Prostheses and Implants; Scalp; Surgical Flaps | 1988 |
Point: extensive scalp-lifting.
Topics: Alopecia; Humans; Methods; Scalp; Surgical Flaps | 1988 |
Counterpoint: the risks of the bilateral lateral scalp reduction.
Topics: Alopecia; Humans; Methods; Postoperative Complications; Risk Factors; Scalp; Surgical Flaps | 1988 |
Postoperative necrosis following bilateral lateral scalp reduction.
Topics: Adult; Alopecia; Humans; Male; Necrosis; Postoperative Complications; Scalp | 1988 |
The one-stage preauricular flap for male pattern baldness: long-term results and risk factors.
Topics: Adult; Alopecia; Humans; Male; Methods; Middle Aged; Necrosis; Postoperative Complications; Recurren | 1988 |
Scalp expansion for male pattern baldness.
Topics: Alopecia; Humans; Male; Scalp; Surgery, Plastic | 1988 |
Hair transplantation between identical twins.
Topics: Adolescent; Alopecia; Connective Tissue Diseases; Diseases in Twins; Female; Hair; Humans; Scalp; Tw | 1988 |
Parietal cephalocele: clinical importance of its atretic form and associated malformations.
Topics: Alopecia; Brain; Brain Diseases; Cysts; Encephalocele; Female; Humans; Hydrocephalus; Infant; Infant | 1988 |
[Scalp hypothermia as a preventive of alopecia in patients receiving combined chemotherapy including anthracyclines].
Topics: Alopecia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Humans; Hypot | 1987 |
Marsupial minigrafts for alopecia following surgical procedures of the scalp repaired by split-thickness skin grafts.
Topics: Adult; Alopecia; Carcinoma, Basal Cell; Female; Hair; Humans; Postoperative Complications; Scalp; Sk | 1986 |
[Surgical treatment of baldness. 20 years' experience].
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Surgical Flaps | 1986 |
Action of topical minoxidil in the bald stump-tailed macaque.
Topics: Administration, Topical; Alopecia; Animals; Female; Hair; Macaca; Male; Minoxidil; Scalp | 1987 |
A six-step approach for the treatment of extensive baldness.
Topics: Alopecia; Evaluation Studies as Topic; Hair; Humans; Male; Methods; Scalp; Surgical Flaps | 1987 |
Tissue expansion in cicatricial alopecia.
Topics: Adult; Alopecia; Cicatrix; Female; Humans; Prostheses and Implants; Scalp; Skin; Skin Physiological | 1987 |
New aspects of hair transplantation.
Topics: Alopecia; Hair; Humans; Methods; Scalp | 1987 |
Congenital triangular alopecia. Report of fourteen cases.
Topics: Adolescent; Adult; Alopecia; Biopsy; Child; Child, Preschool; Female; Hair; Humans; Male; Middle Age | 1987 |
Scalp expansion in the treatment of male pattern baldness.
Topics: Adult; Alopecia; Humans; Male; Methods; Prostheses and Implants; Scalp; Surgical Flaps | 1987 |
Advancement in scalp grafts.
Topics: Alopecia; Hair; Humans; Male; Scalp; Surgery, Plastic | 1987 |
A contemporary approach to male pattern alopecia.
Topics: Adult; Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps | 1987 |
[Cerebriform intradermal nevus].
Topics: Alopecia; Child; Humans; Male; Nevus; Scalp; Skin Neoplasms | 1987 |
Scalp expansion for male pattern baldness.
Topics: Alopecia; Humans; Male; Prostheses and Implants; Scalp; Surgery, Plastic; Surgical Flaps | 1987 |
Expansion-assisted treatment of male pattern baldness.
Topics: Adult; Alopecia; Humans; Male; Prostheses and Implants; Scalp; Sodium Chloride; Surgery, Plastic; Su | 1987 |
[Reparative possibilities of alopecia secondary to loss of the scalp substance].
Topics: Alopecia; Female; Humans; Male; Scalp; Surgical Flaps | 1987 |
Widow's peak anomaly with alopecia.
Topics: Adolescent; Alopecia; Female; Humans; Methods; Scalp | 1987 |
Halo scalp ring: a cause of scarring alopecia.
Topics: Alopecia; Birth Injuries; Cicatrix; Female; Humans; Infant; Scalp | 1987 |
Preventing chemotherapy-induced alopecia in cancer patients: is scalp cooling worthwhile?
Topics: Alopecia; Antineoplastic Agents; Cryotherapy; Evaluation Studies as Topic; Humans; Neoplasms; Scalp | 1987 |
Hereditary hypotrichosis simplex of the scalp.
Topics: Adult; Alopecia; Child; Female; Genes, Dominant; Humans; Hypotrichosis; Israel; Jews; Male; Pedigree | 1987 |
Salvage of infected expanded scalp without loss of flap length.
Topics: Alopecia; Anti-Bacterial Agents; Burns; Child; Debridement; Humans; Male; Scalp; Staphylococcal Infe | 1987 |
Alterations in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexyl nicotinate in alopecia.
Topics: Adult; Alopecia; Humans; Male; Minoxidil; Nicotinic Acids; Regional Blood Flow; Scalp | 1987 |
[Changes in telogen rate, hair density, hair diameter and rate of growth in androgenetic alopecia of the male. Simultaneously a contribution to the significance of dysplastic hair].
Topics: Adult; Alopecia; Androgens; Hair; Hair Diseases; Humans; Male; Scalp | 1986 |
Use of the temporary soft-tissue expander in posttraumatic alopecia.
Topics: Adolescent; Adult; Alopecia; Burns, Electric; Child; Female; Humans; Male; Methods; Prostheses and I | 1986 |
Expanders for male pattern baldness.
Topics: Alopecia; Humans; Male; Scalp; Surgery, Plastic | 1986 |
Tissue expansion in the treatment of alopecia.
Topics: Adolescent; Adult; Alopecia; Burns; Child; Child, Preschool; Elasticity; Female; Humans; Male; Middl | 1986 |
Surgical procedures for the treatment of baldness.
Topics: Adult; Alopecia; Hair; Humans; Male; Scalp; Surgical Flaps | 1986 |
Massive lymphocyte-mediated apoptosis during the early stage of pseudopelade.
Topics: Alopecia; Cell Survival; Cicatrix; Epithelium; Hair; Humans; Lymphocytes; Scalp; Time Factors | 1986 |
The bilateral occipito-parietal flap.
Topics: Alopecia; Humans; Male; Methods; Scalp; Surgical Flaps | 1986 |
Scalp expansion flaps.
Topics: Adolescent; Alopecia; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Methods; Pos | 1986 |
Conventional grafting combined with minigrafting: a new approach.
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp | 1987 |
Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice.
Topics: Alopecia; Alopecia Areata; Animals; Cyclosporins; Female; Graft Survival; Hair; Humans; Male; Mice; | 1987 |
Pseudopelade of Brocq: an immunologically mediated disease?
Topics: Alopecia; Humans; Scalp; Skin Diseases | 1987 |
Familial focal alopecia. A new disorder of hair growth clinically resembling pseudopelade.
Topics: Adolescent; Alopecia; Diagnosis, Differential; Female; Hair; Humans; Scalp | 1987 |
Alopecia associated with underlying nerve sheath myxoma.
Topics: Adolescent; Alopecia; Female; Humans; Myxoma; Peripheral Nervous System Neoplasms; Scalp; Skin Neopl | 1987 |
[Repair of large scalp baldness or a defect].
Topics: Alopecia; Humans; Scalp; Surgical Flaps | 1985 |
Hair transplantation, scalp reduction, and flap rotation in black men.
Topics: Alopecia; Black People; Hair; Humans; Male; Pigmentation Disorders; Postoperative Complications; Sca | 1986 |
Male baldness: immediate single-stage rotation of very long arterialized temporo-parieto-occipital flaps.
Topics: Alopecia; Cicatrix; Evaluation Studies as Topic; Humans; Male; Methods; Postoperative Complications; | 1986 |
Tissue expansion in the treatment of alopecia.
Topics: Adolescent; Adult; Alopecia; Burns; Child; Female; Humans; Male; Methods; Middle Aged; Postoperative | 1986 |
The correction of scalp hair defects by tissue expansion.
Topics: Adolescent; Adult; Alopecia; Child; Female; Humans; Male; Middle Aged; Prostheses and Implants; Scal | 1986 |
Pseudopelade of Brocq.
Topics: Adolescent; Adult; Aged; Alopecia; Cicatrix; Diagnosis, Differential; Female; Humans; Immunoglobulin | 1986 |
Hair loss. Common congenital and acquired causes.
Topics: Adolescent; Alopecia; Alopecia Areata; Androgens; Child; Diagnosis, Differential; Female; Hair; Huma | 1986 |
Punch grafting the crown and vertex.
Topics: Alopecia; Hair; Humans; Male; Punctures; Scalp | 1985 |
Postoperative (pressure) alopecia.
Topics: Aged; Alopecia; Cardiac Surgical Procedures; Humans; Immobilization; Ischemia; Male; Middle Aged; Po | 1985 |
Paraffinomas of the scalp.
Topics: Aged; Alopecia; Granuloma; Humans; Male; Middle Aged; Paraffin; Scalp; Scalp Dermatoses; Time Factor | 1985 |
[Alopecia in vulgar psoriasis of the scalp. A clinical and histologic report].
Topics: Adult; Alopecia; Female; Humans; Middle Aged; Psoriasis; Scalp; Scalp Dermatoses | 1985 |
Unravelling the pathophysiology of male pattern baldness.
Topics: Aged; Alopecia; Humans; Male; Minoxidil; Regional Blood Flow; Scalp; Vascular Resistance | 1985 |
Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine.
Topics: Alopecia; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation | 1985 |
How to avoid the principal complication of scalp reduction in the management of extensive alopecia.
Topics: Alopecia; Esthetics; Hair; Humans; Methods; Postoperative Complications; Scalp | 1985 |
Combined surgical treatment of male pattern alopecia.
Topics: Adult; Alopecia; Combined Modality Therapy; Edema; Hair; Hemorrhage; Humans; Intraoperative Complica | 1985 |
[Repair of a scarring alopecia defect with a single-pedicled scalp flap].
Topics: Adolescent; Adult; Alopecia; Cicatrix; Female; Humans; Male; Scalp; Surgical Flaps | 1985 |
[Problems in the free transplantation of the scalp].
Topics: Adult; Alopecia; Hair; Humans; Male; Methods; Scalp; Surgical Instruments | 1985 |
Aplasia cutis congenita.
Topics: Adult; Alopecia; Child, Preschool; Female; Humans; Male; Middle Aged; Pedigree; Scalp; Skin Abnormal | 1985 |
Alopecia associated with syringomas.
Topics: Adenoma; Alopecia; Female; Humans; Middle Aged; Scalp; Skin Neoplasms; Sweat Gland Neoplasms | 1985 |
Expanders for male pattern baldness.
Topics: Alopecia; Humans; Male; Prostheses and Implants; Scalp; Surgical Flaps | 1985 |
[Hypotrichosis congenita hereditaria Maria Unna].
Topics: Adult; Alopecia; Child, Preschool; Female; Hair; Humans; Hypotrichosis; Microscopy, Electron, Scanni | 1985 |
Halo scalp ring associated with caput succedaneum.
Topics: Adult; Alopecia; Birth Injuries; Cicatrix; Edema; Female; Humans; Infant, Newborn; Scalp | 1985 |
Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man.
Topics: Adult; Alopecia; Antineoplastic Agents; Body Temperature; Cold Temperature; Female; Humans; Male; Re | 1985 |
[Fine structure of the alopecia scalp in advanced age (alopecia senilis)].
Topics: Aged; Aging; Alopecia; Arteries; Elastic Tissue; Hair; Humans; Male; Middle Aged; Scalp; Sebaceous G | 1972 |
Hereditary hypotrichosis simplex of the scalp. Evidence for autosomal dominant inheritance.
Topics: Adolescent; Adult; Age Factors; Alopecia; Child; Child, Preschool; Chromatography; Female; Genes, Do | 1974 |
Studies of common baldness in the stumptailed macaque. 3. DNA synthesis in regrowing hair.
Topics: Alopecia; Animals; DNA; Hair; Haplorhini; Male; Scalp; Thymidine; Tritium | 1970 |
[The problem of female alopecias].
Topics: Alopecia; Dermatitis, Seborrheic; Endocrine System Diseases; Female; Humans; Scalp | 1963 |
[Treatment of seborrhoea of the scalp].
Topics: Adolescent; Adult; Alcohols; Alopecia; Anti-Infective Agents, Local; Dermatitis, Seborrheic; Female; | 1969 |
[Modifications of the hairy skin thickness in seborrhoic alopecia].
Topics: Adolescent; Adult; Alopecia; Dermatitis, Seborrheic; Hair; Humans; Male; Middle Aged; Scalp; Skin | 1971 |
[Seborrheic alopecia. Surgical treatment by ligature of the scalp arteries].
Topics: Alopecia; Dermatitis, Seborrheic; Female; Hemodynamics; Humans; Ligation; Male; Prognosis; Scalp; Sy | 1972 |
[Chemical studies on hair from different areas of the scalp].
Topics: Adolescent; Adult; Alopecia; Child; Dermatitis, Seborrheic; Female; Hair; Humans; Male; Middle Aged; | 1971 |
The metabolism of dehydroepiandrosterone by human scalp hair follicles.
Topics: Adult; Alopecia; Androstanes; Androstenes; Carbon Isotopes; Dehydroepiandrosterone; Female; Hair; Hu | 1973 |
[Follicular mucinosis and large area, partly lichenoid, partly sclerodermiform generalized paramyloidosis as a cutaneous paraneoplastic syndrome in myeloma (IgD and light chain plasmacytoma)].
Topics: Alopecia; Amyloidosis; Blood Proteins; Drug Therapy, Combination; Eye Manifestations; Humans; Immuno | 1974 |
Ultrastructure of follicular mucinosis.
Topics: Adult; Alopecia; Cell Nucleus; Connective Tissue; Cytoplasm; Cytoplasmic Granules; Desmosomes; Edema | 1974 |
[Generalized follicular mucinosis revealing cutaneous and bronchopulmonary histiomonocytic reticulosis oa case].
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Alopecia; Bronchial Neoplasms; Carcinoma; Darier Disease; | 1969 |
Adenyl cyclase in human hair follicles: its inhibition by dihydrotestosterone.
Topics: Adenine Nucleotides; Adenylyl Cyclase Inhibitors; Adult; Alcohols; Alopecia; Androgens; Androstanes; | 1970 |
[Picture reports: Microsporia caused by Microsporum canis, milkers' nodule, skin and mucosal changes in monocytic leukemia, nevus cell nevus reaching into subcutaneous tissue on the haired scalp, with central Schridde's hair].
Topics: Adolescent; Adult; Alopecia; Animals; Arthrodermataceae; Child; Child, Preschool; Dermatomycoses; Do | 1973 |
[Transfer by microanastomosis of a scalp flap in a case of cicatricial baldness].
Topics: Alopecia; Burns; Child, Preschool; Cicatrix; Humans; Male; Microsurgery; Scalp; Surgery, Plastic; Tr | 1974 |
Bitemporal aplasia cutis congenita. Occurrence with other cutaneous abnormalities.
Topics: Alopecia; Back; Biopsy; Child; Dermatoglyphics; Elastic Tissue; Face; Female; Humans; Keratosis; Sca | 1974 |
Hair transplantation.
Topics: Alopecia; Follow-Up Studies; Hair; Humans; Male; Methods; Postoperative Care; Scalp; Transplantation | 1972 |
Combined use of punch grafts and an overlay sheet of split-skin graft for a raw area in the scalp. Case report.
Topics: Adult; Alopecia; Bandages; Debridement; Granulation Tissue; Hair; Humans; Male; Scalp; Skin Transpla | 1973 |
Clinical success of distant transfer of free skin flap in head and neck region s by microvascular anastomoses.
Topics: Adult; Alopecia; Burns; Cheek; Chin; Face; Head; Humans; Male; Methods; Microsurgery; Scalp; Skin Tr | 1974 |
Transplants for baldness.
Topics: Alopecia; Hair; Humans; Scalp; Transplantation, Autologous | 1973 |
Diffuse hair loss and oral contraceptives.
Topics: Adolescent; Adult; Alopecia; Biopsy; Contraceptives, Oral; Estrogens; Female; Humans; Middle Aged; P | 1973 |
17- -Hydroxy-steroid-dehydrogenases in hair follicles of normal and bald scalp: a histochemical study.
Topics: Adolescent; Adult; Alopecia; Dihydrotestosterone; Estradiol; Hair; Humans; Hydroxysteroid Dehydrogen | 1973 |
The metabolism of testosterone by human male scalp skin.
Topics: 17-Hydroxycorticosteroids; Alopecia; Androstanes; Androsterone; Autoradiography; Carbon Isotopes; Ch | 1973 |
Cicatricial alopecia of sarcoidosis.
Topics: Adult; Alopecia; Biopsy; Cicatrix; Female; Humans; Middle Aged; Sarcoidosis; Scalp | 1973 |
Correction of alopecia of eyebrows in leprous patients.
Topics: Alopecia; Eyebrows; Follow-Up Studies; Hair; Humans; Leprosy; Male; Methods; Scalp; Time Factors; Tr | 1973 |
[Lichen planus with onychatrophy and cicatricial alopecia (author's transl)].
Topics: Alopecia; Atrophy; Biopsy; Blister; Cicatrix; Female; Foot Dermatoses; Hallux; Humans; Lichen Planus | 1973 |
Congenital temporal alopecia.
Topics: Adult; Alopecia; Biopsy; Hair; Humans; Male; Scalp | 1974 |
Hair transplantation with free scalp flaps.
Topics: Adult; Alopecia; Cicatrix; Female; Hair; Humans; Male; Methods; Scalp; Temporal Arteries; Transplant | 1974 |
Punch scalp autografts for bald spots.
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Skin Transplantation; Surgery, Plastic; Surgical Instr | 1968 |
Effect of triamcinolone on scalp homograft tolerance.
Topics: Alopecia; Antigen-Antibody Reactions; Hair; Humans; Scalp; Skin Transplantation; Tissue Preservation | 1971 |
The surgical treatment of male pattern baldness with punch scalp autografts.
Topics: Adult; Alopecia; Humans; Male; Scalp; Skin Transplantation; Transplantation, Autologous | 1970 |
[Sensitive nerve-endings in the bald-headed skin. Alopecia senilis].
Topics: Aging; Alopecia; Hair; Histological Techniques; Humans; Male; Middle Aged; Myelin Sheath; Nerve Endi | 1971 |
Management of the extensively burned scalp.
Topics: Adult; Alopecia; Burns; Debridement; Hair; Humans; Male; Scalp; Skin Transplantation; Transplantatio | 1971 |
[Hair transplants in accidental baldness].
Topics: Alopecia; Hair; Humans; Infant; Male; Methods; Scalp; Skin Transplantation; Transplantation, Autolog | 1970 |
The skin of primates. 28. The stump-tail macaque (Macaca speciosa).
Topics: Alopecia; Animals; Female; Hair; Haplorhini; Histocytochemistry; Male; Pigmentation; Scalp; Sebaceou | 1966 |
Studies of common baldness in the stumptailed macaque. IV. In vitro metabolism of testosterone in the hair follicles.
Topics: Alopecia; Animals; Back; Chromatography, Thin Layer; Culture Techniques; Female; Hair; Haplorhini; M | 1970 |
Studies of common baldness of the stump-tailed macaque (Macaca speciosa). VI. The effect of testosterone on common baldness.
Topics: Age Factors; Alopecia; Animals; Female; Hair; Haplorhini; Humans; Macaca; Male; Scalp; Sebaceous Gla | 1971 |
Congenitally malformed female infant with hairy pinnae.
Topics: Abnormalities, Multiple; Alopecia; Ear, External; Eye Abnormalities; Face; Female; Humans; Ichthyosi | 1971 |
Trichotillomania. A clinicopathologic study of 24 cases.
Topics: Adolescent; Adult; Alopecia; Biopsy; Child; Child, Preschool; Eyebrows; Eyelashes; Female; Hair; Hum | 1972 |
Pilonidal cyst of the scalp.
Topics: Adolescent; Alopecia; Child, Preschool; Craniocerebral Trauma; Humans; Male; Pilonidal Sinus; Scalp | 1972 |
The thickness of human scalp: normal and bald.
Topics: Adolescent; Adult; Aging; Alopecia; Autopsy; Female; Humans; Male; Middle Aged; Scalp; Skin | 1972 |
Cicatricial alopecia: a complication of vacuum extraction.
Topics: Alopecia; Birth Injuries; Cicatrix; Extraction, Obstetrical; Humans; Infant; Male; Scalp | 1972 |
Psoriatic alopecia.
Topics: Alopecia; Biopsy; Extremities; Humans; Psoriasis; Scalp; Scalp Dermatoses | 1972 |
Hair transplant.
Topics: Alopecia; Hair; Humans; Male; Methods; Postoperative Complications; Scalp; Transplantation, Autologo | 1972 |
[The cosmetological aspects of scalp transplants].
Topics: Alopecia; Humans; Scalp | 1971 |
Hereditary trichodysplasia: Marie Unna's hypotrichosis.
Topics: Adolescent; Adult; Aged; Alopecia; Amino Acids; Blood Proteins; Child, Preschool; Cysteine; Cystine; | 1971 |
[Surgical possibilities in the treatment of baldness].
Topics: Alopecia; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1971 |
Hair transplants for male pattern baldness--special clinical and mathematical considerations.
Topics: Alopecia; Follow-Up Studies; Hair; Humans; Male; Mathematics; Methods; Scalp | 1970 |
[Balance of galeatomy].
Topics: Adolescent; Adult; Alopecia; Hair; Humans; Scalp | 1965 |
[Our attempts at hair grafting].
Topics: Alopecia; Chlorpromazine; Hair; Humans; Scalp; Skin Transplantation | 1965 |
Pustular psoriasis of the scalp.
Topics: Adolescent; Alopecia; Female; Humans; Psoriasis; Scalp; Suppuration | 1969 |
[Excretion of thallium in the urine after sublethal poisoning].
Topics: Adult; Alopecia; Humans; Male; Poisoning; Scalp; Spectrum Analysis; Thallium | 1969 |
Generalized spiny hyperkeratosis, universal alopecia, and deafness. A previously undescribed syndrome.
Topics: Alopecia; Audiometry; Biopsy; Child, Preschool; Deafness; Humans; Keratitis; Male; Physical Examinat | 1969 |
[Metastatic epithelioma of the scalp, probably of mammary origin; primary infiltrating alopecic type].
Topics: Adult; Alopecia; Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Scalp; Skin Neoplasms | 1969 |
[Keratinisation disorders of hairs in psoriasis. Observations using a "Stereoscan" electron microscope].
Topics: Adult; Alopecia; Biopsy; Epithelium; Female; Hair; Humans; Keratosis; Methods; Microscopy, Electron; | 1970 |
Arteriovenous fistula secondary to hair transplantation.
Topics: Adult; Alopecia; Arteriovenous Fistula; Hair; Humans; Male; Postoperative Complications; Scalp; Temp | 1970 |
Histangic patterns in seborrheic alopecia.
Topics: Adolescent; Adult; Alopecia; Electric Conductivity; Humans; Iodine Radioisotopes; Male; Oxidoreducta | 1970 |
[Hair transplantation in post traumatic Alopecia].
Topics: Accidents; Adult; Alopecia; Burns, Electric; Craniocerebral Trauma; Female; Hair; Humans; Male; Meth | 1970 |
Scalp tourniquet to lessen alopecia after vincristine.
Topics: Adolescent; Alopecia; Child; Humans; Methods; Scalp; Tourniquets; Vincristine | 1970 |
Progressive alopecia associated with dry scalp: preliminary observations.
Topics: Alopecia; Female; Humans; Male; Scalp; Skin Diseases; Thyroxine; Vitamin A | 1970 |
Vincristine and alopecia.
Topics: Alopecia; Child; Female; Humans; Scalp; Tourniquets; Vincristine | 1971 |
[New operative technic for grafts of the scalp using free fragments for correction of baldness].
Topics: Alopecia; Hair; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1971 |
Hair transplantation: the punch graft technique.
Topics: Alopecia; Hair; Humans; Methods; Scalp; Transplantation, Autologous; Transplantation, Homologous | 1971 |
Hair transplantation for male pattern baldness.
Topics: Adult; Alopecia; Hair; Humans; Male; Methods; Middle Aged; Postoperative Care; Postoperative Complic | 1971 |
Hair transplantation in male-pattern alopecia.
Topics: Adult; Alopecia; Edema; Hair; Hemorrhage; Humans; Infections; Male; Methods; Motivation; Postoperati | 1971 |
[A new treatment of baldness: the scalp transplantation].
Topics: Alopecia; Female; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1971 |
[Surgical correction of baldness with fragmentary autografts scalp].
Topics: Alopecia; Humans; Male; Methods; Scalp; Transplantation, Autologous | 1971 |
Hereditary hypotrichosis (Marie Unna type).
Topics: Adolescent; Adult; Aged; Alopecia; Child; Child, Preschool; Female; Hair; Humans; Male; Microscopy, | 1971 |
Congenital defect of the scalp.
Topics: Alopecia; Blindness; Child; Cicatrix; Female; Humans; Pigmentation Disorders; Scalp | 1968 |
[Quantitative studies on the function of the sebaceous glands in alopecia].
Topics: Adult; Aged; Alopecia; Humans; Lipid Metabolism; Male; Middle Aged; Scalp; Sebaceous Glands; Sebum | 1968 |
Hot comb alopecia.
Topics: Adult; Alopecia; Black or African American; Cosmetics; Diagnosis, Differential; Female; Hair; Hot Te | 1968 |
The blood vessels of the scalp in patients with alopecia areata before and after corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Alkaline Phosphatase; Alopecia; Alopecia Areata; Biopsy; Hair; Humans; Hydr | 1968 |
[Morphological peculiarities of the skin of the scalp in healthy persons and in premature alopecia].
Topics: Adult; Aged; Alopecia; Female; Humans; Male; Middle Aged; Scalp; Skin | 1968 |
Reconstructive surgery of hair transplantation by improved motorized technique.
Topics: Alopecia; Anesthesia, General; Hair; Hemorrhage; Humans; Methods; Postoperative Care; Preoperative C | 1969 |
Amyloidosis masquerading as epidermolysis bullosa acquisita.
Topics: Aged; Alopecia; Amyloidosis; Biopsy; Diagnosis, Differential; Epidermolysis Bullosa; Female; Humans; | 1969 |
Surgical treatment of the receding hairline.
Topics: Adult; Alopecia; Child, Preschool; Hair; Humans; Male; Methods; Middle Aged; Scalp; Transplantation, | 1969 |
Systemic sarcoidosis with scalp involvement.
Topics: Alopecia; Female; Fluocinolone Acetonide; Humans; Middle Aged; Sarcoidosis; Scalp; Skin Manifestatio | 1969 |
[Relationship of alopecia senilis to the structure of the scalp].
Topics: Adult; Aged; Aging; Alopecia; Female; Humans; Male; Middle Aged; Scalp | 1969 |
Surgery for baldness: a case report.
Topics: Adult; Alopecia; Humans; Male; Scalp; Transplantation, Autologous | 1965 |
[Apropos of a case of extensive avulsion of the scalp. Considerations on the treatment of the residual alopecia].
Topics: Adolescent; Alopecia; Craniocerebral Trauma; Female; Humans; Scalp | 1965 |
Surgical treatment of baldness.
Topics: Alopecia; Humans; Male; Scalp; Transplantation, Autologous | 1966 |
Surgical treatment of cicatricial baldness.
Topics: Adult; Alopecia; Child; Eyebrows; Female; Humans; Male; Scalp; Scalp Dermatoses | 1966 |
[On the therapy of alopecia].
Topics: Adolescent; Adult; Alopecia; Climacteric; Female; Humans; Male; Middle Aged; Prednisolone; Scalp; Va | 1966 |